Professional Documents
Culture Documents
Icd o 3 PDF
Icd o 3 PDF
International
Classification of
Diseases for
Oncology
Third Edition
First Revision
11/21/13 11:55 AM
ICD - O
ICDO.indb 1
International
Classification of
Diseases for
Oncology
Third Edition
First Revision
Editors
April Fritz
Constance Percy
Andrew Jack
Kanagaratnam Shanmugaratnam
Leslie Sobin
D Max Parkin
Sharon Whelan
11/18/13 1:54 PM
Printed in Malta
ICDO.indb 2
11/18/13 1:54 PM
Contents
Dedication
Acknowledgements
v
vii
1. Introduction
1.1 Historical background
1
1
4
5
6
6
6
6
7
7
7
7
7
8
8
9
9
9
10
10
10
14
14
14
16
19
24
27
27
References
29
iii
ICDO.indb 3
11/18/13 1:54 PM
Numerical lists
Topography
5th digit behavior code for neoplasms
6th digit code for histological grading and differentiation
6th digit code for immunophenotype designation for lymphomas and leukemias
Morphology
31
33
52
52
52
53
Alphabetic index
95
Appendixes
1: New codes in ICD-O, third edition
2: New morphology terms and synonyms in ICD-O, third edition
3: Terms that changed morphology code in ICD-O, third edition
4: Terms that changed from tumor-like lesions to neoplasms in ICD-O, third edition
5: Terms in ICD-O, second edition, which were deleted for ICD-O, third edition
6: ICD-O, second edition, terms that changed behaviour code for ICD-O, third edition
7: New codes, preferred terms, related terms, and synonyms in this ICD-O,
third edition, first revision
217
217
222
227
230
230
231
233
iv
ICDO.indb 4
11/18/13 1:54 PM
Dedication
Calum Muir
19301995
This third edition of the International Classification of Diseases for Oncology (ICD-O) is
dedicated to the memory of Dr Calum Muir.
Calum Muir was an editor of the second edition of ICD-O. As a pathologist, he did
much to assemble the new morphologic terms and the latest classifications for lymphomas,
leukemias and brain tumors. His contacts with cancer registries throughout the world helped
to implement ICD-O worldwide.
After his retirement from the International Agency for Research on Cancer, initially
as Chief of the Unit of Epidemiology and later as its Deputy Director, Calum Muir became
the Director of Cancer Registration for Scotland. He was instrumental in founding the
International Association of Cancer Registries (IARC) in 1966, serving as Deputy Secretary
from 1972 to 1990 and as President from 1992 until his death.
Calum Muirs spirit and devotion to accurate and complete classification of neoplasms
lives on in this edition.
ICDO.indb 5
11/18/13 1:54 PM
ICDO.indb 6
11/18/13 1:54 PM
Acknowledgements
We are grateful to the following individuals and their institutions for their contributions to this
edition of ICD-O.
Dr Timothy Cot, National Cancer Institute, Bethesda, MD, USA
Mme Catherine Exbrayat, Registre des Cancers de lIsre, Isre, France
Professor Ekkehard Grundmann, Gerhard Domagk Institut fr Pathologie, Mnster
Universitt, Mnster, Germany
Professor Paul Hermanek, Chirurgische Klinik mit Poliklinik der Universitt ErlangenNrnberg, Erlangen, Germany
Dr Elaine Jaffe, National Cancer Institute, Bethesda, MD, USA
Dr Paul Kleihues, International Agency for Research on Cancer, Lyon, France
Dr Franco Rilke, Societ Italiana di Cancerologia, Milan, Italy
Dr James Vardiman, University of Chicago, Chicago, IL, USA
Mrs Annette Hurlbut, Fulton, NY, USA
We greatly appreciate the input of the expert groups that provided valuable background
material for the development of this third edition and gave the editors the benefit of their advice
on the field-trial edition:
European Network of Cancer Registries (ENCR) Working Group on the coding of
haematological malignancies and lymphomas
Dr Rene Otter, Comprehensive Cancer Centre North, Groningen, The Netherlands
Dr Aurora Astudillo, Hospital General de Asturias, Oviedo, Spain
Professor Paule Marie Carli, Registre des Hmopathies Malignes en Cte dOr, Dijon,
France
Dr Andrew Jack, Leukaemia Research Fund, University of Leeds, Leeds, England
Dr Han Van Krieken, The Academic Hospital, Leiden, The Netherlands
International Society of Pediatric Oncology (SIOP) Working Group
Professor Jillian M. Birch, CRC Paediatric and Familial Cancer Research Group,
Manchester, England
Dr James Ironside, National Creutzfeldt-Jakob Disease Surveillance Unit, Western
General Hospital, Edinburgh, Scotland
Dr Anna M. Kelsey, Royal Manchester Childrens Hospital, Manchester, England
Professor Dietmar Schmidt, Institut fr Pathologie, Mannheim, Germany
We would like to thank the cancer registries and the pathologists and data collectors
associated with these registries who put an immense amount of careful work into the field
testing of ICD-O, third edition.
Australia, New South Wales
Australia, South
Canada, Manitoba
Australia, Victoria
Canada, Ontario
Belarus
Canada, Ontario, Princess Margaret
Belgium
Hospital
Brazil, Campinas
Canada, Nova Scotia
Brazil, Porto Alegre
China, Beijing
Canada, British Columbia
China, Qidong
vii
ICDO.indb 7
11/18/13 1:54 PM
Cuba
Czech Republic
Ecuador, Quito
Egypt, Alexandria
France, Haut-Rhin
France, Hmopathies Malignes en
Cte dOr
France, Hrault
France, Tarn
Germany, Baden-Wrttemberg
Germany, Federal States of Berlin
Germany, National Childhood
Guinea, Conakry
Indonesia
Italy, Ferrara
Italy, Macerata
Italy, Ragusa
Italy, Romagna
Japan, Hiroshima
Japan, Nagasaki
Japan, Osaka
Lithuania
Malta
Netherlands, Amsterdam
New Zealand
Pakistan, Karachi
Peru, Lima
Peru, Trujillo
Philippines, Manila
Philippines, Rizal
Poland, Kielce
Saudi Arabia
Singapore
Slovenia
South Africa
Spain, Asturias
Spain, Granada
Spain, Mallorca
Spain, Murcia
Sweden, Gothenburg
Thailand, Bangkok
Thailand, Chiang Mai
Trinidad and Tobago
Uganda, Kampala
United Kingdom, East Anglia
United Kingdom, Northern and Yorkshire
United Kingdom, Oxford, National
Childhood
USA, Florida, Flagler Hospital
USA, Georgia, Medical Center of Central
Georgia
USA, Missouri, Liberty Hospital
USA, Ohio, Upper Valley Medical Center
USA (SEER), Atlanta
USA (SEER), Connecticut
USA (SEER), Detroit
USA (SEER), Hawaii
USA (SEER), Iowa
USA (SEER), Los Angeles
USA (SEER), New Mexico
USA (SEER), Northern California
USA (SEER), Seattle/Puget Sound
USA (SEER), Utah
USA, Texas, College Station Medical
Center
Viet Nam, Ho Chi Minh
We also gratefully acknowledge the many individuals, institutions, and registries that
took the time to complete the International Association of Cancer Registries questionnaire
and the many registries that offered to participate in the Field Trial when this edition was in
development.
viii
ICDO.indb 8
11/18/13 1:54 PM
1. Introduction
The International Classification of Diseases for
Oncology (ICD-O) (1) has been used for nearly
35 years, principally in tumor or cancer registries, for coding the site (topography) and the
histology (morphology) of the neoplasm, usually
obtained from a pathology report. By agreement
with the College of American Pathologists, the
morphology section of ICD-O is incorporated
into the Systematized Nomenclature of Medicine
(SNOMED) (2, 3) classification as the neoplasm
section of the morphology field.
The International Classification of Diseases for
Oncology, Second Edition (4), edited by Constance
Percy, Valerie Van Holten and Calum Muir, was
published in 1990. The topography section of this
third edition remains the same as in the second
edition, which is based on the neoplasm section of
ICD-10 (5). However, the morphology section has
been revised. New classifications, especially for
lymphomas and leukemias have been introduced
and new codes assigned to accommodate them.
Some years ago the REAL (Revised European
American Lymphoma) Classification (6) for NonHodgkin Lymphoma was introduced and registrars
needed ICD-O codes to record these tumors. Also,
the terms of the FAB (FrenchAmericanBritish)
system (7) for leukemias were added. When the
ICD-O working group convened in 1998, there
was thought of revising only these two sections,
but it was finally decided to review the entire book.
The third edition of the ICD-O morphology section was field-tested during 1999. We are grateful
to registries around the world for their comments
on the content of this edition.
Although one of the prime commitments of
the editors was to change as few terms as possible,
to add new terms at empty spaces, and not to reuse
previously assigned codes, this has not always been
possible. In order to keep groups of similar entities together, the codes for some terms had to be
changed. Furthermore, the sequence or grouping of terms may not always be as logical as possible because of the limitations of available code
numbers.
In developing the previous editions and the
present edition of ICD-O, a particular effort
was made to use the nomenclature appearing in
the World Health Organizations International
Histological Classification of Tumours series
(WHO Blue Books) (8). This series covers all the
principal sites of cancer and includes the morphology codes of ICD-O for each neoplasm.
New morphologic terms added since the
publication of the second edition are listed at the
back of this book. Refractory anemia and other
myelodysplastic syndromes are now considered to
be malignant; their behavior codes have therefore
been changed from /1 (uncertain whether benign
or malignant) to /3. Ovarian cystadenomas of borderline malignancy which were coded as malignant
in ICD-O second edition revert to /1 in the third
edition. For the sake of consistency in longitudinal databases, it is recommended that all of these
ovarian cystadenomas of borderline malignancy
be recoded to /1 or removed from the database.
Since the publication of ICD-O third edition
in 2000, updates to the WHO Blue Book series
have continued. During the development of the
fourth edition of the Blue Book volumes, chapter
authors worked with the International Agency for
Research on Cancer/International Classification of
Diseases for Oncology (IARC/ICD-O) Committee
for ICD-O-3 to review recently identified neoplasm entities and assign morphology codes. This
updated version of ICD-O-3 includes the new
terms, codes, synonyms, related terms, morphology and behavior code changes from the WHO
Blue Books published between 2007 and 2010 on
tumors of hematopoietic and lymphoid tissues (9),
central nervous system (10), and digestive system
(11). Appendix 0 in this manual is a summary of
terms and codes added or revised since the original publication of ICD-O-3.
ICDO.indb 1
11/18/13 1:54 PM
Table 1.
Primarily
Topography
ICD-6
1948
(9)
WHO
ICD-7
1955
Primarily
Morphology
MOTNAC
1951
(10)
ACS
ICD-8
1967
(15)
AMA
CAP
(15)
USA
ICDA-8
1967
(19)
SNDO
4th ed. 1951
5th ed. 1961
(11)
SNOP
1965
Sections 8, 9
Neoplasms
(13)
WHO
ICDA-8
1967
Both
Topography and
Morphology
(14)
Chapter II Neoplasms
MOTNAC
1968
(12)
ACS
WHO
USA
ICD-9
1975
(18)
Chapter II Neoplasms
WHO
ICD-9-CM
1979
ICD-O
1976
(1)
WHO
SNOMED
Morphology
Neoplasms
1977
(2)
CAP
(17)
CPHA
ICD-10
1992
(5)
Chapter II Neoplasms
WHO
ICD-O
Second Ed.
1990
WHO
ICD-O
Third Ed.
2000
WHO
(4)
SNOMED III
(International)
Neoplasms
1993
(3)
CAP
(20)
SNOMED RT
2000 CAP
SNOMET-CT
IHTSDO
CAP
Note: Numbers in boxes correspond to reference list at the end of this section.
ICDO.indb 2
11/18/13 1:54 PM
1. Introduction
ICDO.indb 3
11/18/13 1:54 PM
The second edition of ICD-O has been used extensively throughout the world and has been translated into many languages, including Chinese,
Czech, Dutch, Finnish, French, German, Greek,
Italian, Japanese, Korean, Portuguese, Romanian,
Russian, Slovak, Spanish and Turkish.
This third edition of ICD-O has been developed
by a working party convened by IARC/WHO. The
morphology code for neoplasms has been revised,
especially for lymphomas and leukemias. The
codes incorporate the WHO classification (24, 25),
which superseded the REAL (Revised European
American Lymphoma) classification for lymphomas (6) and the FAB (FrenchAmericanBritish)
classification for leukemias (7). The third edition
also recognizes the WHO classification of myeloid
leukemias, which includes distinct combinations
of morphology and cytogenetic abnormalities, for
example 9875/3, chronic myelogenous leukemia,
Philadelphia chromosome (Phl) positive, which is
also referred to as chronic myelogenous leukemia,
t(9, 22)(q34;q11) or chronic myelogenous leukemia, BCR/ABL.
2. Differences between
ICD-O and ICD-10
There are basic differences between the structure of
ICD-O and that of ICD. In ChapterII (Neoplasms)
of ICD, the topography code describes the behavior of the neoplasm (malignant, benign, in situ,
or uncertain whether malignant or benign) by
assigning it to a specific range of codes identifying each of these types of behavior. As a result, in
ICD-10, five different categories of four characters
each are needed to describe all lung neoplasms (see
Table2). Very few histological types are identified
in ICD. For example, there is no way in ICD to distinguish between an adenocarcinoma of the lung
and a squamous cell carcinoma of the lung: both
would be coded to C34.9.
The ICD-10 alphabetic index (Vol. 3) contains, under the term neoplasm, a table of five
columns with the following headings: Malignant,
Secondary or Metastatic, In situ, Benign, Uncertain
and Unknown Behavior. Appropriate ICD-10 categories for each site of the body are then listed in
alphabetic order. Table2 shows the entry for lung
neoplasms.
In contrast, ICD-O uses only one set of four
characters for topography (based on the malignant
neoplasm section of ICD-10); the topography code
(C34.9, lung) remains the same for all neoplasms
of that site.
The behavior code, incorporated as the fifth
digit in the morphology field, identifies whether
the neoplasm is malignant, benign, and so forth
(see Behavior Code, section 4.3.3). ICD-O also
describes the type or morphology of the neoplasm,
as shown in Table 3; an adenocarcinoma of lung
would thus be coded C34.9, 8140/3, and a squamous cell carcinoma of lung C34.9, 8070/3.
Table4 shows the correspondence between the
behavior code of ICD-O and the different sections
of ChapterII of ICD-10.
Until the publication of ICD-10, there were
only three histologic types of malignant tumors
with unique categories: lymphomas, leukemias,
and melanoma of skin. Several more categories
based on histologic type were added to ICD-10,
principally mesothelioma (C45) and Kaposi sarcoma (C46). In addition, liver cancer (C22) has
been divided into subtypes comprising morphologic entities.
ICDO.indb 4
11/18/13 1:54 PM
Table 2.
Lung
Table 3.
Malignant
Secondary or
metastatic
In situ
Benign
Uncertain and
unknown
C34.9
C78.0
D02.2
D14.3
D38.1
Term
Malignant neoplasm of the lung (such as carcinoma)
Metastatic neoplasm of the lung (such as a metastatic seminoma from the testis)
In situ neoplasm of the lung (such as squamous carcinoma in situ)
Benign neoplasm of lung (such as adenoma)
Uncertain behavior of neoplasm of lung (such as peribronchial myofibroblastic tumor)
Table 4.
/0
/1
/2
/3
/6
Category
D10D36
D37D48
D00D09
C00C76, C80C97
C77C79
C79
D00D09
D10D36
D37D48
C97
8010/3
9061/6
8070/2
8140/0
8827/1
Term
Benign neoplasms
Neoplasms of uncertain and unknown behavior
In situ neoplasms
Malignant neoplasms stated or presumed to be primary
Malignant neoplasms, stated or presumed to be secondary
Term
C78
C34.9
C34.9
C34.9
C34.9
C34.9
ICD-10 Category
C43
C45
C46
C81C96
Morphology
code
Behavior code
Table 5.
Topography
code
Melanoma of skin
Mesothelioma
Kaposis sarcoma
Malignant neoplasms of lymphoid,
hematopoietic and related tissue
Secondary malignant neoplasms of
respiratory and digestive systems
Secondary malignant neoplasm of other
specified sites
In situ neoplasms
Benign neoplasms
Neoplasms of uncertain and unknown
behavior
Malignant neoplasms of independent
(primary) multiple sites
Histology
Behavior
C44._
C_ _._
C_ _._
C00C80
872879
905
9140
959998
/3
/3
/3
/3
C15C39
_____
/6
C00C14, C40C80
_____
/6
C00C80
C00C80
C00C80
_____
_____
_____
/2
/0
/1
/3
ICDO.indb 5
11/18/13 1:54 PM
Blood
C42.1
Bone marrow
C42.2
Spleen
C42.3
C42.4
ICDO.indb 6
11/18/13 1:54 PM
3.1 Abbreviations
The following abbreviations are used throughout:
M Morphology
NOS Not Otherwise Specified (see section
3.10 for discussion of this term)
ICD-O International Classification of
Diseases for Oncology (third edition)
Table 7.
C50.2
Breast, upper inner quadrant
ICDO.indb 7
11/18/13 1:54 PM
Morphology terms have five-digit codes ranging from 8000/0 to 9992/3. The first four digits
indicate the specific histologic term (Table8). The
fifth digit, after the slash or stroke (/), is a behavior
code, which indicates whether a tumor is malignant, benign, in situ, or uncertain whether malignant or benign (see section4.3.3).
Table 8.
___
behavior grade
Table 10.
Code
C07.9
Parotid gland
Parotid, NOS
Stensen duct
Parotid gland duct
A separate one-digit code for histologic grading or differentiation is provided (see Grading and
Differentiation, section4.3.4). For a lymphoma or
leukemia, this element of the code is used to identify T-, B-, Null-, and NK-cell origin.
A complete ICD-O code thus requires 10 digits
or characters to identify the topographic site (4
characters), morphologic type (4digits), behavior
(1digit), and grade or differentiation of a neoplasm
or its equivalent in leukemias and lymphomas
(1digit). Table9 provides an example.
Table 9.
Diagnostic term:
Poorly differentiated squamous cell carcinoma, upper lobe
of lung
C34.1
8070/33
ICDO.indb 8
11/18/13 1:54 PM
A
C76.2
C47.4
C49.4
C49.4
C47.4
C44.5
C49.4
Abdomen
NOS
autonomic nervous system
connective tissue
muscle
peripheral nerve
skin
subcutaneous tissue
C49.4
C15.2
C77.2
C49.4
Abdominal
aorta
esophagus
lymph node
vena cava
8822/1
8822/1
C76.2
C44.5
C49.4
C49.4
C47.4
C49.4
C49.4
C49.4
C49.4
C47.4
C49.4
C44.5
C49.4
C49.4
C72.5
9871/3
9871/3
9898/1
9867/3
8075/3
Abdominal desmoid
Abdominal wall
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
muscle
peripheral nerve
skeletal muscle
skin
subcutaneous tissue
Abducens nerve
Abnormal
marrow eosinophils, acute myeloid
leukemia with (includes all variants)
marrow eosinophils, acute
myelomonocytic leukemia with
(includes all variants)
myelopoiesis, transient
Abnormalities, myeloid and lymphoid
neoplasms with FGFR1
Acantholytic squamous cell carcinoma
ICDO.indb 9
11/18/13 1:54 PM
would have been too long. There is only one list for
lymphoma, malignant and one for leukemia.
8140/3
8140/6
8280/3
8550/3
8550/3
8370/3
8251/3
8215/3
8215/3
8244/3
8244/3
8560/3
8560/3
8401/3
8147/3
8300/3
8160/3
8250/3
8250/3
8420/3
8270/3
10
ICDO.indb 10
11/18/13 1:54 PM
ICDO.indb 11
11/18/13 1:54 PM
ICD-O-3
Myeloproliferative Neoplasms
9964/3
Chronic eosinophilic leukemia, NOS
9875/3
Chronic myelogenous leukemia, BCR-ABL1
positive
9963/3
Chronic neutrophilic leukemia
9740/1
Cutaneous mastocytoma
9962/3
Essential thrombocythemia
9740/1
Extracutaneous mastocytoma
9742/3
Mast cell leukemia
9740/3
Mast cell sarcoma
9975/3
Myeloproliferative neoplasm unclassifiable
9950/3
Polycythemia vera
9961/3
Primary myelofibrosis
9740/1
Solitary mastocytoma of skin
9741/3
Systemic mastocytosis
Myeloid and Lymphoid Neoplasms with Eosinophilia and
Abnormalities of PDGFRA, PDGFRB or FGFR1
9967/3
Myeloid and lymphoid neoplasms with FGFR1
abnormalities
9965/3
Myeloid and lymphoid neoplasms with PDGFRA
rearrangement
9966/3
Myeloid neoplasms with PDGFRB
rearrangement
Myelodysplastic/Myeloproliferative Neoplasms
9876/3
Atypical chronic myeloid leukemia, BCR-ABL1
negative
9945/3
Chronic myelomonocytic leukemia
9946/3
Juvenile myelomonocytic leukemia
9975/3
Myelodysplastic/myeloproliferative neoplasm,
unclassifiable
9982/3
Refractory anemia with ring sideroblasts
Myelodysplastic Syndromes
9986/3
Myelodysplastic syndrome associated with
isolated del(5q)
9989/3
Myelodysplastic syndrome, unclassifiable
9980/3
Refractory anemia
9983/3
Refractory anemia with excess blasts
9982/3
Refractory anemia with ring sideroblasts
ICD-O-3
9985/3
12
ICDO.indb 12
11/18/13 1:54 PM
ICD-O-3
ICD-O-3
13
ICDO.indb 13
11/18/13 1:54 PM
14
ICDO.indb 14
11/18/13 1:54 PM
Table 14.
Subject
Topographic regions
and ill-defined sites
Prefixes
More than one topographic category or
subcategory
Topography codes for
lymphomas
Topography code for
leukemias
Behavior code
Grading or
differentiation
Site-associated
morphology
Compound morphology diagnoses
Coding multiple
morphology terms
Third edition
Second edition*
B
C
3
4
12
13
F
G
5
6
8, 9
10
11
ICDO.indb 15
11/18/13 1:54 PM
4.2 Topography
4.2.1 Introduction
The topography code indicates the site of origin
of a neoplasm; in other words, where the tumor
arose. No changes or additions were made to the
topography codes in the third edition of ICD-O.
Topography codes or rubrics C00C80 are based
on the malignant neoplasm section of ChapterII
of ICD-10, as noted in the section on differences
between ICD-O and ICD-10 (section 2). All
neoplasms, whether malignant, benign, in situ,
or uncertain whether benign or malignant, are
coded with the same set of topography codes in
ICD-O.
C15
C15.0
C15.1
C15.2
C15.3
ESOPHAGUS
Cervical esophagus
Thoracic esophagus
Abdominal esophagus
Upper third of esophagus
Proximal third of esophagus
C15.4 Middle third of esophagus
C15.5 Lower third of esophagus
Distal third of esophagus
C15.8 Overlapping lesion of esophagus
(See note at the beginning of Topography Numeric List)
C15.9 Esophagus, NOS
Both branchial cleft and Meckel diverticulum are congenital abnormalities and as such are
coded to categories Q18.0 and Q43.0 respectively
in ICD-10. However, these anomalies create tissues
in which neoplasms can arise. The codes C10.4,
branchial cleft, and C17.3, Meckel diverticulum,
are included in the topography section in ICD-O.
The phrase site of neoplasm appears in parentheses after each term to indicate that they are to
be used only when they are the site of origin of a
neoplasm. ICD-O topography codes should not be
used for these congenital anomalies unless a neoplasm arises in them.
16
ICDO.indb 16
11/18/13 1:54 PM
ICD-O but some, such as arm, have several component tissues (Table16). The diagnostic statement
may not indicate the tissue in which the tumor
originated. For example, arm may refer to skin
of arm, to various soft tissues of the arm, or even
to the bones of the arm. Arm, NOS, meaning
that nothing more specific is known about the primary site, is coded to C76.4. To facilitate coding of
tumors of the arm, specific tissues are listed below
the term arm in the alphabetic index.
Table 16.
Code
C76.4
C44.6
C49.1
C49.1
C47.1
C40.0
C49.1
C49.1
C49.1
C77.3
C49.1
C47.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
4.2.5 Prefixes
RULE B. If a topographic site is modified by
a prefix such as peri-, para-, or the like, which
is not specifically listed in ICD-O, code to the
appropriate ill-defined subcategory C76 (illdefined site), unless the type of tumor indicates
origin from a particular tissue.
The prefixes peri-, para-, pre-, supra-, infra-,
and others are often used with topographic sites
and various organs of the body. A few topographic
sites modified by such prefixes are listed in ICD-O
and given specific code numbers. For example,
periadrenal tissue, peripancreatic tissue, and
retrocecal tissue are listed and given the code
number C48.0 which is retroperitoneum. Paraaortic lymph node is listed in ICD-O and given
the same code number, C77.2, as aortic lymph
node. It is not possible to list all topographic sites
that might be modified by these prefixes in ICD-O.
In practice, use of such prefixes indicates that the
topographic site is ill-defined. Coders should use
the C76 rubric for other ill-defined sites not listed
in ICD-O. This same rule applies to other imprecise designations such as in the area of or in the
region of a specific topographic site.
17
ICDO.indb 17
11/18/13 1:54 PM
Code
C02.8
C08.8
C14.8
C21.8
C24.8
C26.8
C39.8
C41.8
C49.8
C57.8
C63.8
C68.8
C72.8
18
ICDO.indb 18
11/18/13 1:54 PM
4.3 Morphology
4.3.2 Behavior
The behavior of a tumor is the way it acts within the
body. Pathologists use a variety of observations to
determine the behavior of a tumor. Table18 shows
the spectrum of behaviors. A tumor can grow in
place without the potential for spread (/0, benign);
it can be malignant but still growing in place (/2,
noninvasive or in situ); it can invade surrounding tissues (/3, malignant, primary site); or even
disseminate from its point of origin and begin to
grow at another site (/6, metastatic).
Table 18.
Code
/0
/1
4.3.1 Introduction
The morphology code records the type of cell that
has become neoplastic and its biologic activity;
in other words, it records the kind of tumor that
has developed and how it behaves. There are three
parts to a complete morphology code:
4 digits Cell type (histology)
1 digit Behavior
1 digit Grade, differentiation or phenotype
In ICD-O morphology codes, a common
root codes the cell type of a given tumor, while
an additional digit codes the behavior. The grade,
differentiation, or phenotype code provides supplementary information about the tumor.
/2
/3
/6*
/9*
Benign
Uncertain whether benign or malignant
Borderline malignancy
Low malignant potential
Uncertain malignant potential
Carcinoma in situ
Intraepithelial
Noninfiltrating
Noninvasive
Malignant, primary site
Malignant, metastatic site
Malignant, secondary site
Malignant, uncertain whether primary or
metastatic site
ICDO.indb 19
11/18/13 1:54 PM
a. Biopsy diagnosis: Supraclavicular lymph node, metastatic signet ring cell adenocarcinoma, most likely from stomach
*b. Primary site: Fundus of stomach, signet ring cell adenocarcinoma
c. Metastatic site: Upper lobe bronchus, metastatic signet ring cell adenocarcinoma
Topography
code
Morphology
code
C77.0
8490/6
C16.1
C34.1
8490/3
8490/6
20
ICDO.indb 20
11/18/13 1:54 PM
Table 20.
Example B
Example C
8140
9000
9370
9370/0
/2 In situ; non-invasive
/3 Malignant, primary
/6 Malignant, metastatic*
8140/6 Adenocarcinoma,
metastatic
8140/9
9370/6
9000/9
9370/9
9370/1
9370/2
9370/3 Chordoma
benign, so it is assigned the code 9000/0. If a diagnosis of malignant Brenner tumor were reported,
however, its correct code would be 9000/3; similarly a diagnosis of Brenner tumor, borderline
malignancy would be correctly coded 9000/1. The
codes 9000/2, 9000/6, and 9000/9 have not been
listed in ICD-O. They are available for use when
appropriate; for example, 9000/2 would be used for
Brenner tumor in situ if such an entity were to
be identified.
In the third example (C) only one term, chordoma, is listed. Chordoma is usually considered to be a malignant neoplasm and is therefore
assigned the morphology code 9370/3. Other codes
in the 9370 matrix also exist and could be used
when appropriate, for example 9370/0 for benign
chordoma, even though this term is not actually
listed in ICD-O. It should be noted that some of
the possible combinations probably do not exist or
have not been recognized and defined; a benign
sarcoma would contradict current concepts and
usage.
Usually a histologic term carries a clear indication of the likely behavior of the tumor, whether
malignant or benign, and this is reflected in the
behavior code assigned to it in the ICD-O tabular list. Only a few histologic types of in situ neoplasms are actually listed in ICD-O. The behavior
code /2 could be attached to any of the four-digit
codes in ICD-O if an in situ form of the neoplasm
is diagnosed.
It should be emphasized here that the matrix
system was designed to give the pathologist the
final say on whether a tumor is considered to be
ICDO.indb 21
11/18/13 1:54 PM
Table 21.
Code
1
2
3
4
9
Grade I
Well differentiated
Differentiated, NOS
Grade II
Moderately differentiated
Moderately well differentiated
Intermediate differentiation
Grade III Poorly differentiated
Grade IV Undifferentiated
Anaplastic
Grade or differentiation not determined, not
stated or not applicable
Code
5
6
7
8
9
T-cell
B-cell
Pre-B
B-precursor
Null cell
Non T-non B
NK cell
Natural killer cell
Cell type not determined, not stated or not
applicable
22
ICDO.indb 22
11/18/13 1:54 PM
4.3.5 Site-associated
morphology terms
RULE H. Use the topography code provided when
a topographic site is not stated in the diagnosis.
This topography code should be disregarded if
the tumor is known to arise at another site.
Some terms for neoplasms imply origin in certain sites or types of tissue. Examples are shown
in Table23. To facilitate the coding of such terms,
a topography code has been added in parentheses
in both the numeric list of morphology and the
alphabetic index, when appropriate. Occasionally
the topography code appears in the 3-digit heading and then applies to all terms included under
that heading.
For basal cell carcinoma (Table 23), the
topography code for skin (C44._) is given, with
the fourth digit left open. An underscore ( _ ) following the decimal point indicates the existence of
subsite codes. The appropriate fourth digit for the
site reported should be added here. Coders should
refer to the numerical list or the alphabetic index
for specific subsite codes. For example, a basal cell
carcinoma of the face would be given the site code
C44.3 (skin of face), while one of the arm would
be coded C44.6 (skin of arm). Similarly, the fourth
digit in the topography code (C70._) that follows
meningioma is left open since the site involved
may be either cerebral meninges (C70.0), spinal
meninges (C70.1), or meninges, NOS (C70.9).
The topography code attached to a morphology term may be used when the topographic site
is not given in the diagnosis. Many morphology
Table 23.
Morphology
Term
ICD-O topography
(usual primary site)
Other
primary sites
9510/3
8170/3
8090/3
Retinoblastoma
Hepatocellular carcinoma
Basal cell carcinoma
C69.2
C22.0
C44._
Retina
Liver
Skin
C51._
9530/0
938948
8500/3
Meningioma
Gliomas
Infiltrating duct carcinoma, NOS
C70._
C71._
C50._
Meninges
Brain
Breast
C72.0
C07.9
8470/3
C56.9
Ovary
C25._
C34._
Vulva
C60._ Penis
C63.2 Scrotum
C61.9 Prostate
Spinal cord
Parotid gland
C08._ Salivary gland
C25._ Pancreas
C61.9 Prostate
Pancreas
Lung
23
ICDO.indb 23
11/18/13 1:54 PM
4.3.6 No rule I
There is no Rule I in ICD-O-3 and this was done
intentionally. The rules in ICD-O-2 were numeric.
The rules in ICD-O-3 are alphabetic. The editors of
ICD-O-3 felt it necessary to omit Rule I from ICDO-3 in an attempt to avoid any possible confusion
between the 1 (one) and I (the letter i), as in Rule
1 (one) in ICD-O-2 and Rule I (the letter i) in
ICD-O-3.
4.3.7 Compound
morphology diagnoses
RULE J. Change the order of the word roots in
a compound term if the term is not listed in
ICD-O.
Some tumors have more than one histologic pattern. The most common combinations
have been listed in ICD-O, for example mixed
adenocarcinoma and squamous cell carcinoma
(8560/3), papillary and follicular adenocarcinoma (8340/3), and mixed basal-squamous cell
carcinoma (8094/3).
The compound term fibromyxosarcoma is listed in ICD-O with its code 8811/3,
but myxofibrosarcoma does not appear.
Myxofibrosarcoma is the same as fibromyxosarcoma, except that the word roots have been
inverted, and it should therefore also be coded
8811/3. It was impossible to list all the combinations and permutations of such compound terms.
The coder must check various permutations of
the word roots in a compound term if the version
sought is not listed in ICD-O.
24
ICDO.indb 24
11/18/13 1:54 PM
A working party of IARC recommended definitions of multiple neoplasms for the purpose of
incidence reporting for international comparison
in 1995 and revised them in 2000 (available at:
www.iacr.com.fr/multprim.pdf). Following the
initial publication of ICD-O, third edition, the
IARC/IACR rules were updated again in 2004 (28)
and are included here:
1. Recognition of the existence of two or more
primary cancers does not depend on time.
2. A primary cancer is one that originates in a
primary site or tissue and is not an extension,
a recurrence, or a metastasis.
3. Only one tumor shall be recognized as arising
in an organ or pair of organs or a tissue. Some
groups of codes are considered to be a single
Table 24.
ICD-O-2/3
Label site
code
Term
C01
C02
Base of tongue
Other and unspecified parts of tongue
C02.9
C00
C03
C04
C05
C06
Lip
Gum
Floor of mouth
Palate
Other and unspecified parts of mouth
C06.9
C09
C10
C12
C13
C14
Tonsil
Oropharynx
Pyriform sinus
Hypopharynx
Other and ill-defined sites in lip, oral cavity and pharynx
C14.0
C19
C20
Rectosigmoid junction
Rectum
C20.9
C23
C24
Gallbladder
Other and unspecified parts of biliary tract
C24.9
C33
C34
Trachea
Bronchus and lung
C34.9
C40
C41
C41.9
C65
C66
C67
C68
Renal pelvis
Ureter
Bladder
Other and unspecified urinary organs
C68.9
25
ICDO.indb 25
11/18/13 1:54 PM
Table 25.
Group
ICD-O-3 Morphology
Carcinomas
1. Squamous and transitional cell carcinoma
2. Basal cell carcinomas
3. Adenocarcinomas
4. Other specific carcinomas
(5.) Unspecified carcinomas (NOS)
6. Sarcomas and soft tissue tumors
7. Mesothelioma
Tumors of hematopoietic and lymphoid tissues
8. Myeloid
9. B-cell neoplasms
10. T-cell and NK-cell neoplasms
11. Hodgkin lymphoma
12. Mast-cell Tumors
13. Histiocytes and Accessory Lymphoid cells
(14.) Unspecified types
15. Kaposi sarcoma
16. Other specified types of cancer
(17.) Unspecified types of cancer
8051-8084, 8120-8131
8090-8110
8140-8149, 8160-8162, 8190-8221, 8260-8337, 8350-8551, 8570-8576,
8940-8941
8030-8046, 8150-8157, 8170-8180, 8230-8255, 8340-8347, 8560-8562,
8580-8671
8010-8015, 8020-8022, 8050
8680-8713, 8800-8921, 8990-8991, 9040-9044, 9120-9125, 9130-9136,
9141-9252, 9370-9373, 9540-9582
9050-9055
9840, 9861-9931, 9945-9946, 9950, 9961-9964, 9980-9987
9670-9699, 9728, 9731-9734, 9761-9767, 9769, 9823-9826, 9833, 9836,
9940
9700-9719, 9729, 9768, 9827-9831, 9834, 9837, 9948
9650-9667
9740-9742
9750-9758
9590-9591, 9596, 9727, 9760, 9800-9801, 9805, 9820, 9832, 9835, 9860,
9960, 9970, 9975, 9989
9140
8720-8790, 8930-8936, 8950-8983, 9000-9030, 9060-9110, 9260-9365,
9380- 9539
8000-8005
26
ICDO.indb 26
11/18/13 1:54 PM
1.
Table 26.
Introduction
Code
Description
Criteria
0
Non-microscopic
1
Clinical
Clinical investigation
Microscopic
5
Cytology
Histology of a metastasis
Unknown
27
ICDO.indb 27
11/18/13 1:54 PM
Table 27.
WHO grading system (malignancy scale) for central nervous system tumors (10)
WHO grade
ICD-O code
I
I
II
II
II
III
IV
IV
IV
9384
9421
9425
9400
9424
9401
9440
9441
9442
1
1
3
3
3
3
3
3
3
II
III
9450
9451
3
3
II
III
9382
9382
3
3
I
I
II
III
9383
9394
9391
9392
1
1
3
3
I
II
III
9390
9390
9390
0
1
3
I
II
9431
9444
1
1
I
I
III
I
I
II
II
II
I
I
I
9492
9505
9505
9412
9413
9506
9506
9506
8680
9509
9509
0
1
3
1
0
1
1
1
1
1
1
I
IIIII
IV
IIIII
9361
9362
9362
9395
1
3
3
3
IV
IV
IV
9470
9473
9508
3
3
3
continues ...
28
ICDO.indb 28
11/18/13 1:54 PM
... continued
Tumor type to be coded
Cranial and spinal nerve tumors
Schwannoma
Neurofibroma
Perineurioma
Malignant peripheral nerve sheath tumor (MPNST)
Meningeal tumors
Meningioma, NOS
Atypical meningioma
Anaplastic (malignant) meningioma
Papillary meningioma
Hemangiopericytoma, NOS
Anaplastic hemangiopericytoma
Hemangioblastoma
Tumors of the sellar region
Craniopharyngioma
Granular cell tumor of neurohypophysis
Pituicytoma
Spindle cell oncocytoma of adenohypophysis
WHO grade
ICD-O code
I
I
IIII
IIIV
9560
9540
9571
9540
0
0
0, 3
3
I
II
III
III
II
III
I
9530
9539
9530
9538
9150
9150
9161
0
1
3
3
1
3
1
I
I
I
I
9350
9582
9432
8290
1
0
1
0
References
1.
2.
3.
International Classification of Diseases for Oncology, first edition. Geneva, World Health Organization, 1976.
Cote RA, editor. Systematized nomenclature of medicine. Vols I and II. Skokie, IL, College of American Pathologists, 1977.
Cote RA et al., editors. SNOMED International: the systematized nomenclature of human and veterinary medicine. Vols IIV.
Northfield, IL, College of American Pathologists, 1993.
4. Percy C, Van Holten V, Muir C, editors. International Classification of Diseases for Oncology, second edition. Geneva, World Health
Organization, 1990.
5. International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. Vols 13. Geneva, World Health
Organization, 19921994.
6. Harris NL etal. A revised European-American classification of lymphoid neoplasms: a proposal from the International
Lymphoma Study Group. Blood, 1994, 84:1361-1392. PMID:8068936
7. Bennett JM etal. Proposals for the classification of the acute leukaemias. British Journal of Haematology, 1976, 33:451-458. doi:
http://dx.doi.org/10.1111/j.1365-2141.1976.tb03563.x PMID:188440
8. International histological classification of tumours, 2nd ed. Geneva, World Health Organization, 19812000.
9. Swerdlow SH et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition. Lyon,
International Agency for Research on Cancer, 2008.
10. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System, 4th edition.
Lyon, International Agency for Research on Cancer, 2007.
11. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System, 4th edition. Lyon,
International Agency for Research on Cancer, 2010.
12. International Statistical Classification of Diseases, Injuries, and Causes of Death. Sixth Revision. Geneva, World Health Organization,
1948.
29
ICDO.indb 29
11/18/13 1:54 PM
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
Manual of tumor nomenclature and coding. New York, NY, American Cancer Society, 1951.
Systematized nomenclature of pathology. Chicago, IL, College of American Pathologists, 1965.
Manual of tumor nomenclature and coding. New York, NY, American Cancer Society, 1968.
International Statistical Classification of Diseases, Injuries and Causes of Death. Seventh Revision. Geneva, World Health
Organization, 1957.
International Statistical Classification of Diseases, Injuries and Causes of Death. Eighth Revision. Geneva, World Health
Organization, 1967.
International Classification of Diseases. Eighth Revision. Adapted for use in the United States. Washington, DC, US Department of
Health, Education and Welfare, 1967 (Public Health Service Publication No. 1693).
Hospital Adaptation of International Classification of Diseases, Adapted. Ann Arbor, MI, Commission on Professional and Hospital
Activities, 1968 (Library of Congress Card No. 68-56602).
International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth Revision. Clinical Modification. Washington,
DC, US Department of Health and Human Services, 1979 (DHHS No. (PHS) 80-1260).
International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth Revision. Geneva, World Health
Organization, 1977.
Thompson ET, Hayden AC, editors. Standard Nomenclature of Diseases and Operations, 5th ed. New York, McGraw-Hill, 1961.
Spackman KA, Campbell KE, Cote RA. SNOMED RT: A reference terminology for health care. Northfield, IL, College of American
Pathologists, 2000.
Harris NL etal. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues:
report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 1999,
17:3835-3849. PMID:10577857
Harris NL etal. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues:
report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Annals of Oncology, 1999, 10:14191432. doi: http://dx.doi.org/10.1023/A:1008375931236 PMID:10643532
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours, Volume 2.
IARC WHO Classification of Tumours, No 2, 2008.
The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. Journal of the American Medical Association,
1989, 262:931-934. doi: http://dx.doi.org/10.1001/jama.1989.03430070079034 PMID:2754794
International Association of Cancer Registries. International Rules for Multiple Primary Cancers (ICD-O third edition). Lyon,
International Agency for Research on Cancer Internal Report No. 2004/02, 2004. www.iacr.com.fr/MPrules_july2004.pdf
Berg JW. Morphologic classification of human cancer. In: Shottenfeld D, Fraumeni J, Jr, eds. Cancer epidemiology and prevention,
2nd ed. New York, Oxford University Press, 1996 (Chapter3).
Curado MP et al., editors. Cancer in Five Continents, Volume IX. Lyon, IARC Scientific Publication No. 160, 2009.
Johnson CH et al. The 2007 Multiple Primary and Histology Coding Rules.Bethesda, MD, National Cancer Institute, Surveillance,
Epidemiology and End Results (SEER) Program, 2007 and Johnson CH, Adamo M, Dickie L, Percy-Laurry A, Ruhl J (eds.), 2012
Hematopoietic Manual. Bethesda, MD, National Cancer Institute, Surveillance, Epidemiology and End Results (SEER) Program,
2012. www.seer.cancer.gov/registrars
Jensen OM et al., editors. Cancer registration: principles and methods. Lyon, International Agency for Research on Cancer, 1989
(IARC Scientific Publications, No. 95).
Thornton ML, (ed). Standards for Cancer Registries Volume II: Data Standards and Data Dictionary, Record Layout Version 13,
17th ed. Springfield, Ill.: North American Association of Central Cancer Registries, June 2012..
Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system (International Histological
Classification of Tumours). Berlin, Springer Verlag, 1993.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours, Fourth edition. IARC WHO Classification of
Tumours, 2007.
30
ICDO.indb 30
11/18/13 1:54 PM
Numerical lists
ICDO.indb 31
11/18/13 1:54 PM
ICDO.indb 32
11/18/13 1:54 PM
Topography
Note: In categories C00 to C80.9, neoplasms should be assigned to the category that includes the point
of origin of the tumor. A tumor that overlaps the boundaries of two or more subcategories and
whose point of origin cannot be determined should be classified to subcategory .8. For example, a
neoplasm of cervicothoracic esophagus should be assigned to C15.8.
C00.1
C00.2
C00.3
C00.4
C00.5
C02.1
Border of tongue
Tip of tongue
C02.2
C02.3
C02.4
Lingual tonsil
C02.8
C00.6
Commissure of lip
Labial commissure
C00.8
C00.9
C02.9
Tongue, NOS
Lingual, NOS
33
ICDO.indb 33
11/18/13 1:54 PM
C03 GUM
C03.0
Lower gum
Mandibular gingiva
Lower alveolar mucosa
Lower alveolar ridge mucosa
Lower alveolus
Lower gingiva
C03.9
C06.2
C06.8
C06.9
Mouth, NOS
Buccal cavity
Oral cavity
Oral mucosa
Minor salivary gland, NOS (see section 4.3.5)
C04.1
C04.8
C04.9
C08.0
Hard palate
C05.1
C05.2
Uvula
C05.8
C08.1
C08.8
C08.9
Palate, NOS
Roof of mouth
Cheek mucosa
Buccal mucosa
Internal cheek
Sublingual gland
Sublingual gland duct
C05.9
Submandibular gland
Submaxillary gland
Wharton duct
Submaxillary gland duct
C05 PALATE
C05.0
Parotid gland
Parotid, NOS
Stensen duct
Parotid gland duct
Retromolar area
Retromolar triangle
Retromolar trigone
Gum, NOS
Gingiva, NOS
Alveolar mucosa, NOS
Alveolar ridge mucosa, NOS
Alveolus, NOS
Periodontal tissue
Tooth socket
Vestibule of mouth
Alveolar sulcus
Buccal sulcus
Labial sulcus
Upper gum
Maxillary gingiva
Upper alveolar mucosa
Upper alveolar ridge mucosa
Upper alveolus
Upper gingiva
C03.1
C06.1
C09 TONSIL
C09.0
Tonsillar fossa
C09.1
Tonsillar pillar
Faucial pillar
Glossopalatine fold
34
ICDO.indb 34
11/18/13 1:54 PM
C09.8
C09.9
Piriform sinus
Pyriform fossa
Piriform fossa
C10 OROPHARYNX
C10.0
Vallecula
C10.1
C10.2
C13 HYPOPHARYNX
C13.0
C13.1
C13.2
C13.8
C10.8
Overlapping lesion of
oropharynx (see section 4.2.6)
C13.9
C10.9
Oropharynx, NOS
Mesopharynx, NOS
Fauces, NOS
C11 NASOPHARYNX
C11.0
C11.2
C11.3
C14.2
Waldeyer ring
C14.8
C11.8
C11.9
Overlapping lesion of
nasopharynx (see section 4.2.6)
Nasopharynx, NOS
Nasopharyngeal wall
Pharynx, NOS
Pharyngeal wall, NOS
Wall of pharynx, NOS
Lateral wall of pharynx, NOS
Posterior wall of pharynx, NOS
Retropharynx
Throat
Adenoid
Pharyngeal tonsil
Hypopharynx, NOS
Hypopharyngeal wall
Laryngopharynx
Roof of nasopharynx
C11.1
Hypopharyngeal aspect of
aryepiglottic fold
Aryepiglottic fold, NOS (excludes laryngeal
aspect of aryepiglottic fold C32.1)
Arytenoid fold
C10.4
Postcricoid region
Cricopharynx
Cricoid, NOS
C10.3
Pyriform sinus
C15 ESOPHAGUS
C15.0
Cervical esophagus
C15.1
Thoracic esophagus
C15.2
Abdominal esophagus
35
ICDO.indb 35
11/18/13 1:54 PM
C15.3
C17.1
Jejunum
C17.2
C17.3
C17.8
C17.9
C15.4
C15.5
C15.8
C15.9
Overlapping lesion of
esophagus (see section 4.2.6)
C16 STOMACH
C16.0
Cardia, NOS
Gastric cardia
Cardioesophageal junction
Esophagogastric junction
Gastroesophageal junction
C16.1
Esophagus, NOS
Fundus of stomach
C18 COLON
C18.0
C18.1
Appendix
C18.2
Ascending colon
Right colon
Gastric fundus
C16.2
Body of stomach
Corpus of stomach
Gastric corpus
C16.3
Gastric antrum
Antrum of stomach
Pyloric antrum
C16.4
Pylorus
Pyloric canal
Prepylorus
C16.5
C16.6
C16.8
C18.3
C18.4
Transverse colon
C18.5
C18.6
Descending colon
Left colon
C18.7
Sigmoid, NOS
Sigmoid flexure of colon
Pelvic colon
C18.8
C18.9
Colon, NOS
Large intestine (excludes rectum, NOS
C20.9 and recrectosigmoid junction C19.9)
Large bowel, NOS
Overlapping lesion of
stomach (see section 4.2.6)
Stomach, NOS
Rectosigmoid junction
Rectosigmoid, NOS
Rectosigmoid colon
Colon and rectum
Pelvirectal junction
Gastric, NOS
C17.0
Sigmoid colon
C16.9
Cecum
Ileocecal valve
Ileocecal junction
C20 RECTUM
C20.9
Rectum, NOS
Rectal ampulla
36
ICDO.indb 36
11/18/13 1:54 PM
C25.2
Tail of pancreas
C25.3
Pancreatic duct
Duct of Santorini
Duct of Wirsung
Anal canal
Anal sphincter
C21.2
Cloacogenic zone
C21.8
C25.4
Islands of Langerhans
Endocrine pancreas
C25.7
Liver
Hepatic, NOS
C22.1
C25.8
Overlapping lesion of
pancreas (see section 4.2.6)
C25.9
Pancreas, NOS
C26.0
Gallbladder
C26.8
C24.1
Ampulla of Vater
Periampullary
C24.8
C24.9
C23 GALLBLADDER
C23.9
Islets of Langerhans
C26.9
C25 PANCREAS
C25.0
Head of pancreas
C25.1
Body of pancreas
37
ICDO.indb 37
11/18/13 1:54 PM
C30.1
C33 TRACHEA
Middle ear
Inner ear
Auditory tube
Eustachian tube
Mastoid antrum
Tympanic cavity
C33.9
Maxillary sinus
Maxillary antrum
Antrum, NOS
C31.1
Ethmoid sinus
C31.2
Frontal sinus
C31.3
Sphenoid sinus
C31.8
C31.9
C34.1
C34.2
C34.3
C34.8
C34.9
Lung, NOS
Bronchus, NOS
Bronchiole
Bronchogenic
Pulmonary, NOS
C32 LARYNX
C37 THYMUS
Glottis
Intrinsic larynx
Laryngeal commissure
Vocal cord, NOS
True vocal cord
True cord
C32.1
C32.0
Main bronchus
Carina
Hilus of lung
Trachea
C37.9
Heart
Endocardium
Epicardium
Myocardium
Pericardium
Cardiac ventricle
Cardiac atrium
Supraglottis
Epiglottis, NOS (excludes anterior surface of
epiglottis C10.1)
Extrinsic larynx
Laryngeal aspect of aryepiglottic fold
Posterior surface of epiglottis
Ventricular band of larynx
False vocal cord
False cord
Thymus
C38.1
Anterior mediastinum
C38.2
Posterior mediastinum
C32.2
Subglottis
C38.3
Mediastinum, NOS
C32.3
Laryngeal cartilage
C38.4
Pleura, NOS
Arytenoid cartilage
Cricoid cartilage
Cuneiform cartilage
Thyroid cartilage
C32.8
C32.9
Larynx, NOS
Parietal pleura
Visceral pleura
C38.8
38
ICDO.indb 38
11/18/13 1:54 PM
C39.8
C39.9
C40.2
Bone of leg
Femur
Fibula
Knee joint, NOS
Semilunar cartilage
Lateral meniscus of knee joint
Medial meniscus of knee joint
Tibia
C40.3
C40.1
C40.0
C40.8
C40.9
39
ICDO.indb 39
11/18/13 1:54 PM
C41.1
C41.2
Mandible
C42.3
C42.4
C41.3
C41.8
C41.9
C44.0
C44.1
Eyelid
Lid, NOS
Palpebra
Canthus, NOS
Inner canthus
Lower lid
Meibomian gland
Outer canthus
Upper lid
C41.4
C44.2
External ear
Auricle, NOS
Pinna
Ceruminal gland
Concha
Ear, NOS
Ear lobule
Earlobe
External auditory canal
Auditory canal, NOS
Auricular canal, NOS
External auricular canal
Ear canal
External auditory meatus
Helix
Skin of auricle
Skin of ear, NOS
Tragus
Bone, NOS
Joint, NOS
Cartilage, NOS
Skeletal bone
Articular cartilage, NOS
Blood
C42.1
Bone marrow
C42.2
Spleen
40
ICDO.indb 40
11/18/13 1:54 PM
C44.3
C44.4
C44.6
Skin of:
antecubital space
arm
elbow
finger
forearm
hand
palm
shoulder
thumb
upper limb
wrist
Finger nail
Palmar skin
C44.7
Skin of trunk
Skin of:
abdomen
abdominal wall
anus
axilla
back
breast
buttock
chest
chest wall
flank
groin
perineum
thoracic wall
thorax
trunk
umbilicus
gluteal region
infraclavicular region
inguinal region
sacrococcygeal region
scapular region
Perianal skin
Umbilicus, NOS
Skin of neck
Skin of scalp
Scalp, NOS
Skin of cervical region
Skin of supraclavicular region
C44.5
C44.8
C44.9
41
ICDO.indb 41
11/18/13 1:54 PM
C47.3
C47.1
C47.2
C47.4
C47.5
42
ICDO.indb 42
11/18/13 1:54 PM
C47.6
C47.8
C47.9
Retroperitoneum
Periadrenal tissue
Perinephric tissue
Peripancreatic tissue
Perirenal tissue
Retrocecal tissue
Retroperitoneal tissue
C48.1
C48.2
Peritoneum, NOS
Peritoneal cavity
C48.8
C49.1
43
ICDO.indb 43
11/18/13 1:54 PM
C49.2
C49.3
C49.4
C49.5
C49.6
C49.8
44
ICDO.indb 44
11/18/13 1:54 PM
C49.9
C51.1
C51.2
Clitoris
C51.8
C51.9
Vulva, NOS
External female genitalia
Fourchette
Labia, NOS
Labium, NOS
Mons pubis
Mons veneris
Pudendum
Skin of vulva
Nipple
Areola
C50.1
C50.2
C50.3
C50.4
C50.5
C50.6
C52 VAGINA
C52.9
C50.9
Endocervix
Internal os
Cervical canal
Endocervical canal
Endocervical gland
Nabothian gland
Vagina, NOS
Vaginal vault
Fornix of vagina
Gartner duct
Hymen
C50.8
Labium minus
Labia minora
Labium majus
C53.1
Exocervix
External os
C53.8
Breast, NOS
Mammary gland
C53.9
Cervix uteri
Cervix, NOS
Uterine cervix
45
ICDO.indb 45
11/18/13 1:54 PM
Isthmus uteri
Lower uterine segment
C54.1
Endometrium
Endometrial gland
Endometrial stroma
C54.2
Myometrium
C54.3
Fundus uteri
C54.8
C54.9
Corpus uteri
Body of uterus
Uterus, NOS
C57.9
C58 PLACENTA
C58.9
C56.9
Ovary
Fallopian tube
Uterine tube
C57.1
Broad ligament
Mesovarium
Parovarian region
C57.2
Round ligament
C57.3
Parametrium
Uterine ligament
Uterosacral ligament
Uterine adnexa
Adnexa, NOS
C57.4
C57.7
Uterine adnexa
C60.1
Glans penis
C60.2
Body of penis
Corpus cavernosum
Corpus of penis
C60.8
C60.9
Penis, NOS
Skin of penis
C62 TESTIS
C62.0
C62.1
C62.9
Adnexa, NOS
Prostate gland
Prostate, NOS
Descended testis
Scrotal testis
Testis, NOS
Testicle, NOS
Wolffian body
Wolffian duct
C57.8
Prepuce
Foreskin
Placenta
Fetal membranes
Uterine, NOS
C56 OVARY
Epididymis
46
05-978-9241548496 topography.indd 46
11/28/13 2:51 PM
C63.1
Spermatic cord
C67.7
Urachus
C67.8
C67.9
Bladder, NOS
Vas deferens
C63.2
Scrotum, NOS
Skin of scrotum
C63.7
Seminal vesicle
Tunica vaginalis
C63.8
Urethral gland
Cowper gland
Prostatic utricle
C63.9
C68.1
Paraurethral gland
C68.8
Kidney, NOS
Renal, NOS
Kidney parenchyma
C66 URETER
C66.9
Ureter
C67 BLADDER
C67.0
Trigone of bladder
C67.1
Dome of bladder
C67.2
C67.3
C67.4
C67.5
Bladder neck
Internal urethral orifice
C67.6
C68.9
Renal pelvis
Pelvis of kidney
Renal calyces
Renal calyx
Pelviureteric junction
Urethra
Conjunctiva
Cornea, NOS
Limbus of cornea
C69.2
Retina
C69.3
Choroid
Crystalline lens
C69.4
Ciliary body
Iris
Sclera
Uveal tract
Intraocular
Eyeball
C69.5
Lacrimal gland
Lacrimal duct, NOS
Nasal lacrimal duct
Nasolacrimal duct
Lacrimal sac
Ureteric orifice
47
ICDO.indb 47
11/18/13 1:54 PM
C69.6
Orbit, NOS
C71.1
C69.8
C69.9
C71.2
Hippocampus
Uncus
C71.3
Parietal lobe
C71.4
Occipital lobe
C71.5
Cerebral meninges
C71.6
C71.7
Meninges, NOS
C71.8
Cerebrum
Basal ganglia
Central white matter
Cerebral cortex
Cerebral hemisphere
Cerebral white matter
Corpus striatum
Globus pallidus
Hypothalamus
Insula
Internal capsule
Island of Reil
Operculum
Pallium
Putamen
Rhinencephalon
Supratentorial brain, NOS
Thalamus
Brain stem
Cerebral peduncle
Basis pedunculi
Choroid plexus of fourth ventricle
Fourth ventricle, NOS
Infratentorial brain, NOS
Medulla oblongata
Midbrain
Olive
Pons
Pyramid
Arachnoid, NOS
Dura, NOS
Dura mater, NOS
Pia mater, NOS
C71.0
Cerebellum, NOS
Cerebellopontine angle
Vermis of cerebellum
Spinal meninges
C71 BRAIN
Ventricle, NOS
Cerebral ventricle
Choroid plexus, NOS
Choroid plexus of lateral ventricle
Choroid plexus of third ventricle
Ependyma
Lateral ventricle, NOS
Third ventricle, NOS
Spinal arachnoid
Spinal dura mater
Spinal pia mater
C70.9
Temporal lobe
Occipital pole
C70.1
Frontal pole
Eye, NOS
C70 MENINGES
C70.0
Frontal lobe
C71.9
Brain, NOS
Intracranial site
Cranial fossa, NOS
Anterior cranial fossa
Middle cranial fossa
Posterior cranial fossa
Suprasellar
48
ICDO.indb 48
11/18/13 1:54 PM
C74.1
C74.9
Spinal cord
Cervical cord
Conus medullaris
Filum terminale
Lumbar cord
Sacral cord
Thoracic cord
C72.1
Cauda equina
C72.2
Olfactory nerve
C72.3
Optic nerve
Suprarenal gland
Adrenal, NOS
Parathyroid gland
C75.1
Pituitary gland
Pituitary, NOS
Hypophysis
Rathke pouch
Sella turcica
Pituitary fossa
Optic chiasm
Optic tract
C72.4
C72.5
Acoustic nerve
C75.2
Craniopharyngeal duct
C75.3
Pineal gland
C75.4
Carotid body
C75.5
Abducens nerve
Accessory nerve, NOS
Spinal accessory nerve
Facial nerve
Glossopharyngeal nerve
Hypoglossal nerve
Oculomotor nerve
Trigeminal nerve
Trochlear nerve
Vagus nerve
C72.8
C72.9
Coccygeal body
Coccygeal glomus
Glomus jugulare
Para-aortic body
Organ of Zuckerkandl
Paraganglion
C75.8
C75.9
Thyroid gland
Thyroid, NOS
Thyroglossal duct
49
ICDO.indb 49
11/18/13 1:54 PM
C76.1
C76.2
Thorax, NOS
Axilla, NOS
Chest, NOS
Chest wall, NOS
Intrathoracic site, NOS
Thoracic wall, NOS
Infraclavicular region, NOS
Scapular region, NOS
C77.0
Abdomen, NOS
Abdominal wall, NOS
Intra-abdominal site, NOS
C76.3
Pelvis, NOS
Buttock, NOS
Groin, NOS
Ischiorectal fossa
Pelvic wall, NOS
Perineum, NOS
Rectovaginal septum
Rectovesical septum
Gluteal region, NOS
Inguinal region, NOS
Perirectal region, NOS
Presacral region, NOS
Sacrococcygeal region, NOS
C76.4
C76.5
C77.1
C76.7
C76.8
50
ICDO.indb 50
11/18/13 1:54 PM
C77.2
C77.3
C77.5
C77.8
C77.9
C77.4
51
ICDO.indb 51
11/18/13 1:54 PM
Digit codes
5th digit behavior code
for neoplasms
/0
/1
/2
/3
/6*
/9*
Benign
Uncertain whether benign or malignant
Borderline malignancy
Low malignant potential
Uncertain malignant potential
Carcinoma in situ
Intraepithelial
Noninfiltrating
Noninvasive
Malignant, primary site
Malignant, metastatic site
Malignant, secondary site
Malignant, uncertain whether primary or
metastatic site
3
4
9
Grade I
Well differentiated
Differentiated, NOS
Grade II Moderately differentiated
Moderately well differentiated
Intermediate differentiation
Grade III Poorly differentiated
Grade IV Undifferentiated
Anaplastic
Grade or differentiation not determined, not
stated or not applicable
7
8
9
T-cell
B-cell
Pre-B
B-precursor
Null cell
Non T-non B
NK cell
Natural killer cell
Cell type not determined, not stated or not
applicable
52
ICDO.indb 52
11/18/13 1:54 PM
Morphology
800 Neoplasms, NOS
8000/0 Neoplasm, benign
Tumor, benign
Unclassified tumor, benign
8010/9 Carcinomatosis
8011/0 Epithelioma, benign
8011/3 Epithelioma, malignant
Epithelioma, NOS
53
ICDO.indb 53
11/18/13 1:54 PM
Papillomatosis, NOS
54
ICDO.indb 54
11/18/13 1:54 PM
ICDO.indb 55
11/18/13 1:54 PM
56
ICDO.indb 56
11/18/13 1:54 PM
57
ICDO.indb 57
11/18/13 1:54 PM
58
ICDO.indb 58
11/18/13 1:54 PM
59
ICDO.indb 59
11/18/13 1:54 PM
8248/1 Apudoma
60
ICDO.indb 60
11/18/13 1:54 PM
ICDO.indb 61
11/18/13 1:54 PM
62
ICDO.indb 62
11/18/13 1:54 PM
Hidradenoma papilliferum
Porocarcinoma (C44._)
ICDO.indb 63
11/18/13 1:54 PM
64
ICDO.indb 64
11/18/13 1:54 PM
8501/2 Comedocarcinoma,
noninfiltrating (C50._)
Ductal carcinoma in situ, comedo type
(C50._)
DCIS, comedo type (C50._)
65
ICDO.indb 65
11/18/13 1:54 PM
66
ICDO.indb 66
11/18/13 1:54 PM
67
ICDO.indb 67
11/18/13 1:54 PM
859-867 Specialized
gonadal neoplasms
8590/1 Sex cord-gonadal stromal tumor, NOS
Gonadal stromal tumor, NOS
Sex cord tumor, NOS
Ovarian stromal tumor (C56.9)
Testicular stromal tumor (C62._)
68
ICDO.indb 68
11/18/13 1:54 PM
868-871 Paragangliomas
and glomus tumors
69
ICDO.indb 69
11/18/13 1:54 PM
8710/3 Glomangiosarcoma
Glomoid sarcoma
8712/0 Glomangioma
8713/0 Glomangiomyoma
70
ICDO.indb 70
11/18/13 1:54 PM
8811/0 Fibromyxoma
Myxofibroma, NOS
Myxoid fibroma
Plexiform fibromyxoma
8811/3 Fibromyxosarcoma
8812/0 Periosteal fibroma (C40._,C41._)
8812/3 Periosteal fibrosarcoma (C40._,C41._)
Periosteal sarcoma, NOS (C40._,C41._)
Congenital fibrosarcoma
71
ICDO.indb 71
11/18/13 1:54 PM
8825/0 Myofibroblastoma
8825/1 Myofibroblastic tumor, NOS
8826/0 Angiomyofibroblastoma
8827/1 Myofibroblastic tumor,
peribronchial (C34._)
Congenital peribronchial myofibroblastic
tumor (C34._)
8851/0 Fibrolipoma
8851/3 Liposarcoma, well differentiated
Lipoma-like liposarcoma
Liposarcoma, differentiated
Inflammatory liposarcoma
Sclerosing liposarcoma
8852/0 Fibromyxolipoma
Myxolipoma
72
ICDO.indb 72
11/18/13 1:54 PM
8860/0 Angiomyolipoma
8870/0 Myelolipoma
8880/0 Hibernoma
8881/0 Lipoblastomatosis
Fetal lipoma, NOS
Fetal lipomatosis
Lipoblastoma
Rhabdosarcoma
8894/0 Angiomyoma
Angioleiomyoma
Vascular leiomyoma
8894/3 Angiomyosarcoma
8895/0 Myoma
8895/3 Myosarcoma
73
ICDO.indb 73
11/18/13 1:54 PM
8932/0 Adenomyoma
Atypical polypoid adenomyoma
8933/3 Adenosarcoma
8934/3 Carcinofibroma
8935/0 Stromal tumor, benign
8935/1 Stromal tumor, NOS
8935/3 Stromal sarcoma, NOS
8936/0 Gastrointestinal stromal tumor, benign
GIST, benign
74
ICDO.indb 74
11/18/13 1:54 PM
75
ICDO.indb 75
11/18/13 1:54 PM
9064/3 Germinoma
Germ cell tumor, NOS
9072/3 Polyembryoma
Embryonal carcinoma, polyembryonal
type
9073/1 Gonadoblastoma
Gonocytoma
9081/3 Teratocarcinoma
Mixed embryonal carcinoma and teratoma
Embryonal adenocarcinoma
76
ICDO.indb 76
11/18/13 1:54 PM
911 Mesonephromas
9110/0 Mesonephroma, benign
Mesonephric adenoma
Wolffian duct adenoma
9120/3 Hemangiosarcoma
Angiosarcoma
9141/0 Angiokeratoma
9142/0 Verrucous keratotic hemangioma
9150/0 Hemangiopericytoma, benign
9150/1 Hemangiopericytoma, NOS
Hemangiopericytic meningioma (C70._)
[obs]
77
ICDO.indb 77
11/18/13 1:54 PM
9170/3 Lymphangiosarcoma
Lymphangioendothelial sarcoma
Lymphangioendothelioma, malignant
9174/0 Lymphangiomyoma
9174/1 Lymphangiomyomatosis
Lymphangioleiomyomatosis
9175/0 Hemolymphangioma
78
ICDO.indb 78
11/18/13 1:54 PM
79
ICDO.indb 79
11/18/13 1:54 PM
9311/0 Odontoameloblastoma
9312/0 Squamous odontogenic tumor
9320/0 Odontogenic myxoma
Odontogenic myxofibroma
938-948 Gliomas
9380/3 Glioma, malignant (C71._)
Glioma, NOS (C71._) (except nasal glioma,
not neoplastic)
9351/1 Craniopharyngioma,
adamantinomatous (C75.2)
9352/1 Craniopharyngioma, papillary (C75.2)
9360/1 Pinealoma (C75.3)
9361/1 Pineocytoma (C75.3)
80
ICDO.indb 80
11/18/13 1:54 PM
Gemistocytoma (C71._)
ICDO.indb 81
11/18/13 1:54 PM
949-952 Neuroepitheliomatous
neoplasms
9490/0 Ganglioneuroma
9490/3 Ganglioneuroblastoma
9491/0 Ganglioneuromatosis
9492/0 Gangliocytoma
953 Meningiomas
9530/0 Meningioma, NOS
Lymphoplasmacyte-rich meningioma
Metaplastic meningioma
Microcystic meningioma
Secretory meningioma
82
ICDO.indb 82
11/18/13 1:54 PM
9560/1 Neurinomatosis
9562/0 Neurothekeoma
Nerve sheath myxoma
83
ICDO.indb 83
11/18/13 1:54 PM
84
ICDO.indb 84
11/18/13 1:54 PM
85
ICDO.indb 85
11/18/13 1:54 PM
86
ICDO.indb 86
11/18/13 1:54 PM
ICDO.indb 87
11/18/13 1:54 PM
88
ICDO.indb 88
11/18/13 1:54 PM
9767/1 Angioimmunoblastic
lymphadenopathy (AIC)
Immunoblastic lymphadenopathy (IBL)
[obs]
980-994 Leukemias
980 Leukemias, NOS
9800/3 Leukemia, NOS
Aleukemic leukemia, NOS [obs]
Chronic leukemia, NOS [obs]
Subacute leukemia, NOS [obs]
89
ICDO.indb 89
11/18/13 1:54 PM
90
ICDO.indb 90
11/18/13 1:54 PM
91
ICDO.indb 91
11/18/13 1:54 PM
995-996 Chronic
myeloproliferative disorders
9950/3 Polycythemia vera
Chronic erythremia [obs]
Polycythemia rubra vera
Proliferative polycythemia
92
ICDO.indb 92
11/18/13 1:54 PM
93
ICDO.indb 93
11/18/13 1:54 PM
ICDO.indb 94
11/18/13 1:54 PM
Alphabetic index
NOS - not otherwise specified
---------------
C76.2
C47.4
C49.4
C49.4
C47.4
C44.5
C49.4
Abdomen
NOS
autonomic nervous system
connective tissue
muscle
peripheral nerve
skin
subcutaneous tissue
C31.9
C72.5
C72.5
C31.9
C31.9
Accessory
nasal sinus
nerve, NOS
nerve, spinal
sinus, nasal
sinus, NOS
C41.4
Acetabulum
8730/0
C49.4
C15.2
C77.2
C49.4
Abdominal
aorta
esophagus
lymph node
vena cava
8280/3
8280/0
8280/3
Acidophil
adenocarcinoma (C75.1)
adenoma (C75.1)
carcinoma (C75.1)
8822/1
8822/1
Abdominal desmoid
Abdominal fibromatosis
C76.2
C44.5
C49.4
C49.4
C47.4
C49.4
C49.4
C49.4
C49.4
C47.4
C49.4
C44.5
C49.4
C49.4
Abdominal wall
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C72.5
Abducens nerve
9871/3
9871/3
9898/1
9867/3
8075/3
Abnormal
marrow eosinophils, acute myeloid
leukemia with (includes all variants)
marrow eosinophils, acute
myelomonocytic leukemia with
(includes all variants)
myelopoiesis, transient
Abnormalities, myeloid and lymphoid
neoplasms with FGFR1
Acantholytic squamous cell carcinoma
8281/0
8281/3
8550/3
8550/0
8550/3
Acinar
adenocarcinoma
adenoma
carcinoma
8550/0
8550/3
8551/3
8550/1
Acinar cell
adenoma
carcinoma
cystadenocarcinoma
tumor [obs]
8552/3
8154/3
8154/3
8550/3
8550/0
8550/1
Acinic cell
adenocarcinoma
adenoma
tumor [obs]
C72.4
Acoustic nerve
9560/0
9161/0
8744/3
C40.0
Acromioclavicular joint
95
ICDO.indb 95
11/18/13 1:54 PM
8402/0
8158/1
--------
9840/3
9840/3
9931/3
9931/3
9931/3
9931/3
9751/3
Acute
erythremia (C42.1) [obs]
erythremic myelosis (C42.1) [obs]
myelofibrosis (C42.1)
myelosclerosis, NOS (C42.1)
panmyelosis, NOS (C42.1) [obs]
panmyelosis with myelofibrosis (C42.1)
progressive histiocytosis X [obs]
9310/0
9261/3
9310/3
9261/3
9351/1
8570/3
9300/0
Adamantinoma
NOS (except of long bones 9261/3)
(C41._)
long bones (C40._)
malignant (except of long bones 9261/3)
(C41._)
tibial (C40.2)
Adamantinomatous craniopharyngioma
(C75.2)
Adenoacanthoma
Adenoameloblastoma (C41._)
8313/3
9015/3
9014/3
Adenocarcinofibroma
clear cell (C56.9)
mucinous
serous
8245/3
Adenocarcinoid tumor
8140/3
8140/6
8280/3
8550/3
8550/3
8370/3
8251/3
8215/3
8215/3
8244/3
8244/3
8560/3
8560/3
8401/3
8147/3
8300/3
8160/3
8250/3
8250/3
8420/3
8270/3
8310/3
8310/3
8480/3
8244/3
8045/3
8255/3
8244/3
8201/3
Adenocarcinoma, continued
Combined
carcinoid and adenocarcinoma
(C34._)
small cell-adenocarcinoma
(C34._)
with other types of carcinoma
8200/3
8145/3
8408/3
8500/3
8500/3
8413/3
8408/3
9070/3
8384/3
8154/3
8380/3
8383/3
8382/3
Endometrioid
NOS
ciliated cell variant
secretory variant
8280/3
8154/3
8154/3
8333/3
eosinophil (C75.1)
exocrine and endocrine, mixed (C25._)
exocrine and islet cell, mixed (C25._)
fetal (C73.9)
8330/3
8340/3
8332/3
8332/3
8331/3
Follicular
NOS (C73.9)
and papillary (C73.9)
moderately differentiated (C73.9)
trabecular (C73.9)
well differentiated (C73.9)
8480/3
8320/3
8576/3
8290/3
8210/3
8220/3
8210/3
8503/3
8500/3
8530/3
8221/3
8210/3
gelatinous [obs]
granular cell
hepatoid
Hurthle cell (C73.9)
in adenomatous polyp
in adenomatous polyposis coli (C18._)
in a polyp, NOS
infiltrating and papillary
infiltrating duct (C50._)
inflammatory (C50._)
in multiple adenomatous polyps
in polypoid adenoma
8140/2
8210/2
8210/2
8210/2
8210/2
8263/2
In situ
NOS
in adenomatous polyp
in a polyp, NOS
in polypoid adenoma
in tubular adenoma
in tubulovillous adenoma
8201/3
96
ICDO.indb 96
11/18/13 1:54 PM
Alphabetic index
8261/2
Adenocarcinoma, continued
In situ, continued
in villous adenoma
8144/3
8504/3
8500/2
8503/2
8503/2
8503/3
Intraductal
noninfiltrating, NOS
noninfiltrating, papillary (C50._)
papillary, NOS (C50._)
papillary, with invasion (C50._)
8210/3
8263/3
8261/3
8154/3
8150/3
8520/3
8525/3
8510/3
9110/3
8310/3
in tubular adenoma
in tubulovillous adenoma
in villous adenoma
islet cell and exocrine, mixed (C25._)
islet cell (C25._)
lobular (C50._)
low grade, polymorphous
medullary
mesonephric
mesonephroid, clear cell
8560/3
8560/3
8244/3
8323/3
8154/3
8154/3
8154/3
8482/3
8480/3
8481/3
8481/3
8480/3
8300/3
8480/3
8350/3
8500/2
8503/2
Mixed
adenocarcinoma and epidermoid
carcinoma
adenocarcinoma and squamous
cell carcinoma
carcinoid-adenocarcinoma
cell
endocrine and exocrine (C25._)
exocrine and endocrine (C25._)
islet cell and exocrine (C25._)
8290/3
8290/3
8163/3
8260/3
8340/3
8503/3
8408/3
8408/3
8340/3
8503/3
8504/3
8503/2
8503/2
Papillary
NOS
and follicular (C73.9)
and infiltrating (C50._)
digital (C44._)
eccrine (C44._)
follicular variant (C73.9)
infiltrating (C50._)
intracystic
intraductal, noninfiltrating (C50._)
intraductal, NOS (C50._)
8503/3
8460/3
8450/3
8263/3
8214/3
8525/3
8470/3
8312/3
8141/3
8350/3
8410/3
8441/3
8460/3
8213/3
8490/3
8230/3
8143/3
8400/3
8525/3
8190/3
8211/3
8263/3
8262/3
8322/3
8573/3
8571/3
8571/3
8255/3
8574/3
8571/3
8255/3
8572/3
8570/3
Adenocarcinoma, continued
Papillary, continued
intraductal, with invasion (C50._)
serous (C56.9)
papillocystic
papillotubular
parietal cell (C16._)
polymorphous low grade
pseudomucinous (C56.9)
renal cell (C64.9)
scirrhous
sclerosing, nonencapsulated (C73.9)
sebaceous (C44._)
serous, NOS
serous, papillary (C56.9)
serrated
signet ring cell
solid, with mucin formation
superficial spreading
sweat gland (C44._)
terminal duct
trabecular
tubular
tubulopapillary
villous
water-clear cell (C75.0)
with apocrine metaplasia
with cartilaginous and osseous
metaplasia
with cartilaginous metaplasia
with mixed subtypes
with neuroendocrine differentiation
with osseous metaplasia
with other types of carcinoma,
combined
with spindle cell metaplasia
with squamous metaplasia
8200/3
Adenocystic carcinoma
9013/0
8313/0
8313/1
Adenofibroma
NOS
clear cell (C56.9)
clear cell, of borderline malignancy
(C56.9)
8381/0
8381/1
8381/3
Endometrioid
NOS
borderline malignancy
malignant
9015/0
9015/1
8965/0
9013/0
mucinous
mucinous, of borderline malignancy
nephrogenic (C64.9)
papillary
9014/0
9014/1
9014/3
Serous
NOS
borderline malignancy
malignant
97
ICDO.indb 97
11/18/13 1:54 PM
--------
C11.1
Adenoid
8098/3
8200/3
8075/3
Adenoid
basal carcinoma (C53._)
cystic carcinoma
squamous cell carcinoma
8100/0
8324/0
8561/0
8140/0
8281/0
8280/0
8550/0
8550/0
8550/0
8210/3
Adenoma
NOS
acidophil-basophil, mixed (C75.1)
acidophil (C75.1)
acinar
acinar cell
acinic cell
adenocarcinoma in polypoid
8370/0
8373/0
8371/0
8374/0
8375/0
8372/0
Adrenal cortical
NOS (C74.0)
clear cell (C74.0)
compact cell (C74.0)
glomerulosa cell (C74.0)
mixed cell (C74.0)
pigmented (C74.0)
8408/1
8251/0
8401/0
8140/1
8147/0
8281/0
8300/0
8151/0
8160/0
8372/0
8140/1
8240/3
8200/3
Bronchial
NOS (C34._)
carcinoid (C34._)
cylindroid (C34._)
8149/0
8420/0
8321/0
8270/0
8310/0
8334/0
8408/1
8503/0
8408/0
8191/0
8380/1
8380/0
8280/0
8333/0
8212/0
canalicular
ceruminous (C44.2)
chief cell (C75.0)
chromophobe (C75.1)
clear cell
colloid (C73.9)
digital papillary, aggressive (C44._)
duct, NOS
eccrine papillary (C44._)
embryonal
endometrioid, borderline malignancy
endometrioid, NOS
eosinophil (C75.1)
fetal (C73.9)
flat
8330/0
8330/1
8290/0
8170/0
8290/0
8504/0
8453/0
8150/0
8204/0
8170/0
8334/0
9110/0
8325/0
8202/0
8441/0
8333/0
8281/0
8323/0
8146/0
8480/0
8453/0
Adenoma, continued
Follicular
NOS (C73.9)
atypical (C73.9)
oxyphilic cell (C73.9)
8300/0
8982/0
8506/0
8290/0
8290/0
8290/0
hepatocellular (C22.0)
Hurthle cell (C73.9)
intracystic, papillary
intraductal papillary-mucinous (C25._)
islet cell (C25._)
lactating (C50._)
liver cell (C22.0)
macrofollicular (C73.9)
mesonephric
metanephric (C64.9)
microcystic, NOS (C25._)
microcystic, serous
microfollicular (C73.9)
mixed acidophil-basophil (C75.1)
mixed cell
monomorphic
mucinous
mucinous-papillary, intraductal
(C25._)
mucoid cell (C75.1)
myoepithelial
nipple (C50.0)
oncocytic
oxyphilic
oxyphilic cell follicular (C73.9)
8260/0
8408/1
8408/0
8504/0
Papillary
NOS
aggressive digital (C44._)
eccrine (C44._)
intracystic
8453/0
8263/0
8640/1
8372/0
8272/0
8940/0
8941/3
papillary-mucinous, intraductal
(C25._)
papillotubular
Pick tubular
pigmented (C74.0)
pituitary, NOS (C75.1)
pleomorphic
pleomorphic, carcinoma in
(C07._,C08._)
8210/0
8210/3
8210/2
Polypoid
NOS
adenocarcinoma in
adenocarcinoma in situ in
8410/0
-------8441/0
sebaceous (C44._)
sebaceum (see SNOMED)
serous microcystic
98
ICDO.indb 98
11/18/13 1:54 PM
Alphabetic index
8213/0
8213/0
8213/0
8213/0
Adenoma, continued
Serrated
NOS (C18._)
sessile
traditional
traditional sessile
8640/1
8213/0
8390/0
8400/0
8640/1
8190/0
8336/0
8213/0
8213/0
Sertoli cell
sessile serrated
skin appendage (C44._)
sweat gland (C44._)
testicular
trabecular
trabecular, hyalinizing (C73.9)
traditional serrated
traditional sessile serrated
8220/3
8220/0
8221/0
8221/3
-------8244/3
8933/3
Adenomyoepithelioma (C50._)
Adenomyoma
Adenomyoma, atypical polypoid
Adenomyomatous hyperplasia (see
SNOMED)
Adenomyosis, NOS (see SNOMED)
Adenoneuroendocrine carcinoma, mixed
Adenosarcoma
8211/0
8210/3
8210/2
8640/1
Tubular
NOS
adenocarcinoma in
adenocarcinoma in situ in
Pick
-----------------------------
Adenosis
NOS (see SNOMED)
fibrosing (see SNOMED)
florid (see SNOMED)
sclerosing (see SNOMED)
8263/0
tubulo-papillary
8560/3
Adenosquamous carcinoma
8263/0
8263/3
8263/2
Tubulovillous
NOS
adenocarcinoma in
adenocarcinoma in situ in
8263/0
villoglandular
8261/0
8261/3
8261/2
Villous
NOS
adenocarcinoma in
adenocarcinoma in situ in
8322/0
9110/0
C49.9
C49.4
C49.1
C49.1
C49.3
C49.6
C49.5
C49.2
C49.0
C49.0
C49.3
C49.0
C49.6
C49.2
C49.1
C49.5
C49.5
C49.1
C49.0
C49.2
C49.3
C49.5
C49.2
C49.2
C49.0
C49.2
C49.5
C49.0
C49.3
C49.1
C49.0
C49.0
C49.2
Adipose tissue
NOS
abdominal wall
antecubital space
arm
axilla
back
buttock
calf
cervical region
cheek
chest wall
face
flank
foot
forearm
gluteal region
groin
hand
head
hip
infraclavicular region
inguinal region
knee
leg
neck
popliteal space
sacrococcygeal region
scalp
scapular region
shoulder
supraclavicular region
temple
thigh
8360/1
9054/0
9300/0
8220/0
8360/1
-------8150/0
8250/1
Adenomatosis
NOS
endocrine
fibrosing (see SNOMED)
islet cell (C25._)
pulmonary (C34._)
8213/0
---------------
Adenomatous
and hyperplastic polyp, mixed (C18._)
goiter (see SNOMED)
hyperplasia (see SNOMED)
8210/0
8210/3
8210/2
8210/3
8210/2
8213/0
Polyp
NOS
adenocarcinoma in
adenocarcinoma in situ in
carcinoma in
carcinoma in situ in
mixed, and hyperplastic (C18._)
8983/0
8932/0
8932/0
--------
Adenomatous, continued
polyposis coli, adenocarcinoma in
(C18._)
polyposis coli (C18._)
polyps, multiple
polyps, multiple, adenocarcinoma in
99
ICDO.indb 99
11/18/13 1:54 PM
C49.3
C49.6
8390/3
8407/3
8390/0
Adnexal
carcinoma (C44._)
microcystic, carcinoma (C44._)
tumor, benign (C44._)
C57.4
C57.4
Adnexa, NOS
Adnexa, uterine
9705/3
8077/2
C44.3
C26.9
Ala nasi
Alimentary tract, NOS
8671/0
Adrenal
medullary paraganglioma (C74.1)
medullary paraganglioma, malignant
(C74.1)
rest tumor
8370/3
Adrenal cortical
adenocarcinoma (C74.0)
9826/3
9836/3
9837/3
9836/3
9837/3
9836/3
9836/3
9837/3
9836/3
9837/3
ALL
B (see also 9687/3)
common precursor B (see also 9728/3)
cortical T (see also 9729/3)
c (see also 9728/3)
mature T (see also 9729/3)
Pre-B (see also 9728/3)
Pre-pre-B (see also 9728/3)
Pre-T (see also 9729/3)
Pro-B (see also 9728/3)
Pro-T (see also 9729/3)
8152/3
8152/1
9762/3
Alpha
cell tumor, malignant (C25._)
cell tumor, NOS (C25._)
heavy chain disease
8700/0
8700/3
8370/0
8373/0
8371/0
8374/0
8375/0
8372/0
Adenoma
NOS (C74.0)
clear cell (C74.0)
compact cell (C74.0)
glomerulosa cell (C74.0)
mixed cell (C74.0)
pigmented (C74.0)
8370/3
carcinoma (C74.0)
8370/0
8370/0
8370/3
Tumor
NOS (C74.0)
benign (C74.0)
malignant (C74.0)
C74.9
C74.0
C74.1
Adrenal gland
NOS
cortex
medulla
9080/0
8904/0
9080/0
9080/0
8620/1
8901/3
Adult
cystic teratoma
rhabdomyoma
teratoma, cystic
teratoma, NOS
type, granulosa cell tumor (C56.9)
type, pleomorphic rhabdomyosarcoma
9827/3
9827/3
9827/3
9827/3
8841/1
8408/1
8821/1
9741/3
9948/3
9200/1
Adult T-cell
leukemia (includes all variants)
leukemia/lymphoma (HTLV-1
positive) (includes all variants)
lymphoma (includes all variants)
lymphoma/leukemia (includes all
variants)
Aggressive
angiomyxoma
digital papillary adenoma (C44._)
fibromatosis
mastocytosis, systemic
NK-cell leukemia
osteoblastoma (C40._, C41._)
8408/1
9741/3
9961/3
9741/3
9767/1
8251/3
8251/0
8902/3
8251/3
8250/3
8920/3
8902/3
9581/3
9133/3
Aggressive, continued
papillary adenoma, digital (C44._)
systemic mastocytosis
Alveolar
adenocarcinoma (C34._)
adenoma (C34._)
and embryonal rhabdomyosarcoma,
mixed
carcinoma (C34._)
cell carcinoma (C34._)
rhabdomyosarcoma
rhabdomyosarcoma and embryonal
rhabdomyosarcoma, mixed
soft part sarcoma
tumor, intravascular bronchial (C34._)
[obs]
C03.9
C03.1
C03.0
Alveolar mucosa
NOS
lower
upper
C03.9
C03.1
C03.0
C06.1
Alveolar sulcus
100
ICDO.indb 100
11/18/13 1:54 PM
Alphabetic index
C03.9
C03.1
C03.0
8745/3
Alveolus
NOS
lower
upper
8730/3
9270/3
9271/0
9290/3
9330/0
9290/0
9290/3
9330/3
9290/3
9330/3
Ameloblastic
carcinoma (C41._)
fibrodentinoma (C41._)
fibrodentinosarcoma (C41._)
fibroma (C41._)
fibro-odontoma (C41._)
fibro-odontosarcoma (C41._)
fibrosarcoma (C41._)
odontosarcoma (C41._)
sarcoma (C41._)
9310/3
9310/0
8152/1
-------
C24.1
C20.9
Ampulla of Vater
Ampulla, rectal
-------9769/1
8345/3
-------8215/3
8215/3
8077/2
8077/0
Anal
ducts adenocarcinoma (C21.1)
glands adenocarcinoma (C21.1)
intraepithelial neoplasia, grade III
(C21.1)
intraepithelial neoplasia, low grade
(C21.1)
C21.1
C21.1
Anal canal
Anal sphincter
9401/3
8021/3
9390/3
9392/3
9505/3
9082/3
9474/3
9530/3
9382/3
9451/3
9062/3
9082/3
Anaplastic
astrocytoma (C71._)
carcinoma, NOS
choroid plexus papilloma (C71.5)
ependymoma (C71._)
ganglioglioma
malignant teratoma
medulloblastoma
meningioma (C70._)
oligoastrocytoma (C71._)
oligodendroglioma (C71._)
seminoma (C62._)
teratoma, malignant
-----/-4
9560/0
8630/1
8630/0
8630/3
8640/1
8641/0
Androblastoma
NOS
benign
malignant
tubular, NOS
tubular, with lipid storage (C56.9)
9982/3
Anemia
Refractory
NOS (C42.1)
with excess blasts in
transformation (RAEB-T)
(C42.1) [obs]
with excess blasts (RAEB) (C42.1)
without sideroblasts (C42.1)
with ringed sideroblasts (RARS)
(C42.1)
with ring sideroblasts associated
with marked thrombocytosis
with sideroblasts (C42.1)
-------9535/0
9161/1
9431/1
9766/1
9130/1
9135/1
9130/1
Angioendothelioma
NOS
endovascular papillary
spindle cell
9712/3
Angioendotheliomatosis
9160/0
9160/0
9160/0
9160/0
Angiofibroma
NOS
cellular
giant cell
juvenile
9980/3
9984/3
9983/3
9980/3
9982/3
9982/3
-------9767/1
9705/3
9141/0
8894/0
8856/0
8861/0
9120/0
-------8836/1
--------------9534/0
101
ICDO.indb 101
11/18/13 1:54 PM
8826/0
8860/0
8894/0
8894/3
8841/1
8841/1
9120/3
Angiomyofibroblastoma
Angiomyolipoma
Angiomyoma
Angiomyosarcoma
Angiomyxoma
Angiomyxoma, aggressive
Angiosarcoma
C76.5
C44.7
C49.2
C47.2
C40.3
C49.2
C49.2
C40.3
C47.2
C44.7
C49.2
C49.2
C49.2
C49.2
Ankle
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
bone
connective tissue
fibrous tissue
joint
peripheral nerve
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
9363/0
8623/1
C21.8
C21.8
Anorectal junction
Anorectum
C76.4
C44.6
C49.1
C49.1
C47.1
C49.1
C49.1
C49.1
C47.1
C44.6
C49.1
C49.1
Antecubital space
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
C71.9
C04.0
C38.1
C10.1
Anterior
cranial fossa
floor of mouth
mediastinum
surface of epiglottis
C67.3
C11.3
C16.8
C31.0
C16.3
C30.1
C31.0
C16.3
C16.3
Anterior wall
bladder
nasopharynx
stomach, NOS (not classifiable to
C16.0 to C16.4)
Antrum
NOS
gastric
mastoid
maxillary
pyloric
stomach
C44.5
C49.4
C49.3
C75.5
8691/1
8691/1
C77.2
8691/1
8401/3
8401/0
8401/0
8573/3
8573/3
Apocrine
adenocarcinoma
adenoma
cystadenoma
metaplasia, adenocarcinoma with
metaplasia, carcinoma with
C21.0
9044/3
C49.9
C49.1
C49.2
--------------8480/1
C18.1
Appendix
8248/1
Apudoma
C02.3
C02.0
C02.2
C70.9
C70.0
C70.1
Arachnoid
NOS
intracranial
spinal
9471/3
C02.3
C02.0
C02.2
Anterior tongue
NOS
dorsal surface
ventral surface
C50.0
Areola
8241/3
8240/1
102
ICDO.indb 102
11/18/13 1:54 PM
Alphabetic index
8241/3
8240/1
C76.4
C44.6
C49.1
C49.1
C47.1
C40.0
C49.1
C49.1
C49.1
C77.3
C49.1
C47.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
Arm
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fatty tissue
fibrous tissue
lymph node
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
8630/1
8630/0
8630/3
Arrhenoblastoma
NOS
benign
malignant
9123/0
Arteriovenous hemangioma
C49.9
C49.4
C49.3
C49.3
C49.0
C49.4
C49.2
C49.5
C49.3
C49.4
C49.1
C49.4
C49.3
C49.1
Artery
NOS
aorta, abdominal
aorta, NOS
axillary
carotid
celiac
femoral
iliac
internal mammary
mesenteric
radial
renal
subclavian
ulnar
C40.9
C41.9
C13.1
C32.1
Aryepiglottic fold
NOS (excludes laryngeal aspect of
aryepiglottic fold C32.1)
hypopharyngeal aspect
laryngeal aspect
C32.3
C13.1
C18.2
Arytenoid cartilage
Arytenoid fold
Ascending colon
C13.1
9365/3
9741/3
Askin tumor
Associated hematological clonal non-mast
cell disorder, systemic mastocytosis with
8503/3
8470/3
8470/3
9430/3
9400/3
Astroblastoma (C71._)
Astrocytic glioma (C71._)
9400/3
9401/3
9400/3
9412/1
9400/3
9400/3
9420/3
9420/3
9411/3
9421/1
9400/3
9400/3
9421/1
9421/1
9425/3
9410/3
9384/1
9383/1
Astrocytoma
NOS (C71._)
anaplastic (C71._)
cystic (C71._) [obs]
desmoplastic infantile (C71._)
diffuse (C71._)
diffuse, low grade (C71._)
fibrillary (C71._)
fibrous (C71._)
gemistocytic (C71._)
juvenile (C71._)
low grade (C71._)
low grade diffuse (C71._)
pilocytic (C71._)
piloid (C71._)
pilomyxoid
protoplasmic (C71._)
subependymal, giant cell (C71._)
subependymal, NOS (C71._)
9400/3
C41.2
C38.0
Atlas
Atrium, cardiac
8140/1
8249/3
9390/1
8830/1
8830/1
8330/1
-------8893/0
8850/1
8513/3
9539/1
8932/0
8444/1
8442/1
Atypical
adenoma
carcinoid tumor
choroid plexus papilloma (C71.5)
fibrous histiocytoma
fibroxanthoma
follicular adenoma (C73.9)
hyperplasia (see SNOMED)
leiomyoma
lipoma
medullary carcinoma (C50._)
meningioma (C70._)
polypoid adenomyoma
proliferating clear cell tumor (C56.9)
proliferating serous tumor (C56.9)
8503/3
8453/3
8380/1
8472/1
8462/1
Proliferative
endometrioid tumor
mucinous tumor (C56.9)
papillary serous tumor (C56.9)
103
ICDO.indb 103
11/18/13 1:54 PM
9508/3
8585/3
8585/1
Atypical, continued
teratoid/rhabdoid tumor (C71._)
thymoma, malignant (C37.9)
thymoma, NOS (C37.9)
C44.2
C44.2
C44.2
C30.1
Auditory
canal, external
canal, NOS
meatus, external
tube
C44.2
C44.2
Auricle, NOS
Auricle, skin
C44.2
C44.2
C49.0
C77.0
Auricular
canal, external
canal, NOS
cartilage
lymph node
8936/1
C47.9
C47.4
C47.4
C47.2
C47.1
C47.1
C47.3
C47.6
C47.5
C47.2
C47.0
C47.0
C47.3
C47.3
C47.0
C47.1
C47.0
C47.1
C47.6
C47.2
C47.1
C47.0
C47.5
C47.5
C47.1
C47.0
C47.2
C47.2
C47.3
C47.5
C47.2
C47.2
C47.0
C69.6
C47.5
C47.5
C47.2
C47.1
C47.2
C47.6
C47.4
C47.1
C76.1
C44.5
C49.3
C49.3
C47.3
C49.3
C49.3
C49.3
C77.3
C47.3
C44.5
C49.3
C49.3
Axilla
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
peripheral nerve
skin
soft tissue
subcutaneous tissue
C49.3
C77.3
C50.6
Axillary
artery
lymph node
tail of breast
C41.2
Axis
C47.0
C47.5
C47.0
C47.3
C47.1
C47.0
C47.0
C47.2
C47.3
C47.3
104
ICDO.indb 104
11/18/13 1:54 PM
Alphabetic index
B
C76.7
C44.5
C49.6
C49.6
C47.6
C41.2
C49.6
C49.6
C49.6
C49.6
C49.6
C47.6
C49.6
C44.5
C49.6
C49.6
C49.6
C49.6
Back
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fascia
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
9826/3
9836/3
8722/3
8722/0
9699/3
--------
C51.0
Bartholin gland
8098/3
8147/3
8147/0
Basal cell
adenocarcinoma (C07._, C08._)
adenoma (C07._, C08._)
8090/3
8092/3
8093/3
8093/3
8092/3
8092/3
8092/3
8097/3
8092/3
8091/3
8091/3
8097/3
8090/3
Carcinoma
NOS (C44._)
desmoplastic type (C44._)
fibroepithelial (C44._)
fibroepithelial, Pinkus type
infiltrating, non-sclerosing (C44._)
infiltrating, NOS (C44._)
infiltrating, sclerosing (C44._)
micronodular (C44._)
morpheic (C44._)
multicentric (C44._)
multifocal superficial (C44._)
nodular (C44._)
pigmented (C44._)
8090/3
-------8090/1
epithelioma (C44._)
papilloma (see SNOMED)
tumor (C44._)
C71.0
Basal ganglia
8123/3
8083/3
8094/3
C01.9
C01.9
C71.7
8281/0
8281/3
8300/3
8300/0
8300/3
Basophil
acidophil adenoma, mixed (C75.1)
acidophil carcinoma, mixed (C75.1)
adenocarcinoma (C75.1)
adenoma (C75.1)
carcinoma (C75.1)
8281/0
8833/3
8319/3
-----/0
8151/0
8151/3
C49.1
C49.2
8281/3
8094/3
-------9591/3
8160/3
8161/3
8161/0
C24.0
C24.0
C24.0
C24.0
C24.0
C22.1
8160/3
8160/0
8180/3
8148/2
8148/2
Biliary (morphology)
grade 3 intraepithelial neoplasia
(BilIN-3)
high grade intraepithelial neoplasia
8148/2
8148/2
8148/0
Intraepithelial neoplasia
grade 3 (BilIN-3)
high grade
low grade
8148/0
8264/0
105
ICDO.indb 105
11/18/13 1:54 PM
C22.1
C24.0
C24.9
8148/2
Biliary (topography)
canaliculus
duct, NOS
tract, NOS
BilIN-3, biliary intraepithelial neoplasia,
grade 3
9053/3
9053/3
9043/3
Biphasic
mesothelioma, malignant
mesothelioma, NOS
synovial sarcoma
-------8893/0
8372/0
C67.9
C67.3
C67.1
C67.5
C67.2
C67.5
C67.4
C67.0
C67.7
C67.6
C67.9
C67.3
C67.2
C67.9
C67.4
Bladder
NOS
anterior wall
dome
internal urethral orifice
lateral wall
neck
posterior wall
trigone
urachus
ureteric orifice
urinary, NOS
wall, anterior
wall, lateral
wall, NOS
wall, posterior
8120/1
9727/3
8000/3
8973/3
8972/3
Blastoma
NOS
pleuropulmonary
pulmonary (C34._)
C42.0
C49.9
Blood
Blood vessel, NOS
8780/0
8790/0
8780/0
8780/3
Blue nevus
NOS (C44._)
cellular (C44._)
Jadassohn (C44._)
malignant (C44._)
C75.5
C75.4
C69.4
C75.5
C25.1
C75.5
C60.2
C16.2
Body
aortic
carotid
ciliary
coccygeal
pancreas
para-aortic
penis
stomach
C54.9
C57.7
Body, continued
uterus
Wolffian
C41.9
C41.4
C40.3
C40.0
C41.2
C41.2
C41.2
C41.0
C40.1
C41.3
C41.4
C41.0
C41.0
C41.0
C41.0
C40.2
C40.2
C40.1
C40.3
C40.0
C41.0
C40.1
C40.3
C41.4
C40.0
C41.0
C41.4
C41.4
C41.4
C41.1
C41.1
C41.0
C40.2
C40.9
C40.2
C40.0
C41.1
C40.2
C40.3
C41.1
C42.1
C41.0
C40.1
C40.3
C41.0
C41.0
C41.0
C41.0
C40.3
C41.4
C40.3
C40.1
C41.4
Bone
NOS
acetabulum
ankle
arm
atlas
axis
back
calvarium
carpal
clavicle
coccyx
cranial
ethmoid
face (excludes mandible C41.1)
facial
femur
fibula
finger
foot
forearm
frontal
hand
heel
hip
humerus
hyoid
ilium
innominate
ischium
jaw, lower
jaw, NOS
jaw, upper
leg
limb, NOS
long, lower limb
long, upper limb
lower jaw
lower limb, long
lower limb, short
mandible
marrow
maxilla
metacarpal
metatarsal
nasal
occipital
orbital
parietal
patella
pelvic
phalanx of foot
phalanx of hand
pubic
106
ICDO.indb 106
11/18/13 1:54 PM
Alphabetic index
C40.0
C41.3
C41.4
C40.0
C40.3
C40.1
C40.0
C40.0
C41.9
C41.0
C41.0
C41.2
C41.2
C41.3
C40.3
C41.0
C40.1
C40.2
C40.3
C40.0
C41.0
C40.0
C40.1
C41.2
C41.2
C40.1
C41.0
Bone, continued
radius
rib
sacrum
scapula
short, lower limb
short, upper limb
shoulder
shoulder girdle
skeletal
skull
sphenoid
spinal column
spine
sternum
tarsal
temporal
thumb
tibia
toe
ulna
upper jaw
upper limb, long
upper limb, short
vertebra
vertebral column (excludes sacrum and
coccyx C41.4)
wrist
zygomatic
-----/1
C02.1
Border of tongue
8910/3
8910/3
Botryoides, sarcoma
Botryoid sarcoma
C26.0
C18.9
C17.9
Bowel
NOS
large, NOS
small, NOS
8081/2
8081/2
-----/-6
C77.3
C47.1
C47.1
Brachial
lymph node
nerve
plexus
C49.1
Brachialis muscle
C71.9
C70.0
C70.9
C71.0
Brain
NOS
arachnoid, intracranial
arachnoid, NOS
basal ganglia
C71.7
C71.0
C71.0
C71.6
C71.6
C71.6
C71.0
C71.0
C70.0
C71.7
C71.5
C71.0
C71.0
C72.3
C71.7
C71.5
C71.5
C71.5
C71.8
C71.0
C71.0
C70.0
C71.9
C71.9
C71.9
C71.9
C70.0
C70.0
C70.0
C70.9
C70.9
C71.5
C70.0
C70.0
C70.0
C71.7
C71.7
C71.1
C71.1
C71.0
C71.0
C71.0
C71.2
C71.0
C71.7
C71.0
C71.0
C70.0
C70.0
C71.9
C71.0
C71.5
C71.5
C71.1
C71.4
C71.3
C71.2
Brain, continued
basis pedunculi
capsule, internal
central white matter
cerebellopontine angle
cerebellum, NOS
cerebellum, vermis
cerebral cortex
cerebral hemisphere
cerebral meninges
cerebral peduncle
cerebral ventricle
cerebral white matter
cerebrum
chiasm, optic
choroid plexus, fourth ventricle
choroid plexus, lateral ventricle
choroid plexus, NOS
choroid plexus, third ventricle
corpus callosum
corpus striatum
cortex, cerebral
cranial dura mater
cranial fossa, anterior
cranial fossa, middle
cranial fossa, NOS
cranial fossa, posterior
cranial meninges
cranial pia mater
dura mater, cranial
dura mater, NOS
dura, NOS
ependyma
falx cerebelli
falx cerebri
falx, NOS
fourth ventricle, choroid plexus
fourth ventricle, NOS
frontal lobe
frontal pole
ganglia, basal
globus pallidus
hemisphere, cerebral
hippocampus
hypothalamus
infratentorial, NOS
insula
internal capsule
intracranial arachnoid
intracranial meninges
intracranial site
island of Reil
lateral ventricle, choroid plexus
lateral ventricle, NOS
lobe, frontal
lobe, occipital
lobe, parietal
lobe, temporal
107
ICDO.indb 107
11/18/13 1:54 PM
C71.7
C70.0
C70.0
C70.9
C71.7
C71.4
C71.4
C71.7
C71.0
C72.3
C72.3
C71.0
C71.3
C71.7
C70.0
C70.9
C71.5
C71.1
C71.4
C71.7
C71.0
C71.7
C71.0
C71.7
C71.9
C71.0
C71.8
C71.2
C70.0
C70.0
C71.0
C71.5
C71.5
C72.3
C71.2
C71.5
C71.7
C71.7
C71.5
C71.5
C71.5
C71.5
C71.5
C71.6
C71.0
C71.0
Brain, continued
medulla oblongata
meninges, cerebral
meninges, cranial
meninges, NOS
midbrain
occipital lobe
occipital pole
olive
operculum
optic chiasm
optic tract
pallium
parietal lobe
peduncle, cerebral
pia mater, cranial
pia mater, NOS
plexus, choroid
pole, frontal
pole, occipital
pons
putamen
pyramid
rhinencephalon
stem
suprasellar
supratentorial, NOS
tapetum
temporal lobe
tentorium cerebelli
tentorium, NOS
thalamus
third ventricle, choroid plexus
third ventricle, NOS
tract, optic
uncus
ventricle, cerebral
ventricle, fourth, choroid plexus
ventricle, fourth, NOS
ventricle, lateral, choroid plexus
ventricle, lateral, NOS
ventricle, NOS
ventricle, third, choroid plexus
ventricle, third, NOS
vermis, cerebellum
white matter, central
white matter, cerebral
C10.4
C50.9
C50.0
C50.6
C50.1
C50.8
C50.8
C50.3
C50.5
Breast
NOS (excludes skin of breast C44.5)
areola
axillary tail
central portion
inner
lower
lower-inner quadrant
lower-outer quadrant
C50.8
C50.0
C50.8
C50.3
C50.5
C50.2
C50.4
C44.5
C50.6
C50.8
C50.2
C50.4
Breast, continued
midline
nipple
outer
quadrant, lower-inner
quadrant, lower-outer
quadrant, upper-inner
quadrant, upper-outer
skin
tail
upper
upper-inner quadrant
upper-outer quadrant
9000/0
9000/1
9000/3
9000/1
Brenner tumor
NOS (C56.9)
borderline malignancy (C56.9)
malignant (C56.9)
proliferating (C56.9)
C57.1
Broad ligament
8140/1
8240/3
8200/3
Bronchial adenoma
NOS (C34._)
carcinoid (C34._)
cylindroid (C34._)
9133/3
C77.1
8250/3
8250/3
C34.9
Bronchiole
8250/3
Bronchiolo-alveolar
adenocarcinoma, NOS (C34._)
8250/3
8254/3
8252/3
8253/3
8254/3
8254/3
8253/3
8252/3
8254/3
8252/3
Carcinoma
NOS (C34._)
Clara cell and goblet cell type
(C34._)
Clara cell (C34._)
goblet cell type (C34._)
indeterminate type (C34._)
mixed mucinous and nonmucinous (C34._)
mucinous (C34._)
non-mucinous (C34._)
type II pneumocyte and goblet cell
type (C34._)
type II pneumocyte (C34._)
C34.9
C77.1
Bronchogenic
Bronchopulmonary lymph node
C34.9
C34.0
C34.3
C34.0
Bronchus
NOS
carina
lower lobe
main
108
ICDO.indb 108
11/18/13 1:54 PM
Alphabetic index
C34.2
C34.1
Bronchus, continued
middle lobe
upper lobe
8100/0
C44.3
Brow
8880/0
C06.9
C06.0
C06.1
Buccal
cavity
mucosa
sulcus
9826/3
9680/3
Burkitt
cell leukemia (see also 9687/3)
lymphoma, B-cell lymphoma,
unclassifiable, with features
intermediate between diffuse large
B-cell lymphoma and
lymphoma, NOS (includes all variants)
(see also 9826/3)
tumor [obs] (includes all variants) (see
also 9826/3)
type, acute leukemia (see also 9687/3)
type, malignant lymphoma, small
noncleaved [obs] (includes all
variants) (see also 9826/3)
type, malignant lymphoma,
undifferentiated [obs] (includes all
variants) (see also 9826/3)
C
C18.0
9340/0
8975/1
8110/0
8975/1
9301/0
8642/1
8975/1
--------
Caecum
Calcifying
epithelial odontogenic tumor (C41._)
epithelial stromal tumor, nested
(C22.0)
epithelioma of Malherbe (C44._)
nested epithelial stromal tumor (C22.0)
odontogenic cyst (C41._)
Sertoli cell tumor, large cell
stromal tumor, nested epithelial
(C22.0)
Calcinosis, tumoral (see SNOMED)
Calf
9687/3
Burkitt-like lymphoma
C76.5
C44.7
C49.2
C49.2
C49.2
C49.2
C49.2
C49.2
C49.2
C44.7
C49.2
C49.2
C49.2
C49.2
C49.9
Bursa, NOS
9836/3
C76.3
C44.5
C49.5
C49.5
C47.5
C49.5
C49.5
C49.5
C49.5
C47.5
C49.5
C44.5
C49.5
C49.5
Buttock
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C41.0
C65.9
C65.9
Calvarium
Calyces, renal
Calyx, renal
C21.1
C44.2
C44.2
C44.2
C44.2
C53.0
C44.2
C53.0
C16.4
Canal
anal
auditory, external
auditory, NOS
auricular, external
auricular, NOS
cervical
ear
endocervical
pyloric
8149/0
Canalicular adenoma
C22.1
Canaliculus, biliary
8000/3
C44.1
C44.1
C44.1
Canthus
NOS
inner
outer
9687/3
9687/3
9826/3
9687/3
9687/3
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
connective tissue
fatty tissue
fibrous tissue
muscle
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
109
ICDO.indb 109
11/18/13 1:54 PM
9131/0
9171/0
Capillary hemangioma
Capillary lymphangioma
C71.0
Capsule, internal
8934/3
Carcinofibroma
8240/3
8244/3
8244/3
8244/3
8240/3
8244/3
8244/3
8244/3
8241/3
8242/3
8242/1
8241/3
8242/1
8243/3
8244/3
8243/3
8241/3
9091/1
9091/1
8245/1
Carcinoid
NOS
adenocarcinoma and, combined
adenocarcinoma and, combined/mixed
adenocarcinoma and, mixed
bronchial adenoma (C34._)
combined adenocarcinoma and
combined/mixed adenocarcinoma and
composite
EC cell
ECL cell, malignant
ECL cell, NOS
enterochromaffin cell
enterochromaffin-like cell, NOS
goblet cell
mixed carcinoid-adenocarcinoma
mucinous
serotonin producing
strumal (C56.9)
struma ovarii and (C56.9)
tubular
8240/3
8241/3
8240/1
8249/3
8240/1
Tumor
NOS
argentaffin, malignant
argentaffin, NOS
atypical
uncertain malignant potential
8240/3
typical
8010/3
8010/6
8075/3
8281/3
8280/3
8550/3
8550/3
8552/3
8154/3
8200/3
8098/3
8200/3
8075/3
Adenoid
basal (C53._)
cystic
squamous cell
8244/3
8560/3
8390/3
8407/3
8370/3
8251/3
8250/3
adenoneuroendocrine, mixed
adenosquamous
adnexal (C44._)
adnexal, microcystic (C44._)
adrenal cortical (C74.0)
alveolar (C34._)
alveolar cell (C34._)
9270/3
8021/3
8503/3
8453/3
8503/3
8470/3
8470/3
Carcinoma, continued
ameloblastic (C41._)
anaplastic, NOS
Associated invasive
intracystic papillary neoplasm
with (C23.9)
intraductal papillary-mucinous
neoplasm with
intraductal papillary neoplasm
with
mucinous cystic neoplasm with
(C25._)
mucinous cystic tumor with
(C25._)
8098/3
8090/3
8092/3
8093/3
8093/3
8097/3
8092/3
8091/3
8091/3
8097/3
8092/3
8090/3
8092/3
8091/3
Basal cell
NOS (C44._)
desmoplastic type (C44._)
fibroepithelial (C44._)
fibroepithelial, Pinkus type
micronodular (C44._)
morpheic (C44._)
multicentric (C44._)
multifocal superficial (C44._)
nodular (C44._)
non-sclerosing, infiltrating (C44._)
pigmented (C44._)
sclerosing, infiltrating (C44._)
superficial, multifocal (C44._)
8123/3
8083/3
8094/3
8281/3
8300/3
8094/3
8319/3
8180/3
8160/3
8081/2
8250/3
8250/3
8254/3
8252/3
8253/3
8254/3
8254/3
8253/3
8252/3
8254/3
8252/3
basaloid (C21.1)
basaloid squamous cell
basal-squamous cell, mixed (C44._)
basophil-acidophil, mixed (C75.1)
basophil (C75.1)
basosquamous (C44._)
Bellini duct (C64.9)
bile duct and hepatocellular, mixed
(C22.0)
bile duct (C22.1, C24.0)
Bowen type, intraepidermal squamous
cell (C44._)
bronchiolar (C34._)
Bronchiolo-alveolar
NOS (C34._)
Clara cell and goblet cell type
(C34._)
Clara cell (C34._)
goblet cell type (C34._)
indeterminate type (C34._)
mixed mucinous and nonmucinous (C34._)
mucinous (C34._)
non-mucinous (C34._)
type II pneumocyte and goblet cell
type (C34._)
type II pneumocyte (C34._)
110
ICDO.indb 110
11/18/13 1:54 PM
Alphabetic index
8345/3
8420/3
9390/3
8270/3
8317/3
8310/3
8507/2
8124/3
8490/3
8319/3
8480/3
8523/3
8255/3
8180/3
8045/3
8045/3
8045/3
8201/3
8051/3
Carcinoma, continued
C cell (C73.9)
ceruminous (C44.2)
choroid plexus (C71.5)
chromophobe (C75.1)
chromophobe cell renal (C64.9)
clear cell
clinging, intraductal (C50._)
cloacogenic (C21.2)
cohesive, poorly
collecting duct (C64.9)
colloid
colloid and infiltrating duct (C50._)
Combined
adenocarcinoma with other types
of carcinoma
hepatocellular and
cholangiocarcinoma (C22.0)
small cell
small cell-large cell (C34._)
small cell-squamous cell (C34._)
comedo-type cribriform (C18._, C19.9,
C20.9)
condylomatous
8201/2
Cribriform
NOS
and infiltrating duct (C50._)
comedo-type (C18._, C19.9,
C20.9)
in situ (C50._)
8121/3
8508/3
8145/3
8201/3
8523/3
8201/3
8523/3
8500/3
Duct
NOS
cell
collecting (C64.9)
desmoplastic type
infiltrating and colloid (C50._)
infiltrating and cribriform (C50._)
infiltrating and lobular carcinoma
(C50._)
infiltrating and lobular carcinoma
in situ (C50._)
infiltrating and mucinous (C50._)
infiltrating and Paget disease,
breast (C50._)
infiltrating and tubular (C50._)
infiltrating (C50._)
8500/3
8522/3
8201/3
8154/3
Ductal
NOS
and lobular (C50._)
cribriform type (C50._)
endocrine-acinar-, mixed
8500/3
8500/3
8319/3
8514/3
8523/3
8523/3
8522/3
8522/3
8523/3
8541/3
8522/3
8501/2
8201/2
8507/2
8500/2
8503/2
8230/2
Carcinoma, continued
Ductal, continued
in situ and infiltrating lobular
(C50._)
in situ, comedo type (C50._)
in situ, cribriform type (C50._)
in situ, micropapillary (C50._)
in situ, NOS (C50._)
in situ, papillary (C50._)
in situ, solid type (C50._)
8552/3
8521/3
ductal-acinar, mixed
ductular, infiltrating (C50._)
9070/3
9081/3
9101/3
9071/3
9072/3
Embryonal
NOS
and teratoma, mixed
combined with choriocarcinoma
infantile
polyembryonal type
8154/3
8380/3
8280/3
endocrine-ductal-acinar
endometrioid, NOS
eosinophil (C75.1)
8071/3
8072/3
8052/3
8073/3
8074/3
8051/3
Epidermoid
NOS
and adenocarcinoma, mixed
in situ, NOS
in situ with questionable stromal
invasion
keratinizing
large cell, nonkeratinizing
papillary
small cell, nonkeratinizing
spindle cell
verrucous
8562/3
8171/3
epithelial-myoepithelial
fibrolamellar hepatocellular (C22.0)
8330/3
8340/3
8335/3
8335/3
8332/3
8290/3
8332/3
8331/3
Follicular
NOS (C73.9)
and papillary (C73.9)
encapsulated (C73.9)
minimally invasive (C73.9)
moderately differentiated (C73.9)
oxyphilic cell (C73.9)
trabecular (C73.9)
well differentiated (C73.9)
8346/3
8480/3
8031/3
8030/3
8015/3
8315/3
8320/3
8620/3
8172/3
8070/3
8560/3
8070/2
8076/2
111
ICDO.indb 111
11/18/13 1:54 PM
8170/3
8180/3
8180/3
8174/3
8171/3
8175/3
8173/3
8172/3
8173/3
Carcinoma, continued
Hepatocellular
NOS (C22.0)
and bile duct, mixed (C22.0)
and cholangiocarcinoma,
combined (C22.0)
clear cell type (C22.0)
fibrolamellar (C22.0)
pleomorphic type (C22.0)
sarcomatoid (C22.0)
scirrhous (C22.0)
spindle cell variant (C22.0)
8575/3
8290/3
8210/3
8210/3
9071/3
hepatoid
Hurthle cell (C73.9)
in adenomatous polyp
in a polyp, NOS
infantile, embryonal
8500/3
8523/3
8523/3
8522/3
8522/3
8523/3
8541/3
8523/3
8523/3
Infiltrating duct
NOS (C50._)
and colloid (C50._)
and cribriform (C50._)
and lobular (C50._)
and lobular in situ (C50._)
and mucinous (C50._)
and Paget disease, breast (C50._)
and tubular (C50._)
mixed with other types (C50._)
8521/3
8520/3
8522/3
8524/3
8530/3
8941/3
Infiltrating lobular
NOS (C50._)
and ductal carcinoma in situ
(C50._)
mixed with other types (C50._)
inflammatory (C50._)
in pleomorphic adenoma (C07._,
C08._)
8520/2
8050/2
8120/2
In situ
NOS
ductal and infiltrating lobular
(C50._)
epidermoid, NOS
epidermoid, with questionable
stromal invasion
in adenomatous polyp
in a polyp, NOS
lobular and intraductal (C50._)
lobular carcinoma and infiltrating
duct (C50._)
lobular, NOS (C50._)
papillary
urothelial (C67._)
8337/3
8144/3
8504/2
insular (C73.9)
intestinal type (C16._)
intracystic, noninfiltrating
8010/2
8522/3
8070/2
8076/2
8210/2
8210/2
8522/2
8522/3
8504/3
8504/3
8500/2
8522/3
8522/2
8543/3
8507/2
8507/2
8500/2
8503/2
8503/2
8503/2
8230/2
8070/2
8081/2
8010/2
8070/2
9270/3
8150/3
8502/3
Carcinoma, continued
intracystic, NOS
intracystic, papillary
Intraductal
NOS
and lobular (C50._)
and lobular in situ (C50._)
and Paget disease, breast (C50._)
clinging (C50._)
micropapillary (C50._)
noninfiltrating, NOS
noninfiltrating, papillary (C50._)
papillary, noninfiltrating (C50._)
papillary, NOS (C50._)
solid type
intraepidermal, NOS
intraepidermal squamous cell, Bowen
type (C44._)
intraepithelial, NOS
intraepithelial squamous cell
intraosseous, primary (C41.1)
islet cell (C25._)
juvenile, breast (C50._)
8014/3
Large cell
NOS
epidermoid, nonkeratinizing
neuroendocrine
squamous cell, keratinizing
squamous cell, nonkeratinizing,
NOS
with rhabdoid phenotype
8045/3
8314/3
8170/3
8012/3
8072/3
8013/3
8071/3
8072/3
8522/2
8520/2
8520/2
Lobular
NOS (C50._)
and ductal (C50._)
and infiltrating duct (C50._)
and intraductal (C50._)
infiltrating and ductal in situ
(C50._)
infiltrating (C50._)
in situ and infiltrating duct
(C50._)
in situ and intraductal (C50._)
in situ (C50._)
noninfiltrating (C50._)
8082/3
8082/3
8110/3
lymphoepithelial
lymphoepithelioma-like
matrical (C44._)
8510/3
8513/3
8345/3
8512/3
Medullary
NOS
atypical (C50._)
with amyloid stroma (C73.9)
with lymphoid stroma
8520/3
8522/3
8522/3
8522/3
8522/3
8520/3
8522/3
112
ICDO.indb 112
11/18/13 1:54 PM
Alphabetic index
8346/3
8347/3
8247/3
8575/3
8010/6
8490/6
8095/3
8407/3
8076/3
Carcinoma, continued
medullary-follicular mixed (C73.9)
medullary-papillary, mixed (C73.9)
Merkel cell (C44._)
metaplastic, NOS
metastatic, NOS
metastatic signet ring cell
metatypical (C44._)
microcystic adnexal (C44._)
microinvasive squamous cell
8265/3
8507/2
8460/3
8131/3
Micropapillary
NOS (C18._, C19.9, C20.9)
intraductal (C50._)
serous (C56.9)
transitional cell (C67._)
8552/3
8154/3
8154/3
8560/3
8560/3
8244/3
8094/3
8552/3
8154/3
8154/3
8154/3
8346/3
8180/3
8346/3
8347/3
8347/3
8045/3
8560/3
8523/3
8524/3
Mixed
acinar-ductal
acinar-endocrine (C25._)
acinar-endocrine-ductal
adenocarcinoma and epidermoid
adenocarcinoma and squamous
cell
adenoneuroendocrine
basal-squamous cell (C44._)
ductal-acinar
ductal-acinar-endocrine
ductal-endocrine (C25._)
endocrine-ductal-acinar
follicular-medullary (C73.9)
hepatocellular and bile duct (22.0)
medullary-follicular (C73.9)
medullary-papillary (C73.9)
papillary-medullary (C73.9)
small cell
squamous cell and
adenocarcinoma
with other types, infiltrating duct
(C50._)
with other types, infiltrating
lobular (C50._)
8480/3
8523/3
8481/3
8481/3
8430/3
8480/3
8480/3
8091/3
8091/3
8982/3
8562/3
mucinous
mucinous and infiltrating duct (C50._)
mucin-producing
mucin-secreting
mucoepidermoid
mucoid
mucous
multicentric basal cell (C44._)
multifocal superficial basal cell (C44._)
myoepithelial
myoepithelial-epithelial
8246/3
8013/3
8240/3
8249/3
Neuroendocrine
NOS
large cell
low grade
moderately differentiated
8247/3
8240/3
Carcinoma, continued
Neuroendocrine, continued
primary cutaneous (C44._)
well-differentiated
8350/3
8504/2
8500/2
8503/2
8520/2
Noninfiltrating
intracystic
intraductal, NOS
intraductal papillary (C50._)
lobular (C.50_)
8130/2
8130/2
8046/3
8042/3
9270/3
8290/3
8523/3
8524/3
8163/3
8050/3
8340/3
8344/3
8350/3
8343/3
8052/3
8340/3
8050/2
8504/3
8503/2
8503/2
8342/3
8260/3
8461/3
8461/3
8052/3
8052/2
8052/2
8344/3
8260/3
8130/3
8130/2
8130/3
8130/2
8347/3
8453/2
8345/3
113
ICDO.indb 113
11/18/13 1:54 PM
8075/3
8033/3
Carcinoma, continued
parietal cell (C16._)
pigmented basal cell (C44._)
pilomatrix (C44._)
pituitary, NOS (C75.1)
pleomorphic
polygonal cell
poorly cohesive
primary intraosseous carcinoma
(C41.1)
primary serous papillary, peritoneum
(C48.1)
pseudoglandular squamous cell
pseudosarcomatous
8312/3
8317/3
8316/3
8260/3
8318/3
8318/3
Renal cell
NOS (C64.9)
chromophobe type (C64.9)
cyst-associated (C64.9)
papillary (C64.9)
sarcomatoid (C64.9)
spindle cell (C64.9)
8317/3
8319/3
8041/3
8041/3
8033/3
8318/3
8121/3
8141/3
8350/3
8407/3
8410/3
8010/6
8502/3
8214/3
8090/3
8110/3
8272/3
8022/3
8034/3
8490/3
9270/3
8461/3
8461/3
Serous
NOS
papillary, primary, peritoneum
(C48.1)
surface papillary (C56.9)
8640/3
8589/3
8589/3
8490/3
8490/6
8231/3
8390/3
8041/3
8043/3
8044/3
8041/3
8073/3
Small cell
NOS
fusiform cell
intermediate cell
neuroendocrine
squamous cell, nonkeratinizing
8045/3
8441/3
8461/3
8230/3
8452/3
8230/3
Carcinoma, continued
Solid
NOS
pseudopapillary (C25._)
with mucin formation
8032/3
8030/3
8318/3
Spindle cell
NOS
and giant cell
renal cell (C64.9)
8070/3
squamous
8070/2
8071/3
8071/3
8072/3
8070/6
8076/3
8072/3
8052/3
8052/2
8075/3
8074/3
8073/3
8074/3
8051/3
8078/3
Squamous cell
NOS
NOS, metastatic
acantholytic
adenoid
basaloid
clear cell type
in situ, NOS
in situ with questionable stromal
invasion
intraepidermal, Bowen type
(C44._)
intraepithelial
keratinizing, NOS
large cell, keratinizing
large cell, nonkeratinizing, NOS
metastatic, NOS
microinvasive
nonkeratinizing, NOS
papillary
papillary, non-invasive
pseudoglandular
sarcomatoid
small cell, nonkeratinizing
spindle cell
verrucous
with horn formation
8407/3
8400/3
8407/3
8586/3
8585/3
8190/3
8120/3
8120/3
8120/2
8131/3
8130/3
8130/2
8122/3
8122/3
Transitional cell
NOS
in situ
micropapillary (C67._)
papillary (C67._)
papillary, non-invasive (C67._)
sarcomatoid
spindle cell
8102/3
8211/3
trichilemmal (C44._)
tubular
8070/3
8070/6
8075/3
8075/3
8083/3
8084/3
8070/2
8076/2
8081/2
114
ICDO.indb 114
11/18/13 1:54 PM
Alphabetic index
8523/3
8020/3
Carcinoma, continued
tubular and infiltrating duct (C50._)
undifferentiated, NOS
8120/3
8120/2
8130/2
8130/2
Urothelial
NOS
in situ
non-invasive, papillary (C67._)
papillary, non-invasive (C67._)
9210/0
8571/3
Cartilaginous
and osseous metaplasia,
adenocarcinoma with
exostosis (C40._, C41._)
metaplasia, adenocarcinoma with
8589/3
CASTLE
C72.1
Cauda equina
8051/3
8051/3
8051/3
Verrucous
NOS
epidermoid
squamous cell
9121/0
9172/0
Cavernous hemangioma
Cavernous lymphangioma
8051/3
8322/3
8573/3
8574/3
8035/3
8141/3
9110/3
warty
water-clear cell (C75.0)
with apocrine metaplasia
with neuroendocrine differentiation
with osteoclast-like giant cells
with productive fibrosis
Wolffian duct
C06.9
C30.0
C06.9
C48.2
C30.1
Cavity
buccal
nasal (excludes nose, NOS C76.0)
oral
peritoneal
tympanic
8571/3
8345/3
9718/3
8010/9
Carcinomatosis
9718/3
8980/3
8981/3
9342/3
Carcinosarcoma
NOS
embryonal
odontogenic (C41._)
C18.0
C49.4
C77.2
Cecum
Celiac artery
Celiac lymph node
C38.0
C38.0
C16.0
C16.0
C16.0
C34.0
C49.0
C75.4
Cardiac atrium
Cardiac ventricle
Cardia, gastric
Cardia, NOS
Cardioesophageal junction
Carina
Carotid artery
Carotid body
-----/-9
8692/1
8692/1
C40.1
Carpal bone
C41.9
C41.9
C40.9
C32.3
C49.0
C41.3
C32.3
C32.3
C49.0
C32.3
C40.9
C30.0
C40.2
C32.3
Cartilage
NOS
articular, NOS
articular of limb, NOS
arytenoid
auricular
costal
cricoid
cuneiform
ear
laryngeal
limb, NOS
nasal
semilunar
thyroid
9160/0
8790/0
9391/3
8810/1
8892/0
9560/0
9272/0
9274/0
9273/0
9275/0
9272/0
9272/0
9274/0
9321/0
-------9500/3
9506/1
9321/0
9186/3
9186/3
9473/3
Cellular
angiofibroma
blue nevus (C44._)
ependymoma (C71._)
fibroma (C56.9)
leiomyoma
schwannoma
Cemental dysplasia, periapical (C41._)
Cementifying fibroma (C41._)
Cementoblastoma, benign (C41._)
Cementoma, gigantiform (C41._)
Cementoma, NOS (C41._)
Cemento-osseous dysplasia, periapical
(C41._)
Cemento-ossifying fibroma (C41._)
Central (morphology)
fibroma, odontogenic (C41._)
giant cell granuloma (see SNOMED)
neuroblastoma (C71._)
neurocytoma
odontogenic fibroma (C41._)
osteosarcoma (C40._, C41._)
osteosarcoma, conventional
(C40._,C41._)
primitive neuroectodermal tumor,
NOS (C71._)
115
ICDO.indb 115
11/18/13 1:54 PM
C72.9
C50.1
C71.0
Central (topography)
nervous system
portion of breast
white matter
9480/3
Cerebellar
liponeurocytoma
sarcoma, arachnoidal, circumscribed
(C71.6) [obs]
sarcoma, NOS (C71.6) [obs]
C71.6
C71.6
C71.6
Cerebellopontine angle
Cerebellum, NOS
Cerebellum, vermis
C71.0
C71.0
C70.0
C71.7
C71.5
C71.0
Cerebral
cortex
hemisphere
meninges
peduncle
ventricle
white matter
9381/3
C71.0
C44.2
Cerebrum
Ceruminal gland
8420/3
8420/0
8420/3
Ceruminous
adenocarcinoma (C44.2)
adenoma (C44.2)
carcinoma (C44.2)
C53.0
C72.0
C15.0
C77.0
C47.0
C76.0
C53.8
Cervical
canal
cord
esophagus
lymph node
plexus
region, NOS
stump
9506/1
9471/3
8077/2
8077/0
C76.0
C44.4
C49.0
C49.0
C47.0
C49.0
C49.0
C49.0
C47.0
C44.4
C49.0
C49.0
C53.9
C53.8
C53.9
C53.9
Cervix
NOS
squamocolumnar junction
uteri
uterine
9762/3
9762/3
9762/3
9762/3
Chain disease
NOS, heavy
alpha heavy
gamma heavy
mu heavy
--------
C76.0
C44.3
C49.0
C49.0
C47.0
C49.0
C44.3
C49.0
C49.0
C06.0
C06.0
C47.0
C44.3
C49.0
C49.0
Cheek
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
external
fatty tissue
fibrous tissue
internal
mucosa
peripheral nerve
skin
soft tissue
subcutaneous tissue
8693/1
Chemodectoma
C76.1
C44.5
C49.3
C47.3
C49.3
C49.3
C47.3
C44.5
C49.3
C49.3
Chest
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
connective tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
C76.1
C44.5
C49.3
C49.3
C47.3
C49.3
C49.3
C49.3
C49.3
C47.3
C49.3
C44.5
C49.3
C49.3
Chest wall
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
116
ICDO.indb 116
11/18/13 1:54 PM
Alphabetic index
C72.3
Chiasm, optic
8321/0
9985/3
9724/3
C44.3
C44.3
C49.0
C47.0
C49.0
C49.0
C47.0
C44.3
C49.0
C49.0
Chin
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
connective tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
9930/3
Chloroma
C11.3
Choana
8180/3
8160/3
C22.1
Cholangiole
8160/0
C24.0
Choledochal duct
--------------9181/3
9230/0
9371/3
8862/0
8940/0
8940/3
Chondroid
chordoma
lipoma
syringoma (C44._)
syringoma, malignant (C44._)
9220/0
9221/0
9221/0
Chondroma
NOS (C40._, C41._)
juxtacortical (C40._, C41._)
periosteal (C40._, C41._)
9230/3
9220/1
-------9230/0
9241/0
Chondromatosis, NOS
Chondromatosis, synovial (see SNOMED)
Chondromatous giant cell tumor (C40._,
C41._)
Chondromyxoid fibroma (C40._, C41._)
9220/3
9242/3
9243/3
9221/3
9240/3
Chondrosarcoma
NOS (C40._, C41._)
clear cell (C40._, C41._)
dedifferentiated (C40._, C41._)
juxtacortical (C40._, C41._)
mesenchymal
9231/3
9221/3
Chondrosarcoma, continued
myxoid
periosteal (C40._, C41._)
9444/1
9444/1
9538/1
Chordoid
glioma (C71._)
glioma of third ventricle (C71.5)
meningioma (C70._)
9370/3
9371/3
9372/3
Chordoma
NOS
chondroid
dedifferentiated
9100/1
9100/1
9120/0
Chorioadenoma (C58.9)
Chorioadenoma destruens (C58.9)
Chorioangioma (C58.9)
9101/3
Choriocarcinoma
NOS
combined with embryonal carcinoma
combined with other germ cell
elements
combined with teratoma
9100/3
9100/3
--------
Chorioepithelioma
Chorionepithelioma
Choristoma (see SNOMED)
C69.3
Choroid
C71.5
C71.7
C71.5
C71.5
Choroid plexus
NOS
fourth ventricle
lateral ventricle
third ventricle
9390/3
9390/0
9390/3
9390/1
9390/3
8700/0
8700/0
8700/0
Chromaffinoma
Chromaffin paraganglioma
Chromaffin tumor
8270/3
8270/0
8270/3
8317/3
Chromophobe
adenocarcinoma (C75.1)
adenoma (C75.1)
carcinoma (C75.1)
cell renal carcinoma (C64.9)
9100/3
9101/3
9101/3
9950/3
9961/3
9831/3
9960/3
9960/3
Chronic
erythremia [obs]
idiopathic myelofibrosis
lymphoproliferative disorder of NK
cells
myeloproliferative disease
myeloproliferative disorder
117
ICDO.indb 117
11/18/13 1:54 PM
--------
C69.4
Ciliary body
8383/3
8077/2
8077/2
9471/3
8254/3
8252/3
C41.3
Clavicle
8084/3
8444/1
8005/0
C10.4
8507/2
C51.2
Clitoris
8124/3
C21.2
Cloacogenic zone
-------8313/3
8310/3
8310/3
8313/0
8313/1
8310/0
8373/0
8310/3
9242/3
8313/3
8313/0
8313/1
8443/0
8444/1
9391/3
8174/3
8402/0
8005/3
9538/1
9341/1
9044/3
8964/3
9044/3
9741/3
C77.4
C75.5
C75.5
C41.4
9230/0
8490/3
C77.2
-------8319/3
8319/3
8480/3
8334/0
8480/3
8523/3
--------
Colloid
adenocarcinoma
adenoma (C73.9)
carcinoma
carcinoma and infiltrating duct (C50._)
goiter (see SNOMED)
C18.9
C18.1
C18.2
C18.0
C18.6
C18.3
C18.6
C18.7
C19.9
C18.2
C18.7
C18.7
C18.5
C18.4
Colon
NOS
appendix
ascending
cecum
descending
hepatic flexure
left
pelvic
rectosigmoid
right
sigmoid
sigmoid flexure
splenic flexure
transverse
C19.9
8344/3
8121/1
C44.3
C41.2
C41.2
Columnella
Column, spinal
Column, vertebral (excludes sacrum and
coccyx C41.4)
8244/3
9101/3
9101/3
9101/3
8180/3
8045/3
8045/3
Combined
carcinoid and adenocarcinoma
choriocarcinoma with embryonal
carcinoma
choriocarcinoma with other germ cell
elements
choriocarcinoma with teratoma
hepatocellular carcinoma and
cholangiocarcinoma (C22.0)
small cell-adenocarcinoma (C34._)
small cell carcinoma
118
ICDO.indb 118
11/18/13 1:54 PM
Alphabetic index
8045/3
8045/3
8244/3
8501/2
8501/3
Combined, continued
small cell-large cell carcinoma (C34._)
small cell-squamous cell carcinoma
(C34._)
Combined/mixed carcinoid and
adenocarcinoma
Comedocarcinoma, noninfiltrating (C50._)
Comedocarcinoma, NOS (C50._)
8501/2
8501/2
Comedo type
adenocarcinoma, cribriform (C18._,
C19.9, C20.9)
carcinoma, cribriform (C18._, C19.9,
C20.9)
DCIS (C50._)
ductal carcinoma in situ (C50._)
C00.6
C32.0
C00.6
Commissure
labial
laryngeal
lip
C24.0
C24.0
C77.2
Common
bile duct
duct
duct lymph node
8201/3
8201/3
8371/0
8760/0
9281/0
C44.2
Concha
----------------------
Condyloma
NOS (see SNOMED)
acuminatum (see SNOMED)
giant, acuminatum (see SNOMED)
8051/3
Condylomatous carcinoma
9100/0
9282/0
9442/3
8244/3
9596/3
--------------8824/1
8814/3
8761/3
-------8827/1
8761/1
8762/1
Congenital
cyst, NOS (see SNOMED)
dysplasia, NOS (see SNOMED)
fibromatosis, generalized
fibrosarcoma
melanocytic nevus, malignant
melanoma in (C44._)
melanosis (see SNOMED)
myofibroblastic tumor, peribronchial
(C34._)
nevus, intermediate and giant (C44._)
nevus, proliferative dermal lesion in
(C44._)
8761/0
Congenital, continued
nevus, small (C44._)
C69.0
Conjunctiva
C49.9
C49.4
C49.4
C49.2
C49.1
C49.1
C49.3
C49.6
C49.5
C49.2
C49.0
C49.0
C49.3
C49.3
C49.0
C49.1
C49.0
C49.1
C49.6
C49.2
C49.1
C49.0
C49.5
C49.5
C49.1
C49.0
C49.2
C49.2
C49.3
C49.5
C49.2
C49.2
C49.0
C69.6
C49.5
C49.5
C49.2
C49.0
C49.5
C49.0
C49.3
C49.1
C49.0
C49.0
C49.2
C49.3
C49.3
C49.1
C49.2
C49.6
C49.4
C49.1
Connective tissue
NOS
abdomen
abdominal wall
ankle
antecubital space
arm
axilla
back
buttock
calf
cervical region
cheek
chest
chest wall
chin
elbow
face
finger
flank
foot
forearm
forehead
gluteal region
groin
hand
head
heel
hip
infraclavicular region
inguinal region
knee
leg
neck
orbit
pelvis
perineum
popliteal space
pterygoid fossa
sacrococcygeal region
scalp
scapular region
shoulder
supraclavicular region
temple
thigh
thoracic wall
thorax (excludes thymus, heart and
mediastinum C37._, C38._)
thumb
toe
trunk, NOS
umbilicus
wrist
119
ICDO.indb 119
11/18/13 1:54 PM
C72.0
Conus medullaris
9186/3
C49.1
Coracobrachialis muscle
C72.0
C32.1
C72.0
C72.0
C63.1
C72.0
C72.0
C32.0
Cord
cervical
false
lumbar
sacral
spermatic
spinal
thoracic
true
C32.0
C32.1
C32.0
Cord, vocal
NOS
false
true
C69.1
C69.1
Cornea, limbus
Cornea, NOS
C71.8
C60.2
C16.2
C60.2
C16.2
C71.0
C54.9
Corpus
callosum
cavernosum
gastric
penis
stomach
striatum
uteri
C71.0
C74.0
Cortex, cerebral
Cortex of adrenal gland
9837/3
8584/1
8584/3
8583/3
8583/1
C41.3
C41.3
C68.0
Costal cartilage
Costovertebral joint
Cowper gland
9473/3
CPNET (C71._)
C41.0
C70.0
C70.0
C72.5
C70.0
Cranial
bone
dura mater
meninges
nerve, NOS
pia mater
C71.9
C71.9
C71.9
C71.9
Cranial fossa
NOS
anterior
middle
posterior
C75.2
Craniopharyngeal duct
9350/1
9351/1
9352/1
Craniopharyngioma
NOS (C75.2)
adamantinomatous (C75.2)
papillary (C75.2)
8201/3
8201/3
8201/3
8201/3
8201/2
8523/3
8201/2
8201/3
C32.3
C13.0
C13.0
C69.4
C77.3
C48.1
C32.3
9718/3
8832/0
-------9709/3
9740/1
9740/1
8247/3
Cribriform (type)
adenocarcinoma, comedo-type (C18._,
C19.9, C20.9)
Carcinoma
NOS
comedo-type (C18._, C19.9,
C20.9)
ductal (C50._)
ductal in situ (C50._)
infiltrating duct and (C50._)
in situ (C50._)
comedo-type adenocarcinoma (C18._,
C19.9, C20.9)
Cricoid cartilage
Cricoid, NOS
Cricopharynx
Crystalline lens
Cubital lymph node
Cul de sac
Cuneiform cartilage
Cutaneous
CD30+ T-cell lymphoproliferative
disorder, primary (C44._)
histiocytoma, NOS (C44._)
horn (see SNOMED)
lymphoma, NOS (C44_) [obs]
mastocytosis
mastocytosis, diffuse
neuroendocrine carcinoma, primary
(C44._)
8121/3
8121/1
8200/3
8200/3
8200/3
8200/0
8200/0
Cylindroma
NOS (except cylindroma of skin 8200/0)
eccrine dermal (C44._)
skin (C44._)
120
ICDO.indb 120
11/18/13 1:54 PM
Alphabetic index
--------------9301/0
---------------
Cyst
NOS (see SNOMED)
aneurysmal bone (see SNOMED)
calcifying odontogenic (C41._)
congenital, NOS (see SNOMED)
dentigerous (see SNOMED)
9084/3
Dermoid
NOS
with malignant transformation
(C56.9)
with secondary tumor
---------------------------------------------------------
-------9301/0
-----------------------------
Odontogenic
NOS (see SNOMED)
calcifying (C41._)
dentigerous (see SNOMED)
eruptive (see SNOMED)
gingival (see SNOMED)
primordial (see SNOMED)
--------------8103/0
----------------------------8103/0
9084/0
9084/3
8313/3
9015/3
9014/3
Cystadenocarcinofibroma
clear cell (C56.9)
mucinous
serous
8440/3
8551/3
8161/3
8380/3
8470/2
8470/3
Cystadenocarcinoma
NOS
acinar cell
bile duct (C22.1, C24.0)
endometrioid
mucinous, non-invasive (C25._)
mucinous, NOS (C56.9)
8450/3
8471/3
8471/3
8460/3
Papillary
NOS (C56.9)
mucinous (C56.9)
pseudomucinous (C56.9)
serous (C56.9)
8470/3
8441/3
8313/0
Cystadenofibroma
NOS
clear cell, borderline malignancy
(C56.9)
clear cell (C56.9)
8381/0
8381/1
8381/3
Endometrioid
NOS
borderline malignancy
malignant
9015/0
9015/1
9015/3
Mucinous
NOS
borderline malignancy
malignant
9014/0
9014/1
9014/3
Serous
NOS
borderline malignancy
malignant
9013/0
8313/1
8440/0
8401/0
8161/0
8443/0
8404/0
8380/1
8380/0
8561/0
8472/1
8470/0
8450/0
8451/1
8561/0
8473/1
8471/0
8473/1
8471/0
8462/1
8460/0
8472/1
8470/0
8442/1
8441/0
8316/3
Cystadenoma
NOS
apocrine
bile duct (C22.1, C24.0)
clear cell (C56.9)
eccrine (C44._)
endometrioid, borderline malignancy
endometrioid, NOS
lymphomatosum, papillary (C07._,
C08._)
mucinous, borderline malignancy
(C56.9)
mucinous, NOS (C56.9)
Papillary
NOS (C56.9)
borderline malignancy (C56.9)
lymphomatosum (C07._, C08._)
mucinous, borderline malignancy
(C56.9)
mucinous, NOS (C56.9)
pseudomucinous, borderline
malignancy (C56.9)
pseudomucinous, NOS (C56.9)
serous, borderline malignancy
(C56.9)
serous, NOS (C56.9)
pseudomucinous, borderline
malignancy (C56.9)
pseudomucinous, NOS (C56.9)
serous, borderline malignancy (C56.9)
serous, NOS (C56.9)
Cyst-associated renal cell carcinoma
(C64.9)
121
ICDO.indb 121
11/18/13 1:54 PM
8452/1
9400/3
8200/3
8444/1
-------9173/0
8508/3
9173/0
9055/0
9055/1
8470/3
8959/1
8959/0
8959/3
8959/3
8452/1
8959/1
8462/1
9080/0
9080/0
C24.0
C24.0
8470/3
8470/2
8470/2
8470/0
8470/0
8470/0
8470/0
8454/0
8444/1
8472/1
8470/2
8470/0
8470/0
Cystic
and solid tumor (C25._)
astrocytoma (C71._) [obs]
carcinoma, adenoid
clear cell, tumor of borderline
malignancy (C56.9)
disease of the breast (see SNOMED)
hygroma
hypersecretory carcinoma (C50._)
lymphangioma
mesothelioma, benign (C48._) [obs]
mesothelioma, NOS (C48._)
Mucinous
with an associated invasive
carcinoma (C25._)
nephroblastoma, partially
differentiated (C64.9)
Nephroma
benign (C64.9)
malignant (C64.9)
multilocular, malignant (C64.9)
papillary, tumor (C25._)
partially differentiated,
nephroblastoma (C64.9)
serous papillary, tumor, borderline
malignancy (C56.9)
teratoma, adult
teratoma, NOS
Cystic bile duct
Cystic duct
Cystic neoplasm
Mucinous
with an associated invasive
carcinoma (C25._)
with high grade dysplasia (C25._)
with high grade intraepithelial
neoplasia (C22._)
with intermediate grade
intraepithelial neoplasia (C22._)
with intermediate grade
intraepithelial neoplasia (C22._)
with low grade dysplasia (C25._)
with low grade intraepithelial
neoplasia (C22._)
Cystic tumor
atrio-ventricular node (C38.0)
clear cell, borderline malignancy
(C56.9)
Mucinous
of borderline malignancy (C56.9)
with high grade dysplasia (C25._)
with intermediate dysplasia
(C25._)
with low grade dysplasia (C25._)
8470/0
8452/1
8462/1
8100/0
---------------
8440/0
8470/0
8441/0
Cystoma
NOS
mucinous (C56.9)
serous (C56.9)
9020/1
9020/0
9020/3
Cystosarcoma phyllodes
NOS (C50._)
benign (C50._) [obs]
malignant (C50._)
9985/3
9985/3
D
9135/1
Dabska tumor
8500/2
8501/2
8503/2
DCIS
NOS
comedo type (C50._)
papillary (C50._)
--------
9243/3
9372/3
8858/3
Dedifferentiated
chondrosarcoma (C40._, C41._)
chordoma
liposarcoma
8831/0
9560/0
9986/3
Deep histiocytoma
Degenerated schwannoma
Del (5q), myelodysplastic syndrome with
isolated
C49.1
Deltoideus muscle
9727/3
Dendritic cell
neoplasm, blastic plasmacytoid
9757/3
9758/3
9757/3
Sarcoma
NOS
follicular
interdigitating
9758/3
9757/3
tumor, follicular
tumor, indeterminate
122
ICDO.indb 122
11/18/13 1:54 PM
Alphabetic index
-------9271/0
9769/1
8760/0
8200/0
8200/0
8762/1
8750/0
8762/1
8832/0
8832/0
8832/3
8832/3
8833/3
Dermatofibrosarcoma
NOS (C44._)
protuberans, NOS (C44._)
protuberans, pigmented (C44._)
9084/0
Dermoid
NOS
9084/0
9084/3
9084/3
Cyst
NOS
with malignant transformation
(C56.9)
with secondary tumor
C62.1
C18.6
Descended testis
Descending colon
8821/1
8822/1
8821/1
Desmoid
NOS
abdominal
extra-abdominal
9412/1
8823/0
9412/1
9412/1
9412/1
9471/3
9471/3
8745/3
8745/3
9051/3
8806/3
8092/3
8514/3
Desmoplastic
astrocytoma, infantile
fibroma
ganglioglioma, infantile
infantile astrocytoma (C71._)
infantile ganglioglioma
medulloblastoma (C71.6)
medulloblastoma, nodular (C71.6)
melanoma, amelanotic (C44._)
melanoma, malignant (C44._)
mesothelioma
small round cell tumor
type, basal cell carcinoma (C44._)
type, duct carcinoma
9100/1
C49.3
C77.1
Diaphragm
Diaphragmatic lymph node
8851/3
9511/3
9080/0
-----/-1
8574/3
8589/3
8574/3
9561/3
9561/3
9540/3
9540/3
9561/3
9362/3
8921/3
8631/1
8634/1
8588/3
Differentiated
liposarcoma
retinoblastoma (C69.2)
teratoma
Differentiated, NOS (see grading code,
section 4.3.4)
Differentiation
adenocarcinoma with neuroendocrine
carcinoma showing thymus-like
carcinoma with neuroendocrine
malignant peripheral nerve sheath
tumor with rhabdomyoblastic
malignant schwannoma with
rhabdomyoblastic
MPNST
with glandular
with mesenchymal
with rhabdomyoblastic
pineal parenchymal tumor,
intermediate (C75.3)
rhabdomyosarcoma with ganglionic
Sertoli-Leydig cell tumor, intermediate
Sertoli-Leydig cell tumor, intermediate,
with heterologous elements
spindle epithelial tumor with thymuslike
9400/3
9400/3
9740/1
8505/0
-------9591/3
9740/1
8728/0
9530/1
8350/3
8505/0
9513/3
8350/3
8145/3
8145/3
Diffuse
astrocytoma (C71._)
astrocytoma, low grade (C71._)
cutaneous mastocytosis
intraductal papillomatosis
lipomatosis (see SNOMED)
lymphosarcoma
mastocytosis, cutaneous
melanocytosis (C70.9)
meningiomatosis (C70._)
papillary carcinoma, sclerosing (C73.9)
papillomatosis, intraductal
retinoblastoma (C69.2)
sclerosing papillary carcinoma (C73.9)
type, adenocarcinoma (C16._)
type, carcinoma (C16._)
C26.9
8408/3
8408/1
9840/3
9501/0
9501/3
8500/2
C41.2
Disc, intervertebral
123
ICDO.indb 123
11/18/13 1:54 PM
9762/3
8081/2
9960/3
9769/1
9840/3
9724/3
9762/3
9762/3
9751/3
9762/3
9762/3
9762/3
9762/3
------9769/1
9760/3
9764/3
9751/3
9970/1
9724/3
9768/1
9741/3
9762/3
9960/3
9960/3
------9540/1
9701/3
9764/3
9724/3
9769/1
9741/3
9724/3
9768/1
9540/1
9960/3
9970/1
9831/3
9971/1
9971/3
Disease
alpha heavy chain
Bowen (C44._)
chronic myeloproliferative (C42.1)
deposition, immunoglobulin
Di Guglielmo [obs]
EBV positive T-cell
lymphoproliferative, systemic, of
childhood
Franklin
gamma heavy chain
Hand-Schuller-Christian [obs]
Heavy chain
NOS
alpha
gamma
mu
Hodgkin (see Hodgkin disease)
immunoglobulin deposition
immunoproliferative, NOS
immunoproliferative small intestinal
(C17._)
Letterer-Siwe [obs]
Lymphoproliferative
NOS
systemic EBV positive T-cell, of
childhood
T-gamma
mast cell, systemic tissue
mu heavy chain
myeloproliferative, chronic (C42.1)
myeloproliferative, NOS (C42.1)
Paget (see Paget disease)
Recklinghausen (except of bone)
Sezary
small intestinal, immunoproliferative
(C17._)
Systemic
EBV positive T-cell
lymphoproliferative, of
childhood
light chain
tissue mast cell
T-cell lymphoproliferative, systemic
EBV positive, of childhood
T-gamma lymphoproliferative
von Recklinghausen (except of bone)
Disorder
chronic myeloproliferative
Lymphoproliferative
NOS
chronic, of NK cells
post transplant, NOS
post transplant, polymorphic
9741/3
Disorder, continued
systemic mastocytosis with associated
hematological clonal non-mast cell
9751/3
C15.5
C17.3
C67.1
C02.0
C02.0
C01.9
C02.0
Dorsal surface
anterior tongue
tongue, anterior 2/3
tongue, base
tongue, NOS
C48.1
Douglas pouch
8552/3
Ductal
acinar-ductal carcinoma, mixed
8500/3
8522/3
8201/3
8201/2
Carcinoma
NOS
and lobular (C50._)
cribriform type (C50._)
cribriform type, in situ (C50._)
8501/2
8201/2
8507/2
8503/2
8230/2
Carcinoma in situ
NOS (C50._)
and infiltrating lobular carcinoma
(C50._)
comedo type (C50._)
cribriform type (C50._)
micropapillary (C50._)
papillary (C50._)
solid type (C50._)
8500/2
8522/3
8500/2
8522/3
8552/3
8154/3
8154/3
8503/0
8500/3
8500/3
8503/0
8319/3
Mixed
ductal-acinar carcinoma
ductal-endocrine-acinar
carcinoma
ductal-endocrine carcinoma
(C25._)
papilloma
Duct (morphology)
adenocarcinoma, infiltrating (C50._)
adenocarcinoma, NOS
adenoma, NOS
Bellini, carcinoma (C64.9)
8500/3
8319/3
8319/3
8514/3
8407/3
Carcinoma
NOS
Bellini (C64.9)
collecting (C64.9)
desmoplastic type
sclerosing sweat (C44._)
8500/3
--------
cell carcinoma
ectasia, mammary (see SNOMED)
124
ICDO.indb 124
11/18/13 1:54 PM
Alphabetic index
8500/3
8523/3
8523/3
8522/3
8522/3
8523/3
8541/3
8523/3
8500/3
8523/3
8506/0
8319/3
8407/3
8525/3
9110/0
9110/3
9110/1
Wolffian
adenoma
carcinoma
tumor
C24.0
C24.0
C24.0
C24.0
C24.0
C75.2
C24.0
C24.0
C24.0
C52.9
C24.0
C24.0
C22.1
C69.5
C69.5
C69.5
C25.3
C07.9
C25.3
C07.9
C08.1
C08.0
C49.3
C73.9
C08.0
C25.3
C57.7
Duct (topography)
bile, NOS
biliary, NOS
choledochal
common
common bile
craniopharyngeal
cystic
cystic bile
extrahepatic bile
Gartner
hepatic
hepatic bile
intrahepatic bile
lacrimal, NOS
nasal lacrimal
nasolacrimal
pancreatic
parotid gland
Santorini
Stensen
sublingual gland
submaxillary gland
thoracic
thyroglossal
Wharton
Wirsung
Wolffian
8521/3
C17.0
Duodenum
C70.9
C70.0
C70.1
Dura mater
NOS
cranial
spinal
C70.9
Dura, NOS
9413/0
-------9060/3
-------8077/2
-------8148/2
8148/0
8077/0
8077/2
-------8148/2
9275/0
8503/2
8453/0
8453/0
8503/2
8503/2
--------------8470/2
8470/0
8470/0
8470/3
8470/2
8470/0
8470/0
8470/0
9895/3
9985/3
8163/2
8163/0
8163/2
Dysplasia
NOS (see SNOMED)
CIN III with severe (C53._)
congenital, NOS (see SNOMED)
esophageal glandular, high grade
(C15._)
esophageal glandular, low grade
(C15._)
esophageal squamous, low grade
(C15._)
espophageal squamous, high grade
(C15._)
fibrous, NOS (see SNOMED)
flat, high grade (C24.1)
florid osseous (C41._)
intracystic papillary tumor with high
grade (C23.9)
intraductal papillary-mucinous tumor
with intermediate (C25._)
intraductal papillary-mucinous tumor
with moderate (C25._)
intraductal papillary neoplasm with
high grade
intraductal papillary tumor with high
grade
mild (see SNOMED)
moderate (see SNOMED)
Mucinous cystic neoplasm
with high grade (C25._)
with intermediate grade (C25._)
with moderate (C25._)
Mucinous cystic tumor
with an associated invasive
carcinoma (C25._)
with high grade (C25._)
with intermediate (C25._)
with low grade (C25._)
with moderate (C25._)
multilineage, acute myeloid leukemia
with
multilineage, refractory cytopenia with
non-invasive pancreatobiliary papillary
neoplasm with high grade (C24.1)
non-invasive pancreatobiliary papillary
neoplasm with low grade
pancreatobiliary papillary neoplasm,
non-invasive, with high grade
125
ICDO.indb 125
11/18/13 1:54 PM
8163/0
9272/0
9272/0
-------8077/2
8077/0
9493/0
8727/0
9705/3
Dysplasia, continued
pancreatobiliary papillary neoplasm,
non-invasive, with low grade
periapical cemental (C41._)
periapical cemento-osseous (C41._)
severe (see SNOMED)
squamous esophageal, high grade
(C15._)
squamous esophageal, low grade
(C15._)
Dysplastic gangliocytoma of cerebellum
(Lhermitte-Duclos) (C71.6)
Dysplastic nevus (C44._)
Dysproteinemia, peripheral T-cell
lymphoma, Angioimmunoblastic
Lymphadenopathy with (AILD) [obs]
E
C44.2
C44.2
C49.0
C44.2
C30.1
C44.2
C30.1
C44.2
Ear
NOS
canal
cartilage
external
inner
lobule
middle
skin, NOS
C44.2
Earlobe
9724/3
8241/3
9210/0
9210/1
8402/0
8413/3
8408/3
8408/0
8404/0
8200/0
8408/3
8408/0
8409/0
8409/3
8403/0
8403/3
Eccrine
acrospiroma (C44._)
adenocarcinoma (C44._)
adenocarcinoma, papillary (C44._)
adenoma, papillary (C44._)
cystadenoma (C44._)
dermal cylindroma (C44._)
papillary adenocarcinoma (C44._)
papillary adenoma (C44._)
poroma (C44._)
poroma, malignant (C44._)
spiradenoma (C44._)
spiradenoma, malignant (C44._)
8242/3
8242/1
-------8921/3
--------
-------8587/0
C62.0
8820/0
Elastofibroma
C76.4
C44.6
C49.1
C47.1
C49.1
C49.1
C40.0
C47.1
C44.6
C49.1
C49.1
Elbow
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
connective tissue
fibrous tissue
joint
peripheral nerve
skin
soft tissue
subcutaneous tissue
8634/1
8634/3
8634/1
Element
Sertoli-Leydig cell tumor
intermediate differentiation, with
heterologous
poorly differentiated, with
heterologous
retiform, with heterologous
8588/3
9101/3
8593/1
8000/6
9070/3
8191/0
8902/3
Embryonal
adenocarcinoma
adenoma
and alveolar rhabdomyosarcoma,
mixed
9070/3
9081/3
9101/3
9071/3
9072/3
Carcinoma
NOS
and teratoma, mixed
combined with choriocarcinoma
infantile
polyembryonal type
8981/3
8970/3
--------
carcinosarcoma
hepatoma (C22.0)
rest, NOS (see SNOMED)
8910/3
8902/3
8910/3
Rhabdomyosarcoma
NOS
and alveolar, mixed
pleomorphic
8991/3
9080/3
sarcoma
teratoma
8335/3
8343/3
126
ICDO.indb 126
11/18/13 1:54 PM
Alphabetic index
9220/0
--------
C38.0
C53.0
C53.0
Endocardium
Endocervical canal
Endocervical gland
8930/3
8930/3
8931/3
8384/3
8482/3
8931/3
Endometrial stromatosis
C53.0
Endocervix
8154/3
8380/3
8383/3
8382/3
Endometrioid
Adenocarcinoma
NOS
ciliated cell variant
secretory variant
8154/3
8154/3
8154/3
8360/1
8360/1
8154/3
8154/3
8154/3
8150/1
8150/0
8158/1
8154/3
8150/3
8154/3
8150/3
8150/1
8154/3
8150/0
8150/3
8150/3
Endocrine (morphology)
acinar-ductal- carcinoma, mixed
adenomas, multiple
adenomatosis
and exocrine adenocarcinoma, mixed
(C25._)
mixed acinar-ductal- carcinoma
mixed exocrine adenocarcinoma and
(C25._)
Tumor
NOS, pancreatic (C25._)
benign, pancreatic (C25._)
functioning, NOS
malignant mixed pancreatic
exocrine and (C25._)
malignant, pancreatic (C25._)
mixed pancreatic exocrine and,
malignant (C25._)
non-functioning, pancreatic
(C25._)
Pancreatic
NOS (C25._)
and exocrine tumor,
malignant mixed (C25._)
benign (C25._)
malignant (C25._)
non-functioning (C25._)
C75.9
C75.8
C25.4
Endocrine (topography
gland, NOS
glands, multiple
pancreas
9071/3
8931/3
8930/3
C54.1
Endometrial stroma
8930/0
Endometrial stromal
nodule (C54.1)
8381/0
8381/1
8381/3
Adenofibroma
NOS
borderline malignancy
malignant
8380/1
8380/0
8380/3
8380/3
8381/0
8381/1
8381/3
Cystadenofibroma
NOS
borderline malignancy
malignant
8380/1
8380/0
8380/1
8380/1
--------
---------------------8931/3
Endometriosis
NOS (see SNOMED)
external (see SNOMED)
internal (see SNOMED)
stromal (C54.1)
C54.1
Endometrium
9531/0
9135/1
8241/3
8242/1
8242/3
-------8152/3
8152/1
8280/3
8280/0
8280/3
Eosinophil
adenocarcinoma (C75.1)
adenoma (C75.1)
carcinoma (C75.1)
9751/3
C71.5
Ependyma
9392/3
Ependymoblastoma (C71._)
127
ICDO.indb 127
11/18/13 1:54 PM
9391/3
9392/3
9391/3
9391/3
9391/3
9394/1
9393/3
9391/3
9383/1
Ependymoma
NOS (C71._)
anaplastic (C71._)
cellular (C71._)
clear cell (C71._)
epithelial (C71._)
myxopapillary (C72.0)
papillary (C71._)
tanycytic (C71._)
--------
Ependymoma-subependymoma, mixed
(C71._)
Ephelis (see SNOMED)
C38.0
Epicardium
8760/0
8071/3
8072/3
8052/3
8073/3
8074/3
8051/3
Epidermoid carcinoma
NOS
and adenocarcinoma, mixed
in situ, NOS
in situ with questionable stromal
invasion
keratinizing
large cell, nonkeratinizing
papillary
small cell, nonkeratinizing
spindle cell
verrucous
---------------
C63.0
C72.9
Epididymis
Epidural
8070/3
8560/3
8070/2
8076/2
C32.1
C10.1
C32.1
9391/3
8452/1
9340/0
8975/1
8585/3
8585/1
8010/0
8010/3
8588/3
8588/3
8970/3
8562/3
Epiglottis
NOS (excludes anterior surface of
epiglottis C10.1)
anterior surface
posterior surface
Epithelial
ependymoma (C71.1)
neoplasm, solid and papillary (C25._)
odontogenic tumor, calcifying (C41._)
stromal tumor, calcifying nested
(C22.0)
thymoma, malignant (C37.9)
thymoma, NOS (C37.9)
Tumor
benign
malignant
spindle, with thymus-like
differentiation
spindle, with thymus-like element
Epithelial-mesenchymal hepatoblastoma,
mixed (C22.0)
Epithelial-myoepithelial carcinoma
8770/3
8770/0
8771/3
8771/0
8804/3
9042/3
Epithelioid
and spindle cell melanoma, mixed
and spindle cell nevus (C44._)
Cell
melanoma
nevus (C44._)
sarcoma
synovial sarcoma
9133/3
9133/1
9125/0
8970/3
8891/0
8891/3
hemangioendothelioma, malignant
hemangioendothelioma, NOS
hemangioma
hepatoblastoma (C22.0)
leiomyoma
leiomyosarcoma
9052/3
9052/0
9052/3
Mesothelioma
NOS
benign
malignant
9540/3
8804/3
9105/3
MPNST
sarcoma
trophoblastic tumor
8011/3
8100/0
8090/3
8011/0
8110/0
8096/0
8011/3
8410/0
8070/3
Epithelioma
NOS
adenoides cysticum (C44._)
basal cell (C44._)
benign
calcifying, Malherbe (C44._)
intraepidermal, Jadassohn (C44._)
malignant
sebaceous (C44._)
squamous cell
C77.3
-------9840/3
9950/3
9840/3
9840/3
9840/3
8080/2
8148/2
8148/0
8148/2
8148/0
8077/2
8077/0
Esophageal
glandular dysplasia (intraepithelial
neoplasia), high grade (C15._)
glandular dysplasia (intraepithelial
neoplasia), low grade (C15._)
glandular intraepithelial neoplasia,
high grade (C15._)
glandular intraepithelial neoplasia, low
grade (C15._)
squamous intraepithelial neoplasia
(dysplasia), high grade (C15._)
squamous intraepithelial neoplasia
(dysplasia), low grade (C15._)
128
ICDO.indb 128
11/18/13 1:54 PM
Alphabetic index
C77.1
C16.0
C15.9
C15.2
C15.0
C15.5
C15.5
C15.4
C15.3
C15.1
C15.3
Esophagus
NOS
abdominal
cervical
distal third
lower third
middle third
proximal third
thoracic
upper third
9522/3
9521/3
9523/3
C41.0
C31.1
C30.1
Ethmoid bone
Ethmoid sinus
Eustachian tube
9260/3
9260/3
9984/3
9983/3
C53.1
Exocervix
-------9962/3
9962/3
8154/3
8154/3
8154/3
8121/0
Exocrine
and endocrine adenocarcinoma, mixed
(C25._)
and endocrine tumor, malignant mixed
(C25._)
and islet cell adenocarcinoma, mixed
(C25._)
Exophytic sinonasal papilloma (C30.0,
C31._)
-------9210/0
9210/0
Exostosis
NOS (see SNOMED)
cartilaginous (C40._, C41._)
osteocartilaginous (C40._, C41._)
9471/3
C44.2
C44.2
C44.2
C44.3
C44.2
C51.9
C00.1
C00.2
C00.0
External
auditory canal
auditory meatus
auricular canal
cheek
ear
female genitalia
lip, lower
lip, NOS
lip, upper
C44.3
C53.1
External, continued
nose
os
-------8821/1
8693/3
8693/1
9740/1
C72.9
C24.0
Extradural
Extrahepatic bile duct
8542/3
9734/3
C69.6
Extraocular muscle
9734/3
9506/1
Extraosseous plasmacytoma
Extraventricular neurocytoma
C32.1
Extrinsic larynx
C69.9
C44.1
C44.1
C44.1
C69.3
C69.4
C69.0
C69.6
C69.1
C69.1
C69.4
C69.6
C69.4
C44.3
C44.1
C44.1
C44.1
C44.1
C69.4
C69.4
C69.5
C69.5
C69.5
C69.5
C69.4
C44.1
C69.6
C69.5
C69.5
C72.3
C69.6
C69.6
C69.6
C44.1
C44.1
Eye
NOS
canthus, inner
canthus, NOS
canthus, outer
choroid
ciliary body
conjunctiva
connective tissue, orbit
cornea, limbus
cornea, NOS
crystalline lens
extraocular muscle
eyeball
eyebrow
eyelid, lower
eyelid, NOS
eyelid, upper
inner canthus
intraocular
iris
lacrimal duct, nasal
lacrimal duct, NOS
lacrimal gland
lacrimal sac
lens, crystalline
Meibomian gland
muscle, extra-ocular
nasal lacrimal duct
nasolacrimal duct
optic nerve
orbit, connective tissue
orbit, NOS
orbit, soft tissue
outer canthus
palpebra
129
ICDO.indb 129
11/18/13 1:54 PM
C69.2
C69.6
C69.4
C69.4
Eye, continued
retina
retrobulbar tissue
sclera
uveal tract
C69.4
Eyeball
C44.1
C44.1
C44.1
Eyelid
NOS
lower
upper
8880/0
-------8880/0
F
-------
C76.0
C44.3
C49.0
C49.0
C41.0
C49.0
C49.0
C49.0
C77.0
C49.0
C49.0
C44.3
C49.0
C49.0
Face
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
bone (excludes mandible C41.1)
connective tissue
fatty tissue
fibrous tissue
lymph node
muscle
skeletal muscle
skin
soft tissue
subcutaneous tissue
C41.0
C77.0
C72.5
Facial
bone
lymph node
nerve
C57.0
C32.1
C32.1
Fallopian tube
False cord
False vocal cord
C70.0
C70.0
C70.0
8220/0
Falx
----------------------
NOS
cerebelli
cerebri
Fascia
NOS
palmar
plantar
8813/0
8813/3
Fascial fibroma
Fascial fibrosarcoma
Fat
C49.9
C49.4
C49.1
C49.1
C49.3
C49.6
C49.5
C49.2
C49.0
C49.0
C49.3
C49.0
C49.6
C49.2
C49.1
C49.5
C49.5
C49.1
C49.0
C49.2
C49.3
C49.5
C49.2
C49.2
C49.0
C49.2
C49.5
C49.0
C49.1
C49.0
C49.0
C49.2
C49.6
Fatty tissue
NOS
abdominal wall
antecubital space
arm
axilla
back
buttock
calf
cervical region
cheek
chest wall
face
flank
foot
forearm
gluteal region
groin
hand
head
hip
infraclavicular region
inguinal region
knee
leg
neck
popliteal space
sacrococcygeal region
scalp
shoulder
supraclavicular region
temple
thigh
trunk, NOS
C10.9
C09.1
C09.9
Fauces, NOS
Faucial pillar
Faucial tonsil
C51.9
C57.9
C57.9
C57.9
Female
genitalia, external
genital organs, NOS
genital tract, NOS
genitourinary tract, NOS
C49.9
C49.1
C49.2
Fasciitis
infiltrative (see SNOMED)
nodular (see SNOMED)
pseudosarcomatous (see SNOMED)
130
ICDO.indb 130
11/18/13 1:54 PM
Alphabetic index
C49.2
C77.4
C47.2
Femoral
artery
lymph node
nerve
C40.2
Femur
8333/3
8333/0
8880/0
8881/0
8881/0
8903/0
Fetal
adenocarcinoma (C73.9)
adenoma (C73.9)
fat cell lipoma
lipoma, NOS
lipomatosis
rhabdomyoma
C58.9
Fetal membranes
9867/3
9420/3
9010/0
9016/0
9011/0
9030/0
9012/0
Fibroadenoma
NOS (C50._)
giant (C50._)
intracanalicular (C50._)
juvenile (C50._)
pericanalicular (C50._)
9290/0
8857/3
9532/0
9182/3
9759/3
Fibroblastic
liposarcoma
meningioma (C70._)
osteosarcoma (C40._, C41._)
reticular cell tumor
8834/1
9220/3
-------9271/0
9290/3
8093/3
8093/3
---------------
Fibroepithelial
basal cell carcinoma (C44._)
basal cell carcinoma, Pinkus type
papilloma (see SNOMED)
polyp (see SNOMED)
8093/3
8093/3
8391/0
8835/1
8890/0
8171/3
8851/0
8850/3
Fibroepithelioma, NOS
Fibroepithelioma of Pinkus type
Fibrofolliculoma (C44._)
Fibrohistiocytic tumor, plexiform
Fibroid uterus (C55.9)
Fibrolamellar hepatocellular carcinoma
(C22.0)
Fibrolipoma
Fibroliposarcoma
8810/0
9330/0
8810/1
9274/0
9274/0
9321/0
9241/0
8823/0
8813/0
8391/0
8821/1
-------8811/0
-------9321/0
9321/0
9322/0
9262/0
8391/0
8812/0
9322/0
8966/0
Fibroma
NOS
ameloblastic (C41._)
cellular (C56.9)
cementifying (C41._)
cemento-ossifying (C41._)
central odontogenic (C41._)
chondromyxoid (C40._, C41._)
desmoplastic
fascial
follicular (C44._)
invasive
juvenile aponeurotic (see SNOMED)
myxoid
nonossifying (see SNOMED)
odontogenic, central (C41._)
odontogenic, NOS (C41._)
odontogenic, peripheral (C41._)
ossifying (C41._)
perifollicular (C44._)
periosteal (C40._, C41._)
peripheral odontogenic (C41._)
renomedullary (C64.9)
-------8822/1
8821/1
-------8824/1
8822/1
-------------8822/1
Fibromatosis
NOS (see SNOMED)
abdominal
aggressive
cicatricial (see SNOMED)
congenital generalized
mesenteric (C48.1)
musculo-aponeurotic (see SNOMED)
pseudosarcomatous
retroperitoneal (C48.0)
8890/0
8842/0
8852/0
8811/0
8811/0
8811/3
9290/0
9290/3
9262/0
Fibromyoma
Fibromyxoid tumor, ossifying
Fibromyxolipoma
Fibromyxoma
Fibromyxoma, plexiform
Fibromyxosarcoma
Fibro-odontoma, ameloblastic (C41._)
Fibro-odontosarcoma, ameloblastic
Fibro-osteoma (C40._, C41._)
8810/3
9330/3
8814/3
8813/3
8814/3
9330/3
8812/3
Fibrosarcoma
NOS
ameloblastic (C41._)
congenital
fascial
infantile
odontogenic (C41._)
periosteal (C40._, C41._)
----------------------
131
11/28/13 3:05 PM
-------8141/3
8832/0
Fibrosis
NOS (see SNOMED)
carcinoma with productive
subepidermal nodular (C44._)
9420/3
---------------
Fibrous
astrocytoma (C71._)
defect, metaphyseal (see SNOMED)
dysplasia, NOS (see SNOMED)
8830/0
8836/1
8830/1
8830/0
8830/3
9252/0
Histiocytoma
NOS
angiomatoid
atypical
benign
malignant
tendon sheath (C49.0)
9532/0
meningioma (C70._)
9051/3
9051/0
9051/3
Mesothelioma
NOS
benign
malignant
9160/0
-------9041/3
8815/0
8815/0
8815/3
Tumor
localized
solitary
solitary, malignant
C49.9
C49.4
C49.2
C49.1
C49.1
C49.3
C49.6
C49.5
C49.2
C49.0
C49.0
C49.3
C49.3
C49.0
C49.1
C49.0
C49.1
C49.6
C49.2
C49.1
C49.0
C49.5
C49.5
C49.1
C49.0
C49.2
C49.2
Fibrous tissue
NOS
abdominal wall
ankle
antecubital space
arm
axilla
back
buttock
calf
cervical region
cheek
chest
chest wall
chin
elbow
face
finger
flank
foot
forearm
forehead
gluteal region
groin
hand
head
heel
hip
C49.3
C49.5
C49.2
C49.2
C49.0
C49.5
C49.2
C49.0
C49.5
C49.0
C49.3
C49.1
C49.0
C49.0
C49.2
C49.3
C49.1
C49.2
C49.6
C49.4
C49.1
8830/0
8830/1
8830/3
Fibroxanthoma
NOS
atypical
malignant
C40.2
C72.0
Fibula
Filum terminale
C76.4
C44.6
C49.1
C47.1
C40.1
C49.1
C49.1
C49.1
C44.6
C47.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
Finger
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
bone
connective tissue
fibrous tissue
muscle
nail
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
C76.7
C44.5
C49.6
C49.6
C47.6
C49.6
C49.6
C49.6
C49.6
C47.6
Flank
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
132
ICDO.indb 132
11/18/13 1:54 PM
Alphabetic index
C49.6
C44.5
C49.6
C49.6
C49.6
C49.6
8212/0
8148/2
8148/2
8148/2
Flank, continued
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
Flat
adenoma
intraepithelial glandular neoplasia,
high grade (C24.1)
intraepithelial neoplasia (dysplasia),
high grade (C24.1)
intraepithelial neoplasia, high grade
C04.9
C04.0
C04.1
Floor of mouth
NOS
anterior
lateral
-------9275/0
--------
C13.1
C09.1
Fold
aryepiglottic, hypopharyngeal aspect
aryepiglottic, laryngeal aspect
aryepiglottic, NOS (excludes laryngeal
aspect of aryepiglottic fold C32.1)
arytenoid
glossopalatine
8330/3
8332/3
8332/3
8331/3
Follicular
Adenocarcinoma
NOS (C73.9)
moderately differentiated (C73.9)
trabecular (C73.9)
well differentiated (C73.9)
C13.1
C32.1
C13.1
8330/0
8330/1
8290/0
Adenoma
NOS (C73.9)
atypical (C73.9)
oxyphilic cell (C73.9)
8340/3
8340/3
8330/3
8335/3
8335/3
8332/3
8290/3
8332/3
8331/3
Carcinoma
NOS (C73.9)
encapsulated (C73.9)
minimally invasive (C73.9)
moderately differentiated (C73.9)
oxyphilic cell (C73.9)
trabecular (C73.9)
well differentiated (C73.9)
-------9758/3
9758/3
8391/0
--------
------8340/3
8340/3
8346/3
Follicular, continued
lymphoma (see lymphoma, malignant,
follicular)
variant, papillary adenocarcinoma
(C73.9)
variant, papillary carcinoma (C73.9)
8641/0
C76.5
C44.7
C49.2
C49.2
C47.2
C40.3
C49.2
C49.2
C49.2
C40.3
C49.2
C47.2
C40.3
C49.2
C44.7
C49.2
C44.7
C49.2
C49.2
C49.2
Foot
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fatty tissue
fibrous tissue
joint
muscle
peripheral nerve
phalanx
skeletal muscle
skin
soft tissue
sole
subcutaneous tissue
tendon
tendon sheath
--------
C76.4
C44.6
C49.1
C49.1
C47.1
C40.0
C49.1
C49.1
C49.1
C49.1
C47.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
Forearm
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
C44.3
C44.3
C49.0
C47.0
C49.0
Forehead
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
connective tissue
133
ICDO.indb 133
11/18/13 1:54 PM
C49.0
C47.0
C44.3
C49.0
C49.0
Forehead, continued
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
C60.0
C11.3
C52.9
Foreskin
Fornix, pharyngeal
Fornix, vagina
C71.9
C71.9
C71.9
C71.9
Fossa
Cranial
NOS
anterior
middle
posterior
C76.3
C75.1
C49.0
C12.9
C11.2
C09.0
ischiorectal
pituitary
pterygoid, NOS
pyriform
Rosenmuller
tonsillar
G
C23.9
Gallbladder
9762/3
9765/1
9765/1
C71.0
C47.9
Ganglia, basal
Ganglia, NOS
8683/0
9492/0
9493/0
9505/1
9505/3
9412/1
Ganglioglioma
NOS
anaplastic
desmoplastic infantile
C51.9
C71.7
Fourchette
Fourth ventricle
-------9490/3
9490/0
9491/0
8921/3
9762/3
Franklin disease
8936/1
-------8742/2
8742/3
Freckle
NOS (see SNOMED)
Hutchinson melanotic, NOS (C44._)
malignant melanoma in Hutchinson
melanotic (C44._)
C52.9
Gartner duct
C16.9
C16.3
C16.0
C16.2
C16.1
C77.2
8153/1
8153/3
8153/3
8153/1
C49.2
C16.0
Gastrocnemius muscle
Gastroesophageal junction
8936/1
8936/1
8936/3
Gastrointestinal stromal
sarcoma
C00.5
C02.2
C00.5
C00.4
C00.3
Frenulum
labii, NOS
linguae
lip, NOS
lower lip
upper lip
C41.0
C71.1
C71.1
C31.2
Frontal
bone
lobe
pole
sinus
8158/1
C16.1
C16.1
C54.3
Fundus
gastric
stomach
uteri
8121/0
9700/3
8043/3
8004/3
8936/1
8936/0
8936/3
8936/1
Tumor
NOS
benign
malignant
uncertain malignant potential
C26.9
8153/3
8153/1
134
ICDO.indb 134
11/18/13 1:54 PM
Alphabetic index
8480/3
8480/3
9411/3
9411/3
8824/1
9751/3
C57.9
C63.9
C57.9
C63.9
Genital
organs, female, NOS
organs, male, NOS
tract, female, NOS
tract, male, NOS
C51.9
8905/0
C57.9
C63.9
9101/3
9064/2
9064/3
9085/3
9065/3
9064/2
9064/3
9302/0
Germ cell
elements, choriocarcinoma combined
with other
neoplasia, intratubular (C62._)
Tumor
NOS
mixed
nonseminomatous (C62._)
Germ cells, intratubular malignant (C62._)
Germinoma
Ghost cell tumor, odontogenic (C41._)
8761/1
--------
Giant
condyloma acuminatum (see
SNOMED)
congenital nevus, intermediate and
(C44._)
fibroadenoma (C50._)
osteoid osteoma (C40._, C41._)
pigmented nevus, malignant melanoma
in (C44._)
pigmented nevus, NOS (C44._)
rugal hypertrophy (see SNOMED)
8030/3
9160/0
9384/1
8031/3
8035/3
8834/1
9441/3
--------------8802/3
9250/3
--------
Giant cell
and spindle cell carcinoma
angiofibroma
astrocytoma, subependymal (C71._)
carcinoma
carcinoma with osteoclast-like
fibroblastoma
glioblastoma (C71._)
granuloma, central (see SNOMED)
reparative granuloma (see SNOMED)
sarcoma (except of bone 9250/3)
sarcoma of bone (C40._, C41._)
tendon sheath (see SNOMED)
-------8761/1
9016/0
9200/0
8761/3
9250/3
9250/1
9230/0
9251/3
9251/1
9252/0
9252/3
9252/0
9252/3
8003/3
9275/0
C03.9
C03.1
C03.1
C03.0
C03.0
Gingiva
NOS
lower
mandibular
maxillary
upper
---------------
C40.0
Girdle, shoulder
8936/1
8936/0
8936/3
GIST
NOS
benign
malignant
C74.9
C51.0
C44.2
C68.0
C53.0
C75.8
C75.9
C54.1
C69.5
C50.9
C44.1
C53.0
C75.0
C68.1
C07.9
C07.9
C75.3
C75.1
C61.9
C08.9
C06.9
Gland
adrenal
Bartholin
ceruminal
Cowper
endocervical
endocrine, multiple
endocrine, NOS
endometrial
lacrimal
mammary
Meibomian
Nabothian
parathyroid
paraurethral
parotid
parotid, duct
pineal
pituitary
prostate
salivary, major, NOS
salivary, minor, NOS (see coding
guidelines, section 4.3.5, pseudotopographic morphology terms, and
note under C08)
135
ICDO.indb 135
11/18/13 1:54 PM
C08.1
C08.1
C08.0
C08.0
C08.0
C74.9
C73.9
C68.0
Gland, continued
salivary, NOS (excludes minor salivary
gland, NOS C06.9; see coding
guidelines section 4.3.5, pseudotopographic morphology terms, and
note under C08)
sublingual
sublingual, duct
submandibular
submaxillary
submaxillary, duct
suprarenal
thyroid
urethral
C75.8
C08.9
--------
Glandular
and stromal hyperplasia (see
SNOMED)
differentiation, MPNST with glandular
dysplasia, esophageal high grade
(C15._)
dysplasia, esophageal low grade
(C15._)
esophageal dysplasia, high grade
(C15._)
esophageal dysplasia, low grade
(C15._)
high grade dysplasia, esophageal
(C15._)
hyperplasia (see SNOMED)
8148/0
8148/0
8148/0
8148/2
8148/2
8148/0
8148/0
Intraepithelial neoplasia
esophageal, low grade (C15._)
grade I
grade II
grade III
high grade
low grade
low grade esohageal (C15._)
-------9540/3
8148/2
8148/0
8148/2
8148/0
8148/2
8148/0
-------8260/0
8560/0
8264/0
C60.1
Glans penis
8015/3
--------
9440/3
9441/3
9440/3
9442/3
Glioblastoma
NOS (C71._)
giant cell (C71._)
multiforme (C71._)
with sarcomatous component (C71._)
9442/1
Gliofibroma (C71._)
9431/1
9400/3
9444/1
9444/1
9380/3
9382/3
-------9383/1
Glioma
NOS (except nasal gliomanot
neoplastic) (C71._)
angiocentric
astrocytic (C71._)
chordoid (C71._)
chordoid, third ventricle (C71.5)
malignant (C71._)
mixed (C71._)
nasal (see SNOMED)
subependymal (C71._)
9381/3
9505/1
9509/1
9509/1
9442/3
C71.0
Globus pallidus
8712/0
8713/0
8710/3
8374/0
8710/3
Glomangioma
Glomangiomyoma
Glomangiosarcoma
Glomerulosa cell adrenal cortical adenoma
(C74.0)
Glomoid sarcoma
8690/1
8711/3
8711/0
Glomus
jugulare tumor, NOS (C75.5)
tumor, malignant
tumor, NOS
C75.5
C75.5
C09.1
C72.5
C32.0
Glomus, coccygeal
Glomus jugulare
Glossopalatine fold
Glossopharyngeal nerve
Glottis
8152/1
8152/3
8152/1
C76.3
C44.5
C49.5
C49.5
C47.5
C49.5
C49.5
C49.5
C49.5
C47.5
C49.5
C44.5
C49.5
C49.5
Gluteal region
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C49.5
8904/0
8315/3
Glycogenic rhabdomyoma
Glycogen-rich carcinoma (C50._)
9380/3
136
11/28/13 3:05 PM
Alphabetic index
8243/3
8253/3
8254/3
8254/3
Goblet cell
carcinoid
type, bronchiolo-alveolar carcinoma
(C34._)
type, bronchiolo-alveolar carcinoma,
Clara cell and (C34._)
type, bronchiolo-alveolar carcinoma,
type II pneumocyte and (C34._)
-----------------------------
Goiter
NOS (see SNOMED)
adenomatous (see SNOMED)
colloid (see SNOMED)
endemic (see SNOMED)
8590/1
8590/1
8591/1
8592/1
9073/1
9073/1
8240/3
8249/3
8148/2
Gonadoblastoma
Gonocytoma
Grade 1 neuroendocrine tumor
Grade 2 neuroendocrine tumor
Grade 3 biliary intraepithelial neoplasia
(BilIN-3)
8148/0
8077/0
Grade I
glandular intraepithelial neoplasia
squamous intraepithelial neoplasia
8148/0
8077/0
Grade II
glandular intraepithelial neoplasia
squamous intraepithelial neoplasia
8077/2
8077/2
8148/2
8077/2
8077/2
8077/2
Grade III
Intraepithelial neoplasia
anal (C21.1)
cervical (C53._)
glandular
squamous
vaginal (C52._)
vulvar (C51._)
-----/-1
-----/-2
-----/-3
-----/-4
-----/-9
8320/3
8320/3
9580/3
9580/0
Granular cell
adenocarcinoma
carcinoma
myoblastoma, malignant
myoblastoma, NOS
9580/0
9580/3
9582/0
Tumor
NOS
malignant
sellar region (C75.1)
9831/3
-------9930/3
--------------9751/3
-------9661/3
-----------------------------
Granuloma
NOS (see SNOMED)
central giant cell (see SNOMED)
eosinophilic [obs]
giant cell reparative (see SNOMED)
Hodgkin
plasma cell (see SNOMED)
pyogenic (see SNOMED)
reticulohistiocytic (see SNOMED)
sarcoid (see SNOMED)
9751/3
9751/3
9766/1
Granulomatosis
Langerhans cell, NOS [obs]
Langerhans cell, unifocal [obs]
lymphomatoid
8620/3
Granulosa cell
carcinoma (C56.9)
8620/1
8620/1
8622/1
8620/3
8620/3
Tumor
NOS (C56.9)
adult type (C56.9)
juvenile (C56.9)
malignant (C56.9)
sarcomatoid (C56.9)
8621/1
8312/3
C16.6
C76.3
C44.5
C49.5
C49.5
C47.5
C49.5
C49.5
C49.5
C77.4
C47.5
C44.5
C49.5
C49.5
Groin
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
peripheral nerve
skin
soft tissue
subcutaneous tissue
C03.9
C03.1
C03.0
Gum
NOS
lower
upper
8632/1
--------
Gynandroblastoma (C56.9)
Gynecomastia (see SNOMED)
137
11/28/13 3:05 PM
H
9940/3
9591/3
8720/0
8723/0
----------------------
Hamartoma
NOS (see SNOMED)
angiomatous lymphoid (see SNOMED)
mesenchymal (see SNOMED)
8587/0
C76.4
C44.6
C49.1
C49.1
C47.1
C40.1
C49.1
C49.1
C49.1
C40.1
C49.1
C47.1
C40.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
Hand
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fatty tissue
fibrous tissue
joint
muscle
peripheral nerve
phalanx
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
9751/3
C05.0
C05.8
Hard palate
Hard palate and soft palate, junction
C76.0
C44.4
C49.0
C49.0
C47.0
C49.0
C49.0
C49.0
C77.0
C49.0
C47.0
C49.0
C44.4
C49.0
C49.0
Head
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
muscle
peripheral nerve
skeletal muscle
skin, NOS
soft tissue
subcutaneous tissue
C25.0
C38.0
Head of pancreas
Heart
9762/3
9762/3
9762/3
9762/3
C76.5
C44.7
C49.2
C47.2
C40.3
C49.2
C49.2
C47.2
C44.7
C49.2
C49.2
C49.2
Heel
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
bone
connective tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
tendon sheath
C44.2
Helix
9535/0
9161/1
9130/3
9130/1
9130/0
9133/3
9133/1
9130/1
9130/3
9136/1
Hemangioendothelioma
NOS
benign
epithelioid, malignant
epithelioid, NOS
Kaposiform
malignant
spindle cell
9120/0
9161/0
9123/0
9131/0
9121/0
9125/0
-------9125/0
9131/0
9132/0
9131/0
9131/0
9123/0
8832/0
9131/0
9122/0
9142/0
Hemangioma
NOS
acquired tufted
arteriovenous
capillary
cavernous
epithelioid
granulation tissue type (see SNOMED)
histiocytoid
infantile
intramuscular
juvenile
plexiform
racemose
sclerosing (C44._)
simplex
venous
verrucous keratotic
--------------9150/1
138
ICDO.indb 138
11/18/13 1:54 PM
Alphabetic index
9150/1
9150/0
9150/3
9120/3
9741/3
Hemangiopericytoma
NOS
benign
malignant
--------
Hemangiosarcoma
Hematological clonal non-mast cell
disorder, systemic mastocytosis with
associated
Hematoma, NOS (see SNOMED)
C42.4
C71.0
9175/0
Hemolymphangioma
9140/3
9962/3
9962/3
Hemorrhagic
sarcoma, multiple
thrombocythemia, essential (C42.1)
thrombocythemia, idiopathic (C42.1)
C22.0
C24.0
C24.0
C18.3
C77.2
Hepatic
NOS
bile duct
duct
flexure of colon
lymph node
8172/3
8970/3
8970/3
8970/3
Hepatoblastoma (C22.0)
NOS
epithelioid
mixed epithelial-mesenchymal
8170/3
Hepatocarcinoma (C22.0)
8170/0
8180/3
Hepatocellular
adenoma (C22.0)
and bile duct carcinoma, mixed
(C22.0)
8174/3
8171/3
8175/3
8173/3
8172/3
8173/3
Carcinoma
NOS (C22.0)
and cholangiocarcinoma,
combined (C22.0)
clear cell type (C22.0)
fibrolamellar (C22.0)
pleomorphic type (C22.0)
sarcomatoid (C22.0)
scirrhous (C22.0)
spindle cell variant (C22.0)
8180/3
Hepatocholangiocarcinoma (C22.0)
8576/3
8576/3
9071/3
Hepatoid
adenocarcinoma
carcinoma
yolk sac tumor
8170/3
8180/3
8170/3
8170/0
8970/3
8170/3
Hepatoma
NOS (C22.0)
benign (C22.0)
embryonal (C22.0)
malignant (C22.0)
8634/1
8634/3
8634/1
Heterologous elements
Sertoli-Leydig cell tumor
intermediate differentiation, with
poorly differentiated, with
retiform, with
--------------8880/0
8402/3
8400/0
8402/0
8402/0
8402/3
8405/0
8405/0
Hidradenoma
NOS (C44._)
clear cell (C44._)
nodular (C44._)
nodular, malignant (C44._)
papillary (C44._)
papilliferum (C44._)
8404/0
Hidrocystoma (C44._)
8148/2
8503/2
8503/2
8503/2
High grade
esophageal glandular dysplasia (C15._)
intraductal tubular-papillary neoplasm
neoplasm, intraductal tubular-papillary
tubular-papillary neoplasm, intraductal
8503/2
8470/2
8148/2
8470/2
8148/2
8148/2
8077/2
8148/2
8148/2
8470/2
8470/2
8148/2
8503/2
8453/2
8503/2
8503/2
8470/2
8470/2
8470/2
8163/2
8453/2
139
ICDO.indb 139
11/18/13 1:54 PM
8077/2
8077/2
8660/0
C77.1
C77.1
C77.2
8660/0
C34.0
Hilus of lung
8148/2
8503/2
8503/2
8503/2
8503/2
8470/2
8470/2
8163/2
8163/2
8163/2
C76.5
C44.7
C49.2
C49.2
C47.2
C41.4
C49.2
C49.2
C49.2
C41.4
C47.2
C44.7
C49.2
C49.2
C49.2
C49.2
Hip
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fatty tissue
fibrous tissue
joint
peripheral nerve
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
8830/0
8836/1
8830/1
8830/0
8830/3
9252/0
8831/0
-------9751/3
9751/3
9751/3
9751/3
9751/3
9751/3
9751/3
9750/3
-------9751/3
9751/3
9650/3
9651/3
9651/3
9651/3
9663/3
9667/3
9665/3
9665/3
9667/3
Histiocytoma, continued
Fibrous
NOS
angiomatoid
atypical
benign
malignant
tendon sheath (C49._)
juvenile
Histiocytosis
NOS (see SNOMED)
Langerhans cell
NOS
disseminated [obs]
generalized [obs]
mono-ostotic [obs]
multifocal [obs]
poly-ostotic [obs]
unifocal [obs]
malignant
sinus, with massive lymphadenopathy
(see SNOMED)
X, acute progressive [obs]
X, NOS [obs]
Hodgkin disease (see also Hodgkin
lymphoma)
NOS
lymphocyte predominance, diffuse
[obs]
lymphocyte predominance, NOS [obs]
lymphocytic-histiocytic predominance
[obs]
Nodular sclerosis
NOS
lymphocyte depletion
lymphocyte predominance
mixed cellularity
syncytial variant
9661/3
9650/3
9596/3
Hodgkin lymphoma
NOS
and non-Hodgkin lymphoma,
composite
C71.2
Hippocampus
9680/3
9755/3
9750/3
9755/3
Histiocytic
lymphoma, NOS (see also lymphoma)
lymphoma, true
medullary reticulosis [obs]
sarcoma
9596/3
9125/0
Histiocytoid hemangioma
9654/3
8831/0
8832/0
8831/0
Histiocytoma
NOS (C44._)
cutaneous, NOS (C44._)
deep
9653/3
9655/3
9651/3
9652/3
Classical
B-cell lymphoma, unclassifiable,
with features intermediate
between diffuse large B-cell
lymphoma and
lymphocyte depletion, diffuse
fibrosis
lymphocyte depletion, NOS
lymphocyte depletion, reticular
lymphocyte-rich
mixed cellularity, NOS
140
ICDO.indb 140
11/18/13 1:54 PM
Alphabetic index
9664/3
9665/3
9667/3
9663/3
9653/3
9655/3
9654/3
Lymphocyte depletion
NOS
depletion, reticular
diffuse fibrosis
9659/3
9651/3
9652/3
9659/3
9663/3
9664/3
9665/3
9667/3
Nodular sclerosis
NOS
cellular phase
grade 1
grade 2
9659/3
9659/3
9662/3
8078/3
9827/3
C40.0
Humerus
8290/3
8290/0
8290/3
8290/0
Hurthle cell
adenocarcinoma (C73.9)
adenoma (C73.9)
carcinoma (C73.9)
tumor (C73.9)
8742/3
8742/2
8336/0
9100/0
9100/0
9100/1
9100/1
9103/0
Hydatidiform mole
NOS (C58.9)
complete (C58.9)
invasive (C58.9)
malignant (C58.9)
partial (C58.9)
9100/0
9173/0
9173/0
C52.9
C41.0
Hymen
Hyoid bone
9964/3
8311/1
8312/3
Hypereosinophilic syndrome
Hypernephroid tumor [obs]
Hypernephroma (C64.9) [obs]
----------------------------------------------------------------------------------------------------------
Hyperplasia
NOS (see SNOMED)
adenomatous (see SNOMED)
adenomyomatous (see SNOMED)
angiofollicular, benign (see SNOMED)
atypical (see SNOMED)
glandular and stromal (see SNOMED)
glandular (see SNOMED)
lobular (see SNOMED)
lymphoid, NOS (see SNOMED)
nodular focal (see SNOMED)
nodular, NOS (see SNOMED)
papilliferous (see SNOMED)
pseudoepitheliomatous (see SNOMED)
stromal and glandular (see SNOMED)
stromal (see SNOMED)
8213/0
---------------
Hyperplastic
and adenomatous polyp, mixed (C18._)
polyp (see SNOMED)
scar (see SNOMED)
8508/3
----------------------
C77.5
C72.5
C13.1
C13.9
C13.9
C13.2
C75.1
C71.0
I
9961/3
9962/3
9962/3
Idiopathic
myelofibrosis, chronic
thrombocythemia (C42.1)
thrombocythemia, hemorrhagic
(C42.1)
C18.0
C18.0
C77.2
C17.2
Ileocecal junction
Ileocecal valve
Ileocolic lymph node
Ileum (excludes ileocecal valve C18.0)
C49.5
C77.5
C49.5
Iliac
artery
lymph node
vein
C49.4
C41.4
Iliopsoas muscle
Ilium
9080/3
141
ICDO.indb 141
11/18/13 1:54 PM
9080/3
9767/1
9684/3
9671/3
9769/1
9766/1
9760/3
9764/3
9766/1
9764/3
Immunoproliferative
angiocentric lesion
disease, NOS
disease, small intestinal (C17._)
lesion, angiocentric
small intestinal disease (C17._)
8591/1
9741/1
9741/1
9412/1
9412/1
9071/3
8814/3
9412/1
9131/0
8824/1
Infantile
astrocytoma, desmoplastic (C71._)
embryonal carcinoma
fibrosarcoma
ganglioglioma, desmoplastic
hemangioma
myofibromatosis
C77.5
C77.2
C49.4
Inferior
epigastric lymph node
mesenteric lymph node
vena cava
8503/3
8856/0
Infiltrating
and papillary adenocarcinoma (C50._)
angiolipoma
9757/3
8254/3
8092/3
8092/3
8092/3
8500/3
8523/3
8523/3
8522/3
8522/3
8523/3
8523/3
8541/3
8500/3
8523/3
8521/3
8856/0
8522/3
8520/3
8524/3
Infiltrating, continued
Lobular
carcinoma and ductal carcinoma
in situ (C50._)
carcinoma, NOS (C50._)
mixed with other types of
carcinoma (C50._)
8503/3
papillary adenocarcinoma
--------
8530/3
8530/3
8851/3
8825/1
---------------
Inflammatory
adenocarcinoma (C50._)
carcinoma (C50._)
liposarcoma
myofibroblastic tumor
polyp (see SNOMED)
pseudotumor (see SNOMED)
C77.3
C76.1
C44.5
C49.3
C49.3
C47.3
C49.3
C49.3
C49.3
C77.3
C47.3
C44.5
C49.3
C49.3
Infraclavicular region
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
peripheral nerve
skin
soft tissue
subcutaneous tissue
C71.7
C77.4
C76.3
C44.5
C49.5
C49.5
C47.5
C49.5
C49.5
C49.5
C77.4
C47.5
C44.5
C49.5
C49.5
Inguinal region
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
peripheral nerve
skin
soft tissue
subcutaneous tissue
C50.8
C44.1
C30.1
Inner
breast
canthus
ear
ductular carcinoma
lipoma
142
ICDO.indb 142
11/18/13 1:54 PM
Alphabetic index
C00.5
C00.4
C00.3
C77.1
C49.3
C47.3
Intercostal
lymph node
muscle
nerve
C41.4
C77.1
Innominate bone
Innominate lymph node
9757/3
9757/3
-----/2
8140/2
8210/2
8210/2
8210/2
8210/2
8263/2
8261/2
8010/2
8070/2
8210/2
8210/2
Carcinoma
NOS
epidermoid, NOS
in adenomatous polyp
in a polyp, NOS
8201/2
8500/2
8522/3
8501/2
8201/2
8507/2
8503/2
8230/2
8070/2
8076/2
Ductal carcinoma
NOS (C50._)
and infiltrating lobular carcinoma
(C50._)
comedo type (C50._)
cribriform type (C50._)
micropapillary (C50._)
papillary (C50._)
solid type (C50._)
epidermoid carcinoma, NOS
epidermoid carcinoma with
questionable stromal invasion
8520/2
8522/3
8522/2
Lobular carcinoma
NOS (C50._)
and infiltrating duct (C50._)
and intraductal carcinoma (C50._)
8720/2
8050/2
8052/2
melanoma
papillary carcinoma
papillary squamous cell carcinoma
8070/2
8052/2
8076/2
8120/2
C71.0
Insula
8337/3
8151/3
8151/0
8761/1
8044/3
8453/0
8470/0
8503/0
8503/0
9083/3
9362/3
8631/1
8634/1
-----/-2
8470/0
8470/0
Intermediate
and giant congenital nevus (C44._)
cell, small cell carcinoma
dysplasia, intraductal papillarymucinous tumor with (C25._)
dysplasia, mucinous cystic tumor with
(C25._)
grade neoplasia, intracystic papillary
neoplasm with (C23.9)
grade neoplasia, intraductal papillary
neoplasm with (C22._, C24.0)
malignant teratoma
Intermediate differentiation
pineal parenchymal tumor of (C75.3)
Sertoli-Leydig cell tumor of
Sertoli-Leydig cell tumor of, with
heterologous elements
Intermediate differentiation (see grading
code, section 4.3.4)
Intermediate grade dysplasia, mucinous
cystic neoplasm with (C25._)
Intermediate grade intraepithelial
neoplasia, mucinous cystic neoplasm with
(C22._)
C71.0
C06.0
C00.5
C49.3
C30.0
C53.0
C67.5
Internal
capsule
cheek
lip, NOS
mammary artery
nose
os
urethral orifice
--------
8650/1
8650/0
8650/3
8966/0
C41.2
Intervertebral disc
8144/3
8144/3
Intestinal
small, immunoproliferative disease
(C17._)
type adenocarcinoma (C16._)
type carcinoma (C16._)
C77.2
C26.0
9764/3
143
ICDO.indb 143
11/18/13 1:54 PM
C17.9
Intestine
NOS
large (excludes rectum, NOS C20.9 and
rectosigmoid junction C19.9)
small, NOS
C77.2
C76.2
9011/0
9195/3
C70.0
C70.0
C71.9
Intracranial
arachnoid
meninges
site
8504/2
8504/3
8504/3
Intracystic
carcinoma, noninfiltrating
carcinoma, NOS
carcinoma, papillary
C26.0
C18.9
8504/3
8504/0
8503/2
8503/2
8504/3
8503/3
8503/2
8503/0
8503/0
8504/0
Papillary
adenocarcinoma
adenoma
tumor with high grade dysplasia
(C23.9)
tumor with high grade
intraepithelial neoplasia (C23.9)
Papillary neoplasm
carcinoma
with associated invasive carcinoma
(C23.9)
with high grade intraepithelial
neoplasia (C23.9)
with intermediate grade
intraepithelial neoplasia (C23.9)
with low grade intraepithelial
neoplasia (C23.9)
papilloma
8750/0
8500/2
8503/2
8503/2
8503/2
8503/3
Intraductal
Adenocarcinoma
noninfiltrating, NOS
noninfiltrating papillary (C50._)
papillary, noninfiltrating (C50._)
papillary, NOS (C50._)
papillary, with invasion (C50._)
8522/3
8500/2
8522/2
8543/3
8507/2
8507/2
8500/2
8503/2
8230/2
Intraductal, continued
Carcinoma, continued
noninfiltrating, papillary (C50._)
solid type
8503/2
8503/0
8503/2
8503/2
8503/2
Papillary
carcinoma, NOS (C50._)
tumor with high grade dysplasia
tumor with high grade
intraepithelial neoplasia
8503/2
8503/2
8503/3
8453/0
8453/3
8453/2
8453/0
8453/0
8453/3
8453/2
8453/0
8453/0
8503/0
8503/3
8503/2
8503/2
8503/0
8503/0
8503/0
8505/0
8505/0
8503/2
8503/0
Papillary adenocarcinoma
NOS (C50._)
noninfiltrating (C50._)
with invasion (C50._)
Papillary-mucinous
adenoma (C25._)
carcinoma, invasive (C25._)
carcinoma, non-invasive (C25._)
tumor with low grade dysplasia
tumor with moderate dysplasia
(C25._)
Papillary-mucinous neoplasm
with an associated invasive
carcinoma
with high grade dysplasia
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
Papillary neoplasm
NOS
with associated invasive carcinoma
with high grade dysplasia
with high grade intraepithelial
neoplasia
with intermediate grade neoplasia
(C22._, C24.0)
with low grade intraepithelial
neoplasia (C22._, C24.0)
papilloma
papillomatosis, diffuse
papillomatosis, NOS
tubular-papillary neoplasm, high grade
tubular-papillary neoplasm, low grade
8070/2
8096/0
8740/0
8081/2
Intraepidermal
carcinoma, NOS
epithelioma of Jadassohn (C44._)
nevus (C44._)
squamous cell carcinoma, Bowen type
(C44._)
8010/2
8077/0
Intraepithelial neoplasia
anal, low grade (C21.1)
144
ICDO.indb 144
11/18/13 1:54 PM
Alphabetic index
8148/2
8148/2
8148/0
8077/0
8148/2
8148/2
8148/2
8148/2
8148/0
8148/0
8148/2
8148/2
8148/0
Glandular
esophageal, high grade (C15._)
flat, high grade (C24.1)
grade I
grade II
grade III
high grade
low grade
8148/2
8148/2
8077/2
8077/2
8077/2
8070/2
8503/0
C22.1
9132/0
8856/0
9571/0
Intramuscular hemangioma
Intramuscular lipoma
Intraneural perineurioma
C69.4
Intraocular
8077/0
8148/0
8077/0
Low grade
anal (C21.1)
biliary
cervical (C53._)
9270/3
9187/3
8470/2
8470/0
8470/0
8503/2
8503/0
8503/2
8503/0
8503/0
8077/2
8077/0
8077/0
8077/0
8077/2
8077/2
8077/0
8077/0
8503/2
-----/2
9187/3
Intraosseous
carcinoma, primary (C41.1)
osteosarcoma, low grade (C40._,
C41._)
osteosarcoma, well differentiated
(C40._, C41._)
C77.5
C77.1
C76.1
Papillary neoplasm
intracystic, with high grade
(C23.9)
intracystic, with intermediate
grade (C23.9)
intraductal, with high grade
intraductal, with low grade (C22._,
C24.0)
intraglandular, with low grade
(C22.1, C24.0)
9064/2
9064/2
9133/3
8890/1
C32.0
Intrinsic larynx
8503/3
Squamous
esophageal, high grade (C15._)
esophageal, low grade (C15._)
grade I
grade II
high grade
high grade esophageal (C15._)
low grade
low grade esophageal (C15._)
8821/1
9100/1
8453/3
8500/2
8077/2
8077/2
8148/2
8148/2
9100/1
8503/3
8453/3
8503/3
-------8053/0
8121/1
8121/0
8121/1
Invasive
fibroma
hydatidiform mole (C58.9)
intraductal papillary-mucinous
carcinoma (C25._)
mole, NOS (C58.9)
Invasive carcinoma
intracystic papillary tumor with
associated (C23.9)
intraductal papillary-mucinous
neoplasm with associated
intraductal papillary neoplasm with
associated
Inverted
follicular keratosis (see SNOMED)
papilloma, squamous cell
Schneiderian papilloma (C30.0, C31._)
transitional cell papilloma, benign
transitional cell papilloma, NOS
145
ICDO.indb 145
11/18/13 1:54 PM
8121/1
Inverted, continued
transitional papilloma, NOS
9160/0
C69.4
C76.3
C41.4
C71.0
C25.4
Iris
Ischiorectal fossa
Ischium
Island of Reil
Islands of Langerhans
8150/3
8150/0
8150/1
Islet cell
adenocarcinoma (C25._)
adenoma (C25._)
adenomatosis (C25._)
and exocrine adenocarcinoma, mixed
(C25._)
carcinoma (C25._)
tumor, benign (C25._)
tumor, NOS (C25._)
C25.4
Islets of Langerhans
9986/3
C54.0
Isthmus uteri
8150/3
8150/0
8150/0
8154/3
C76.0
C41.1
C41.1
C41.0
C44.3
Jadassohn
blue nevus (C44._)
intraepidermal epithelioma (C44._)
nevus sebaceus (see SNOMED)
Jaw
NOS
bone, lower
bone, NOS
bone, upper
skin
C17.1
Jejunum
--------
C41.9
C40.0
C40.3
C41.3
C40.0
C40.3
C40.1
C41.4
C40.2
C40.2
C40.2
C40.9
Joint, continued
shoulder
sternocostal
temporomandibular
wrist
8690/1
C77.0
8690/1
8690/1
C21.8
C16.0
C16.0
C16.0
C05.8
C18.0
C19.9
C65.9
C19.9
C05.8
C53.8
Junction
anorectal
cardioesophageal
esophagogastric
gastroesophageal
hard and soft palate
ileocecal
pelvirectal
pelviureteric
rectosigmoid
soft and hard palate
squamocolumnar of cervix
8740/3
J
8780/0
8096/0
--------
C40.0
C41.3
C41.1
C40.1
Joint
NOS
acromioclavicular
ankle
costovertebral
elbow
foot
hand
hip
knee, lateral meniscus
knee, medial meniscus
knee, NOS
limb, NOS
8740/0
C10.8
C02.8
8740/0
9160/0
-------9421/1
8502/3
9030/0
8622/1
9131/0
8831/0
8770/0
8770/0
---------------
Juvenile
angiofibroma
aponeurotic fibroma (see SNOMED)
astrocytoma (C71._)
carcinoma, breast (C50._)
fibroadenoma (C50._)
granulosa cell tumor (C56.9)
hemangioma
histiocytoma
melanoma (C44._)
nevus (C44._)
polyp (see SNOMED)
xanthogranuloma (see SNOMED)
9221/0
9221/3
9192/3
Juxtacortical
chondroma (C40._, C41._)
chondrosarcoma (C40._, C41._)
osteosarcoma (C40._, C41._)
8361/0
146
ICDO.indb 146
11/18/13 1:54 PM
Alphabetic index
K
9130/1
9140/3
--------
Kaposiform hemangioendothelioma
Kaposi sarcoma
Keloid (see SNOMED)
8071/3
8071/3
8071/3
Keratinizing
epidermoid carcinoma
squamous cell carcinoma, large cell
squamous cell carcinoma, NOS
---------------
--------------------------------------------------
Keratosis
NOS (see SNOMED)
actinic (see SNOMED)
benign squamous (see SNOMED)
inverted follicular (see SNOMED)
obturans (see SNOMED)
seborrheic (see SNOMED)
senile (see SNOMED)
9142/0
8052/0
C64.9
C64.9
C65.9
Kidney
NOS
parenchyma
pelvis
8162/3
C76.5
C44.7
C49.2
C49.2
C47.2
C49.2
C49.2
C49.2
C40.2
C40.2
C40.2
C40.3
C47.2
C44.7
C49.2
C49.2
C49.2
C49.2
Knee
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
joint, lateral meniscus
joint, medial meniscus
joint, NOS
patella
peripheral nerve
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
8490/6
9124/3
L
C51.9
C51.0
C51.0
C51.1
Labia
NOS
majora, NOS
majora, skin
minora
C00.6
C06.1
Labial commissure
Labial sulcus
C51.9
C51.0
C51.1
Labium
NOS
majus
minus
C69.5
C69.5
C69.5
C69.5
Lacrimal
duct, nasal
duct, NOS
gland
sac
8204/0
9751/3
9751/3
Langerhans cell
granulomatosis, NOS [obs]
granulomatosis, unifocal [obs]
9751/3
9751/3
9751/3
9751/3
9751/3
9751/3
9751/3
Histiocytosis
NOS
disseminated [obs]
generalized [obs]
mono-ostotic [obs]
multifocal [obs]
poly-ostotic [obs]
unifocal [obs]
9756/3
sarcoma
C25.4
C25.4
C18.9
Langerhans, islands
Langerhans, islets
Large bowel, NOS
8642/1
8012/3
8072/3
8013/3
8071/3
8072/3
8014/3
9474/3
8045/3
9831/3
9831/3
147
11/28/13 3:05 PM
9831/3
C18.9
C32.1
C32.3
C32.0
Laryngeal
aspect of aryepiglottic fold
cartilage
commissure
C13.9
Laryngopharynx
C32.1
C32.1
C32.1
C32.1
C32.0
C32.0
C32.1
C32.3
C32.0
C32.2
C32.1
C32.3
C32.0
C32.0
C32.1
C32.0
Larynx
NOS
arytenoid cartilage
cricoid cartilage
cuneiform cartilage
epiglottis, NOS (excludes anterior
surface of epiglottis C10.1)
epiglottis, posterior surface
extrinsic
false cord
false vocal cord
glottis
intrinsic
laryngeal aspect of aryepiglottic fold
laryngeal cartilage
laryngeal commissure
subglottis
supraglottis
thyroid cartilage
true cord
true vocal cord
ventricular band
vocal cord, NOS
C04.1
C40.2
C71.5
C71.5
Lateral
floor of mouth
meniscus of knee joint
ventricle, choroid plexus
ventricle, NOS
C67.2
C10.2
C11.2
C10.2
C14.0
Lateral wall
bladder
mesopharynx
nasopharynx
oropharynx
pharynx, NOS
C49.3
8152/1
8520/2
L-cell tumor
LCIS, NOS (C50._)
C18.6
Left colon
C32.9
C32.3
C32.3
C32.3
C32.1
C76.5
C44.7
C49.2
C49.2
C47.2
C40.2
Leg
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
C49.2
C49.2
C49.2
C77.4
C49.2
C47.2
C49.2
C44.7
C49.2
C49.2
C49.2
C49.2
Leg, continued
connective tissue
fatty tissue
fibrous tissue
lymph node
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
8891/0
8890/0
Leiomyoblastoma
Leiomyofibroma
8890/0
8893/0
8893/0
8892/0
8891/0
8898/1
8893/0
8890/0
8893/0
8894/0
Leiomyoma
NOS
atypical
bizarre
cellular
epithelioid
metastasizing
pleomorphic
plexiform
symplastic
vascular
8890/1
8890/1
Leiomyomatosis, intravascular
Leiomyomatosis, NOS
8890/3
8891/3
8896/3
Leiomyosarcoma
NOS
epithelioid
myxoid
9702/3
Lennert lymphoma
C69.4
Lens, crystalline
8832/0
8744/3
8746/3
-------8742/2
8742/3
Lentigo
NOS (see SNOMED)
maligna (C44._)
maligna melanoma (C44._)
9530/3
9766/1
8762/1
C16.5
9751/3
---------------
148
11/28/13 3:05 PM
Alphabetic index
9800/3
9897/3
9801/3
9826/3
9870/3
9805/3
9805/3
9808/3
9826/3
9837/3
9840/3
9861/3
9835/3
9835/3
9835/3
9835/3
9826/3
9835/3
9835/3
9835/3
9837/3
9910/3
9805/3
9808/3
9809/3
9806/3
9807/3
9891/3
9891/3
9891/3
9891/3
9872/3
9861/3
9874/3
9861/3
9861/3
9897/3
9896/3
9871/3
Leukemia (C42.1)
NOS
11q23 abnormalities, acute myeloid
Acute
NOS
B-ALL (see also 9687/3)
basophilic
bilineal
biphenotypic
B/myeloid, NOS, mixed phenotype
Burkitt type (see also 9687/3) [obs]
cortical T ALL (see also 9729/3)
erythroid
granulocytic (FAB or WHO type
not specified)
L2 type lymphoblastic, NOS (see
also 9727/3)
lymphatic (see also 9727/3)
Lymphoblastic
NOS (see also 9727/3)
L2 type, NOS (see also
9727/3)
mature B-cell type (see also
9687/3)
precursor-cell type (see also
9727/3)
lymphocytic (see also 9727/3)
lymphoid (see also 9727/3)
mature T ALL (see also 9729/3)
megakaryoblastic
mixed lineage
9895/3
9865/3
9869/3
9871/3
9840/3
9911/3
9872/3
9897/3
9897/3
9861/3
9861/3
9895/3
9866/3
9911/3
9869/3
9911/3
9869/3
Mixed phenotype
B/myeloid, NOS
T/myeloid, NOS
with t(9;22)(q34;q11.2);
BCR-ABL1
with T(v;11q23); MLL
rearranged
9865/3
9866/3
9871/3
9920/3
Myeloid
NOS (FAB or WHO type not
specified)
11q23 abnormalities
AML1(CBF-alpha)/ETO
CBF-beta/MYH11
9896/3
9896/3
9897/3
9920/3
9920/3
9871/3
9874/3
9895/3
9895/3
9873/3
9895/3
149
11/28/13 3:05 PM
9895/3
9867/3
9871/3
9836/3
9836/3
9837/3
9836/3
myelomonocytic, NOS
myelomonocytic, with abnormal
eosinophils
non-lymphocytic (FAB or WHO
type not specified)
pre-B ALL (see also 9728/3)
pre-pre-B ALL (see also 9728/3)
Pre-T ALL (see also 9729/3)
pro-B ALL (see also 9728/3)
9866/3
9866/3
9866/3
Promyelocytic
NOS (includes variants)
PML/RAR-alpha
t(15;17)(q22;q11-12)
9861/3
9837/3
9809/3
9871/3
9895/3
9873/3
9895/3
9895/3
9827/3
9827/3
9827/3
9948/3
aggressive NK-cell
9800/3
9860/3
9820/3
9820/3
9820/3
9860/3
9860/3
9860/3
Aleukemic
NOS [obs]
granulocytic [obs]
lymphatic [obs]
lymphocytic [obs]
lymphoid [obs]
monocytic [obs]
myelogenous [obs]
myeloid [obs]
9920/3
9896/3
9896/3
9840/3
9898/3
9876/3
9876/3
9826/3
9870/3
9833/3
B-cell
chronic lymphocytic leukemia/
small lymphocytic lymphoma
(see also 9670/3)
lymphoblastic, precursor (see also
9728/3)
type, chronic lymphocytic,
(includes all variants of BCLL)
(see also 9670/3)
type, mature, acute lymphoblastic,
(see also 9687/3)
type, prolymphocytic
9875/3
9876/3
9875/3
BCR/ABL
chronic granulocytic
negative, atypical chronic myeloid
positive, chronic myelogenous
9823/3
9836/3
9823/3
9826/3
9806/3
9805/3
9805/3
9801/3
9808/3
9826/3
9826/3
9836/3
9871/3
9861/3
9895/3
9800/3
9876/3
9876/3
9823/3
9964/3
9863/3
9875/3
9875/3
9875/3
150
ICDO.indb 150
11/18/13 1:54 PM
Alphabetic index
9946/3
9823/3
9823/3
9823/3
9823/3
9823/3
9860/3
9863/3
9874/3
Myelogenous
NOS
BCR/ABL
Philadelphia chromosome
Ph1 positive
t(9;22)(q34;q11)
9863/3
9875/3
9875/3
9875/3
Myeloid
NOS
BCR/ABL negative, atypical
Philadelphia chromosome
Ph1 negative, atypical
9863/3
9876/3
9876/3
9945/3
9945/3
9946/3
9945/3
9945/3
Myelomonocytic
NOS
in transformation [obs]
juvenile
Type I
Type II
9963/3
neutrophilic
9836/3
9836/3
9837/3
9865/3
9898/3
9860/3
9964/3
9920/3
9840/3
9835/3
9835/3
9826/3
9872/3
9873/3
9896/3
9874/3
9896/3
9866/3
9867/3
9871/3
9891/3
9840/3
9910/3
9831/3
9831/3
9860/3
9861/3
9860/3
9875/3
Chronic
NOS
BCR/ABL
Philadelphia chromosome
(Ph1) positive
t(9;22)(q34;q11)
9860/3
subacute [obs]
9863/3
9875/3
9875/3
9940/3
9591/3
9869/3
9871/3
9946/3
9946/3
9835/3
9831/3
9831/3
hairy cell
hairy cell, variant
inv(3)(q21;q26.2) or t(3;3)(q21;q26.2);
RPN1-EVI1, acute myeloid
inv(16)(p13:q22), acute myeloid
juvenile myelomonocytic
juvenile myelomonocytic, chronic
L2 type acute lymphoblastic, NOS
large granular lymphocytic, NK cell
large granular lymphocytic, T-cell
9820/3
9835/3
9820/3
9823/3
9820/3
Lymphatic
NOS [obs]
acute (see also 9727/3)
aleukemic [obs]
chronic (see also 9670/3)
subacute [obs]
9835/3
Lymphoblastic
NOS (see also 9727/3)
9835/3
9835/3
9826/3
9835/3
9836/3
9835/3
9837/3
Acute
NOS (see also 9727/3)
L2 type, NOS
mature B-cell type (see also
9727/3)
precursor-cell type (see also
9727/3)
Precursor
B-cell (see also 9728/3)
cell, not phenotyped (see also
9727/3)
T-cell (see also 9729/3)
151
ICDO.indb 151
11/18/13 1:54 PM
9820/3
9835/3
9820/3
9826/3
9823/3
9823/3
9823/3
9831/3
9836/3
9836/3
9836/3
9820/3
9831/3
9820/3
9835/3
9820/3
9823/3
9820/3
9820/3
9840/3
9840/3
9840/3
9742/3
9826/3
9910/3
9911/3
9910/3
9872/3
9805/3
9808/3
9809/3
9806/3
9807/3
9897/3
9807/3
9897/3
9891/3
9891/3
9891/3
9891/3
9860/3
9891/3
9860/3
9891/3
9860/3
9891/3
9860/3
9895/3
9861/3
9861/3
9872/3
9860/3
9861/3
9874/3
9863/3
9895/3
9860/3
9861/3
9860/3
9875/3
Chronic
NOS
BCR/ABL
Philadelphia chromosome
Ph1 positive
t(9;22)(q34;q11)
9860/3
subacute [obs]
9863/3
9875/3
9875/3
9860/3
9897/3
9896/3
9871/3
9895/3
9865/3
9869/3
9871/3
9840/3
9911/3
9872/3
9897/3
Myeloid
NOS
11q23 abnormalities, acute
Acute
AML1(CBF-alpha)/ETO
CBF-beta/MYH11
changes, myelodysplasiarelated
DEK-NUP214; t(6;9)
(p23;q34)
inv(3)(q21;q26.2) or t(3;3)
(q21;q26.2); RPN1-EVI1
inv(16)(p13:q22)
M6 type
megakaryoblastic with
t(1;22)(p13;q13); RBM15MKL1
minimal differentiation
MLL
152
ICDO.indb 152
11/18/13 1:54 PM
Alphabetic index
9897/3
9861/3
9861/3
9895/3
9866/3
9911/3
9869/3
9896/3
9911/3
9869/3
9865/3
9896/3
9896/3
9897/3
9866/3
9871/3
9920/3
9920/3
9920/3
9871/3
9874/3
9895/3
9895/3
9873/3
9895/3
9895/3
9861/3
9860/3
9898/3
9876/3
9876/3
9863/3
9876/3
9876/3
9871/3
9895/3
9860/3
9871/3
9874/3
9895/3
9895/3
9873/3
9895/3
9895/3
9860/3
9867/3
9871/3
9945/3
9945/3
9946/3
9945/3
9945/3
9945/3
9946/3
9946/3
9871/3
9963/3
9948/3
9831/3
9861/3
9860/3
9861/3
neutrophilic, chronic
NK-cell, aggressive
NK-cell large granular lymphocytic
non-lymphocytic, acute (FAB or WHO
type not specified)
non-lymphocytic, NOS
NPM1, mutated
9876/3
9875/3
9875/3
9733/3
9733/3
9836/3
153
11/28/13 3:05 PM
9836/3
9835/3
9835/3
9837/3
9836/3
9832/3
9833/3
9834/3
Prolymphocytic
NOS
B-cell type
T-cell type
9866/3
9866/3
9866/3
Promyelocytic
Acute
NOS (includes variants)
PML/RAR-alpha
t(15;17)(q22;q11-12)
9836/3
9837/3
9895/3
9895/3
9801/3
9800/3
9860/3
9820/3
9820/3
9820/3
9860/3
9860/3
9860/3
Subacute
NOS [obs]
granulocytic [obs]
lymphatic [obs]
lymphocytic [obs]
lymphoid [obs]
monocytic [obs]
myelogenous [obs]
myeloid [obs]
9837/3
9911/3
9869/3
9896/3
9898/3
9911/3
9869/3
9865/3
9896/3
9896/3
9897/3
9806/3
9875/3
9875/3
9866/3
9866/3
9871/3
9896/3
9834/3
T-cell
adult (includes all variants)
large granular lymphocytic
leukemia/lymphoma (HTLV-1
positive), adult (includes all
variants)
lymphoblastic, precursor (see also
9729/3)
lymphoma/leukemia, adult
(includes all variants)
type, prolymphocytic
9920/3
9920/3
9920/3
9827/3
9831/3
9827/3
9837/3
9827/3
9809/3
9807/3
9801/3
9871/3
9871/3
9874/3
9895/3
9873/3
9895/3
9895/3
9835/3
9827/3
9827/3
9823/3
9812/3
154
ICDO.indb 154
11/18/13 1:54 PM
Alphabetic index
9811/3
9812/3
9818/3
9816/3
9817/3
9813/3
9818/3
9817/3
9812/3
9814/3
9814/3
9813/3
9815/3
9816/3
9818/3
9816/3
9817/3
9837/3
9813/3
9818/3
9817/3
9812/3
9814/3
9814/3
9837/3
9813/3
9815/3
9816/3
Leukemia-lymphoma, continued
B lymphoblastic
NOS
BCR-ABL1; t(9;22)(q34;q11.2)
E2A-PBX1 (TCF-PBX1); t(1;19)
(q23;p13.3)
hypodiploid ALL; hypodiploidy
IL3-IGH; t(5;14)(q31;q32)
MLL rearranged; t(v;11q23)
t(1;19)(q23;p13.3); E2A-PBX1
(TCF-PBX1)
t(5;14)(q31;q32); IL3-IGH
t(9;22)(q34;q11.2); BCR-ABL1
t(12;21)(p13;q22); TEL-AML1
(ETV6-RUNX1)
TEL-AML1 (ETV6-RUNX1);
t(12;21)(p13;q22)
t(v;11q23), MLL rearranged
with hyperdiploidy
with hypodiploidy (Hypodiploid
ALL)
E2A-PBX1 (TCF-PBX1); t(1;19)
(q23;p13.3), B lymphoblastic
hypodiploid ALL; hypodiploidy, B
lymphoblastic
IL3-IGH; t(5;14)(q31;q32), B
lymphoblastic
lymphoblastic, T
MLL rearranged; t(v;11q23), B
lymphoblastic
t(1;19)(q23;p13.3); E2A-PBX1 (TCFPBX1), B lymphoblastic
t(5;14)(q31;q32); IL3-IGH, B
lymphoblastic
t(9;22)(q34;q11.2); BCR-ABL1, B
lymphoblastic
t(12;21)(p13;q22); TEL-AML1 (ETV6RUNX1), B lymphoblastic
TEL-AML1 (ETV6-RUNX1); t(12;21)
(p13;q22), B lymphoblastic
T lymphoblastic
t(v;11q23), MLL rearranged, B
lymphoblastic
with hyperdiploidy, B lymphoblastic
with hypodiploidy (Hypodiploid ALL),
B lymphoblastic
9940/3
Leukemic reticuloendotheliosis
8650/1
8650/0
8650/3
8631/1
8631/1
8634/1
8631/3
8634/3
8633/1
8634/1
8631/3
8631/0
9493/0
C44.1
C44.1
C44.1
NOS
lower
upper
C49.9
C57.1
C57.2
C57.3
C57.3
Ligament
NOS
broad
round
uterine
uterosacral
9769/1
C69.1
C02.9
C02.4
C34.1
Limbus of cornea
Lingual, NOS
Lingual tonsil
Lingula, lung
8142/3
C00.9
C00.6
C00.6
Lip
C00.2
C00.1
C00.0
External
NOS
lower
upper
C00.5
C00.5
C00.4
C00.3
Fenulum
NOS
labii, NOS
lower
upper
C00.5
C00.4
C00.3
Inner aspect
NOS
lower
upper
C00.5
C00.6
internal, NOS
labial commissure
155
ICDO.indb 155
11/18/13 1:54 PM
C00.1
C00.1
C00.4
C00.4
C00.4
C44.0
C00.1
Lip, continued
Lower
NOS (excludes skin of lower lip
C44.0)
external
frenulum
inner aspect
mucosa
skin
vermilion border
C00.5
C00.4
C00.3
Mucosa
NOS
lower
upper
C44.0
skin, NOS
C00.0
C00.3
C00.3
C00.3
C44.0
C00.0
Upper
NOS (excludes skin of upper lip
C44.0)
external
frenulum
inner aspect
mucosa
skin
vermilion border
C00.2
C00.1
C00.0
Vermilion border
NOS
lower
upper
C00.0
8670/0
8641/0
8641/0
Lipid
cell tumor of ovary (C56.9)
storage, Sertoli cell tumor with (C56.9)
storage, tubular androblastoma with
(C56.9)
8641/0
8314/3
8641/0
8324/0
8881/0
8881/0
-------8670/0
8890/0
Lipidique, folliculome
Lipid-rich carcinoma (C50._)
Lipid-rich Sertoli cell tumor (C56.9)
Lipoadenoma
Lipoblastoma
Lipoblastomatosis
Lipogranuloma, NOS (see SNOMED)
Lipoid cell tumor, ovary (C56.9)
Lipoleiomyoma
8850/0
8850/1
8862/0
8880/0
8881/0
8856/0
8856/0
8854/0
8857/0
Lipoma
NOS
atypical
chondroid
fetal fat cell
fetal, NOS
infiltrating
intramuscular
pleomorphic
spindle cell
8851/3
Lipoma-like liposarcoma
--------------8881/0
Lipomatosis
NOS (see SNOMED)
diffuse (see SNOMED)
fetal
9506/1
9506/1
8850/3
8858/3
8851/3
8857/3
8851/3
8851/3
8855/3
8852/3
8854/3
8853/3
8851/3
8850/1
8851/3
8850/1
Liposarcoma
NOS
dedifferentiated
differentiated
fibroblastic
inflammatory
lipoma-like
mixed
myxoid
pleomorphic
round cell
sclerosing
superficial well differentated
well differentiated
well differentiated, superficial soft
tissue
C22.0
Liver
8170/0
8170/3
C71.1
C34.3
C34.3
C34.2
C34.2
C71.4
C71.3
C71.2
C34.1
C34.1
Lobe
frontal
lower, bronchus
lower, lung
middle, bronchus
middle, lung
occipital
parietal
temporal
upper, bronchus
upper, lung
8520/3
8522/3
8522/3
8522/3
Lobular
adenocarcinoma (C50._)
and ductal carcinoma (C50._)
and infiltrating duct carcinoma (C50._)
and intraductal carcinoma (C50._)
8520/3
8522/3
8520/3
Carcinoma
NOS (C50._)
infiltrating, and ductal carcinoma
in situ (C50._)
infiltrating (C50._)
8520/2
8522/3
8522/2
In situ
NOS (C50._)
and infiltrating duct (C50._)
and intraductal carcinoma
(C50._)
8520/2
noninfiltrating (C50._)
156
ICDO.indb 156
11/18/13 1:54 PM
Alphabetic index
-------8524/3
Lobular, continued
hyperplasia (see SNOMED)
infiltrating, mixed with other types of
carcinoma (C50._)
C44.2
Lobule, ear
8815/0
C03.1
C03.1
C03.1
C50.8
C03.1
C03.1
C50.3
C41.1
C44.1
Lower
alveolar mucosa
alveolar ridge mucosa
alveolus
breast
gingiva
gum
inner quadrant of breast
jaw bone
lid
C00.1
C00.1
C00.4
C00.4
C00.4
C44.0
C00.1
C34.3
C34.3
C50.5
C15.5
C54.0
C76.5
C44.7
C49.2
C49.2
C47.2
C49.2
C49.2
C49.2
C40.2
C40.2
C77.4
C49.2
C47.2
C40.3
C40.3
C49.2
C44.7
C49.2
C49.2
C49.2
C49.2
Lip
lobe, bronchus
lobe, lung
outer quadrant of breast
third of esophagus
uterine segment
Lower limb
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
long bones
long bones, joints
lymph node
muscle
peripheral nerve
short bones
short bones, joints
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
8525/3
8077/0
8480/1
9400/3
8240/3
8077/0
9400/3
8931/3
8077/0
8503/0
8480/1
8503/0
8480/1
8240/3
9187/3
8077/0
8503/0
8470/0
8453/0
8453/0
8470/0
8470/0
8163/0
8453/0
8453/0
8470/0
8077/0
8148/0
8077/0
8470/0
8148/0
8077/0
8148/0
8148/0
8503/0
8503/0
8503/0
8470/0
8163/0
8163/0
Low grade
adenocarcinoma, polymorphous
anal intraepithelial neoplasia (C21.1)
appendiceal mucinous neoplasm
(C18.1)
astrocytoma (C71._)
carcinoma, neuroendocrine
cervical intraepithelial neoplasia
(C53._)
diffuse astrocytoma (C71._)
endometrial stromal sarcoma (C54.1)
esophagus squamous intraepithelial
neoplasia (C15._)
intraductal tubular-papillary neoplasm
mucinous neoplasm, appendiceal
(C18.1)
neoplasm, intraductal tubular-papillary
neoplasm, mucinous appendiceal
(C18.1)
neuroendocrine carcinoma
osteosarcoma, intraosseous
squamous intraepithelial neoplasia
tubular-papillary neoplasm, intraductal
Low grade dysplasia (with)
cystic neoplasm, mucinous (C25._)
intraductal papillary-mucinous
neoplasm (C25._)
intraductal papillary-mucinous tumor
(C25._)
mucinous cystic neoplasm (C25._)
mucinous cystic tumor (C25._)
non-invasive pancreatobiliary papillary
neoplasm, with (C24.1)
papillary-mucinous neoplasm,
intraductal (C25._)
papillary-mucinous tumor, intraductal
(C25._)
tumor, mucinous cystic (C25._)
Low grade intraepithelial neoplasia (with)
anal (C21.1)
biliary
cervical (C53._)
cystic neoplasm, mucinous (C22._)
esophageal glandular (C15._)
esophageal squamous (C15._)
glandular
glandular esophageal (C15._)
intracystic papillary neoplasm (C23.9)
intraductal papillary neoplasm (C22._,
C24.0)
intraglandular papillary neoplasm
(C22.1, C24.0)
mucinous cystic neoplasm (C22._)
non-invasive pancreatobiliary papillary
neoplasm, with
pancreatobiliary papillary neoplasm,
non-invasive, with
157
ICDO.indb 157
11/18/13 1:54 PM
8503/0
8503/0
8503/0
8077/0
8077/0
8380/1
8472/1
8473/1
8462/1
8130/1
8130/1
8442/1
-------
C72.0
C77.2
C47.6
Lumbar
cord
lymph node
nerve
C47.5
Lumbosacral plexus
C34.9
C34.9
C34.9
Lung
NOS
bronchiole
bronchogenic
-----/1
C34.9
C34.3
C34.0
C34.2
C34.1
Bronchus
NOS
lower lobe
main
middle lobe
upper lobe
C34.0
C34.0
C34.1
C34.3
C34.3
C34.0
C34.2
C34.2
C34.9
C34.1
C34.1
carina
hilus
lingula
lower lobe
lower lobe, bronchus
main bronchus
middle lobe
middle lobe, bronchus
pulmonary, NOS
upper lobe
upper lobe, bronchus
8601/0
8610/0
8610/0
--------
9767/1
9170/3
9170/3
9170/0
9174/1
Lymphadenopathy, angioimmunoblastic
(AIL)
Lymphadenopathy, angioimmunoblastic,
with dysproteinemia (AILD), peripheral
T-cell lymphoma, [obs]
Lymphadenopathy, immunoblastic (IBL)
[obs]
Lymphangioendothelial sarcoma
Lymphangioendothelioma, malignant
Lymphangioendothelioma, NOS
Lymphangioleiomyomatosis
9170/0
9171/0
9172/0
9173/0
Lymphangioma
NOS
capillary
cavernous
cystic
9705/3
9767/1
9174/0
9174/1
9170/3
C49.9
C77._
Lymphatic, NOS
Lymph gland (see lymph node)
C77.9
C77.2
C77.2
C77.3
C77.0
C77.3
C77.3
C77.3
C77.1
C77.1
C77.2
C77.0
C77.4
C77.2
C77.2
C77.3
C77.1
C77.5
C77.3
C77.1
C77.0
C77.0
C77.4
C77.2
C77.4
C77.0
C77.2
Lymph node
NOS
abdominal
aortic
arm
auricular
axilla
axillary
brachial
bronchial
bronchopulmonary
celiac
cervical
Cloquet
colic
common duct
cubital
diaphragmatic
epigastric, inferior
epitrochlear
esophageal
face
facial
femoral
gastric
groin
head
hepatic
C77.1
C77.1
C77.2
Hilar
NOS
pulmonary
splenic
--------
158
ICDO.indb 158
11/18/13 1:54 PM
Alphabetic index
C77.5
C77.2
C77.5
C77.5
C77.2
C77.3
C77.4
C77.4
C77.1
C77.1
C77.2
C77.2
C77.5
C77.1
C77.0
C77.4
C77.4
C77.2
C77.0
C77.1
C77.2
C77.2
C77.2
Mesenteric
NOS
inferior
superior
C77.2
C77.8
C77.0
C77.5
C77.0
C77.2
C77.2
C77.5
C77.5
C77.1
C77.0
C77.3
C77.5
C77.2
C77.2
C77.4
C77.2
C77.2
C77.0
C77.0
C77.5
C77.0
C77.1
C77.1
C77.2
C77.2
C77.0
C77.4
C77.5
C77.0
C77.2
C77.2
midcolic
multiple regions
neck
obturator
occipital
pancreatic
para-aortic
paracervical
parametrial
parasternal
parotid
pectoral
pelvic
periaortic
peripancreatic
popliteal
porta hepatis
portal
preauricular
prelaryngeal
presymphysial
pretracheal
pulmonary hilar
pulmonary, NOS
pyloric
retroperitoneal
retropharyngeal
Rosenmuller
sacral
scalene
splenic hilar
splenic, NOS
C77.3
C77.4
C77.0
C77.0
C77.0
C77.0
C77.3
C77.2
C77.0
C77.1
C77.4
C77.1
C77.1
C77.3
C77.8
9835/3
9727/3
8583/3
8583/1
-------8583/3
8583/1
-------9831/3
8082/3
-------8082/3
8082/3
Lymphocytic
infiltrate of Jessner, benign (see
SNOMED)
thymoma, malignant (C37.9)
thymoma, NOS (C37.9)
Lymphocytoma cutis, benign (see
SNOMED)
Lymphocytosis, T-cell large granular
Lymphoepithelial carcinoma
Lymphoepithelial lesion, benign (see
SNOMED)
Lymphoepithelioma
Lymphoepithelioma-like carcinoma
---------------------8512/3
Lymphoid
hamartoma, angiomatous (see
SNOMED)
hyperplasia, NOS (see SNOMED)
polyp, benign (see SNOMED)
polyp, NOS (see SNOMED)
stroma, medullary carcinoma with
9827/3
9591/3
9591/3
9827/3
--------
159
11/28/13 3:05 PM
9702/3
9714/3
9737/3
9680/3
Lymphoma (malignant)
NOS
adult T-cell (includes all variants)
adult T-cell leukemia/lymphoma
(HTLV-1 positive) (includes all
variants)
adult T-cell lymphoma/leukemia
(includes all variants)
aggressive epdermotropic cytotoxic
T-cell, primary cutaneous CD8positive
AILD (Angioimmunoblastic
Lymphadenopathy with
Dysproteinemia), peripheral T-cell
[obs]
ALK negative anaplastic large cell
ALK positive anaplastic large cell
ALK positive large B-cell
anaplastic large B-cell
9714/3
9702/3
9714/3
9714/3
9718/3
9714/3
9590/3
9827/3
9827/3
9827/3
9709/3
9705/3
9719/3
9705/3
9705/3
9712/3
9738/3
9699/3
9591/3
9737/3
9680/3
B-cell
NOS
ALK positive large
anaplastic large
9680/3
9680/3
9680/3
9680/3
9596/3
9680/3
9680/3
9684/3
Diffuse large
NOS
associated with chronic
inflammation
B-cell lymphoma,
unclassifiable, with features
intermediate between
Burkitt lymphoma and
B-cell lymphoma,
unclassifiable, with
features intermediate
between classical Hodgkin
lymphoma and
centroblastic, NOS
EBV positive, of the elderly
immunoblastic, NOS
9680/3
9680/3
9712/3
9712/3
9737/3
9680/3
9737/3
9680/3
9680/3
9688/3
9728/3
9699/3
9679/3
9699/3
9728/3
9670/3
9591/3
9689/3
9688/3
9680/3
9679/3
9680/3
9596/3
9727/3
9670/3
9699/3
9687/3
9680/3
9687/3
9687/3
ALK positive
anaplastic
arising in HHV8-associated
multicentric Castleman
disease
histiocyte-rich
T-cell rich
T-cell rich/histiocyte-rich
160
ICDO.indb 160
11/18/13 1:54 PM
Alphabetic index
9687/3
9738/3
9714/3
9718/3
9709/3
9709/3
9680/3
9680/3
9698/3
9680/3
Centroblastic
NOS
diffuse
follicular
large B-cell, diffuse, NOS
9675/3
9675/3
9690/3
Centroblastic-centrocytic
NOS [obs]
diffuse [obs]
follicular [obs] (see also 9675/3)
9680/3
9591/3
9695/3
Cleaved cell
NOS [obs]
follicular small
9673/3
9680/3
9680/3
9680/3
9698/3
9680/3
9691/3
9591/3
9591/3
9695/3
9680/3
9596/3
9727/3
9709/3
9718/3
9709/3
9709/3
9680/3
9597/3
Large
NOS [obs]
diffuse
follicular [obs]
NOS [obs]
diffuse [obs]
follicular [obs]
9718/3
9718/3
9709/3
9709/3
9680/3
9597/3
9726/3
9718/3
9709/3
9709/3
9591/3
9680/3
9675/3
9680/3
9680/3
9680/3
9680/3
9680/3
9684/3
9680/3
9680/3
9680/3
9680/3
9670/3
9673/3
9591/3
9670/3
9670/3
9675/3
9675/3
9675/3
161
ICDO.indb 161
11/18/13 1:54 PM
9680/3
9591/3
9591/3
9670/3
9591/3
9670/3
9687/3
9591/3
9680/3
9680/3
9717/3
9717/3
9709/3
9699/3
9719/3
9690/3
9690/3
9597/3
9690/3
9698/3
9690/3
9690/3
9695/3
9691/3
9698/3
9698/3
9698/3
9698/3
9698/3
9698/3
9691/3
9691/3
9698/3
9695/3
9726/3
9716/3
9716/3
9738/3
9680/3
9688/3
9680/3
9680/3
9698/3
9755/3
Histiocytic
NOS [obs]
diffuse
nodular [obs]
true
9596/3
9650/3
9725/3
9684/3
9684/3
9684/3
Immunoblastic
NOS
large B-cell, diffuse, NOS
large cell
9680/3
9680/3
9596/3
9673/3
9591/3
9717/3
9717/3
9712/3
9712/3
9714/3
intestinal T-cell
intestinal T-cell, enteropathy type
intravascular B-cell
intravascular large B-cell (C49.9)
Ki-1+ large cell [obs]
9680/3
Large
NOS
9680/3
9712/3
9679/3
9680/3
9688/3
9679/3
B-cell
NOS
ALK positive
anaplastic
arising in HHV8-associated
multicentric Castleman
disease
histiocyte-rich large
intravascular (C49.9)
mediastinal (C38.3)
T-cell rich
T-cell rich/histiocyte-rich
thymic (C37.9)
9698/3
9680/3
9680/3
9737/3
9680/3
9738/3
162
ICDO.indb 162
11/18/13 1:54 PM
Alphabetic index
9680/3
9714/3
9675/3
9691/3
9702/3
9718/3
9714/3
9718/3
9688/3
9680/3
9714/3
9702/3
9714/3
9680/3
9714/3
9714/3
9714/3
CD30+ anaplastic
9680/3
9680/3
9680/3
Cleaved
NOS [obs]
and noncleaved [obs]
diffuse
9680/3
9698/3
9684/3
9680/3
9680/3
9698/3
Non-cleaved
NOS
diffuse
follicular [obs]
9702/3
9718/3
9680/3
9680/3
9680/3
9680/3
9684/3
9680/3
9680/3
9702/3
peripheral T-cell
primary cutaneous anaplastic
(C44._)
9727/3
9728/3
9727/3
9729/3
9670/3
9670/3
9670/3
9673/3
9591/3
9670/3
9670/3
9673/3
9690/3
9591/3
9695/3
9698/3
9591/3
9695/3
9670/3
9670/3
9670/3
9670/3
9670/3
Large diffuse
B-cell
NOS
associated with chronic
inflammation
centroblastic, NOS
EBV positive, of the elderly
immunoblastic, NOS
primary, of CNS (C70._,
C71._, C72._)
9698/3
9699/3
9699/3
9675/3
9691/3
9702/3
9699/3
9699/3
163
ICDO.indb 163
11/18/13 1:54 PM
9671/3
9671/3
9699/3
9673/3
9673/3
9699/3
9699/3
9689/3
9699/3
9699/3
9689/3
9689/3
9702/3
9679/3
9764/3
9702/3
9675/3
9691/3
9691/3
9675/3
9691/3
9675/3
9691/3
9699/3
9699/3
9699/3
9680/3
9680/3
9698/3
9591/3
9680/3
Non-cleaved
NOS
and cleaved large cell [obs]
cell, follicular, NOS [obs]
cell, NOS
diffuse, NOS [obs]
9680/3
9680/3
9698/3
9687/3
Mixed
Cell type
diffuse [obs]
follicular [obs]
nodular [obs]
9680/3
lymphocytic-histiocytic, diffuse
[obs]
lymphocytic-histiocytic, nodular
[obs]
small and large cell, diffuse [obs]
small cleaved and large cell,
follicular [obs]
9690/3
9698/3
Nodular
NOS [obs] (see also 9675/3)
histiocytic [obs]
9695/3
9698/3
9591/3
9719/3
9719/3
9727/3
9719/3
9719/3
9699/3
9690/3
9591/3
9591/3
monocytoid B-cell
mucosa-associated lymphoid tissue
mucosa-associated lymphoid tissue,
extranodal marginal zone of
multicentric Castleman disease, large
B-cell, arising in HHV8-associated
nasal and nasal-type NK/T-cell
nasal type extranodal NK/T-cell
NK cell, blastic [obs]
NK/T-cell, extranodal, nasal type
NK/T-cell, nasal and nasal-type
nodal marginal zone
9738/3
9691/3
9691/3
9596/3
9591/3
9714/3
9680/3
9708/3
9702/3
9705/3
9702/3
9702/3
9702/3
9735/3
9671/3
9671/3
9702/3
9702/3
9591/3
9695/3
Large cell
NOS
diffuse
follicular [obs]
small, Burkitt type [obs] (includes
all variants)
small cell, diffuse [obs]
non-Hodgkin and Hodgkin, composite
non-Hodgkin, NOS
null cell and T-cell type anaplastic large
cell
of CNS, diffuse large B-cell (C70._,
C71._, C72._)
of the elderly, EBV positive diffuse
large B-cell
panniculitis-like T-cell lymphoma,
subcutaneous
Peripheral T-cell
NOS
AILD (Angioimmunoblastic
Lymphadenopathy with
Dysproteinemia) [obs]
large cell
pleomorphic medium and large
cell
pleomorphic small cell
plasmablastic
plasmacytic [obs]
plasmacytoid [obs]
pleomorphic medium and large cell,
peripheral T-cell
pleomorphic small cell, peripheral
T-cell
Poorly differentiated
lymphocytic, diffuse [obs]
lymphocytic, nodular [obs]
Lymphocytic
NOS [obs] (see also 9675/3)
intermediate differentiation
[obs]
poorly differentiated [obs]
well differentiated [obs]
164
ICDO.indb 164
11/18/13 1:54 PM
Alphabetic index
9728/3
9727/3
9729/3
9718/3
9718/3
9709/3
9709/3
9680/3
9597/3
9726/3
9680/3
9678/3
9591/3
9699/3
9699/3
9675/3
9591/3
9670/3
9670/3
9670/3
9591/3
9702/3
9691/3
9591/3
9591/3
9695/3
9670/3
9670/3
9670/3
9670/3
9687/3
Cleaved
and large cell, mixed,
follicular [obs]
cell, diffuse [obs]
cell, NOS [obs]
cleaved cell, follicular [obs]
lymphocytic/B-cell chronic
lymphocytic leukemia (see also
9823/3)
lymphocytic, B, NOS (see also
9823/3)
lymphocytic, diffuse, NOS (see
also 9823/3)
lymphocytic, NOS (see also
9823/3)
noncleaved, Burkitt type [obs]
(includes all variants)
9591/3
9689/3
9689/3
9689/3
9708/3
9702/3
9709/3
9827/3
9827/3
9827/3
9709/3
9714/3
9719/3
9705/3
9709/3
9709/3
9709/3
9709/3
9717/3
9717/3
9709/3
9716/3
9717/3
9702/3
9729/3
9702/3
9702/3
9705/3
9702/3
9702/3
9702/3
9729/3
165
ICDO.indb 165
11/18/13 1:54 PM
9718/3
9709/3
9709/3
9726/3
9688/3
9680/3
9709/3
9708/3
9679/3
9719/3
9755/3
9702/3
9596/3
9680/3
9591/3
9591/3
Undifferentiated
Burkitt type [obs] (includes all
variants)
cell, non-Burkitt [obs]
cell type, NOS [obs]
9725/3
vacciniforme-like, hydroa
9687/3
9670/3
9698/3
9680/3
9596/3
9590/3
9766/1
9718/3
8561/0
9673/3
9530/0
Well-differentiated
lymphocytic, diffuse (see also
9823/3)
lymphocytic, nodular [obs]
with features intermediate between
diffuse large B-cell lymphoma and
Burkitt lymphoma
with features intermediate between
diffuse large B-cell lymphoma and
classical Hodgkin lymphoma
Lymphoma, NOS (see Lymphoma
(malignant))
Lymphomatoid granulomatosis
Lymphomatoid papulosis (C44._)
Lymphomatosum, papillary cystadenoma
(C07._, C08._)
Lymphomatous polyposis, malignant
(includes all variants: blastic, pleomorphic,
small cell)
Lymphoplasmacyte-rich meningioma
(C70._)
9724/3
9768/1
9970/1
9831/3
9971/1
9971/3
9718/3
9591/3
9820/3
9591/3
Lymphoproliferative
disease of childhood, systemic EBV
positive T-cell
disease, T-gamma
Disorder
NOS
chronic, of NK cells
post transplant, NOS
post transplant, polymorphic
primary cutaneous CD30+ T-cell
(C44._)
Lymphosarcoma
NOS [obs]
cell leukemia [obs]
diffuse [obs]
M
8334/0
9761/3
8726/0
C34.0
C08.9
Main bronchus
Major salivary gland, NOS
--------
C63.9
C63.9
C63.9
Male
genital organs, NOS
genital tract, NOS
genitourinary tract, NOS
8110/0
8742/2
8742/3
8000/3
-----/1
-----------/6
-----/3
-----/6
-----/9
9699/3
MALT lymphoma
C49.3
--------
166
11/28/13 3:05 PM
Alphabetic index
C50.9
Mammary gland
8540/3
C41.1
C03.1
C77.0
Mandible
Mandibular gingiva
Mandibular lymph node
8244/3
9673/3
9982/3
MANEC
Mantle zone lymphoma [obs]
Marked thrombocytosis, refractory anemia
with ring sideroblasts associated with
C42.1
Marrow, bone
8670/0
Masculinovoblastoma (C56.9)
C49.0
Masseter muscle
9741/3
9742/3
9740/3
9740/3
9740/1
Mast cell
disease, systemic tissue
leukemia (C42.1)
sarcoma
tumor, malignant
tumor, NOS
9740/1
9740/1
9740/3
9740/1
Mastocytoma
NOS
extracutaneous
malignant
solitary, of skin
9741/3
9740/1
9740/1
9740/1
9741/1
9741/3
Mastocytosis
aggressive systemic
cutaneous
cutaneous, diffuse
diffuse cutaneous
indolent systemic
malignant
9741/3
9741/1
9741/3
9741/3
9741/3
Systemic
aggressive
indolent
with AHNMD
with associated hematological
clonal non-mast cell disorder
with associated hematological clonal
non-mast cell disorder, systemic
C30.1
Mastoid antrum
8110/3
9080/0
C41.0
Maxilla
C31.0
C03.0
C31.0
Maxillary
antrum
gingiva
sinus
C44.2
C17.3
C40.2
C47.1
C77.1
Median nerve
Mediastinal lymph node
C38.3
C38.1
C38.2
Mediastinum
NOS
anterior
posterior
9764/3
Mediterranean lymphoma
C71.7
C74.1
Medulla oblongata
Medulla of adrenal gland
8510/3
8700/0
8700/3
Medullary
adenocarcinoma
adrenal, paraganglioma (C74.1)
adrenal, paraganglioma, malignant
(C74.1)
8510/3
8513/3
8345/3
8512/3
9186/3
8700/0
8700/3
9750/3
8581/3
8581/1
8346/3
8347/3
Carcinoma
NOS
atypical (C50._)
with amyloid stroma (C73.9)
with lymphoid stroma
osteosarcoma (C40._, C41._)
paraganglioma, adrenal (C74.1)
paraganglioma, adrenal, malignant
(C74.1)
reticulosis, histiocytic [obs]
thymoma, malignant (C37.9)
thymoma, NOS (C37.9)
Medullary-follicular carcinoma, mixed
(C73.9)
Medullary-papillary carcinoma, mixed
(C73.9)
9470/3
9474/3
9471/3
9471/3
9474/3
9506/1
9470/3
9471/3
Medulloblastoma
NOS (C71.6)
anaplastic
desmoplastic (C71.6)
desmoplastic nodular (C71.6)
large cell (C71.6)
lipomatous (C71.6)
melanotic (C71.6)
with extensive nodularity
9506/1
Medullocytoma (C71.6)
9501/3
9501/0
9502/0
9502/3
Medulloepithelioma
NOS
benign (C69.4)
teratoid, benign (C69.4)
teratoid (C69.4)
9472/3
Medullomyoblastoma (C71.6)
9910/3
9910/3
9961/3
Megakaryocytic
leukemia, acute (C42.1)
leukemia (C42.1)
myelosclerosis (C42.1)
167
ICDO.indb 167
11/18/13 1:54 PM
C44.1
Meibomian gland
9363/0
8720/0
8761/3
8726/0
8726/0
8728/1
Melanocytoma
NOS
eyeball (C69.4)
meningeal (C70.9)
8728/0
8720/3
8744/3
8730/3
8745/3
8722/3
8745/3
8745/3
8770/3
8771/3
8720/2
8770/0
8744/3
8742/3
Melanoma
NOS
acral lentiginous, malignant (C44._)
amelanotic (C44._)
amelanotic, desmoplastic (C44._)
balloon cell (C44._)
desmoplastic, amelanotic (C44._)
desmoplastic, malignant (C44._)
epithelioid and spindle cell, mixed
epithelioid cell
in situ
juvenile (C44._)
lentiginous, acral, malignant (C44._)
lentigo maligna (C44._)
8740/3
8741/3
8745/3
8723/3
9044/3
Malignant
NOS (except juvenile melanoma
M-8770/0)
acral lentiginous (C44._)
desmoplastic (C44._)
in congenital melanocytic nevus
(C44._)
in giant pigmented nevus (C44._)
in Hutchinson melanotic freckle
(C44._)
in junctional nevus (C44._)
in precancerous melanosis (C44._)
neurotropic (C44._)
regressing (C44._)
soft parts (C49._)
8746/3
8745/3
8721/3
8723/3
mucosal lentiginous
neurotropic, malignant (C44._)
nodular (C44._)
regressing, malignant (C44._)
8772/3
8770/3
8773/3
8774/3
Spindle cell
NOS
and epithelioid, mixed
type A (C69._)
type B (C69._)
8743/3
8720/3
8744/3
8745/3
8761/3
8761/3
8742/3
8728/3
-------8741/3
8741/2
Melanosis
congenital (see SNOMED)
precancerous, malignant melanoma in
(C44._)
precancerous, NOS (C44._)
8742/2
9470/3
9540/3
9540/3
9363/0
9541/0
9363/0
9540/3
9560/0
Melanotic
freckle, Hutchinson, malignant
melanoma in (C44._)
freckle, Hutchinson, NOS (C44._)
medulloblastoma (C71.6)
MPNST
MPNST, psammomatous
neuroectodermal tumor
neurofibroma
progonoma
psammomatous MPNST
schwannoma
C58.9
Membranes, fetal
8728/1
8728/3
9530/3
9539/3
Meningeal
melanocytoma (C70.9)
melanomatosis (C70.9)
sarcoma (C70._)
sarcomatosis (C70._)
C70.9
C70.0
C70.0
C70.0
C70.1
Meninges
NOS
cerebral
cranial
intracranial
spinal
9530/0
9530/3
9535/0
9534/0
9539/1
9538/1
9538/1
9531/0
9532/0
9532/0
9535/0
9150/1
9530/0
9530/3
9531/0
9530/0
9530/0
9537/0
9538/3
9533/0
9538/3
9530/0
9531/0
9537/0
Meningioma (C70._)
NOS
anaplastic
angioblastic [obs]
angiomatous
atypical
chordoid
clear cell
endotheliomatous
fibroblastic
fibrous
hemangioblastic [obs]
hemangiopericytic [obs]
lymphoplasmacyte-rich
malignant
meningothelial
metaplastic
microcytic
mixed
papillary
psammomatous
rhabdoid
secretory
syncytial
transitional
8742/3
168
ICDO.indb 168
11/18/13 1:54 PM
Alphabetic index
9530/1
9530/1
9530/1
9531/0
9530/3
C40.2
C40.2
8247/3
8247/3
9240/3
9540/3
-------8990/3
8800/3
8990/1
Mesenchymal
chondrosarcoma
differentiation, MPNST with
hamartoma (see SNOMED)
sarcoma, mixed
tumor, malignant
tumor, mixed
8970/3
Mesenchymal-epithelial hepatoblastoma,
mixed (C22.0)
8990/1
8990/0
8990/3
Mesenchymoma
NOS
benign
malignant
C49.4
Mesenteric artery
8822/1
C77.2
C77.2
C77.2
C48.1
C48.1
Mesentery
Mesoappendix
8960/1
Mesoblastic nephroma
C48.1
Mesocolon
8951/3
9110/3
9110/0
9110/1
Mesonephric
adenocarcinoma
adenoma
tumor, NOS
8310/3
9050/3
9050/0
9053/3
9053/3
9055/0
9055/1
9051/3
Mesothelioma
NOS
benign
biphasic, malignant
biphasic, NOS
cystic, benign (C48._)
cystic, NOS (C48._)
desmoplastic
9052/3
9052/0
9052/3
Epithelioid
NOS
benign
malignant
9051/3
9051/0
9051/3
Fibrous
NOS
benign
malignant
9050/3
9055/0
9052/0
9051/3
9051/3
malignant
multicystic, benign
papillary, well differentiated, benign
sarcomatoid
spindled
C57.1
C40.1
Mesovarium
Metacarpal bone
8325/0
--------
-------9961/3
8573/3
8573/3
8571/3
8571/3
--------
Metaplasia
NOS (see SNOMED)
agnogenic myeloid
apocrine, adenocarcinoma with
apocrine, carcinoma with
cartilaginous, adenocarcinoma with
cartilaginous and osseous,
adenocarcinoma with
glandular (see SNOMED)
-------9961/3
9961/3
Myeloid
NOS (see SNOMED)
with myelofibrosis
with myelosclerosis
8571/3
8572/3
8570/3
--------
9110/3
9110/0
9110/3
Mesonephroma
NOS
benign
malignant
8575/3
9530/0
8898/1
C10.9
C10.2
C10.3
Mesopharynx
NOS
lateral wall
posterior wall
9052/0
Mesothelial papilloma
8140/6
8010/6
8000/6
8490/6
8070/6
8000/6
Metastatic
adenocarcinoma, NOS
carcinoma, NOS
neoplasm
signet ring cell carcinoma
squamous cell carcinoma, NOS
tumor
169
ICDO.indb 169
11/18/13 1:54 PM
-----/6
C40.3
Metatarsal bone
8095/3
9765/1
8150/0
8341/3
8202/0
8441/0
8407/3
9530/0
Microcystic
adenoma (C25._)
adenoma, serous
adnexal carcinoma (C44._)
meningioma (C70._)
8333/0
9590/3
8076/3
8097/3
8507/2
8265/3
8507/2
8460/3
8131/3
Micropapillary
carcinoma, intraductal (C50._)
carcinoma, NOS (C18._, C19.9, C20.9)
ductal carcinoma in situ (C50._)
serous carcinoma (C56.9)
transitional cell carcinoma (C67._)
C71.7
C77.2
Midbrain
Midcolic lymph node
C71.9
C30.1
C34.2
C34.2
C15.4
Middle
cranial fossa
ear
lobe, bronchus
lobe, lung
third of esophagus
C50.8
C02.0
Midline of breast
Midline of tongue
9719/3
8335/3
C06.9
8593/1
8281/0
8281/3
8552/3
8154/3
8154/3
8560/3
8560/3
8154/3
8154/3
8244/3
8213/0
8244/3
8902/3
8094/3
8281/0
8281/3
8180/3
8244/3
8323/3
8323/0
8375/0
8552/3
8154/3
8154/3
8523/3
9081/3
8902/3
8154/3
8154/3
8154/3
8154/3
8154/3
9383/1
8560/3
8970/3
8770/3
8154/3
8154/3
8154/3
8346/3
9085/3
8560/0
9382/3
Mixed, continued
Adenocarcinoma
and epidermoid carcinoma
and squamous cell carcinoma
endocrine and exocrine (C25._)
islet cell and exocrine (C25._)
adenocarcinoma-carcinoid
adenomatous and hyperplastic polyp
(C18._)
adenoneuroendocrine carcinoma
alveolar rhabdomyosarcoma and
embryonal rhabdomyosarcoma
basal-squamous cell carcinoma (C44._)
basophil-acidophil adenoma (C75.1)
basophil-acidophil carcinoma (C75.1)
bile duct and hepatocellular carcinoma
(C22.0)
carcinoid-adenocarcinoma
Cell
adenocarcinoma
adenoma
adrenal cortical adenoma (C74.0)
ductal-acinar carcinoma
ductal-endocrine-acinar carcinoma
ductal-endocrine carcinoma (C25._)
duct, infiltrating, with other types of
carcinoma (C50._)
embryonal carcinoma and teratoma
embryonal rhabdomyosarcoma and
alveolar rhabdomyosarcoma
endocrine-acinar carcinoma (C25._)
endocrine and exocrine
adenocarcinoma (C25._)
endocrine and exocrine tumor,
malignant pancreatic (C25._)
endocrine-ductal-acinar carcinoma
endocrine-ductal carcinoma (C25._)
ependymoma-subependymoma
(C71._)
epidermoid carcinoma and
adenocarcinoma
epithelial-mesenchymal
hepatoblastoma (C22.0)
epithelioid and spindle cell melanoma
Exocrine
and endocrine adenocarcinoma
(C25._)
and islet cell adenocarcinoma
(C25._)
and pancreatic endocrine tumor,
malignant (C25._)
follicular-medullary carcinoma (C73.9)
germ cell tumor
glandular and squamous cell papilloma
glioma (C71._)
170
ICDO.indb 170
11/18/13 1:54 PM
Alphabetic index
8970/3
8180/3
8213/0
8523/3
8524/3
8154/3
8855/3
8524/3
8346/3
8347/3
9537/0
8970/3
8990/3
8990/1
8951/3
8254/3
8950/3
8254/3
8154/3
8347/3
9362/3
9362/3
8902/3
9085/3
8592/1
8045/3
8770/3
8094/3
8560/0
8560/3
9383/1
8255/3
9081/3
9085/3
Mixed, continued
hepatoblastoma, epithelialmesenchymal (C22.0)
hepatocellular and bile duct carcinoma
(C22.0)
hyperplastic and adenomatous polyp
(C18._)
infiltrating duct with other types of
carcinoma (C50._)
infiltrating lobular with other types of
carcinoma (C50._)
islet cell and exocrine adenocarcinoma
(C25._)
liposarcoma
lobular, infiltrating, with other types of
carcinoma (C50._)
medullary-follicular carcinoma (C73.9)
medullary-papillary carcinoma (C73.9)
meningioma (C70._)
mesenchymal-epithelial
hepatoblastoma (C22.0)
mesenchymal sarcoma
mesenchymal tumor
mesodermal tumor
mucinous and non-mucinous
bronchiolo- alveolar carcinoma,
(C34._)
Mullerian tumor (C54._)
non-mucinous and mucinous
bronchiolo- alveolar carcinoma,
(C34._)
pancreatic endocrine and exocrine
tumor, malignant (C25._)
papillary-medullary carcinoma (C73.9)
pineal tumor (C75.3)
pineocytoma-pineoblastoma (C75.3)
rhabdomyosarcoma, alveolar and
embryonal
seminoma and teratoma
sex cord-gonadal stromal tumor, mixed
forms
small cell carcinoma
spindle cell and mixed epithelioid
melanoma
squamous-basal cell carcinoma (C44._)
squamous cell and glandular papilloma
squamous cell carcinoma and
adenocarcinoma
subependymoma-ependymoma
(C71._)
subtypes, adenocarcinoma with
teratoma and embryonal carcinoma
teratoma and seminoma
8940/0
8940/3
8951/3
8950/3
9362/3
8940/3
8940/0
8902/3
8582/3
8582/1
8470/0
8453/0
8470/0
8453/0
8453/0
8249/3
8332/3
8332/3
8249/3
-----/-2
-----/-2
9100/0
Mixed, continued
Tumor
NOS
malignant, NOS
mesodermal
Mullerian (C54._)
pineal (C75.3)
salivary gland type, malignant
(C07._, C08._)
salivary gland type, NOS (C07._,
C08._)
Type
rhabdomyosarcoma
thymoma, malignant (C37.9)
thymoma, NOS (C37.9)
Moderate dysplasia (with)
cystic tumor, mucinous (C25._)
intraductal papillary-mucinous tumor
(C25._)
mucinous cystic tumor (C25._)
papillary mucinous neoplasm,
intraductal (C25._)
papillary mucinous tumor, intraductal
(C25._)
Moderately differentiated
carcinoma, neuroendocrine
follicular adenocarcinoma (C73.9)
follicular carcinoma (C73.9)
neuroendocrine carcinoma
Moderately differentiated (see grading code,
section 4.3.4)
Moderately well differentiated (see grading
code, section 4.3.4)
Mole
hydatid (C58.9)
9100/0
9100/0
9100/1
9100/1
9103/0
Hydatidiform
NOS (C58.9)
complete (C58.9)
invasive (C58.9)
malignant (C58.9)
partial (C58.9)
9100/1
9041/3
C51.9
Mons pubis
9441/3
--------------9765/1
9765/1
8146/0
9751/3
171
ICDO.indb 171
11/18/13 1:54 PM
C51.9
Mons veneris
8092/3
C06.9
C04.0
C04.1
C04.9
C05.9
C06.1
Mouth
NOS
floor, anterior
floor, lateral
floor, NOS
roof
vestibule
9540/3
9540/3
9540/3
9540/3
9571/3
9540/3
9540/3
MPNST
NOS
epithelioid
melanotic
melanotic psammomatous
perineural
with glandular differentiation
with mesenchymal differentiation
8470/0
8480/1
8472/1
8472/1
8473/1
8470/3
8470/2
8470/2
8470/0
8470/0
8230/3
9015/3
8480/3
8482/3
Mucinous
adenocarcinofibroma
adenocarcinoma
adenocarcinoma, endocervical type
8472/1
8470/3
9015/0
9015/3
9015/1
Adenofibroma
NOS
malignant
of borderline malignancy
8470/2
8470/0
8470/0
8470/0
------8230/3
8480/0
8523/3
8480/1
8243/3
8480/3
9015/3
adenoma
and infiltrating duct carcinoma (C50._)
appendiceal neoplasm, low grade
(C18.1)
bronchiolo-alveolar carcinoma (C34._)
bronchiolo-alveolar carcinoma, nonmucinous and, mixed (C34._)
carcinoid
carcinoma
cystadenocarcinofibroma
8470/3
8470/2
8471/3
Cystadenocarcinoma
NOS (C56.9)
non-invasive (C25._)
papillary (C56.9)
9015/0
9015/3
9015/1
Cystadenofibroma
NOS
malignant
of borderline malignancy
8253/3
8254/3
8470/0
8472/1
8473/1
8471/0
Cystadenoma
NOS (C56.9)
borderline malignancy (C56.9)
papillary, borderline malignancy
(C56.9)
papillary, NOS (C56.9)
8470/0
8470/0
8453/0
8453/3
8453/2
8453/3
8453/2
8453/0
8453/0
8453/0
8453/0
8453/0
8481/3
8481/3
8481/3
8481/3
8243/3
--------
Mucinous, continued
cystoma (C56.9)
neoplasm, appendiceal, low grade
(C18.1)
Tumor
NOS, of low malignant potential
(C56.9)
atypical proliferative (C56.9)
papillary, of low malignant
potential (C56.9)
Mucinous cystic neoplasm
with an associated invasive carcinoma
(C25._)
with high grade dysplasia (C25._)
with high grade intraepithelial
neoplasia (C22._)
with intermediate grade intermediate
grade dysplasia (C25._)
with intermediate grade intraepithelial
neoplasia (C22._)
with low grade dysplasia (C25._)
with low grade intraepithelial neoplasia
(C22._)
Mucinous cystic tumor
of borderline malignancy (C56.9)
with an associated invasive carcinoma
(C25._)
with high grade dysplasia (C25._)
with intermediate dysplasia (C25._)
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
Mucinous-papillary
adenoma, intraductal (C25._)
carcinoma, intraductal, invasive
(C25._)
carcinoma, intraductal, non-invasive
(C25._)
Intraductal neoplasm
with an associated invasive
carcinoma
with high grade dysplasia (C25._)
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
Intraductal tumor
with intermediate dysplasia
(C25._)
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
Mucin-producing adenocarcinoma
Mucin-producing carcinoma
Mucin-secreting adenocarcinoma
Mucin-secreting carcinoma
Mucocarcinoid tumor
Mucocele (see SNOMED)
172
ICDO.indb 172
11/18/13 1:54 PM
Alphabetic index
8430/3
8430/1
Mucoepidermoid carcinoma
Mucoepidermoid tumor [obs]
8480/3
8480/3
8300/3
8300/0
Mucoid
adenocarcinoma
carcinoma
cell adenocarcinoma (C75.1)
cell adenoma (C75.1)
C03.1
C03.9
C03.1
C03.9
C03.0
C03.0
C06.0
C06.0
C00.4
C00.5
C00.3
C30.0
C06.9
Mucosa
alveolar, lower
alveolar, NOS
alveolar ridge, lower
alveolar ridge, NOS
alveolar ridge, upper
alveolar, upper
buccal
cheek
lip, lower
lip, NOS
lip, upper
nasal
oral
8746/3
8480/3
8480/3
9762/3
8950/3
8091/3
9055/0
9751/3
8091/3
9440/3
9440/3
9985/3
8959/3
8360/1
8221/0
8221/3
9140/3
9530/1
9732/3
9540/1
8221/0
8221/3
C75.8
C77.8
C49.9
C49.4
C49.4
C49.1
C49.6
C49.1
C49.2
C49.1
C49.5
C49.2
C49.3
C49.1
C49.1
C69.6
C49.0
C49.1
C49.6
C49.2
C49.1
C49.2
C49.5
C49.1
C49.0
C49.4
C49.3
C49.3
C49.2
C49.0
C49.0
C49.3
C49.5
C49.5
C49.4
C49.2
C49.4
C49.5
C49.0
C49.1
C49.9
C49.0
C49.2
C49.3
C49.3
C49.1
C49.2
C49.3
C49.1
C49.6
8897/1
8897/1
-------9700/3
9975/3
Muscle
NOS
abdomen
abdominal wall
arm
back
biceps brachii
biceps femoris
brachialis
buttock
calf
chest wall
coracobrachialis
deltoideus
extraocular
face
finger
flank
foot
forearm
gastrocnemius
gluteus maximus
hand
head
iliopsoas
intercostal
latissimus dorsi
leg
masseter
neck
pectoralis major
pelvis
perineum
psoas
quadriceps femoris
rectus abdominis
sacrococcygeal region
scalp
shoulder
skeletal, NOS
sternocleidomastoid
thigh
thoracic wall
thorax
thumb
toe
trapezius
triceps brachii
trunk, NOS
Muscle tumor, smooth, NOS
Muscle tumor, smooth, uncertain
malignant potential
Musculo-aponeurotic fibromatosis (see
SNOMED)
Mycosis fungoides (C44._)
Myelodysplastic/myeloproliferative
neoplasm, unclassifiable
173
ICDO.indb 173
11/18/13 1:54 PM
9989/3
9987/3
9987/3
9895/3
9895/3
Myelodysplastic syndrome
NOS
alkylating agent related, therapy related
epipodophyllotoxin related, therapy
related
prior, acute myeloid leukemia with
prior, acute myeloid leukemia without
9987/3
9987/3
9987/3
Therapy related
NOS
alkylating agent related
epipodophyllotoxin related
9989/3
9986/3
9989/3
unclassifiable
with 5q deletion (5q) syndrome
with isoleted del (5q)
-------9931/3
9961/3
9961/3
9961/3
9961/3
9931/3
Myelofibrosis
NOS (see SNOMED)
acute (C42.1)
as a result of myeloproliferative disease
chronic idiopathic
primary
with myeloid metaplasia
with panmyelosis (C42.1)
9967/3
9965/3
9961/3
9961/3
9961/3
9966/3
9920/3
9930/3
9920/3
Myeloid
and lymphoid neoplasms with FGFR1
abnormalities
and lymphoid neoplasms with
PDGFRA rearrangement
Metaplasia
agnogenic
with myelofibrosis
with myelosclerosis
neoplasms with PDGFRB
rearrangement
neoplasm, therapy related
sarcoma (see also 9861/3)
therapy related neoplasm
8870/0
Myelolipoma
9732/3
9732/3
9732/3
9731/3
Myeloma
NOS (C42.1)
multiple (C42.1)
plasma cell (C42.1)
solitary (C42.1)
9732/3
9898/1
Myelomatosis (C42.1)
Myelopoiesis, transient abnormal
9960/3
9960/3
9975/3
Myeloproliferative
disorder, chronic
neoplasm, NOS
neoplasm, unclassifiable
9960/3
9960/3
9961/3
9975/3
Myeloproliferative disease
NOS [obs]
chronic (C42.1)
myelofibrosis as a result of
Myeloproliferative/myelodysplastic
neoplasm, unclassifiable
9931/3
9931/3
9961/3
9961/3
Myelosclerosis
acute, NOS (C42.1)
malignant (C42.1) [obs]
megakaryocytic
with myeloid metaplasia
9840/3
9840/3
9580/3
9580/0
C38.0
Myocardium
8982/0
8982/3
8982/0
Myoepithelial
adenoma
carcinoma
tumor
8562/3
8982/0
8982/3
Myoepithelial-epithelial carcinoma
Myoepithelioma
Myoepithelioma, malignant
8825/1
8825/1
8827/1
8827/1
Myofibroblastic tumor
NOS
inflammatory
peribronchial (C34._)
peribronchial, congenital (C34._)
8825/0
8824/0
8824/1
8824/1
8895/0
Myofibroblastoma
Myofibroma
Myofibromatosis
Myofibromatosis, infantile
Myoma
C54.2
Myometrium
8895/3
8931/3
8931/3
-------8811/0
9320/0
Myosarcoma
Myosis, stromal, endolymphatic (C54.1)
Myosis, stromal, NOS (C54.1)
Myositis ossificans, NOS (see SNOMED)
Myxofibroma, NOS
Myxofibroma, odontogenic (C41._)
9231/3
8811/0
8896/3
8852/3
Myxoid
chondrosarcoma
fibroma
leiomyosarcoma
liposarcoma
8852/0
8852/3
Myxolipoma
Myxoliposarcoma
174
ICDO.indb 174
11/18/13 1:54 PM
Alphabetic index
8840/0
9562/0
9320/0
Myxoma
NOS
nerve sheath
odontogenic (C41._)
9394/1
8840/3
N
C53.0
C44.6
C44.7
C30.0
Nabothian gland
Nail, finger
Nail, toe
Naris
C11.3
C31.9
C30.0
Nasal
bone
cartilage
cavity (excludes nose, NOS C76.0)
lacrimal duct
mucosa
septum, NOS (excludes posterior
margin of nasal septum C11.3)
septum, posterior margin
sinus, accessory
turbinate
---------------
C69.5
C69.5
--------
C11.3
C11.9
C11.9
C11.3
C11.2
C11.1
C11.0
C11.0
Nasopharynx
NOS
anterior wall
lateral wall
posterior wall
roof
superior wall
C76.0
C44.4
C49.0
C49.0
C47.0
C49.0
C49.0
C49.0
C77.0
C49.0
C47.0
C49.0
Neck
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
muscle
peripheral nerve
skeletal muscle
C41.0
C30.0
C30.0
C69.5
C30.0
C30.0
C44.4
C49.0
C49.0
C49.0
C49.0
Neck, continued
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
C67.5
C25.7
Neck, bladder
Neck, pancreas
--------
8077/2
8077/2
8500/2
9064/2
8503/0
8503/0
8503/2
8503/0
8503/0
8503/0
8503/2
8503/2
8077/2
8077/2
8077/2
8000/1
8480/1
8000/0
9727/3
9727/3
8453/3
8453/2
8453/0
8453/0
8480/1
9967/3
9965/3
Neoplasia
anal intraepithelial, grade III (C21.1)
cervical intraepithelial, grade III
(C53._)
ductal intraepithelial 3 (C50._)
intratubular germ cell (C62._)
Papillary neoplasm
intracystic, with intermediate
grade intraepithelial (C23.9)
intracystic, with low grade
intraepithelial (C23.9)
intraductal, with high grade
intraepithelial
intraductal, with intermediate
grade (C22._, C24.0)
intraductal, with low grade
intraepithelial (C22._, C24.0)
intraglandular, with low grade
intraepithelial (C22.1, C24.0)
papillary tumor, intracystic, with high
grade intraepithelial (C23.9)
papillary tumor, intraductal with high
grade intraepithelial
squamous intraepithelial, grade III
vaginal intraepithelial, grade III
(C52._)
vulvar intraepithelial, grade III (C51._)
Neoplasm
NOS
appendiceal mucinous, low grade
(C18.1)
benign
blastic plasmacytoid dendritic cell
dendritic cell, blastic plasmacytoid
Intraductal papillary-mucinous
with an associated invasive
carcinoma
with high grade dysplasia
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
low grade appendiceal mucinous
lymphoid and myeloid, with FGFR1
abnormalities
lymphoid and myeloid, with PDGFRA
rearrangement
175
ICDO.indb 175
11/18/13 1:54 PM
8000/3
8000/9
8000/6
8480/1
9975/3
9960/3
9975/3
8163/0
8163/0
8452/1
8503/3
8503/2
8503/0
8503/0
8503/0
8503/3
8503/2
8503/2
8503/0
8503/0
8503/0
8163/2
8163/2
8163/0
8163/0
8163/2
8130/1
8130/1
Neoplasm, continued
malignant
malignant, uncertain whether primary
or metastatic
metastatic
mucinous, low grade appendiceal
myelodysplastic/myeloproliferative,
unclassifiable
myeloproliferative, NOS
myeloproliferative, unclassifiable
non-invasive pancreatobiliary
pancreatobiliary, non-invasive
Papillary
and solid epithelial (C25._)
Intracystic
with associated invasive
carcinoma (C23.9)
with high grade
intraepithelial neoplasia
(C23.9)
with intermediate grade
intraepithelial neoplasia
(C23.9)
with low grade intraepithelial
neoplasia (C23.9))
Intraductal
NOS
with an associated invasive
carcinoma
with high grade dysplasia
with high grade
intraepithelial neoplasia
with intermediate grade
neoplasia (C22._, C24.0)
with low grade intraepithelial
neoplasia (C22._, C24.0)
intraglandular, with low grade
intraepithelial neoplasia (C22.1,
C24.0)
Non-invasive pancreatobiliary
with high grade dysplasia
(C24.1)
with high grade
intraepithelial neoplasia
(C24.1)
with low grade dysplasia
with low grade intraepithelial
neoplasia
pancreatobiliary-type, with high
grade intraepithelial neoplasia
(C24.1)
transitional cell, low malignant
potential (C67._)
urothelial, low malignant potential
(C67._)
8453/3
8453/2
8453/0
8453/0
9727/3
8000/6
8452/1
9920/3
8503/2
8503/0
8000/1
9975/3
9975/3
8130/1
9967/3
9965/3
9967/3
9965/3
9966/3
8959/1
Neoplasm, continued
Papillary-mucinous intraductal
with an associated invasive
carcinoma
with high grade dysplasia
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
plasmacytoid dendritic cell, blastic
secondary
solid and papillary epithelial (C25._)
therapy related myeloid
tubular-papillary, intraductal, high
grade
tubular-papillary, intraductal, low
grade
uncertain whether benign or malignant
unclassifiable, myelodysplastic/
myeloproliferative
unclassifiable, myeloproliferative
urothelial, low malignant potential
(C67._)
Neoplasms
lymphoid and myeloid, with FGFR1
abnormalities
lymphoid and myeloid, with PDGFRA
rearrangement
myeloid and lymphoid, with FGFR1
abnormalities
myeloid and lymphoid, with PDGFRA
rearrangement
myeloid, with PDGFRB rearrangement
8960/3
8965/0
8960/3
8959/0
8959/3
8959/3
8960/1
Nephroma
NOS (C64.9)
cystic, benign (C64.9)
cystic, malignant (C64.9)
cystic, multilocular, malignant (C64.9)
mesoblastic
C47.9
C72.5
C72.5
C72.5
C72.4
C47.1
C72.5
C72.5
C47.2
C72.5
C72.5
C47.3
C47.6
Nerve
NOS
abducens
accessory, NOS
accessory, spinal
acoustic
brachial
cranial, NOS
facial
femoral
glossopharyngeal
hypoglossal
intercostal
lumbar
176
ICDO.indb 176
11/18/13 1:54 PM
Alphabetic index
C47.1
C47.2
C72.5
C72.2
C72.3
C47.9
C47.1
C47.5
C47.2
C72.5
C47.9
C72.5
C72.5
C47.1
C72.5
9562/0
9540/3
9561/3
C72.9
C47.9
C72.9
C47.9
C47.9
8150/0
8975/1
Nerve, continued
median
obturator
oculomotor
olfactory
optic
peripheral, NOS
radial
sacral
sciatic
spinal accessory
spinal, NOS
trigeminal
trochlear
ulnar
vagus
Nerve sheath
myxoma
tumor, malignant peripheral
tumor, malignant peripheral with
rhabdomyoblastic differentiation
Nervous system
NOS
autonomic, NOS
central
parasympathetic, NOS
sympathetic, NOS
8574/3
8574/3
8240/3
8249/3
Neuroendocrine
differentiation, adenocarcinoma with
differentiation, carcinoma with
tumor, grade 1
tumor, grade 2
8246/3
8013/3
8240/3
8249/3
8247/3
8041/3
8240/3
Neuroendocrine carcinoma
NOS
large cell
low grade
moderately differentiated
primary cutaneous (C44._)
small cell
well-differentiated
9413/0
9503/3
9523/3
9540/0
9541/0
9550/0
Neurofibroma
NOS
melanotic
plexiform
9540/1
9540/1
9540/3
9540/3
9520/3
9506/1
Neurofibromatosis, multiple
Neurofibromatosis, NOS
Neurofibrosarcoma [obs]
Neurogenic sarcoma [obs]
Neurogenic tumor, olfactory
Neurolipocytoma (C71.6)
9570/0
9560/0
-------9550/0
--------
Neuroma
NOS
acoustic (C72.4)
amputation (see SNOMED)
plexiform
traumatic (Morton) (see SNOMED)
Neuronevus (C44._)
Neurosarcoma [obs]
Neurothekeoma
Neurotropic melanoma, malignant (C44._)
Neutropenia, refractory
Nevoxanthoendothelioma (see SNOMED)
Nevus
NOS (C44._)
achromic (C44._)
araneus (see SNOMED)
balloon cell (C44._)
9560/3
9560/0
9560/3
9560/0
9560/1
9505/1
Nesidioblastoma (C25._)
Nested epithelial stromal tumor, calcifying
(C22.0)
Neurilemoma, malignant [obs]
Neurilemoma, NOS
Neurilemosarcoma [obs]
Neurinoma
Neurinomatosis
Neuroastrocytoma [obs]
9500/3
9500/3
9522/3
Neuroblastoma
NOS
central (C71._)
olfactory (C30.0)
8725/0
9540/3
9562/0
8745/3
9991/3
--------
9506/1
9506/1
9506/1
9521/3
Neurocytoma
NOS
central
extraventricular
olfactory (C30.0)
8720/0
8730/0
-------8722/0
9364/3
9473/3
9363/0
9364/3
9364/3
9473/3
9473/3
Neuroectodermal tumor
NOS
central primitive, NOS (C71._)
melanotic
peripheral
peripheral primitive, NOS
primitive, central, NOS (C71._)
primitive, NOS
8780/0
8790/0
8780/0
8780/3
8760/0
Blue
NOS (C44._)
cellular (C44._)
Jadassohn (C44._)
malignant (C44._)
compound (C44._)
177
ICDO.indb 177
11/18/13 1:55 PM
8761/0
Nevus, continued
Congenital
intermediate and giant (C44._)
melanocytic, malignant melanoma
in (C44._)
proliferative dermal lesion in
(C44._)
small (C44._)
8760/0
8750/0
8727/0
8770/0
8771/0
--------
8761/1
8761/3
8762/1
8761/1
8761/3
8761/1
8720/0
8723/0
8761/1
Giant
and intermediate congenital
(C44._)
pigmented, malignant melanoma
in (C44._)
pigmented, NOS (C44._)
8730/0
hairy (C44._)
halo (C44._)
intermediate and giant congenital
(C44._)
intradermal (C44._)
intraepidermal (C44._)
involuting (C44._) [obs]
Jadassohn blue (C44._)
Jadassohn sebaceus (see SNOMED)
junctional, malignant melanoma in
(C44._)
junctional, NOS (C44._)
junction (C44._)
juvenile (C44._)
magnocellular (C69.4)
melanocytic (C44._)
melanocytic, congenital, malignant
melanoma (C44._)
nonpigmented (C44._)
8720/0
8761/1
8770/0
Pigmented
NOS (C44._)
giant, NOS (C44._)
spindle cell, Reed
-------8770/0
8723/0
--------------8761/0
--------
8772/0
8770/0
8770/0
Spindle cell
NOS (C44._)
and epithelioid cell (C44._)
pigmented, Reed
8750/0
8740/0
9160/0
8780/0
-------8740/3
8740/0
8740/0
8770/0
8726/0
8720/0
8761/3
8770/0
------------------------------------
Nevus, continued
Spitz (C44._)
strawberry (see SNOMED)
unius lateris (see SNOMED)
vascular (see SNOMED)
verrucosus (see SNOMED)
white sponge (see SNOMED)
C50.0
Nipple
9831/3
C77._
8097/3
-------8402/0
8402/3
--------------9471/3
8721/3
8832/0
-------9471/3
Nodular
basal cell carcinoma (C44._)
fasciitis (see SNOMED)
hidradenoma (C44._)
hidradenoma, malignant (C44._)
hyperplasia, focal (see SNOMED)
hyperplasia, NOS (see SNOMED)
medulloblastoma, desmoplastic
(C71.6)
melanoma (C44._)
subepidermal fibrosis (C44._)
tenosynovitis (see SNOMED)
8930/0
8693/3
8693/1
8350/3
8350/3
8350/3
Nonencapsulated sclerosing
adenocarcinoma (C73.9)
carcinoma (C73.9)
tumor (C73.9)
8150/3
-------
8500/2
8503/2
8504/2
8500/2
8503/2
8520/2
Carcinoma
intracystic
intraductal, NOS (C50._)
intraductal papillary (C50._)
lobular (C50._)
8501/2
comedocarcinoma (C50._)
-----/2
8163/2
178
ICDO.indb 178
11/18/13 1:55 PM
Alphabetic index
8163/2
8163/0
8163/0
8453/2
8052/2
8130/2
8130/2
8470/2
-----/2
8072/3
8073/3
8072/3
8072/3
8073/3
9751/3
9741/3
8254/3
8252/3
-------8730/0
8092/3
8046/3
-----/-7
C76.0
C44.3
C41.0
C30.0
C11.3
C44.3
C30.0
C30.0
C30.0
C41.0
C30.0
C30.0
C30.0
C11.3
Non-invasive, continued
Pancreatobiliary papillary neoplasm,
continued
with high grade intraepithelial
neoplasia (C24.1)
with low grade dysplasia
with low grade intraepithelial
neoplasia
C44.3
C30.0
C30.0
Nose, continued
skin
turbinate
vestibule
C30.0
C41.2
Nostril
Nucleus pulposus
-----/-7
Non-invasive carcinoma
intraductal papillary-mucinous (C25._)
papillary squamous cell
papillary transitional cell (C67._)
papillary urothelial (C67._)
Non-invasive cystadenocarcinoma,
mucinous (C25._)
Noninvasive (see behavior code, section
4.3.3)
Nonkeratinizing
epidermoid carcinoma, large cell
epidermoid carcinoma, small cell
Squamous cell carcinoma
NOS
large cell, NOS
small cell
Nonlipid reticuloendotheliosis [obs]
Non-mast cell disorder, systemic
mastocytosis with associated
hematological clonal
Non-mucinous and mucinous bronchioloalveolar carcinoma, mixed (C34._)
Non-mucinous bronchiolo-alveolar
carcinoma (C34._)
Nonossifying fibroma (see SNOMED)
Nonpigmented nevus (C44._)
Non-sclerosing infiltrating basal cell
carcinoma (C44._)
Non-small cell carcinoma (C34._)
Non T-non B (see cell designation code,
section 4.3.4)
Nose
NOS
ala nasi
bone
cartilage
choana
external
internal
mucosa
naris
nasal bone
nasal cavity (excludes Nose, NOS C76.0)
nostril
septum, NOS
septum, posterior margin
O
8042/3
C77.5
C47.2
C41.0
C71.4
C77.0
C71.4
Occipital
bone
lobe
lymph node
pole
C72.5
Oculomotor nerve
9311/0
Odontoameloblastoma (C41._)
9300/0
9270/3
9342/3
Odontogenic
adenomatoid tumor (C41._)
carcinoma (C41._)
carcinosarcoma (C41._)
-------9301/0
-----------------------------
Cyst
9321/0
9321/0
9322/0
Fibroma
NOS (C41._)
central (C41._)
peripheral (C41._)
9330/3
9302/0
9320/0
9320/0
9270/3
fibrosarcoma (C41._)
ghost cell tumor (C41._)
myxofibroma (C41._)
myxoma (C41._)
sarcoma (C41._)
9270/1
9300/0
9270/0
9340/0
9341/1
9270/3
9312/0
Tumor
NOS (C41._)
adenomatoid (C41._)
benign (C41._)
calcifying epithelial (C41._)
clear cell (C44._)
malignant (C41._)
squamous (C41._)
179
ICDO.indb 179
11/18/13 1:55 PM
9280/0
9282/0
9281/0
9290/0
Odontoma
NOS (C41._)
complex (C41._)
compound (C41._)
fibroameloblastic (C41._)
9290/3
C15._
9522/3
9521/3
9523/3
9520/3
Olfactory
neuroblastoma (C30.0)
neurocytoma (C30.0)
neuroepithelioma (C30.0)
neurogenic tumor (C30.0)
C72.2
Olfactory nerve
9382/3
9382/3
9460/3
9451/3
9450/3
C71.7
C48.1
Olive
Omentum
8290/3
8290/0
8290/3
8121/1
Oncocytic
adenocarcinoma
adenoma
carcinoma
Schneiderian papilloma (C30.0, C31._)
8290/0
8290/0
--------
Oncocytoma
Oncocytoma, spindle cell (C75.1)
Oncocytosis (see SNOMED)
C71.0
Operculum
C72.3
C72.3
C72.3
Optic
chiasm
nerve
tract
C06.9
C06.9
Oral cavity
Oral mucosa
C69.6
C69.6
C69.6
C69.6
C69.6
Orbit
NOS
autonomic nervous system
connective tissue
peripheral nerve
soft tissue
C41.0
Orbital bone
9071/3
Orchioblastoma (C62._)
C71.0
C75.5
Organ of Reil
Organ of Zuckerkandl
8583/3
8583/1
C26.9
C57.9
C63.9
Organs
digestive, NOS
female genital, NOS
male genital, NOS
C67.6
C67.5
Orifice, ureteric
Orifice, urethral, internal
C10.9
C10.8
C10.2
C10.3
Oropharynx
NOS
junctional region
lateral wall
posterior wall
C53.1
C53.0
Os, external
Os, internal
9275/0
8571/3
8571/3
9262/0
8842/0
8967/0
Osseous
dysplasia, florid (C41._)
metaplasia, adenocarcinoma with
(C41._)
metaplasia, adenocarcinoma with
cartilaginous and (C41._)
Ossifying
fibroma (C40._, C41._)
fibromyxoid tumor
renal tumor (C64.9)
9180/3
8035/3
9250/3
9250/1
9262/0
9182/3
9180/3
9200/0
9191/0
9180/0
9200/0
9191/0
Osteoma
NOS (C40._, C41._)
osteoid, giant (C40._, C41._)
osteoid, NOS (C40._, C41._)
9180/3
9186/3
9186/3
9181/3
9182/3
9184/3
Osteosarcoma
NOS (C40._, C41._)
central (C40._, C41._)
central, conventional
chondroblastic (C40._, C41._)
fibroblastic (C40._, C41._)
in Paget disease, bone (C40._, C41._)
--------------9180/3
9200/1
9200/0
9210/0
9210/0
9210/1
--------
180
ICDO.indb 180
11/18/13 1:55 PM
Alphabetic index
9195/3
9187/3
9187/3
9192/3
9186/3
9192/3
9193/3
9185/3
9185/3
9194/3
9183/3
9101/3
8523/3
8524/3
Osteosarcoma, continued
intracortical (C40._, C41._)
intraosseous low grade
intraosseous well differentiated
juxtacortical (C40._, C41._)
medullary (C40._, C41._)
parosteal (C40._, C41._)
periosteal (C40._, C41._)
round cell
small cell (C40._, C41._)
surface, high grade (C40._, C41._)
telangiectatic (C40._, C41._)
Other germ cell elements, choriocarcinoma
combined with
Other types of carcinoma, infiltrating duct
mixed with (C50._)
Other types of carcinoma, infiltrating
lobular mixed with (C50._)
C50.8
C44.1
Outer breast
Outer canthus
8590/1
9090/0
9090/3
C56.9
Ovary
C----.8
8290/3
8290/0
8290/0
8290/3
8342/3
Oxyphilic
adenocarcinoma
adenoma
Cell
P
8936/1
9507/0
8540/3
Paget disease
and infiltrating duct carcinoma of
breast (C50._)
and intraductal carcinoma of breast
(C50._)
bone, osteosarcoma in (C40._, C41._)
bone (see SNOMED)
breast (C50._)
extramammary (except Paget disease of
bone)
mammary (C50._)
9700/3
Pagetoid reticulosis
C05.9
C05.0
C05.8
C11.3
C05.1
Palate
NOS
hard
junction of hard and soft
soft, nasopharyngeal surface
soft, NOS (excludes nasopharyngeal
surface C11.3)
C09.9
C71.0
Palatine tonsil
Pallium
C49.1
C49.1
C44.6
Palmar
aponeurosis
fascia
skin
C44.6
C44.1
Palm, skin
Palpebra
C25.9
C25.1
C25.3
C25.3
C25.3
C25.4
C25.0
C25.4
C25.4
C25.7
C25.2
Pancreas
NOS
body
duct
duct, Santorini
duct, Wirsung
endocrine
head
islands of Langerhans
islets of Langerhans
neck
tail
8541/3
8543/3
9184/3
-------8540/3
8542/3
8150/1
8154/3
8150/0
8150/3
8150/3
Pancreatic
Endocrine tumor
NOS (C25._)
and exocrine tumor, malignant
mixed (C25._)
benign (C25._)
malignant (C25._)
nonfunctioning (C25._)
181
ICDO.indb 181
11/18/13 1:55 PM
8154/3
8150/0
8154/3
8152/1
8152/1
Pancreatic, continued
exocrine and endocrine tumor,
malignant mixed (C25._)
microadenoma (C25._)
mixed endocrine and exocrine tumor,
malignant (C25._)
peptide and pancreatic peptide-like
peptide within terminal tyrosine
amide producing tumor
peptide-like peptide within terminal
tyrosine amide producing tumor,
pancreatic peptide and
C25.3
C77.2
Pancreatic duct
Pancreatic lymph node
8163/0
8163/0
Pancreatobiliary
neoplasm
neoplasm, non-invasive
8163/2
8163/2
8163/0
8163/0
Papillary neoplasm
non-invasive, with high grade
dysplasia (C24.1)
non-invasive, with high grade
intraepithelial neoplasia
non-invasive, with low grade
dysplasia
non-invasive, with low grade
intraepithelial neoplasia
8163/3
8163/3
8163/2
Pancreatobiliary-type
adenocarcinoma (C24.1)
carcinoma (C24.1)
papillary neoplasm with high grade
intraepithelial neoplasia (C24.1)
8971/3
9931/3
9931/3
Pancreatoblastoma (C25._)
Panmyelosis, acute, NOS (C42.1)
Panmyelosis with myelofibrosis (C42.1)
8260/3
8408/3
8408/3
8340/3
8503/3
8504/3
8503/2
8503/3
8503/2
8460/3
Papillary
Adenocarcinoma
NOS
digital (C44._)
eccrine (C44._)
follicular variant (C73.9)
infiltrating (C50._)
intracystic
intraductal, NOS (C50._)
intraductal, with invasion (C50._)
noninfiltrating intraductal (C50._)
serous (C56.9)
9013/0
adenofibroma
8260/0
8408/1
8408/0
8504/0
Adenoma
NOS
aggressive digital (C44._)
eccrine (C44._)
intracystic
8340/3
8340/3
8503/3
8452/1
9135/1
Papillary, continued
and follicular adenocarcinoma
and follicular carcinoma
and infiltrating adenocarcinoma
(C50._)
and solid epithelial neoplasm (C25._)
angioendothelioma, endovascular
8050/3
8344/3
8350/3
8343/3
8052/3
8340/3
Carcinoma
NOS
columnar cell (C73.9)
diffuse sclerosing (C73.9)
encapsulated (C73.9)
epidermoid
follicular variant (C73.9)
8050/2
8503/2
8052/2
In situ
NOS
ductal (C50._)
squamous cell
8504/3
8503/2
8342/3
8461/3
8461/3
8052/3
8052/2
8344/3
8260/3
8130/3
8130/2
intracystic
intraductal, NOS (C50._)
oxyphilic cell (C73.9)
primary serous, peritoneum
(C48.1)
serous surface (C56.9)
squamous cell
squamous cell, non-invasive
tall cell (C73.9)
thyroid (C73.9)
urothelial (C67._)
urothelial, non-invasive (C67._)
9352/1
craniopharyngioma (C75.2)
8450/3
8471/3
8471/3
8460/3
Cystadenocarcinoma
NOS (C56.9)
mucinous (C56.9)
pseudomucinous (C56.9)
serous C56.9)
8450/0
8451/1
8561/0
8473/1
8471/0
8473/1
8471/0
8462/1
8460/0
8452/1
8462/1
-------8503/2
8503/2
Cystadenoma
NOS (C56.9)
borderline malignancy (C56.9)
lymphomatosum (C07._, C08._)
mucinous, borderline malignancy
(C56.9)
mucinous, NOS (C56.9)
pseudomucinous, borderline
malignancy (C56.9)
pseudomucinous, NOS (C56.9)
serous, borderline malignancy
(C56.9)
serous, NOS (C56.9)
cystic tumor (C25._)
cystic tumor, serous, borderline
malignancy (C56.9
cystitis (see SNOMED)
DCIS (C50._)
ductal carcinoma in situ (C50._)
182
ICDO.indb 182
11/18/13 1:55 PM
Alphabetic index
9135/1
9393/3
8052/3
8452/1
8340/3
9509/1
8405/0
8504/3
8504/3
8503/3
8503/2
8503/0
8503/0
8503/2
8503/2
8503/0
8503/3
8503/2
8503/2
8503/0
8503/0
8503/0
8503/2
8503/2
8503/0
9538/3
9052/0
8341/3
8473/1
8461/3
8260/3
Papillary, continued
endovascular, angioendothelioma
ependymoma (C71._)
epidermoid carcinoma
epithelial neoplasm, solid and (C25._)
follicular variant, adenocarcinoma
(C73.9)
glioneuronal tumor
hidradenoma (C44._)
intracystic adenocarcinoma
intracystic carcinoma
Intracystic neoplasm
with associated invasive carcinoma
with high grade intraepithelial
neoplasia (C23.9)
with intermediate grade
intraepithelial neoplasia (C23.9)
with low grade intrepithelial
neoplasia (C23.9)
intracystic tumor with high grade
dysplasia (C23.9)
intracystic tumor with high grade
intraepithelial neoplasia (C23.9)
Intraductal neoplasm
NOS
with associated invasive carcinoma
with high grade dysplasia
with high grade intraepithelial
neoplasia
with intermediate grade neoplasia
(C22._, C24.0)
with low grade intraepithelial
neoplasia (C22._, C24.0)
with low grade intraepithelial
neoplasia (C23.9)
intraductal tumor with high grade
dysplasia
intraductal tumor with high grade
intraepithelial neoplasia
intraglandular neoplasm with low
grade intraepithelial neoplasia (C22.1,
C24.0)
meningioma (C70._)
mesothelioma, well differentiated,
benign
microcarcinoma (C73.9)
mucinous tumor of low malignant
potential (C56.9)
primary serous carcinoma, peritoneum
(C48.1)
renal cell carcinoma (C64.9)
8460/3
8460/3
8462/1
8462/1
Papillary, continued
Serous
adenocarcinoma (C56.9)
cystadenocarcinoma (C56.9)
tumor, atypical proliferative
(C56.9)
tumor, low malignant potential
(C56.9)
8052/3
8052/2
8052/2
8406/0
8406/0
syringadenoma (C44._)
syringocystadenoma (C44._)
8130/3
8130/2
8130/1
Transitional cell
carcinoma (C67._)
carcinoma, non-invasive (C67._)
neoplasm of low malignant
potential (C67._)
9509/1
8503/2
8503/2
9395/3
8130/3
8130/2
8130/1
8347/3
8453/3
8453/2
8453/3
8453/2
8453/0
8453/0
8453/0
8453/0
8453/0
Tumor
glioneuronal
intraductal, with high grade
dysplasia
intraductal, with high grade
intraepithelial neoplasia
of pineal region
Urothelial
carcinoma (C67._)
carcinoma, non-invasive (C67._)
neoplasm of low malignant
potential (C67._)
Papillary-medullary carcinoma, mixed
(C73.9)
Papillary-mucinous
carcinoma, intraductal, invasive
(C25._)
carcinoma, intraductal, non-invasive
(C25._)
Intraductal neoplasm
with an associated invasive
carcinoma
with high grade dysplasia
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
Intraductal tumor
with intermediate dysplasia
(C25._)
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
183
ICDO.indb 183
11/18/13 1:55 PM
8163/2
8163/2
8163/0
8163/0
8163/2
-------8405/0
8406/0
8450/3
8050/0
--------------8120/1
Papillary neoplasm
Pancreatobiliary
Non-invasive
with high grade dysplasia
(C24.1)
with high grade
intraepithelial neoplasia
(C24.1)
with low grade dysplasia
with low grade intraepithelial
neoplasia
pancreatobiliary type, with high grade
intraepithelial neoplasia (C24.1)
Papilliferous hyperplasia (see SNOMED)
Papilliferum, hidradenoma (C44._)
Papilliferum, syringocystadenoma
Papillocystic adenocarcinoma
Papilloma
NOS (except papilloma of bladder
8120/1)
basal cell (see SNOMED)
basosquamous (see SNOMED)
bladder (C67._)
9390/0
9390/3
9390/1
9390/3
Choroid plexus
NOS (C71.5)
anaplastic (C71.5)
atypical (C71.5)
malignant (C71.5)
8121/1
8121/1
8503/0
-------8260/0
8504/0
8503/0
8053/0
8052/0
9052/0
8560/0
columnar cell
cylindrical cell (C30.0, C31._)
ductal
fibroepithelial (see SNOMED)
glandular
intracystic
intraductal
inverted squamous cell
keratotic
mesothelial
mixed squamous cell and glandular
8121/0
8121/1
8121/1
Schneiderian
NOS (C30.0, C31._)
inverted (C30.0, C31._)
oncocytic (C30.0, C31._)
8461/0
8121/0
8121/0
8121/0
Sinonasal
NOS (C30.0, C31._)
exophytic (C30.0, C31._)
fungiform (C30.0, C31._)
8052/0
squamous
8052/0
8560/0
8053/0
Squamous cell
NOS
and glandular, mixed
inverted
8120/0
8120/0
8121/0
8121/1
8120/1
8121/0
8121/1
Papilloma, continued
Transitional
NOS
cell, benign
cell, inverted, benign
cell, inverted, NOS
cell, NOS
inverted, benign
inverted, NOS
8120/1
8051/0
8261/0
8060/0
8264/0
8505/0
8264/0
8505/0
8505/0
8060/0
8506/0
Papillomatosis
NOS
biliary (C22.1, C24.0)
diffuse intraductal
glandular
intraductal, diffuse
intraductal, NOS
squamous
subareolar duct (C50.0)
8263/3
8263/0
9160/0
9718/3
Papillotubular adenocarcinoma
Papillotubular adenoma
Papule, fibrous, of nose (C44.3) [obs]
Papulosis, lymphomatoid (C44._)
C75.5
C77.2
C77.5
Para-aortic body
Para-aortic lymph node
Paracervical lymph node
9373/0
8345/3
Parachordoma
Parafollicular cell carcinoma (C73.9)
8680/1
8700/0
8700/3
8691/1
8691/1
8680/0
8692/1
8700/0
8693/3
8693/1
8683/0
8690/1
8690/1
8680/3
8693/3
8693/1
8682/1
8681/1
Paraganglioma
NOS
adrenal medullary (C74.1)
adrenal medullary, malignant (C74.1)
aortic body (C75.5)
aorticopulmonary (C75.5)
benign
carotid body (C75.4)
chromaffin
extra-adrenal, malignant
extra-adrenal, NOS
gangliocytic (C17.0)
jugular (C75.5)
jugulotympanic (C75.5)
malignant
nonchromaffin, malignant
nonchromaffin, NOS
parasympathetic
sympathetic
C75.5
Paraganglion
9659/3
9659/3
C77.5
184
ICDO.indb 184
11/18/13 1:55 PM
Alphabetic index
C57.3
C31.9
C72.9
C77.1
C47.9
Parametrium
Paranasal sinus
Parasellar
Parasternal lymph node
Parasympathetic nervous system, NOS
8682/1
Parasympathetic paraganglioma
C75.0
C68.1
C64.9
Parathyroid gland
Paraurethral gland
Parenchyma, kidney
9362/3
C41.0
C71.3
C38.4
Parietal
bone
lobe
pleura
8214/3
8214/3
9192/3
C07.9
C07.9
C07.9
C77.0
Parotid
NOS
gland
gland duct
lymph node
C57.1
Parovarian region
9103/0
8959/1
C40.3
Patella
9965/3
9966/3
C49.3
C77.3
C71.7
C41.4
C18.7
C77.5
C48.1
C76.3
Pelvic
bone
colon
lymph node
peritoneum
wall, NOS
C19.9
Pelvirectal junction
C76.3
C49.5
C47.5
C41.4
C49.5
C49.5
C49.5
C47.5
Pelvis
NOS
NOS (sarcoma, lipoma)
autonomic nervous system
bone
connective tissue
fibrous tissue
muscle
peripheral nerve
C49.5
C49.5
C76.3
Pelvis, continued
skeletal muscle
soft tissue
wall, NOS
C65.9
C65.9
C65.9
Pelvis, kidney
Pelvis, renal
Pelviureteric junction
C60.9
C60.2
C60.2
C60.2
C60.0
C60.1
C60.0
C60.9
Penis
NOS
body
corpus
corpus cavernosum
foreskin
glans
prepuce
skin
8152/1
8152/1
8152/1
8152/1
C48.0
C24.1
C44.5
C77.2
Periadrenal tissue
Periampullary
Perianal skin
Periaortic lymph node
9272/0
9272/0
9012/0
C38.0
Pericardium
8391/0
C48.0
Perinephric tissue
C76.3
C44.5
C49.5
C47.5
C49.5
C49.5
C49.5
C47.5
C49.5
C44.5
C49.5
Perineum
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
connective tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
8827/1
8827/1
185
ICDO.indb 185
11/18/13 1:55 PM
C49.5
Perineum, continued
subcutaneous tissue
9571/3
Perineural MPNST
9571/0
9571/0
9571/3
9571/0
Perineurioma
NOS
intraneural
malignant
soft tissue
C03.9
Periodontal tissue
9221/0
9221/3
8812/0
8812/3
9193/3
8812/3
Periosteal
chondroma (C40._, C41._)
chondrosarcoma (C40._, C41._)
fibroma (C40._, C41._)
fibrosarcoma (C40._, C41._)
osteosarcoma (C40._, C41._)
sarcoma, NOS (C40._, C41._)
C77.2
C48.0
9364/3
9322/0
Peripheral
nerve sheath tumor, malignant
nerve sheath tumor with
rhabdomyoblastic differentiation,
malignant
neuroectodermal tumor
odontogenic fibroma (C41._)
C47.9
C47.4
C47.4
C47.2
C47.1
C47.1
C47.3
C47.6
C47.5
C47.2
C47.0
C47.0
C47.3
C47.3
C47.0
C47.1
C47.0
C47.1
C47.6
C47.2
C47.1
C47.0
C47.5
C47.5
C47.1
C47.0
C47.2
C47.2
Peripheral nerve
NOS
abdomen
abdominal wall
ankle
antecubital space
arm
axilla
back
buttock
calf
cervical region
cheek
chest
chest wall
chin
elbow
face
finger
flank
foot
forearm
forehead
gluteal region
groin
hand
head
heel
hip
9540/3
9561/3
C47.1
C47.2
C47.6
C47.4
C47.1
C76.3
C48.0
C48.2
8480/6
8480/3
Peritonei, pseudomyxoma
Peritonei, pseudomyxoma, with unknown
primary site (C80.9)
C47.3
C47.5
C47.2
C47.2
C47.0
C69.6
C47.5
C47.5
C47.2
C47.0
C47.5
C47.0
C47.3
C47.1
C47.0
C47.0
C47.2
C47.3
C47.3
C48.2
C48.2
C48.1
C48.1
C48.1
C48.1
C48.1
C48.1
C48.1
C48.1
Peritoneum
NOS
cavity
cul de sac
mesentery
mesoappendix
mesocolon
omentum
pelvic
pouch, Douglas
pouch, rectouterine
--------
C40.3
C40.1
Phalanx of foot
Phalanx of hand
C11.3
C11.1
C14.0
Pharyngeal
fornix
tonsil
wall, NOS
186
ICDO.indb 186
11/18/13 1:55 PM
Alphabetic index
C14.0
C14.0
C14.0
C14.0
8014/3
Pharynx
NOS
wall, lateral, NOS
wall, NOS
wall, posterior, NOS
8700/3
8700/3
8700/0
9020/1
9020/0
9020/3
Phyllodes
Cystosarcoma
NOS (C50._)
benign (C50._) [obs]
malignant (C50._)
9020/1
9020/0
9020/1
9020/3
Tumor
NOS (C50._)
benign (C50._)
borderline (C50._)
malignant (C50._)
C70.9
C70.0
C70.1
Pia mater
NOS
cranial
spinal
8640/1
8372/0
8372/0
8090/3
8833/3
Pigmented
adenoma (C74.0)
adrenal cortical adenoma (C74.0)
basal cell carcinoma (C44._)
dermatofibrosarcoma protuberans
(C44._)
8761/1
Nevus
NOS (C44._)
giant, malignant melanoma in
(C44._)
giant, NOS (C44._)
9560/0
8770/0
--------
schwannoma
spindle cell nevus of Reed (C44._)
villonodular synovitis (see SNOMED)
8720/0
8761/3
9740/1
-------8103/0
Pigmentosa, urticaria
Pilar cyst (see SNOMED)
Pilar tumor (C44._)
C09.1
C09.1
Pillar, faucial
Pillar, tonsillar
9421/1
9421/1
8110/3
8110/0
8110/3
8110/3
8110/0
9425/3
9340/0
C75.3
Pineal gland
9360/1
9395/3
Pinealoma (C75.3)
Pineal region, papillary tumor of
9362/3
9362/3
9362/3
9362/3
9362/3
9361/1
9362/3
8148/2
Pineal tumor
mixed (C75.3)
parenchymal, intermediate
differentiation (C75.3)
transitional (C75.3)
Pineoblastoma (C75.3)
Pineoblastoma-pineocytoma, mixed
(C75.3)
Pineocytoma (C75.3)
Pineocytoma-pineoblastoma, mixed
(C75.3)
PIN III (C61.9)
8093/3
Pinkus
tumor
type, fibroepithelial basal cell
carcinoma
type, fibroepithelioma
C44.2
C12.9
C12.9
Pinna
Piriform fossa
Piriform sinus
9432/1
Pituicytoma
C75.1
C75.1
C75.1
Pituitary
NOS
fossa
gland
8272/0
8272/3
C58.9
Placenta
9104/1
C49.2
C49.2
C44.7
Plantar
aponeurosis
fascia
skin
-------9733/3
9732/3
-------9731/3
Plasma cell
granuloma (see SNOMED)
leukemia (C42.1)
myeloma (C42.1)
pseudotumor (see SNOMED)
tumor
8093/3
8093/3
9733/3
9671/3
9727/3
187
ICDO.indb 187
11/18/13 1:55 PM
9731/3
9734/3
9734/3
9731/3
9731/3
Plasmacytoma
NOS
extramedullary (not occurring in bone)
extraosseous
of bone (C40._, C41._)
solitary
8142/3
8940/0
8941/3
8022/3
8802/3
8893/0
8854/0
8854/3
Pleomorphic
adenoma
adenoma, carcinoma in (C07._, C08._)
carcinoma
cell sarcoma
leiomyoma
lipoma
liposarcoma
8901/3
8901/3
8910/3
Rhabdomyosarcoma
NOS
adult type
embryonal
8175/3
9424/3
C38.4
C38.4
C38.4
Pleura
NOS
parietal
visceral
8973/3
Pleuropulmonary blastoma
8835/1
8811/0
9131/0
8890/0
9550/0
9550/0
9560/0
Plexiform
fibrohistiocytic tumor
fibromyxoma
hemangioma
leiomyoma
neurofibroma
neuroma
schwannoma
C47.1
C47.0
C71.5
C47.5
C47.5
Plexus
brachial
cervical
choroid
lumbosacral
sacral
C75.8
Pluriglandular
9473/3
9473/3
8972/3
8254/3
PNET, NOS
PNET, supratentorial
Pneumoblastoma (C34._)
Pneumocyte, type II and goblet cell type
bronchiolo-alveolar carcinoma (C34._)
Pneumocyte, type II, bronchiolo-alveolar
carcinoma (C34._)
Polare, spongioblastoma (C71._)
Polar spongioblastoma (C71._)
Polar spongioblastoma, primitive (C71._)
[obs]
8252/3
9423/3
9423/3
9423/3
C71.1
C71.4
Pole, frontal
Pole, occipital
9950/3
9950/3
-------9950/3
Polycythemia
proliferative
rubra vera
secondary (see SNOMED)
vera
9072/3
9072/3
8034/3
9971/3
9719/3
8525/3
9751/3
8210/3
8210/2
8210/3
8210/2
-------8210/0
8210/3
8210/2
8213/0
8210/3
8210/2
8210/2
--------------8213/0
------------------------------------------8213/0
8213/0
8210/0
8210/3
8210/2
8932/0
Polyembryoma
Polyembryonal type embryonal carcinoma
Polygonal cell carcinoma
Polymorphic post transplant
lymphoproliferative disorder
Polymorphic reticulosis [obs]
Polymorphous low grade adenocarcinoma
(C50._)
Poly-ostotic Langerhans cell histiocytosis
[obs]
Polyp
NOS, adenocarcinoma in
NOS, adenocarcinoma in situ in
NOS, carcinoma in
NOS, carcinoma in situ in
NOS (see SNOMED)
Adenomatous
NOS
adenocarcinoma in
adenocarcinoma in situ
and hyperplastic, mixed (C18._)
carcinoma in
carcinoma in situ in
carcinoma in situ in, NOS
fibroepithelial (see SNOMED)
fibrous (see SNOMED)
hyperplastic and adenomatous polyp,
mixed (C18._)
hyperplastic (see SNOMED)
inflammatory (see SNOMED)
juvenile (see SNOMED)
lymphoid, benign (see SNOMED)
lymphoid, NOS (see SNOMED)
Peutz-Jeghers (see SNOMED)
serrated sessile
sessile serrated
Polypoid
adenoma
adenoma, adenocarcinoma in
adenoma, adenocarcinoma in situ in
atypical adenomyoma
188
ICDO.indb 188
11/18/13 1:55 PM
Alphabetic index
8220/3
8220/0
8220/0
9673/3
8221/0
8221/0
8221/3
Polyposis
adenomatous, coli, adenocarcinoma in
(C18._)
adenomatous, coli (C18._)
coli, familial (C18._)
lymphomatous, malignant (includes all
variants: blastic, pleomorphic, small
cell)
multiple
C67.4
C13.2
C10.3
C11.1
C10.3
C14.0
C16.8
Posterior wall
bladder
hypopharynx
mesopharynx
nasopharynx
oropharynx
pharynx, NOS
stomach, NOS (not classifiable to C16.1
to C16.4)
9071/3
C71.7
Pons
8936/1
8490/3
-----/-3
8897/1
C48.1
C75.1
C48.1
Pouch
Douglas
Rathke
rectouterine
C77.4
C76.5
C44.7
C49.2
C49.2
C47.2
C49.2
C49.2
C49.2
C47.2
C44.7
C49.2
C49.2
C49.2
C49.2
Popliteal space
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
9350/1
9364/3
8152/1
C77.0
9836/3
8741/3
--------
C77.0
8409/3
8409/0
8409/3
Porocarcinoma (C44._)
Poroma, eccrine (C44._)
Poroma, eccrine, malignant
9989/3
9989/3
9836/3
Preleukemia [obs]
Preleukemic syndrome (C42.1) [obs]
Pre-pre-B ALL (see also 9728/3)
C77.2
C77.2
--------
C60.0
C16.4
C76.3
C77.5
Prepuce
Prepylorus
Presacral region, NOS
Presymphysial lymph node
C13.0
Postcricoid region
9837/3
C77.0
C71.9
C11.3
C38.2
C32.1
C01.9
C01.9
Posterior
cranial fossa
margin of nasal septum
mediastinum
surface of epiglottis
third of tongue
tongue, NOS
8631/3
8634/3
9971/1
9971/3
8741/2
8583/3
8583/1
9769/1
9718/3
8247/3
9270/3
9961/3
Primary
amyloidosis
cutaneous CD30+ T-cell
lymphoproliferative disorder (C44._)
cutaneous neuroendocrine carcinoma
(C44._)
intraosseous carcinoma (C41._)
myelofibrosis
189
ICDO.indb 189
11/18/13 1:55 PM
8461/3
Primary, continued
serous papillary carcinoma of
peritoneum (C48.1)
-----/3
C80.9
9473/3
9473/3
9364/3
9423/3
Primitive
neuroectodermal tumor, central, NOS
(C71._)
neuroectodermal tumor, NOS
neuroectodermal tumor, peripheral,
NOS
polar spongioblastoma (C71._) [obs]
8152/1
8141/3
9363/0
9751/3
8271/0
9000/1
8444/1
8442/1
8103/0
8103/0
Proliferating
Brenner tumor (C56.9)
clear cell tumor, atypical (C56.9)
serous tumor, atypical (C56.9)
trichilemmal cyst
trichilemmal tumor
-------9836/3
8158/1
8152/1
9950/3
Proliferative
dermal lesion in congenital nevus
(C44._)
endometrioid tumor, atypical
mucinous tumor, atypical (C56.9)
papillary serous tumor, atypical
(C56.9)
polycythemia
C61.9
C61.9
Prostate gland
Prostate, NOS
8148/2
C68.0
Prostatic utricle
9837/3
9410/3
8832/3
8762/1
8380/1
8472/1
8462/1
8833/3
C15.3
9533/0
9540/3
9560/0
Psammomatous
meningioma (C70._)
MPNST, melanotic
schwannoma
8075/3
--------
8470/3
8470/3
8471/3
Pseudomucinous
adenocarcinoma (C56.9)
cystadenocarcinoma, NOS (C56.9)
cystadenocarcinoma, papillary (C56.9)
--------
8470/0
8472/1
8473/1
8471/0
8480/6
8480/3
Cystadenoma
NOS (C56.9)
borderline malignancy (C56.9)
papillary, borderline malignancy
(C56.9)
papillary, NOS (C56.9)
8452/3
8452/1
---------------
Pseudomyxoma peritonei
Pseudomyxoma peritonei with unknown
primary site (C80.9)
Pseudopapillary carcinoma, solid (C25._)
Pseudopapillary tumor, solid (C25._)
Pseudopolyp, NOS (see SNOMED)
Pseudosarcoma (see SNOMED)
8033/3
---------------
Pseudosarcomatous
carcinoma
fasciitis (see SNOMED)
fibromatosis (see SNOMED)
----------------------
Pseudotumor
NOS (see SNOMED)
inflammatory (see SNOMED)
plasma cell (see SNOMED)
C49.4
Psoas muscle
C49.0
C47.0
C49.0
C49.0
C47.0
C49.0
Pterygoid fossa
NOS
autonomic nervous system
connective tissue
fibrous tissue
peripheral nerve
soft tissue
9971/1
PTLD, NOS
C41.4
C51.9
Pubic bone
Pudendum
C34.9
C77.1
C77.1
Pulmonary
NOS
lymph node, hilar
lymph node, NOS
190
ICDO.indb 190
11/18/13 1:55 PM
Alphabetic index
8250/1
8972/3
C71.0
Putamen
C16.3
C16.4
C77.2
Pyloric
antrum
canal
lymph node
C16.4
Pylorus
--------
C71.7
C12.9
C12.9
Pyramid
Pyriform fossa
Pyriform sinus
Q
C49.2
8076/2
8076/2
8080/2
C19.9
C19.9
C19.9
Rectosigmoid
NOS
colon
junction
C48.1
C76.3
C76.3
C19.9
C20.9
C49.4
Rectouterine pouch
Rectovaginal septum
Rectovesical septum
Rectum and colon
Rectum, NOS
Rectus abdominis muscle
8770/0
9985/3
9985/3
9991/3
9992/3
Refractory
cytopenia of childhood
cytopenia with multilineage dysplasia
neutropenia
thrombocytopenia
9980/3
9984/3
9983/3
9980/3
9982/3
9982/3
9982/3
R
9123/0
Racemose hemangioma
C49.1
C47.1
Radial artery
Radial nerve
--------
C40.0
Radius
9983/3
9983/3
9983/3
9984/3
9982/3
RAEB (C42.1)
RAEB I (C42.1)
RAEB II (C42.1)
RAEB-T (C42.1)
RARS (C42.1)
C75.1
Rathke pouch
9350/1
9965/3
9966/3
9540/1
-------C20.9
Rectal ampulla
9395/3
9514/1
8723/3
8723/0
C71.0
C71.0
Reil, island of
Reil, organ of
8312/3
Renal cell
adenocarcinoma (C64.9)
8312/3
8317/3
8316/3
8260/3
8318/3
8318/3
Carcinoma
NOS (C64.9)
chromophobe type (C64.9)
cyst-associated (C64.9)
papillary (C64.9)
sarcomatoid (C64.9)
spindle cell (C64.9)
8317/3
8319/3
8967/0
Renal (morphology)
carcinoma, chromophobe cell (C64.9)
carcinoma, collecting duct type (C64.9)
tumor, ossifying (C64.9)
C64.9
C49.4
C65.9
C65.9
C65.9
Renal (topography)
NOS
artery
calyces
calyx
pelvis
191
ICDO.indb 191
11/18/13 1:55 PM
8361/0
8966/0
8966/0
8041/3
Reninoma (C64.9)
Renomedullary fibroma (C64.9)
Renomedullary interstitial cell tumor
(C64.9)
Reserve cell carcinoma
C48.0
C48.0
C77.0
C14.0
Retroperitoneal tissue
Retroperitoneum
Retropharyngeal lymph node
Retropharynx
C39.9
C39.0
-------8671/0
--------
Rest
embryonal, NOS (see SNOMED)
tumor, adrenal
Walthard (see SNOMED)
9538/3
8014/3
8963/3
8963/3
8963/3
Rhabdoid
meningioma (C70._)
phenotype, large cell carcinoma with
sarcoma
tumor, malignant
tumor, NOS
9508/3
C62.0
9759/3
9561/3
C42.3
9940/3
9751/3
-------8831/0
9591/3
9591/3
Reticuloendotheliosis, leukemic
Reticuloendotheliosis, nonlipid [obs]
Reticulohistiocytic granuloma (see
SNOMED)
Reticulohistiocytoma
Reticulosarcoma, diffuse [obs]
Reticulosarcoma, NOS [obs]
9561/3
9561/3
Rhabdomyoblastic differentiation
malignant peripheral nerve sheath
tumor with
malignant schwannoma with
MPNST with
8900/0
8904/0
8903/0
8905/0
8904/0
Rhabdomyoma
NOS
adult
fetal
genital (C51._, C52.9)
glycogenic
9750/3
9719/3
9719/3
9700/3
9719/3
Reticulosis
histiocytic medullary [obs]
malignant midline [obs]
malignant, NOS [obs]
Pagetoid
polymorphic [obs]
8900/3
8901/3
8920/3
8902/3
8910/3
8910/3
8902/3
8902/3
8901/3
8912/3
8921/3
Rhabdomyosarcoma
NOS
adult type
alveolar
alveolar and embryonal, mixed
embryonal, NOS
embryonal, pleomorphic
mixed embryonal and alveolar
mixed type
pleomorphic, NOS
spindle cell
with ganglionic differentiation
8900/3
Rhabdosarcoma
C71.0
C41.3
C18.2
Rhinencephalon
Rib
Right colon
9982/3
9982/3
8090/3
C05.9
C11.0
C01.9
C11.2
C77.4
Roof of mouth
Roof of nasopharynx
Root of tongue
Rosenmuller fossa
Rosenmuller lymph node
9509/1
9591/3
9591/3
8633/1
8634/1
C69.2
Retina
9363/0
9510/3
9511/3
9513/3
9514/1
9512/3
Retinoblastoma
NOS (C69.2)
differentiated (C69.2)
diffuse (C69.2)
spontaneously regressed (C69.2)
undifferentiated (C69.2)
9510/0
Retinocytoma (C69.2)
C69.6
C48.0
Retrobulbar tissue
Retrocecal tissue
C06.2
C06.2
C06.2
Retromolar
area
triangle
trigone
8822/1
C77.2
192
ICDO.indb 192
11/18/13 1:55 PM
Alphabetic index
8041/3
8853/3
9185/3
8803/3
8806/3
Round cell
carcinoma
liposarcoma
osteosarcoma (C40._, C41._)
sarcoma
tumor, desmoplastic small
C57.2
Round ligament
9950/3
--------
S
C69.5
Sac, lacrimal
C72.0
C77.5
C47.5
C47.5
Sacral
cord
lymph node
nerve
plexus
C76.3
C44.5
C49.5
C49.5
C47.5
C49.5
C49.5
C49.5
C49.5
C47.5
C49.5
C44.5
C49.5
C49.5
Sacrococcygeal region
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C41.4
Sacrum
C08.9
C08.9
C06.9
8940/3
8940/0
-------9699/3
Salivary gland
NOS (excludes minor salivary gland,
NOS C06.9; see coding guidelines,
section 4.3.5, pseudo-topographic
morphology terms, and note under
C08)
major, NOS
minor, NOS (see coding guidelines,
section 4.3.5, pseudo-topographic
morphology terms, and note under
C08)
Salivary gland type mixed tumor, malignant
(C07._, C08._)
Salivary gland type mixed tumor, NOS
(C07._, C08._)
Salpingitis isthmica nodosa (see SNOMED)
SALT lymphoma
C25.3
Santorini duct
--------
8800/3
9581/3
9330/3
9471/3
8910/3
8910/3
9480/3
9471/3
9044/3
8964/3
9044/3
Sarcoma
NOS
alveolar soft part
ameloblastic (C41._)
arachnoidal cerebellar, circumscribed
(C71.6) [obs]
botryoid
botryoides
cerebellar, NOS (C71.6) [obs]
circumscribed arachnoidal cerebellar
(C71.6) [obs]
Clear cell
NOS (except of kidney 8964/3)
of kidney (C64.9)
of tendons and aponeuroses
(C49._)
9757/3
9758/3
9757/3
Dendritic cell
NOS
follicular
interdigitating
8991/3
8930/3
embryonal
endometrial, NOS (C54.1)
8930/3
8930/3
8931/3
Endometrial stromal
NOS (C54.1)
high grade (C54.1)
low grade (C54.1)
8804/3
8804/3
9260/3
9758/3
8936/3
9250/3
8802/3
8710/3
9930/3
9130/3
9140/3
9755/3
9662/3
9684/3
9757/3
9757/3
9140/3
9124/3
9756/3
9530/3
9170/3
9740/3
9530/3
9530/3
8990/3
9441/3
9140/3
epithelioid
epithelioid cell
Ewing (C40._, C41._)
follicular dendritic cell
gastrointestinal stromal
giant cell, bone (C40._, C41._)
giant cell (except of bone 9250/3)
glomoid
granulocytic
hemangioendothelial
hemorrhagic, multiple
histiocytic
Hodgkin [obs]
immunoblastic [obs]
interdigitating cell
interdigitating dendritic cell
Kaposi
Kupffer cell (C22.0)
Langerhans cell
leptomeningeal (C70._)
lymphangioendothelial (C70._)
mast cell
meningeal (C70._)
meningothelial (C70._)
mesenchymal, mixed
monstrocellular [obs] (C71._)
multiple hemorrhagic
193
ICDO.indb 193
11/18/13 1:55 PM
9930/3
9540/3
9270/3
9180/3
9180/3
8812/3
8802/3
9591/3
9591/3
8963/3
8803/3
8803/3
8800/3
8801/3
8935/3
Sarcoma, continued
myeloid (see also 9861/3)
neurogenic [obs]
odontogenic (C41._)
osteoblastic (C40._, C41._)
osteogenic, NOS (C40._, C41._)
periosteal, NOS (C40._, C41._)
pleomorphic cell
reticulum cell, diffuse [obs]
reticulum cell, NOS [obs]
rhabdoid
round cell
small cell
soft tissue
spindle cell
Stromal
NOS
8930/3
8930/3
8931/3
Endometrial
NOS (C54.1)
high grade (C54.1)
low grade (C54.1)
8936/3
gastrointestinal
9040/3
9043/3
9042/3
9041/3
9041/3
Synovial
NOS
biphasic
epithelioid cell
monophasic fibrous
spindle cell
8805/3
undifferentiated
8033/3
8173/3
8318/3
8074/3
8620/3
9051/3
8318/3
8631/3
8074/3
8122/3
Sarcomatoid
Carcinoma
NOS
hepatocellular (C22.0)
renal cell (C64.9)
squamous cell
granulosa cell tumor (C56.9)
mesothelioma
renal cell carcinoma (C64.9)
Sertoli-Leydig cell tumor
squamous cell carcinoma
transitional cell carcinoma
9539/3
8800/9
9442/3
C77.0
C44.4
C44.4
C49.0
C49.0
C47.0
C49.0
Scalp
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
C49.0
C49.0
C49.0
C47.0
C49.0
C44.4
C49.0
C49.0
Scalp, continued
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C40.0
Scapula
C76.1
C44.5
C49.3
C49.3
C47.3
C49.3
C49.3
C49.3
C47.3
C44.5
C49.3
C49.3
Scapular region
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
-------8082/3
8121/3
Schneiderian
carcinoma (C30.0, C31._)
8121/0
8121/1
8121/1
9560/0
9560/0
9560/0
9560/0
9560/3
9561/3
9560/0
9560/0
9560/0
9560/0
9561/3
Papilloma
NOS (C30.0, C31._)
inverted (C30.0, C31._)
oncocytic (C30.0, C31._)
Schwannoma
NOS
ancient
cellular
degenerated
malignant, NOS [obs]
malignant, with rhabdomyoblastic
differentiation
melanotic
pigmented
plexiform
psammomatous
with rhabdomyoblastic differentiation,
malignant
C47.2
Sciatic nerve
8141/3
8141/3
8172/3
Scirrhous
adenocarcinoma
carcinoma
carcinoma, hepatocellular (C22.0)
C69.4
Sclera
194
ICDO.indb 194
11/18/13 1:55 PM
Alphabetic index
8350/3
8350/3
8832/0
8172/3
8851/3
8350/3
8602/0
8407/3
8350/3
8602/0
Sclerosing
adenocarcinoma, nonencapsulated
(C73.9)
adenosis (see SNOMED)
basal cell carcinoma, infiltrating
(C44._)
carcinoma, nonencapsulated (C73.9)
carcinoma, papillary, diffuse (C73.9)
hemangioma (C44._)
hepatic carcinoma (C22.0)
liposarcoma
papillary carcinoma, diffuse (C73.9)
stromal tumor (C56.9)
sweat duct carcinoma (C44._)
tumor, nonencapsulated (C73.9)
tumor, stromal (C56.9)
C62.1
C63.2
C63.2
Scrotal testis
Scrotum, NOS
Scrotum, skin
8410/3
8410/0
8410/3
-------8410/0
Sebaceous
adenocarcinoma (C44._)
adenoma (C44._)
carcinoma (C44._)
cyst (see SNOMED)
epithelioma (C44._)
8350/3
-------8092/3
---------------
8010/6
8000/6
-------8000/6
9084/3
Secondary
carcinoma
neoplasm
polycythemia (see SNOMED)
tumor
tumor, dermoid cyst with (C56.9)
-----/6
8502/3
9530/0
8382/3
Secretory
carcinoma, breast (C50._)
meningioma (C70._)
variant, endometrioid adenocarcinoma
9582/0
C75.1
C40.2
C63.7
Sella turcica
Semilunar cartilage
Seminal vesicle
9061/3
9062/3
9085/3
9063/3
9062/3
Seminoma
NOS (C62._)
anaplastic (C62._)
and teratoma, mixed
spermatocytic (C62._)
with high mitotic index (C62._)
--------
C11.3
C76.3
C76.3
C57.9
C57.9
Septum
nasal, NOS (excludes posterior margin
of nasal septum C11.3)
nasal, posterior margin
rectovaginal
rectovesical
urethrovaginal
vesicovaginal
8241/3
9014/3
8441/3
8460/3
Serous
adenocarcinofibroma
adenocarcinoma, NOS (C56.9)
adenocarcinoma, papillary (C56.9)
C30.0
9014/0
9014/1
9014/3
Adenofibroma
NOS
borderline malignancy
malignant
8441/0
8441/3
8460/3
9014/3
8441/3
8460/3
adenoma, microcystic
carcinoma (C56.9)
carcinoma, micropapillary (C56.9)
cystadenocarcinofibroma
cystadenocarcinoma, NOS (C56.9)
cystadenocarcinoma, papillary (C56.9)
9014/0
9014/1
9014/3
Cystadenofibroma
NOS
borderline malignancy
malignant
8441/0
8442/1
8462/1
8460/0
8441/0
8441/0
8461/3
8462/1
8461/3
8463/1
8461/0
8442/1
8442/1
8462/1
8462/1
Cystadenoma
NOS (C56.9)
borderline malignancy (C56.9)
papillary, borderline malignancy
(C56.9)
papillary, NOS (C56.9)
cystoma (C56.9)
microcystic adenoma
papillary carcinoma, primary,
peritoneum (C48.1)
papillary cystic tumor of borderline
malignancy (C56.9)
Surface
papillary carcinoma (C56.9)
papillary tumor of borderline
malignancy (C56.9)
papilloma (C56.9)
Tumor
NOS, of low malignant potential
(C56.9)
atypical proliferating (C56.9)
papillary, atypical proliferative
(C56.9)
papillary, of low malignant
potential (C56.9)
195
ICDO.indb 195
11/18/13 1:55 PM
8213/3
8213/0
8213/0
8213/0
8213/0
8213/0
Serrated
adenocarcinoma
adenoma (C18._)
adenoma, sessile
adenoma, traditional
adenoma, traditional sessile
polyp, sessile
8640/1
8640/3
Sertoli cell
adenoma
carcinoma (C62._)
8640/1
8642/1
8641/0
8641/0
Tumor
NOS
large cell calcifying
lipid-rich (C56.9)
with lipid storage (C56.9)
8633/1
8634/1
8631/3
8631/0
8213/0
8213/0
8213/0
Sessile
serrated adenoma
serrated polyp
traditional serrated adenoma
8588/3
8077/2
SETTLE
Severe dysplasia, CIN III with (C53._)
8631/1
8631/1
8634/1
8631/3
8634/3
8590/1
8623/1
Sex cord
elements, stromal tumor with minor
(C56.9)
tumor, NOS
tumor with annular tubules (C56.9)
8590/1
8591/1
8592/1
9701/3
9701/3
Sezary disease
Sezary syndrome
C76.4
C44.6
C49.1
C49.1
C47.1
C40.0
C49.1
C49.1
Shoulder
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
bone
connective tissue
fatty tissue
8593/1
C49.1
C40.0
C40.0
C49.1
C47.1
C49.1
C44.6
C49.1
C49.1
Shoulder, continued
fibrous tissue
girdle
joint
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
8974/1
Sialoblastoma
9982/3
9980/3
9982/3
9982/3
Sideroblasts
Refractory anemia
with (C42.1)
without (C42.1)
with ring, associated with marked
thrombocytosis
with ringed (C42.1)
C18.7
C18.7
C18.7
Sigmoid
NOS
colon
flexure of colon
8490/3
8490/3
8490/6
8231/3
9131/0
Simplex, carcinoma
Simplex, hemangioma
8121/0
8121/0
8121/0
Sinonasal papilloma
NOS (C30.0, C31._)
exophytic (C30.0, C31._)
fungiform (C30.0, C31._)
C31.9
C31.9
C31.1
C31.2
C31.0
C31.9
C12.9
C31.3
Sinus
accessory, nasal
accessory, NOS
ethmoid
frontal
maxillary
paranasal
pyriform
sphenoid
-------9071/3
C76.2
C71.9
C76.1
C80.9
C41.9
intra-abdominal, NOS
intracranial
intrathoracic, NOS
primary, unknown
Skeletal bone
196
ICDO.indb 196
11/18/13 1:55 PM
Alphabetic index
C49.9
C49.4
C49.1
C49.6
C49.5
C49.2
C49.3
C49.0
C49.1
C49.6
C49.2
C49.1
C49.1
C49.0
C49.2
C49.0
C49.5
C49.5
C49.0
C49.1
C49.2
C49.3
C49.3
C49.1
C49.2
C49.6
C44.9
C44.5
C44.5
C44.3
C44.7
C44.6
C44.5
C44.6
Skeletal muscle
NOS
abdominal wall
arm
back
buttock
calf
chest wall
face
finger
flank
foot
forearm
hand
head
leg
neck
perineum
sacrococcygeal region
scalp
shoulder
thigh
thoracic wall
thorax
thumb
toe
trunk, NOS
Skin
NOS (excludes skin of vulva C51._, skin
of penis C60.9 and skin of scrotum
C63.2)
abdomen
abdominal wall
ala nasi
ankle
antecubital space
anus
arm
C44.2
C44.2
C44.2
Auditory
canal, external
canal, NOS
meatus, external
C44.2
C44.2
C44.2
C44.5
C44.5
C44.5
C44.3
C44.5
C44.7
auricle
auricular canal, external
auricular canal, NOS
axilla
back
breast
brow
buttock
calf
C44.1
C44.1
C44.1
Canthus
NOS
inner
outer
C44.4
C44.3
C44.3
C44.5
C44.5
C44.3
C44.3
C44.2
C44.2
C44.2
C44.2
C44.2
Skin, continued
cervical region
cheek, external
cheek, NOS
chest
chest wall
chin
columnella
concha
Ear
NOS
canal
external
lobule
C44.2
C44.6
C44.2
C44.3
earlobe
elbow
external ear
eyebrow
C44.1
C44.1
C44.1
Eyelid
NOS
lower
upper
C44.3
C44.6
C44.5
C44.7
C44.6
C44.3
C44.5
C44.5
C44.6
C44.4
C44.7
C44.2
C44.7
C44.5
C44.5
C44.1
C44.3
C44.7
C51.0
C44.7
face
finger
flank
foot
forearm
forehead
gluteal region
groin
hand
head, NOS
heel
helix
hip
infraclavicular region
inguinal region
inner canthus
jaw
knee
labia majora
leg
C44.1
C44.1
C44.1
C44.7
C44.6
C44.0
C44.0
C44.0
C44.2
C44.4
Lid
NOS
lower
upper
limb, lower
limb, upper
Lip
NOS
lower
upper
lobule, ear
neck
197
ICDO.indb 197
11/18/13 1:55 PM
C44.3
C44.3
C44.1
C44.6
C44.6
C44.1
C60.9
C44.5
C44.5
C44.2
C44.7
C44.7
C44.5
C44.4
C44.5
C63.2
C44.6
C44.7
C44.4
C44.3
C44.7
C44.5
C44.5
C44.6
C44.7
C44.2
C44.5
C44.5
C51.9
C44.6
Skin, continued
nose
nose, external
outer canthus
palm
palmar
palpebra
penis
perianal
perineum
pinna
plantar
popliteal space
sacrococcygeal region
scalp
scapular region
scrotum
shoulder
sole, foot
supraclavicular region
temple
thigh
thoracic wall
thorax
thumb
toe
tragus
trunk
umbilicus
vulva
wrist
8390/0
8390/3
8390/0
Skin appendage
adenoma (C44._)
carcinoma (C44._)
tumor, benign (C44._)
C41.0
C41.0
9185/3
8803/3
8002/3
8045/3
8045/3
8045/3
9764/3
C17.9
C17.0
C17.2
C17.1
C17.3
C17.9
8897/1
8897/1
C03.9
Socket, tooth
C05.8
C11.3
Soft palate
NOS (excludes nasopharyngeal surface
C11.3)
and hard palate, junction
nasopharyngeal surface
9251/3
9251/1
9044/3
Soft parts
giant cell tumor, malignant
giant cell tumor, NOS
melanoma, malignant (C49._)
Skull, bone
Skull, NOS
9581/3
9571/0
8800/3
8850/1
8806/3
Small
congenital nevus (C44._)
intestinal disease, immunoproliferative
(C17._)
round cell tumor, desmoplastic
C17.9
8041/3
8045/3
8073/3
8043/3
8044/3
8045/3
8041/3
8073/3
Small cell
Carcinoma
NOS
combined
epidermoid, nonkeratinizing
fusiform cell
intermediate cell
mixed
neuroendocrine
squamous cell, nonkeratinizing
8761/0
9764/3
C05.1
8800/0
8800/3
C49.9
C49.4
C49.4
C49.2
C49.1
C49.1
C49.3
C49.6
C49.5
C49.2
C49.0
C49.0
198
ICDO.indb 198
11/18/13 1:55 PM
Alphabetic index
C49.3
C49.3
C49.0
C49.1
C49.0
C49.1
C49.6
C49.2
C49.1
C49.0
C49.5
C49.5
C49.1
C49.0
C49.2
C49.2
C49.3
C49.5
C49.2
C49.2
C49.0
C69.6
C49.5
C49.2
C49.0
C49.5
C49.0
C49.3
C49.1
C44.7
C49.0
C49.0
C49.2
C49.3
C49.1
C49.2
C49.6
C49.4
C49.1
8230/3
8230/3
8452/3
8452/1
9080/1
8230/2
8230/2
Solid
adenocarcinoma with mucin formation
and cystic tumor (C25._)
and papillary epithelial neoplasm
(C25._)
carcinoma, NOS
carcinoma with mucin formation
pseudopapillary carcinoma (C25._)
pseudopapillary tumor (C25._)
teratoma
type, ductal carcinoma in situ (C50._)
type, intraductal carcinoma
-------8815/0
8815/3
9740/1
Solitary
cyst (see SNOMED)
fibrous tumor
fibrous tumor, malignant
mastocytoma of skin
8230/3
8452/1
8452/1
9731/3
9731/3
Solitary, continued
myeloma
plasmacytoma
8156/3
8156/1
8156/3
8156/1
C63.1
Spermatic cord
9063/3
9063/3
C41.0
C31.3
C21.1
C24.0
Sphenoid bone
Sphenoid sinus
Sphincter, anal
Sphincter of Oddi
----------------------
Spider
angioma (see SNOMED)
nevus (see SNOMED)
vascular (see SNOMED)
C72.5
C70.1
C41.2
C72.0
C70.1
C70.1
C47.9
C70.1
Spinal
accessory nerve
arachnoid
column
cord
dura mater
meninges
nerve, NOS
pia mater
8770/3
8770/0
9130/1
Spindle cell
and epithelioid melanoma, mixed
and epithelioid nevus (C44._)
angioendothelioma
8032/3
8030/3
8318/3
Carcinoma
NOS
and giant cell carcinoma
renal cell (C64.9)
8074/3
9136/1
8857/0
epidermoid carcinoma
hemangioendothelioma
lipoma
8772/3
8770/3
8773/3
8774/3
Melanoma
NOS
and epithelioid melanoma, mixed
type A (C69._)
type B (C69._)
8572/3
8772/0
8770/0
8290/0
8318/3
8912/3
8801/3
8074/3
9041/3
8581/3
199
ICDO.indb 199
11/18/13 1:55 PM
8581/1
8122/3
8004/3
8173/3
9051/3
8588/3
8060/0
8094/3
C41.2
Spine
8070/3
8075/3
8075/3
8560/3
8083/3
8081/2
8403/0
8403/0
8403/3
Spiradenoma
NOS (C44._)
eccrine (C44._)
eccrine, malignant (C44._)
8084/3
8070/2
8076/2
8770/0
8081/2
C42.2
Spleen
C18.5
C77.2
C77.2
Splenic
flexure of colon
lymph node, hilar
lymph node, NOS
8070/2
8071/3
8071/3
8072/3
8070/6
8076/3
8072/3
8588/3
9591/3
--------
9421/1
9440/3
9423/3
9423/3
9423/3
Spongioblastoma
NOS (C71._) [obs]
multiforme (C71._)
polar (C71._)
polare (C71._)
primitive polar (C71._) [obs]
9504/3
9514/1
Spongioneuroblastoma
Spontaneously regressed retinoblastoma
(C69.2)
C53.8
8070/3
Squamous
carcinoma
8077/2
8077/0
8077/0
8077/0
8077/2
8077/2
8077/0
Intraepithelial neoplasia
esophageal, high grade (C15._)
esophageal, low grade (C15._)
grade I
grade II
grade III
high grade
low grade
--------------9312/0
8052/0
Squamous, continued
papillomatosis
Squamous-basal cell carcinoma, mixed
(C44._)
Squamous cell
Carcinoma
NOS
acantholytic
adenoid
and adenocarcinoma, mixed
basaloid
Bowen type, intraepidermal
(C44._)
clear cell type
in situ, NOS
in situ with questionable stromal
invasion
intraepidermal, Bowen type
(C44._)
intraepithelial
keratinizing, NOS
large cell, keratinizing
large cell, nonkeratinizing, NOS
metastatic, NOS
microinvasive
nonkeratinizing, NOS
8052/3
8052/2
8052/2
Papillary
NOS
in situ
non-invasive
8075/3
8074/3
8073/3
8074/3
8051/3
8078/3
pseudoglandular
sarcomatoid
small cell, nonkeratinizing
spindle cell
verrucous
with horn formation
8070/3
8570/3
epithelioma
metaplasia, adenocarcinoma with
8052/0
8560/0
8053/0
Papilloma
NOS
and glandular papilloma, mixed
inverted
8045/3
--------
C71.7
Stem, brain
9801/3
C07.9
C49.0
C41.3
C41.3
Stensen duct
Sternocleidomastoid muscle
Sternocostal joint
Sternum
200
ICDO.indb 200
11/18/13 1:55 PM
Alphabetic index
8670/3
8670/0
C16.4
C16.3
C16.4
C16.4
Stomach
NOS
anterior wall, NOS (not classifiable to
C16.1 to C16.4)
antrum
antrum, gastric
antrum, pyloric
body
cardia, gastric
cardia, NOS
cardioesophageal junction
corpus
corpus, gastric
esophagogastric junction
fundus
fundus, gastric
gastroesophageal junction
greater curvature, NOS (not classifiable
to C16.1 to C16.4)
lesser curvature, NOS (not classifiable
to C16.1 to C16.4)
posterior wall, NOS (not classifiable to
C16.1 to C16.4)
prepylorus
pyloric antrum
pyloric canal
pylorus
8641/0
8641/0
--------
C54.1
Stroma, endometrial
8931/3
-------8931/3
8931/3
8930/0
Stromal
endometriosis (C54.1)
hyperplasia (see SNOMED)
myosis, endolymphatic (C54.1)
myosis, NOS (C54.1)
nodule, endometrial (C54.1)
C16.9
C16.8
C16.3
C16.3
C16.3
C16.2
C16.0
C16.0
C16.0
C16.2
C16.2
C16.0
C16.1
C16.1
C16.0
C16.6
C16.5
C16.8
8935/3
Sarcoma
NOS
8930/3
8930/3
8931/3
Endometrial
NOS (C54.1)
high grade (C54.1)
low grade (C54.1)
8936/3
gastrointestinal
8935/1
8935/0
8975/1
Tumor
NOS
benign
calcifying nested epithelial (C22.0)
8936/1
8936/0
8936/3
8936/1
Stromal, continued
Tumor, continued
Gastrointestinal
NOS
benign
malignant
uncertain malignant
potential
8590/1
8590/1
8602/0
gonadal
ovarian (C56.9)
sclerosing (C56.9)
8590/1
8591/1
8592/1
Sex cord-gonadal
NOS
incompletely differentiated
mixed forms
8590/1
8593/1
8345/3
testicular (C62._)
with minor sex cord elements
(C56.9)
8931/3
9091/1
9090/0
9091/1
9090/3
Struma ovarii
NOS (C56.9)
and carcinoid (C56.9)
malignant (C56.9)
C53.8
Stump, cervical
8506/0
C49.3
C77.3
Subclavian artery
Subclavicular lymph node
C49.9
C49.4
C49.4
C49.2
C49.1
C49.1
C49.3
C49.6
C49.5
C49.2
C49.0
C49.0
C49.3
C49.3
C49.0
C49.1
C49.0
C49.1
C49.6
C49.2
Subcutaneous tissue
NOS
abdomen
abdominal wall
ankle
antecubital space
arm
axilla
back
buttock
calf
cervical region
cheek
chest
chest wall
chin
elbow
face
finger
flank
foot
8512/3
201
ICDO.indb 201
11/18/13 1:55 PM
C49.1
C49.0
C49.5
C49.5
C49.1
C49.0
C49.2
C49.2
C49.3
C49.5
C49.2
C49.2
C49.0
C49.5
C49.2
C49.5
C49.0
C49.3
C49.1
C49.0
C49.0
C49.2
C49.3
C49.3
C49.1
C49.2
C49.6
C49.4
C49.1
9384/1
9383/1
9383/1
Subependymal
astrocytoma, giant cell (C71._)
astrocytoma, NOS (C71._)
glioma (C71._)
9383/1
9383/1
C06.1
C06.1
C06.1
Sulcus
alveolar
buccal
labial
8143/3
8743/3
8850/1
Superficial
basal cell carcinoma, multifocal
(C44._)
soft tissue, well differentiated
liposarcoma
spreading adenocarcinoma
spreading melanoma (C44._)
well differentated liposarcoma
C77.2
C49.3
C11.0
Superior
mesenteric lymph node
vena cava
wall of nasopharynx
C77.0
C76.0
C44.4
C49.0
C49.0
C47.0
C49.0
C49.0
C49.0
C77.0
C47.0
C44.4
C49.0
C49.0
Supraclavicular region
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
lymph node
peripheral nerve
skin
soft tissue
subcutaneous tissue
C32.1
C74.9
C71.9
C71.0
Supraglottis
Suprarenal gland
Suprasellar
Supratentorial brain, NOS (see also brain)
9473/3
Supratentorial PNET
8091/3
8850/1
8832/0
Subependymoma (C71._)
Subependymoma-ependymoma, mixed
(C71._)
Subepidermal nodular fibrosis (C44._)
C32.2
C77.4
Subglottis
Subinguinal lymph node
C08.1
C08.1
C77.0
Sublingual
gland
gland duct
lymph node
8461/3
8463/1
8461/0
Surface
osteosarcoma, high grade (C40._,
C41._)
papillary carcinoma, serous (C56.9)
papillary tumor, serous surface,
borderline malignancy (C56.9)
papilloma, serous (C56.9)
C08.0
C77.0
Submandibular gland
Submandibular lymph node
8407/3
C08.0
C08.0
C77.0
Submaxillary
gland
gland duct
lymph node
8400/3
8400/0
8400/3
Sweat gland
adenocarcinoma (C44._)
adenoma (C44._)
carcinoma (C44._)
C77.0
C77.3
9194/3
8400/1
8400/0
8400/3
Tumor
NOS (C44._)
benign (C44._)
malignant (C44._)
202
ICDO.indb 202
11/18/13 1:55 PM
Alphabetic index
C47.9
8681/1
9500/3
Sympathetic paraganglioma
Sympathicoblastoma
9741/3
9724/3
C41.4
Symphysis pubis
8893/0
9531/0
Symplastic leiomyoma
Syncytial meningioma (C70._)
-------9769/1
--------
Syndrome
5q deletion (5q), with myelodysplastic
syndrome
hypereosinophilic
9741/3
9741/1
9741/3
9986/3
9964/3
9989/3
9986/3
9986/3
Myelodysplastic
NOS (C42.1)
prior, acute myeloid leukemia with
prior, acute myeloid leukemia
without
unclassifiable
with 5q deletion (5q) syndrome
with isolated del (5q)
9989/3
9701/3
9989/3
9895/3
9895/3
Systemic
aggressive mastocytosis
EBV positive T-cell lymphoproliferative
disease of childhood
hemangiomatosis (see SNOMED)
light chain disease
lymphangiomatosis (see SNOMED)
Mastocytosis
aggressive
indolent
with associated hematological
clonal non-mast cell disorder
9741/3
9741/3
9741/3
T
Tail
C50.6
C50.6
C25.2
9040/3
9043/3
9042/3
9041/3
9041/3
Synovial sarcoma
NOS
biphasic
epithelioid cell
monophasic fibrous
spindle cell
8344/3
9837/3
9837/3
9391/3
C49.9
Synovia, NOS
C71.8
C40.3
Tapetum
Tarsal bone
9040/3
9040/0
9040/3
Synovioma
NOS
benign
malignant
9831/3
9724/3
9183/3
C44.3
C44.3
C49.0
C49.0
C47.0
C49.0
C49.0
C49.0
C47.0
C44.3
C49.0
C49.0
Temple
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
---------------
8400/0
8406/0
8406/0
8406/0
8392/0
8407/0
8940/0
8940/3
Syringoma
NOS (C44._)
chondroid (C44._)
chondroid, malignant (C44._)
8407/3
--------
9718/3
-----/-5
breast, axillary
breast, NOS
pancreas
203
11/28/13 3:05 PM
C41.0
C71.2
C41.1
Temporal bone
Temporal lobe
Temporomandibular joint
9502/3
9508/3
C49.9
C49.2
C49.1
C49.6
C49.2
C49.1
C49.6
C49.2
C49.1
C49.1
C49.2
C49.2
C49.2
C49.2
C49.0
C49.2
C49.2
C49.1
C49.2
C49.1
Tendon
NOS
ankle
arm
back
calf
finger
flank
foot
forearm
hand
heel
hip
knee
leg
neck
popliteal space
thigh
thumb
toe
wrist
9080/1
9080/0
9080/0
9082/3
9081/3
9085/3
9080/0
9101/3
9080/0
9080/0
9080/0
9080/3
9080/3
9080/3
9083/3
Teratoma
NOS
adult, cystic
adult, NOS
anaplastic, malignant
and embryonal carcinoma, mixed
and seminoma, mixed
benign
combined with choriocarcinoma
cystic, adult
cystic, NOS
differentiated
embryonal
immature, malignant
immature, NOS
intermediate, malignant
C49.9
C49.2
C49.1
C49.6
C49.2
C49.1
C49.2
C49.1
C49.1
C49.2
C49.2
C49.2
C49.2
C49.0
C49.2
C49.2
C49.1
C49.2
C49.1
Tendon sheath
NOS
ankle
arm
back
calf
finger
foot
forearm
hand
heel
hip
knee
leg
neck
popliteal space
thigh
thumb
toe
wrist
9252/0
9252/3
9080/3
9082/3
9083/3
9102/3
9082/3
Malignant
NOS
anaplastic
intermediate
trophoblastic
undifferentiated
9080/0
9080/1
9102/3
9082/3
9084/3
mature
solid
trophoblastic, malignant
undifferentiated, malignant
with malignant transformation
8525/3
8152/1
C62.9
Testicle, NOS
8640/1
8590/1
C62.9
C62.1
C62.0
C62.0
C62.1
C62.0
Testis
NOS
descended
ectopic (site of neoplasm)
retained (site of neoplasm)
scrotal
undescended (site of neoplasm)
9768/1
C71.0
Thalamus
--------
C70.0
C70.0
Tentorium cerebelli
Tentorium, NOS
8621/1
8600/0
9080/3
9081/3
9502/0
Teratoblastoma, malignant
Teratocarcinoma
Teratoid medulloepithelioma, benign
(C69.4)
8600/0
8601/0
8600/3
Thecoma
NOS (C56.9)
luteinized (C56.9)
malignant (C56.9)
204
ICDO.indb 204
11/18/13 1:55 PM
Alphabetic index
9920/3
9920/3
9920/3
Therapy-related
Acute myeloid leukemia
NOS
alkylating agent related
epipodophyllotoxin related
9987/3
9987/3
9987/3
Myelodysplastic syndrome
NOS
alkylating agent related
epipodophyllotoxin related
9920/3
9920/3
myeloid neoplasm
neoplasm, myeloid
C76.5
C44.7
C49.2
C49.2
C47.2
C49.2
C49.2
C49.2
C49.2
C47.2
C49.2
C44.7
C49.2
C49.2
C49.2
C49.2
Thigh
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
C71.5
C71.5
C72.0
C49.3
C15.1
C77.1
Thoracic
cord
duct
esophagus
lymph node
C76.1
C44.5
C49.3
C49.3
C47.3
C49.3
C49.3
C49.3
C49.3
C47.3
C49.3
C44.5
C49.3
C49.3
Thoracic wall
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C49.3
C47.3
C49.3
C44.5
C49.3
Thorax
NOS
autonomic nervous system
connective tissue (excludes thymus,
heart and mediastinum C37._, C38._)
muscle
peripheral nerve
skeletal muscle
skin
subcutaneous tissue
C14.0
Throat
9962/3
9962/3
9962/3
9962/3
Thrombocythemia
essential (C42.1)
essential, hemorrhagic (C42.1)
idiopathic (C42.1)
idiopathic, hemorrhagic (C42.1)
C76.1
C47.3
C49.3
9992/3
9982/3
C76.4
C44.6
C49.1
C47.1
C40.1
C49.1
C49.1
C49.1
C47.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
8586/3
8585/3
8580/1
8580/3
8585/3
8585/1
8580/0
8584/3
8584/1
8587/0
8585/3
8585/1
8587/0
8583/3
8583/1
8583/3
8583/1
Thrombocytopenia, refractory
Thrombocytosis, marked, refractory anemia
with ring sideroblasts associated with
Thumb
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
bone
connective tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
Thymic carcinoma, NOS (C37.9)
Thymic carcinoma, well differentiated
(C37.9)
Thymoma
NOS (C37.9)
NOS, malignant (C37.9)
atypical, malignant (C37.9)
atypical, NOS (C37.9)
benign (C37.9)
cortical, malignant (C37.9)
cortical, NOS (C37.9)
ectopic hamartomatous
epithelial, malignant (C37.9)
epithelial, NOS (C37.9)
hamartomatous, ectopic
lymphocyte-rich, malignant (C37.9)
lymphocyte-rich, NOS (C37.9)
lymphocytic, malignant (C37.9)
lymphocytic, NOS (C37.9)
205
ICDO.indb 205
11/18/13 1:55 PM
8583/1
8581/3
8581/1
8582/3
8582/1
8581/3
8581/1
8583/3
8583/1
8584/3
8584/1
8585/3
8585/1
8586/3
Thymoma, continued
malignant, NOS (C37.9)
medullary, malignant (C37.9)
medullary, NOS (C37.9)
mixed type, malignant (C37.9)
mixed type, NOS (C37.9)
organoid, malignant (C37.9)
organoid, NOS (C37.9)
predominantly cortical, malignant
(C37.9)
predominantly cortical, NOS (C37.9)
spindle cell, malignant (C37.9)
spindle cell, NOS (C37.9)
type AB, malignant (C37.9)
type AB, NOS (C37.9)
type A, malignant (C37.9)
type A, NOS (C37.9)
type B1, malignant (C37.9)
type B1, NOS (C37.9)
type B2, malignant (C37.9)
type B2, NOS (C37.9)
type B3, malignant (C37.9)
type B3, NOS (C37.9)
type C (C37.9)
C37.9
Thymus
8580/3
8581/3
8581/1
8582/3
8582/1
8583/3
8583/1
8583/3
8589/3
8588/3
8589/3
8588/3
Thymus-like
differentiation, carcinoma showing
differentiation, spindle epithelial tumor
with thymus-like
element, carcinoma showing
element, spindle epithelial tumor with
C44.7
C49.2
C49.2
C49.2
C49.2
Toe, continued
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
C02.9
C02.0
C02.3
C02.2
C02.0
C02.3
C02.2
C01.9
C01.9
C02.1
C02.0
C01.9
C02.2
C02.8
C02.9
C02.4
C02.0
C01.9
C01.9
C01.9
C02.1
C02.2
C02.2
C02.2
Tongue
NOS
anterior 2/3, dorsal surface
anterior 2/3, NOS
anterior 2/3, ventral surface
anterior, dorsal surface
anterior, NOS
anterior, ventral surface
base, dorsal surface
base, NOS
border
dorsal surface, NOS
dorsal surface of base
frenulum linguae
junctional zone
lingual, NOS
lingual tonsil
midline
posterior, NOS
posterior third
root
tip
ventral surface, anterior
ventral surface, anterior 2/3
ventral surface, NOS
C73.9
Thyroglossal duct
C09.9
--------
C73.9
C32.3
C73.9
Thyroid
NOS
cartilage
gland
C09.9
C02.4
C09.9
C11.1
Tonsil
NOS (excludes lingual tonsil C02.4 and
pharyngeal tonsil C11.1)
faucial
lingual
palatine
pharyngeal
C40.2
Tibia
9261/3
C09.0
C09.1
C03.9
Tonsillar fossa
Tonsillar pillar
Tooth socket
C77.4
C02.1
8190/3
8190/0
8336/0
8190/3
8332/3
8332/3
Trabecular
adenocarcinoma
adenoma
adenoma, hyalinizing (C73.9)
carcinoma
follicular adenocarcinoma (C73.9)
follicular carcinoma (C73.9)
C33.9
C77.1
C77.1
Trachea
Tracheal lymph node
Tracheobronchial lymph node
C76.5
C44.7
C49.2
C47.2
C40.3
C49.2
C49.2
C49.2
C44.7
C47.2
C49.2
Toe
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
bone
connective tissue
fibrous tissue
muscle
nail
peripheral nerve
skeletal muscle
206
ICDO.indb 206
11/18/13 1:55 PM
Alphabetic index
C26.9
C24.9
C57.9
C26.9
C57.9
C63.9
C26.0
C63.9
C72.3
C39.9
C39.0
C69.4
Tract
alimentary, NOS
biliary, NOS
female genital, NOS
gastrointestinal, NOS
genitourinary, female, NOS
genitourinary, male, NOS
intestinal, NOS
male genital, NOS
optic
respiratory, NOS
upper respiratory, NOS
uveal
8213/0
8213/0
C44.2
Tragus
9084/3
9084/3
9898/1
8120/3
9537/0
Transitional
carcinoma
meningioma (C70._)
8120/0
8121/0
8121/1
Papilloma
NOS
inverted, benign
inverted, NOS
9362/3
8120/3
8120/2
8131/3
8130/3
8130/2
8122/3
8122/3
8130/1
8120/1
8120/0
8121/0
8121/1
Transitional cell
Carcinoma
NOS
in situ
micropapillary (C67._)
papillary (C67._)
papillary, non-invasive (C67._)
sarcomatoid
spindle cell
neoplasm, papillary, low malignant
potential (C67._)
Papilloma
NOS
benign
inverted, benign
inverted, NOS
8102/3
8103/0
8103/0
Trichilemmal
carcinoma (C44._)
cyst, proliferating
tumor, proliferating
8102/3
8102/0
8391/0
8100/0
8101/0
Trichilemmocarcinoma (C44._)
Trichilemmoma (C44._)
Trichodiscoma (C44._)
Trichoepithelioma (C44._)
Trichofolliculoma (C44._)
C72.5
C67.0
C06.2
Trigeminal nerve
Trigone, bladder
Trigone, retromolar
9561/3
C72.5
Trochlear nerve
9102/3
9105/3
9104/1
Trophoblastic
malignant teratoma
tumor, epithelioid
tumor, placental site (C58.9)
C32.0
True cord
9755/3
C32.0
C76.7
C44.5
C49.6
C49.6
C47.6
C49.6
C49.6
C49.6
C49.6
C47.6
C49.6
C44.5
C49.6
C49.6
Trunk
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
muscle
peripheral nerve
skeletal muscle
skin
soft tissue
subcutaneous tissue
C30.1
C30.1
C57.0
C57.0
Tube
auditory
eustachian
fallopian
uterine
C57.8
Tubo-ovarian
Tubular
adenocarcinoma
C18.4
C49.3
Transverse colon
Trapezius muscle
8211/3
--------
C06.2
C49.1
Triangle, retromolar
Triceps brachii muscle
8211/0
8210/3
8210/2
8523/3
8640/1
Adenoma
NOS
adenocarcinoma in
adenocarcinoma in situ in
and infiltrating duct carcinoma
(C50._)
Pick
207
ICDO.indb 207
11/18/13 1:55 PM
8640/1
8641/0
8245/1
8211/3
8503/2
Tubular, continued
androblastoma, NOS
androblastoma with lipid storage
(C56.9)
carcinoid
carcinoma
8263/3
8263/0
8263/0
8263/3
8263/2
Tubulovillous adenoma
NOS
adenocarcinoma in
adenocarcinoma in situ in
9161/0
8000/1
8550/1
8550/1
8158/1
8245/3
9054/0
9300/0
8390/0
Tumor
NOS
acinar cell [obs]
acinic cell [obs]
ACTH-producing
adenocarcinoid
adenomatoid, NOS
adenomatoid, odontogenic (C41._)
adnexal, benign (C44._)
8503/0
8623/1
8370/0
8370/0
8370/3
8671/0
8152/3
8152/1
9133/3
Adrenal cortical
NOS (C74.0)
benign (C74.0)
malignant (C74.0)
-------8691/1
9365/3
8249/3
9508/3
8936/1
8090/1
8833/3
8000/0
8000/0
8151/3
adrenal rest
alpha cell, malignant (C25._)
alpha cell, NOS (C25._)
alveolar, intravascular bronchial
(C34._) [obs]
amyloid (see SNOMED)
aortic body (C75.5)
Askin
atypical carcinoid
atypical teratoid/rhabdoid (C71._)
autonomic nerve, gastrointestinal
basal cell (C44._)
Bednar (C44._)
benign
benign, unclassified
beta cell, malignant
9000/0
9000/1
9000/3
9000/1
Brenner
NOS (C56.9)
borderline malignancy (C56.9)
malignant (C56.9)
proliferating (C56.9)
9133/3
8100/0
8880/0
9687/3
8975/1
Tumor, continued
bronchial alveolar, intravascular
(C34._) [obs]
Brooke (C44._)
brown fat
Burkitt [obs] (includes all variants)
calcifying nested epithelial stromal
(C22.0)
8240/3
8241/3
8240/1
8249/3
8240/1
Carcinoid
NOS
argentaffin, malignant
argentaffin, NOS
atypical
uncertain malignant potential
8692/1
8001/1
8001/0
8001/3
8001/1
Cells
NOS
benign
malignant
uncertain whether benign or
malignant
9473/3
9230/0
8700/0
8005/3
Clear cell
NOS
atypical proliferating (C56.9)
cystic, borderline malignancy
(C56.9)
type, malignant
9230/0
8005/0
8444/1
8444/1
8452/1
Cystic
and solid (C25._)
atrio-ventricular node (C38.0)
clear cell, borderline malignancy
(C56.9)
mucinous, with moderate
dysplasia (C25._)
papillary (C25._)
9135/1
9758/3
9757/3
8806/3
9413/0
8000/6
Dabska
dendritic cell, follicular
dendritic cell, indeterminate
desmoplastic small round cell
dysembryoplastic neuroepithelial
embolus
8452/1
8454/0
8444/1
8470/0
8158/1
8154/3
8150/0
8154/3
Endocrine
functioning, NOS
malignant mixed pancreatic
exocrine and (C25._)
pancreatic, benign (C25._)
pancreatic exocrine and,
malignant mixed (C25._)
208
ICDO.indb 208
11/18/13 1:55 PM
Alphabetic index
8150/3
8150/3
8150/1
Tumor, continued
Endocrine, continued
pancreatic, malignant (C25._)
pancreatic, non-functioning
(C25._)
pancreatic, NOS (C25._)
9071/3
8380/1
8380/1
8242/3
endodermal sinus
endometrioid, atypical proliferative
endometrioid, low malignant potential
enterochromaffin-like cell, malignant
8010/0
8975/1
8010/3
Epithelial
benign
calcifying nested stromal (C22.0)
malignant
9260/3
8154/3
9759/3
8835/1
8842/0
8815/0
8815/0
8815/3
Fibrous
localized
solitary
solitary, malignant
9758/3
8158/1
8004/3
8153/1
8153/3
8936/1
8936/1
Gastrointestinal
autonomic nerve
pacemaker cell
8936/1
8936/0
8936/3
8936/1
Gastrointestinal stromal
NOS
benign
malignant
uncertain malignant potential
8153/3
8153/1
G cell, malignant
G cell, NOS
9064/3
9085/3
9065/3
Germ cell
NOS
mixed
nonseminomatous (C62._)
9302/0
9250/3
9250/1
9230/0
9251/3
9251/1
9252/0
9252/3
9252/0
Giant cell
bone, malignant (C40._, C41._)
bone, NOS (C40._, C41._)
chondromatous (C40._, C41._)
soft parts, malignant
soft parts, NOS
tendon sheath (C49._)
tendon sheath, malignant (C49._)
tenosynovial (C49._)
9252/3
8003/3
Tumor, continued
Giant cell, continued
tenosynovial, malignant (C49._)
type, malignant
9509/1
9509/1
glioneuronal, papillary
glioneuronal, rosette-forming
8711/0
8690/1
8711/3
Glomus
NOS
jugulare, NOS (C75.5)
malignant
8152/1
8590/1
8590/1
8591/1
8592/1
9580/0
9580/3
9582/0
Granular cell
NOS
malignant
sellar region (C75.1)
8620/1
8620/1
8622/1
8620/3
8620/3
Granulosa cell
NOS (C56.9)
adult type (C56.9)
juvenile (C56.9)
malignant (C56.9)
sarcomatoid (C56.9)
8621/1
8312/3
8660/0
8660/0
8290/0
8311/1
8650/1
8650/0
8650/3
Interstitial cell
NOS
benign
malignant
8453/0
9133/3
8150/0
8150/1
8622/1
8361/0
8162/3
8490/6
8152/1
8650/1
8650/0
8631/0
8670/0
209
ICDO.indb 209
11/18/13 1:55 PM
8670/0
8650/3
8000/3
8005/3
8004/3
8003/3
8800/3
8154/3
8940/3
8940/3
8154/3
8150/3
9540/3
8002/3
8004/3
8000/3
8000/9
9740/3
9740/1
9363/0
8247/3
8800/3
8990/1
8951/3
9110/1
8000/6
8940/0
8154/3
8154/3
9085/3
8940/3
8990/1
8951/3
8940/3
8940/0
8472/1
8472/1
8472/1
8470/0
Tumor, continued
Leydig cell, continued
lipoid cell, ovary (C56.9)
malignant (C62._)
Malignant
NOS
clear cell type
fusiform cell type
giant cell type
mesenchymal
mixed endocrine and exocrine,
pancreatic (C25._)
mixed, NOS
mixed, salivary gland type (C07._,
C08._)
pancreatic endocrine and
exocrine, mixed (C25._)
pancreatic endocrine (C25._)
peripheral nerve sheath
small cell type
spindle cell type
unclassified
unclassified, uncertain whether
primary or metastatic
mast cell, malignant
mast cell, NOS
melanotic neuroectodermal
Merkel cell (C44._)
mesenchymal, malignant
mesenchymal, mixed
mesodermal mixed
mesonephric, NOS
metastatic
Mixed
NOS
endocrine and exocrine, malignant
pancreatic (C25._)
exocrine and pancreatic
endocrine, malignant (C25._)
germ cell
malignant, NOS
mesenchymal
mesodermal
salivary gland type, malignant
(C07._, C08._)
salivary gland type, NOS (C07._,
C08._)
Mucinous
NOS, of low malignant potential
(C56.9)
atypical proliferative (C56.9)
cystic, of borderline malignancy
(C56.9)
cystic, with moderate dysplasia
(C25._)
8473/1
8453/0
Tumor, continued
Mucinous, continued
papillary, of low malignant
potential (C56.9)
8243/3
8430/1
8950/3
8982/0
8825/1
8827/1
8825/1
8827/1
Myofibroblastic
NOS
congenital peribronchial
inflammatory
peribronchial (C34._)
9540/3
9561/3
9364/3
9473/3
9363/0
9364/3
9473/3
8240/3
8249/3
9413/0
9520/3
8350/3
8150/3
9065/3
neuroendocrine, grade 1
neuroendocrine, grade 2
neuroepithelial, dysembryoplastic
neurogenic, olfactory
nonencapsulated sclerosing (C73.9)
nonfunctioning pancreatic endocrine
(C25._)
nonseminomatous germ cell (C62._)
9270/1
9300/0
9270/0
9340/0
9341/1
9302/0
9270/3
9312/0
Odontogenic
NOS (C41._)
adenomatoid (C41._)
benign (C41._)
calcifying epithelial (C41._)
clear cell (C41._)
ghost cell (C41._)
malignant (C41._)
squamous (C41._)
9395/3
9520/3
8842/0
8967/0
8590/1
8936/1
9507/0
8150/1
8150/0
8150/3
8150/3
Pancreatic
Endocrine
NOS (C25._)
benign (C25._)
malignant (C25._)
non-functioning (C25._)
210
ICDO.indb 210
11/18/13 1:55 PM
Alphabetic index
8154/3
8152/1
8152/1
8452/1
9509/1
8503/2
8503/2
8503/2
8503/2
8473/1
9395/3
8462/1
8462/1
8453/0
8453/0
8453/0
9362/3
8152/1
Tumor, continued
Pancreatic, continued
mixed endocrine and exocrine,
malignant (C25._)
peptide and pancreatic peptidelike peptide within terminal
tyrosine amide producing tumor
peptide-like peptide within
terminal tyrosine amide
producing tumor, pancreatic
peptide and
Papillary
cystic (C25._)
glioneuronal
intracystic, with high grade
dysplasia (C23.9)
intracystic, with high grade
intraepithelial neoplasia (C23.9)
intraductal, with high grade
dysplasia
intraductal, with high grade
intraepithelial neoplasia
mucinous, of low malignant
potential (C56.9)
pineal region
serous, atypical proliferative
(C56.9)
serous, of low malignant potential
(C56.9)
Papillary-mucinous intraductal
with intermediate dysplasia
(C25._)
with low grade dysplasia (C25._)
with moderate dysplasia (C25._)
parenchymal, pineal, intermediate
differentiation (C75.3)
peptide-producing glucagon-like
9364/3
9364/3
Peripheral
nerve sheath, malignant
nerve sheath, malignant, with
rhabdomyoblastic differentiation
neuroectodermal
primitive neuroectodermal, NOS
9020/1
9020/0
9020/1
9020/3
Phyllodes
NOS (C50._)
benign (C50._)
borderline (C50._)
malignant (C50._)
8103/0
9340/0
pilar (C44._)
Pindborg (C41._)
9540/3
9561/3
9362/3
9362/3
9395/3
9362/3
Tumor, continued
Pineal
mixed (C75.3)
parenchymal, intermediate
differentiation (C75.3)
region, papillary
transitional (C75.3)
8093/3
9104/1
9731/3
8835/1
9071/3
8152/1
Pinkus
placental site trophoblastic (C58.9)
plasma cell
plexiform fibrohistiocytic
polyvesicular vitelline
PP/PYY producing
9473/3
9473/3
9364/3
Primitive neuroectodermal
NOS
central, NOS (C71._)
peripheral, NOS
8152/1
8103/0
8452/1
9350/1
8967/0
8966/0
9759/3
9363/0
8963/3
8963/3
9508/3
9509/1
8806/3
8082/3
8350/3
8602/0
8000/6
9084/3
producing, PP/PYY
proliferating trichilemmal
pseudopapillary, solid (C25._)
Rathke pouch (C75.1)
renal, ossifying (C64.9)
renomedullary interstitial cell (C64.9)
reticular cell, fibroblastic
retinal anlage
rhabdoid, malignant
rhabdoid, NOS
rhabdoid/teratoid, atypical (C71._)
rosette-forming glioneuronal
round cell, desmoplastic small
Schmincke (C11._)
sclerosing, nonencapsulated (C73.9)
sclerosing stromal (C56.9)
secondary
secondary, dermoid cyst with
8442/1
8442/1
8462/1
8462/1
8463/1
8640/1
8642/1
8641/0
8641/0
Serous
NOS, of low malignant potential
(C56.9)
atypical proliferating (C56.9)
papillary cystic, of borderline
malignancy (C56.9)
papillary, of low malignant
potential (C56.9)
surface papillary, of borderline
malignancy (C56.9)
Sertoli cell
NOS (C56.9)
large cell calcifying
lipid-rich (C56.9)
with lipid storage
211
ICDO.indb 211
11/18/13 1:55 PM
8631/1
8631/1
8634/1
8631/3
8634/3
8633/1
8634/1
8631/3
8631/0
8590/1
8591/1
8592/1
8590/1
8623/1
9071/3
8390/0
8002/3
8806/3
8897/1
8897/1
8800/0
8800/3
8452/1
8156/3
8156/1
8004/3
8588/3
8588/3
Tumor, continued
Sertoli-Leydig cell
NOS
intermediate differentiation
intermediate differentiation, with
heterologous elements
poorly differentiated
poorly differntiated, with
heterologous elements
retiform
retiform, with heterologous
elements
sarcomatoid
well differentiated
Sex cord-gonadal stromal
NOS
incompletely differentiated
mixed forms
sex cord, NOS
sex cord, with annular tubules (C56.9)
sinus, endodermal
skin appendage, benign (C44._)
small cell type, malignant
small round cell, desmoplastic
smooth muscle, NOS
smooth muscle, uncertain malignant
potential
soft tissue, benign
soft tissue, malignant
solid and cystic (C25._)
somatostatin cell tumor, malignant
somatostatin cell tumor, NOS
Spindle
cell type, malignant
epithelial, with thymus-like
differentiation
epithelial, with thymus-like
element
9312/0
8670/3
8670/0
8935/1
8935/0
8975/1
8975/1
Stromal
NOS
benign
calcifying nested epithelial (C22.0)
epithelial, calcifying nested
(C22.0)
8936/1
8936/0
8936/3
8936/1
Gastrointestinal
NOS
benign
malignant
uncertain malignant
potential
8602/0
8593/1
8400/1
8400/0
8400/3
9252/0
9252/3
9508/3
8152/1
8590/1
8600/0
8621/1
9362/3
8103/0
9561/3
9105/3
9104/1
-------8200/0
8152/1
8000/0
8000/1
8000/3
8000/9
8000/1
9071/3
8561/0
8960/3
9110/1
9071/3
9071/3
Tumor, continued
Stromal, continued
sclerosing (C56.9)
with minor sex cord elements
(C56.9)
Sweat gland
NOS (C44._)
benign (C44._)
malignant (C44._)
tenosynovial giant cell (C49._)
tenosynovial giant cell, malignant
(C49._)
teratoid/rhabdoid, atypical (C71._)
terminal tyrosine amide producing,
pancreatic peptide and pancreatic
peptide-like peptide within
testicular stromal (C62._)
theca cell (C56.9)
theca cell-granulosa cell (C56.9)
transitional pineal (C75.3)
trichilemmal, proliferating
Triton, malignant
trophoblastic, epithelioid
trophoblastic, placental site (C58.9)
Tumoral calcinosis (see SNOMED)
turban (C44.4)
tyrosine amide producing, pancreatic
peptide and pancreatic peptide-like
peptide within terminal
Unclassified
benign
borderline malignancy
malignant
malignant, uncertain whether
primary or metastatic
uncertain whether benign or
malignant
vitelline, polyvesicular
Warthin (C07._, C08._)
Wilms (C64.9)
Wolffian duct
yolk sac
yolk sac, hepatoid
8040/0
8040/1
Tumorlet, benign
Tumorlet, NOS
C63.7
Tunica vaginalis
8200/0
C30.0
C30.1
Turbinate, nasal
Tympanic cavity
8240/3
8152/1
Typical carcinoid
Tyrosine amide producing tumor,
pancreatic peptide and pancreatic
peptide-like peptide within terminal
212
ICDO.indb 212
11/18/13 1:55 PM
Alphabetic index
U
8090/3
C40.0
C49.1
C47.1
Ulna
Ulnar artery
Ulnar nerve
C44.5
C44.5
C49.4
C47.4
C49.4
C49.4
C47.4
C44.5
C49.4
C49.4
Umbilicus
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
autonomic nervous system
connective tissue
fibrous tissue
peripheral nerve
skin
soft tissue
subcutaneous tissue
8240/1
8936/1
8897/1
-----/1
-----/9
9975/3
9989/3
9975/3
9591/3
8000/1
Unclassified tumor
benign
borderline malignancy
malignant
malignant, uncertain whether primary
or metastatic
uncertain whether benign or malignant
C71.2
C62.0
Uncus
Undescended testis (site of neoplasm)
9765/1
8000/0
8000/1
8000/3
8000/9
8020/3
9512/3
8805/3
9082/3
-----/-4
9751/3
9751/3
Undifferentiated
carcinoma, NOS
retinoblastoma (C69.2)
sarcoma
teratoma, malignant
Undifferentiated (see grading code, section
4.3.4)
Unifocal Langerhans cell granulomatosis
[obs]
Unifocal Langerhans cell histiocytosis [obs]
C80.9
8480/3
C03.0
C03.0
C03.0
C50.8
C03.0
C03.0
C50.2
C41.0
C44.1
C00.0
C00.0
C00.3
C00.3
C00.3
C44.0
C00.0
C34.1
C34.1
C50.4
C39.0
C15.3
Upper
alveolar mucosa
alveolar ridge mucosa
alveolus
breast
gingiva
gum
inner quadrant of breast
jaw bone
lid
Lip
lobe, bronchus
lobe, lung
outer quadrant of breast
respiratory tract, NOS
third of esophagus
C76.4
C44.6
C49.1
C49.1
C47.1
C49.1
C49.1
C49.1
C40.0
C40.0
C77.3
C49.1
C47.1
C40.1
C40.1
C49.1
C44.6
C49.1
C49.1
C49.1
C49.1
Upper limb
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
adipose tissue
autonomic nervous system
connective tissue
fatty tissue
fibrous tissue
long bone
long bones, joints
lymph node
muscle
peripheral nerve
short bone
short bones, joints
skeletal muscle
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
C67.7
C66.9
C67.6
C68.0
C68.0
C67.5
Urachus
Ureter
Ureteric orifice
Urethra
Urethral gland
Urethral orifice, internal
213
ICDO.indb 213
11/18/13 1:55 PM
C57.9
C67.9
C68.9
Urethrovaginal septum
Urinary bladder, NOS (see also bladder)
Urinary system, NOS
C53.0
C57.3
C58.9
C53.8
C57.4
C53.9
Uterus, continued
Nabothian gland
parametrium
placenta
squamocolumnar junction of cervix
uterine adnexa
uterine cervix
8890/0
C68.0
C69.4
C05.2
Utricle, prostatic
Uveal tract
Uvula
8120/1
Urothelial
carcinoma in situ (C67._)
carcinoma, NOS (C67._)
carcinoma, papillary (C67._)
carcinoma, papillary, non-invasive
(C67._)
neoplasm, papillary, of low malignant
potential (C67._)
papilloma, NOS (C67._)
9741/1
Urticaria pigmentosa
C55.9
C57.4
C53.9
C57.3
C54.0
C57.0
Uterine
NOS
adnexa
cervix
ligament
lower segment
tube
C52.9
Vagina, fornix
8077/2
C57.8
C57.3
Utero-ovarian
Uterosacral ligament
C52.9
C52.9
C72.5
Vaginal vault
Vagina, NOS
Vagus nerve
C55.9
C57.4
C57.4
C54.9
C53.0
C53.8
Uterus
NOS
adnexa, NOS
adnexa, uterine
body
cervical canal
cervical stump
8077/2
C10.0
C18.0
Vallecula
Valve, ileocecal
8894/0
---------------
Vascular
leiomyoma
nevus (see SNOMED)
spider (see SNOMED)
C63.1
C52.9
C49.5
C49.9
Vas deferens
Vault, vaginal
Vein, iliac
Vein, NOS
C49.4
C49.4
C49.4
C49.3
Vena cava
NOS
abdominal
inferior
superior
9122/0
Venous hemangioma
C02.2
C02.2
C02.2
C71.5
C38.0
C71.5
C71.7
C71.7
C71.5
C71.5
Ventricle
NOS
cardiac
cerebral
fourth, choroid plexus
fourth, NOS
lateral, choroid plexus
lateral, NOS
8120/2
8120/3
8130/3
8130/2
8130/1
C53.9
C53.8
C53.9
Cervix
NOS
squamocolumnar junction
uteri
C54.9
C53.0
C53.0
C53.0
C54.1
C54.1
C54.1
C53.1
C53.1
C58.9
C54.3
C53.0
C54.0
corpus uteri
endocervical canal
endocervical gland
endocervix
endometrial gland
endometrial stroma
endometrium
exocervix
external os
fetal membranes
fundus uteri
internal os
isthmus uteri
C57.1
C57.2
C57.3
C57.3
Ligament
ligament, broad
ligament, round
ligament, uterine
ligament, uterosacral
C54.0
C54.2
214
ICDO.indb 214
11/18/13 1:55 PM
Alphabetic index
C71.5
C71.5
Ventricle, continued
third, choroid plexus
third, NOS
C32.1
C00.2
C00.1
C00.0
Vermilion border
lip, NOS
lower lip
upper lip
C71.6
Vermis of cerebellum
-----------------------------
Verruca
NOS (see SNOMED)
plana (see SNOMED)
seborrheic (see SNOMED)
vulgaris (see SNOMED)
8051/3
8051/3
8051/3
9142/0
8051/0
Verrucous
carcinoma, epidermoid
carcinoma, NOS
carcinoma, squamous cell
keratotic hemangioma
papilloma
C41.2
C41.2
C63.7
C57.9
C57.9
C49.9
C06.1
C30.0
8263/0
--------
Vertebra
Vertebral column (excludes sacrum and
coccyx C41.4)
Vesicle, seminal
Vesicocervical tissue
Vesicovaginal septum
Vessel, NOS
Vestibule of mouth
Vestibule of nose
Villoglandular adenoma
Villonodular pigmented synovitis (see
SNOMED)
8262/3
8261/3
8261/2
8261/0
8261/0
Villous
adenocarcinoma
adenoma, adenocarcinoma in
adenoma, adenocarcinoma in situ in
adenoma, NOS
papilloma
8077/2
8155/3
8155/1
-------9540/1
C51.9
Vulva, NOS
8077/2
C51.9
Vulva, skin
W
9761/3
C14.2
Waldeyer ring
-------8561/0
8051/3
8322/3
8322/0
8322/3
Water-clear cell
adenocarcinoma (C75.0)
adenoma (C75.0)
carcinoma (C75.0)
8240/3
8331/3
8331/3
Well differentiated
carcinoma, neuroendocrine
follicular adenocarcinoma (C73.9)
follicular carcinoma (C73.9)
8851/3
8850/1
8850/1
Liposarcoma
NOS
superficial
superficial soft tissue
8240/3
9187/3
9052/0
8631/0
8585/3
neuroendocrine carcinoma
osteosarcoma, intraosseous
papillary mesothelioma, benign
Sertoli-Leydig cell tumor
thymic carcinoma (C37.9)
-----/-1
C08.0
C71.0
C71.0
Wharton duct
White matter, central
White matter, cerebral
C38.4
Visceral pleura
9071/3
-------8960/3
C32.0
C32.1
C32.0
Vocal cord
NOS
false
true
C25.3
C57.7
C57.7
Wirsung duct
Wolffian body
Wolffian duct
9110/0
9110/3
9110/1
Wolffian duct
adenoma
carcinoma
tumor
215
ICDO.indb 215
11/18/13 1:55 PM
C76.4
C44.6
C49.1
C40.1
C49.1
C49.1
C40.1
C44.6
C49.1
C49.1
C49.1
C49.1
Wrist
NOS
NOS (carcinoma, melanoma, nevus)
NOS (sarcoma, lipoma)
bone
connective tissue
fibrous tissue
joint
skin
soft tissue
subcutaneous tissue
tendon
tendon sheath
X
9424/3
8830/0
-----------------------------
Y
9071/3
9071/3
Z
C21.2
C02.8
C75.5
C41.0
Zone, cloacogenic
Zone, junctional of tongue
Zuckerkandl organ
Zygomatic bone
216
ICDO.indb 216
11/18/13 1:55 PM
Code
Term
8005/0
8005/3
8013/3
8014/3
8015/3
8035/3
8046/3
8078/3
8083/3
8084/3
8097/3
8098/3
8103/0
8131/3
8148/2
8149/0
8156/1
8156/3
8157/1
8157/3
8172/3
8173/3
8174/3
8175/3
8204/0
8212/0
8213/0
8214/3
8215/3
8242/1
Code
8242/3
8249/3
8252/3
8253/3
8254/3
8255/3
8264/0
8272/0
8272/3
8316/3
8317/3
8318/3
8319/3
8325/0
8335/3
8336/0
8337/3
8341/3
8342/3
8343/3
8344/3
8346/3
Term
ECL cell carcinoid, NOS
Enterochromaffin-like cell tumor, malignant
ECL cell carcinoid, malignant
Atypical carcinoid tumor
Bronchiolo-alveolar carcinoma, non-mucinous
(C34._)
Bronchiolo-alveolar carcinoma, Clara cell (C34._)
Bronchiolo-alveolar carcinoma, type II pneumocyte (C34._)
Bronchiolo-alveolar carcinoma, mucinous
(C34._)
Bronchiolo-alveolar carcinoma, goblet cell type
(C34._)
Bronchiolo-alveolar carcinoma, mixed mucinous
and non-mucinous (C34._)
Bronchiolo-alveolar carcinoma, Clara cell and
goblet cell type (C34._)
Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type (C34._)
Bronchiolo-alveolar carcinoma, indeterminate
type (C34._)
Adenocarcinoma with mixed subtypes
Adenocarcinoma combined with other types of
carcinoma
Papillomatosis, glandular
Biliary papillomatosis (C22.1, C24.0)
Pituitary adenoma, NOS (C75.1)
Pituitary carcinoma, NOS (C75.1)
Cyst-associated renal cell carcinoma (C64.9)
Renal cell carcinoma, chromophobe cell (C64.9)
Chromophobe cell renal carcinoma (C64.9)
Renal cell carcinoma, sarcomatoid (C64.9)
Renal cell carcinoma, spindle cell (C64.9)
Collecting duct carcinoma (C64.9)
Bellini duct carcinoma (C64.9)
Renal carcinoma, collecting duct type (C64.9)
Metanephric adenoma (C64.9)
Follicular carcinoma, minimally invasive (C73.9)
Follicular carcinoma, encapsulated (C73.9)
Hyalinizing trabecular adenoma (C73.9)
Insular carcinoma (C73.9)
Papillary microcarcinoma (C73.9)
Papillary carcinoma, oxyphilic cell (C73.9)
Papillary carcinoma, encapsulated (C73.9)
Papillary carcinoma, columnar cell (C73.9)
Papillary carcinoma, tall cell (C73.9)
Mixed medullary-follicular carcinoma (C73.9)
continues ...
217
ICDO.indb 217
11/18/13 1:55 PM
... continued
Code
Term
Code
Term
8347/3
8382/3
8383/3
8581/1
8384/3
8391/0
8392/0
8409/3
8413/3
8443/0
8444/1
8453/0
8453/1
8453/2
8453/3
8454/0
8463/1
8482/3
8507/2
8508/3
8513/3
8514/3
8523/3
8524/3
8525/3
8551/3
8574/3
8575/3
8576/3
8581/3
8582/1
8582/3
8583/1
8583/3
8584/1
8584/3
8585/1
8585/3
8586/3
8587/0
8588/3
8591/1
8592/1
8593/1
8633/1
8634/1
continues ...
218
ICDO.indb 218
11/18/13 1:55 PM
... continued
Code
Term
Code
Term
8634/3
8959/1
8642/1
8728/0
8728/1
8728/3
8746/3
8762/1
8805/3
8806/3
8815/0
8815/3
8825/0
8825/1
8826/0
8827/1
8831/0
8834/1
8835/1
8836/1
8842/0
8862/0
8898/1
8905/0
8912/3
8921/3
8934/3
8935/1
8935/3
8936/0
8936/1
8936/3
8959/0
8959/3
8965/0
8966/0
8967/0
8973/3
8974/1
8983/0
9065/3
9105/3
9135/1
9136/1
9186/3
9187/3
9193/3
9194/3
9195/3
9242/3
9243/3
9252/0
9252/3
9341/1
9342/3
9351/1
9352/1
9365/3
9371/3
9372/3
9373/0
9412/1
9413/0
9444/1
9474/3
continues ...
219
ICDO.indb 219
11/18/13 1:55 PM
... continued
Code
Term
Code
Term
9493/0
9751/1
9508/3
9513/3
9514/1
9571/0
9571/3
9582/0
9596/3
9651/3
9678/3
9679/3
9689/3
9699/3
9708/3
9716/3
9717/3
9718/3
9719/3
9727/3
9728/3
9729/3
9752/1
9753/1
9754/3
9755/3
9756/3
9757/3
9758/3
9769/1
9805/3
9831/1
9833/3
9834/3
9835/3
9836/3
9837/3
continues ...
220
ICDO.indb 220
11/18/13 1:55 PM
... continued
Code
9871/3**
9872/3**
9873/3**
9874/3**
9875/3
9876/3
9895/3
9896/3
9897/3
9920/3
9945/3
Term
Pro-T ALL
Pre-T ALL
Cortical T ALL
Mature T ALL
Acute myeloid leukemia with abnormal marrow
eosinophils (includes all variants)
Acute myeloid leukemia, inv(16)(p13;q22)
Acute myeloid leukemia, t(16;16)(p13;q11)
Acute myeloid leukemia, CBF-beta/MYH11
Acute myelomonocytic leukemia with abnormal
eosinophils
FAB M4Eo
Acute myeloid leukemia, minimal differentiation
FAB M0
Acute myeloid leukemia without maturation
FAB M1
Acute myeloid leukemia with maturation
FAB M2, NOS
Chronic myelogenous leukemia, BCR/ABL
positive
Chronic myelogenous leukemia, Philadelphia
chromosome (Ph1) positive
Chronic myelogenous leukemia, t(9;22)(q34;q11)
Chronic granulocytic leukemia, Philadelphia
chromosome (Ph1) positive
Chronic granulocytic leukemia, t(9;22)(q34;q11)
Chronic granulocytic leukemia, BCR/ABL
Atypical chronic myeloid leukemia, BCR/ABL
negative
Atypical chronic myeloid leukemia, Philadelphia
chromosome (Ph1) negative
Acute myeloid leukemia with multilineage
dysplasia (see also M-9984/3)
Acute myeloid leukemia with prior myelodysplastic syndrome
Acute myeloid leukemia without prior myelodysplastic syndrome
Acute myeloid leukemia, t(8;21) (q22;q22)
Acute myeloid leukemia, AML1(CBF-alpha)/ETO
FAB M2, t(8;21)(q22;q22)
FAB M2, AML1(CBF-alpha)/ETO
Acute myeloid leukemia, 11q23 abnormalities
Acute myeloid leukemia, MLL
Therapy-related acute myeloid leukemia and
myelodysplastic syndrome, NOS
Therapy-related acute myeloid leukemia, alkylating agent related
Therapy-related acute myeloid leukemia,
epipodophyllotoxin-related
Chronic myelomonocytic leukemia, Type I
Chronic myelomonocytic leukemia, Type II
Code
9946/3
9948/3
9963/3
9964/3
9985/3
9986/3
9987/3
Term
Chronic myelomonocytic leukemia in transformation [obs]
Juvenile myelomonocytic leukemia
Juvenile chronic myelomonocytic leukemia
Aggressive NK-cell leukemia
Chronic neutrophilic leukemia
Hypereosinophilic syndrome
Chronic eosinophilic leukemia
Refractory cytopenia with multilineage dysplasia
Myelodysplastic syndrome with 5q deletion
(5q) syndrome
Therapy-related myelodysplastic syndrome, NOS
Therapy-related myelodysplastic syndrome,
alkylating agent related
Therapy-related myelodysplastic syndrome,
epidopophyllotoxin-related
221
ICDO.indb 221
11/18/13 1:55 PM
Term
Code
Term
8000/1
8033/3
8040/0
8040/1
8041/3
8045/3
8121/1
8051/3
8052/2
8053/0
8060/0
8074/3
8075/3
8077/2
8082/3
8091/3
8092/3
8093/3
8102/3
8110/0
8110/3
8120/1
8120/2
8121/0
8121/3
8122/3
8130/1
8130/2
8130/3
8140/1
8150/0
8150/1
8152/1
8153/1
8153/3
8154/3
8155/3
8201/2
8201/3
8230/2
8230/3
8240/1
8240/3
8241/3
8244/3
8245/1
8152/1
8247/3
8260/0
8260/3
8263/3
8290/0
8290/3
continues ...
222
ICDO.indb 222
11/18/13 1:55 PM
... continued
Code
Term
Code
Term
8313/1
8501/2
8313/3
8330/1
8333/3
8350/3
8372/0
8380/1
8401/0
8402/3
8403/3
8404/0
8405/0
8406/0
8407/3
8408/1
8408/3
8410/0
8441/0
8441/3
8442/1
8452/1
8452/3
8460/3
8461/3
8462/1
8470/1
8470/2
8472/1
8480/3
8500/2
8503/2
8503/3
8520/2
8522/3
8560/0
8620/1
8620/3
8631/0
8631/1
8631/3
8641/0
8670/0
8670/3
8680/0
8690/1
8691/1
8700/0
8700/3
8711/3
8726/0
8745/3
8761/0
8761/1
8761/3
8770/0
8810/1
8824/1
8830/0
8832/0
8841/1
8850/1
8851/3
8857/3
8890/0
8893/0
continues ...
223
ICDO.indb 223
11/18/13 1:55 PM
... continued
Code
Term
Code
Term
8897/1
9161/0
9174/1
9185/3
9221/3
9270/3
9271/0
9274/0
9290/3
8901/3
8902/3
8905/0
8910/3
8930/3
8931/3
8932/0
8940/3
8963/3
8982/0
8982/3
9014/1
9014/3
9015/1
9015/3
9020/1
9041/3
9051/3
9052/0
9055/0
9062/3
9064/2
9071/3
9080/3
9084/3
9085/3
9110/1
9130/1
9160/0
9362/3
9364/3
9382/3
9383/1
9390/1
9390/3
9391/3
9400/3
9423/3
9442/1
9470/3
9471/3
9473/3
9500/3
9501/0
9501/3
9502/0
9505/3
9506/1
9510/0
9521/3
9530/0
continues ...
224
ICDO.indb 224
11/18/13 1:55 PM
... continued
Code
Term
Code
Term
9530/3
9538/1
Meningioma, anaplastic
Clear cell meningioma
Chordoid meningioma
Rhabdoid meningioma
Atypical meningioma
Malignant peripheral nerve sheath tumor
MPNST, NOS
MPNST with glandular differentiation
Epithelioid MPNST
MPNST with mesenchymal differentiation
Melanotic MPNST
Melanotic psammomatous MPNST
Melanotic schwannoma
Plexiform schwannoma
Cellular schwannoma
Degenerated schwannoma
Ancient schwannoma
Psammomatous schwannoma
Malignant peripheral nerve sheath tumor with
rhabdomyoblastic differentiation
MPNST with rhabdomyoblastic differentiation
B cell lymphoma, NOS
Classical Hodgkin lymphoma, mixed cellularity,
NOS
Classical Hodgkin lymphoma, lymphocyte depletion, NOS
Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
Classical Hodgkin lymphoma, lymphocyte depletion, reticular
Classical Hodgkin lymphoma, nodular sclerosis,
NOS
Classical Hodgkin lymphoma, nodular sclerosis,
cellular phase
Hodgkin lymphoma, nodular sclerosis, grade 1
Classical Hodgkin lymphoma, nodular sclerosis,
grade 1
Hodgkin lymphoma, nodular sclerosis, grade 2
Classical Hodgkin lymphoma, nodular sclerosis,
grade 2
Malignant lymphoma, small B lymphocytic, NOS
(see also M-9823/3)
Malignant lymphoma, small lymphocytic, NOS
Malignant lymphoma, small cell diffuse
Mantle cell lymphoma
Malignant lymphoma, large B-cell, diffuse,
centroblastic, NOS
Intravascular large B-cell lymphoma (C49.9)
Intravascular B-cell lymphoma
Angiotropic lymphoma
T-cell rich large B-cell lymphoma
Histiocyte-rich large B-cell lymphoma
T-cell rich/histiocyte-rich large B-cell lymphoma
Anaplastic large B-cell lymphoma
9684/3
9538/3
9539/1
9540/3
9560/0
9561/3
9591/3
9652/3
9653/3
9654/3
9655/3
9663/3
9664/3
9665/3
9667/3
9670/3
9673/3
9680/3
9687/3
9690/3
9691/3
9695/3
9698/3
9700/3
9702/3
9709/3
9714/3
9731/3
9762/3
9765/1
9801/3
9823/3
9826/3
9827/3
9840/3
9860/3
9861/3
9866/3
9867/3
continues ...
225
ICDO.indb 225
11/18/13 1:55 PM
... continued
Code
Term
9870/3
9891/3
9910/3
9930/3
9931/3
9940/3
9950/3
9961/3
9982/3
9983/3
9984/3
226
ICDO.indb 226
11/18/13 1:55 PM
ICD-O, third
edition
8240/1
8240/1
8402/0
8409/0
8345/3
8345/3
8345/3
8586/3
9160/0
9160/0
9365/3
8831/0
8824/0
8935/3
9125/0
9192/3
9192/3
9193/3
9421/1
9423/3
9441/3
9492/0
9150/1
9591/3
9591/3
9591/3
9591/3
9591/3
9591/3
9590/3
9591/3
9651/3
9651/3
9651/3
9659/3
9659/3
9665/3
9591/3
9591/3
9591/3
9591/3
9673/3
9675/3
9675/3
9673/3
9680/3
9680/3
continues ...
227
ICDO.indb 227
11/18/13 1:55 PM
... continued
ICD-O, second
edition
9681/3
9682/3
9682/3
9682/3
9682/3
9683/3
9683/3
9685/3
9685/3
9685/3
9686/3
9686/3
9686/3
9688/3 *
9692/3
9693/3
9694/3
9696/3
9697/3
9703/3
9704/3
9704/3
9706/3
9707/3
9710/3 *
9711/3
9712/3
9713/3
9713/3
9688/3 *
9692/3
9693/3
9694/3
9713/3
9713/3
9715/3 *
9715/3 *
9720/3
9720/3
9722/3
9722/3
9722/3
9723/3
9731/3
9763/3
9763/3
9802/3
9803/3
9804/3
ICD-O, third
edition
9680/3
9680/3
9680/3
9680/3
9680/3
9680/3
9680/3
9727/3
9727/3
9727/3
9591/3
9591/3
9591/3
9680/3
9690/3
9698/3
9591/3
9695/3
9698/3
9702/3
9702/3
9702/3
9702/3
9702/3
9699/3
9699/3
9680/3
9719/3
9719/3
9680/3
9690/3
9698/3
9591/3
9719/3
9719/3
9699/3
9699/3
9750/3
9750/3
9754/3
9754/3
9754/3
9755/3
9734/3
9762/3
9762/3
9800/3
9800/3
9800/3
continues ...
228
ICDO.indb 228
11/18/13 1:55 PM
... continued
ICD-O, second
edition
9821/3
9821/3
9713/3
9713/3
9821/3
9821/3
9821/3 **
9822/3
9822/3
9822/3
9824/3
9824/3
9824/3
9825/3
9828/3 **
9828/3 **
9830/3
9830/3
9841/3
9841/3
9841/3
9842/3
9850/3
9862/3
9862/3
9862/3
9864/3
9864/3
9864/3
9868/3
9880/3
9890/3
9892/3
9893/3
9894/3
9900/3
9932/3
9941/3
9960/1
9981/1
ICD-O, third
edition
9835/3
9835/3
9719/3
9719/3
9835/3
9835/3
9835/3
9820/3
9820/3
9820/3
9820/3
9820/3
9820/3
9832/3
9835/3
9835/3
9733/3
9733/3
9840/3
9840/3
9840/3
9950/3
9820/3
9860/3
9860/3
9860/3
9860/3
9860/3
9860/3
9945/3
9860/3
9860/3
9860/3
9860/3
9860/3
9742/3
9931/3
9940/3
9975/1
9980/3
229
ICDO.indb 229
11/18/13 1:55 PM
Reticulohistiocytoma
Lymphomatoid papulosis (C44._)
Giant cell tumor of tendon sheath
Histiocytosis X, NOS
Eosinophilic granuloma
Hand-Schuller-Christian disease
8092/3
8152/0
8332/3
8810/0
8851/0
8851/0
9053/0
9190/3
9190/3
9382/3
9531/0
9560/0
9722/3
230
ICDO.indb 230
11/18/13 1:55 PM
8442/3
8442/3
8451/3
8462/3
8462/3
8462/3
8462/3
8472/3
8472/3
8472/3
8472/3
8473/3
8473/3
8473/3
9421/3
9421/3
9421/3
9422/3
8931/3
8931/3
8931/3
8931/3
8931/3
9393/3
9538/3
9950/3
9950/3
9960/3
9960/3
9961/3
9961/3
9961/3
9962/3
9962/3
9962/3
9962/3
9980/3
9980/3
9982/3
9982/3
9983/3
9984/3
9989/3
9989/3
9989/3
8442/1
8442/1
8451/1
8462/1
8462/1
8462/1
8462/1
8472/1
8472/1
8472/1
8472/1
8473/1
8473/1
8473/1
9421/1
9421/1
9421/1
9421/1
continues ...
231
ICDO.indb 231
11/18/13 1:55 PM
... continued
ICD-O, second edition
8120/0
8152/0
8580/0
8640/0
8640/0
8640/0
8640/0
8640/0
9506/0
8120/1
8152/1
8580/1
8640/1
8640/1
8640/1
8640/1
8640/1
9506/1
8261/1
8261/1
8361/1
8361/1
8823/1
9080/1
8261/0
8261/0
8361/0
8361/0
8823/0
9080/0
232
ICDO.indb 232
11/18/13 1:55 PM
ICD-O-3
Morphology Code
Term
8077/0
8077/0
8077/0
8077/0
8077/0
8077/0
8077/2
8077/2
8077/2
8148/0
8148/0
8148/0
8148/0
8148/0
8148/2
8148/2
8148/2
8148/2
8148/2
8148/2
8148/2
8148/2
New synonym
8148/2
8150/0
8150/0
8150/0
Action
continues ...
233
ICDO.indb 233
11/18/13 1:55 PM
... continued
Status
ICD-O-3
Morphology Code
8150/1
8150/1
8150/3
8150/3
8150/3
8152/1
8152/1
8152/1
8152/1
8152/1
8152/3
Enteroglucagonoma, malignant
8154/3
8154/3
8154/3
8154/3
8158/1
8158/1
8163/0
8163/0
New synonym
8163/0
8163/2
New synonym
8163/2
New synonym
8163/2
8163/3
8163/3
8201/3
8201/3
8213/0
8213/0
8213/0
8213/0
Term
Action
Was 8157/3
continues ...
234
ICDO.indb 234
11/18/13 1:55 PM
Appendix 7: New codes, preferred terms, related terms, and synonyms in this ICD-O, third edition, first revision
... continued
Status
ICD-O-3
Morphology Code
Term
New term
8213/3
Serrated adenocarcinoma
Behavior code
change
Behavior code
change
8240/1
8240/1
Wording change
8240/3
Wording change
8240/3
Carcinoid, NOS
8240/3
8240/3
8240/3
8244/3
8244/3
8244/3
8244/3
New synonym
New related term
8249/3
8249/3
New synonym
8263/0
8265/3
8290/0
8453/0
New synonym
8453/0
8453/0
New synonym
8453/0
8453/0
8453/2
8453/3
8470/0
8470/0
8470/0
Action
Delete (except of
appendix M-8240/1)
Delete (except of
appendix M-8240/1)
Tubulo-papillary adenoma
Was 8453/1
continues ...
235
ICDO.indb 235
11/18/13 1:55 PM
... continued
Status
ICD-O-3
Morphology Code
Term
8470/0
8470/0
8470/0
8470/0
8470/2
8470/2
New synonym
8470/2
8470/3
New synonym
8470/3
8480/1
8490/3
8503/0
8503/0
New synonym
8503/0
8503/0
New synonym
8503/0
New synonym
8503/0
8503/0
8503/2
New synonym
8503/2
New synonym
8503/2
New synonym
New synonym
8503/2
8503/2
New synonym
8503/2
New synonym
8503/2
8503/2
Action
Was 8470/1
continues ...
236
ICDO.indb 236
11/18/13 1:55 PM
Appendix 7: New codes, preferred terms, related terms, and synonyms in this ICD-O, third edition, first revision
... continued
Status
ICD-O-3
Morphology Code
Term
8503/3
8503/3
8552/3
8811/0
Plexiform fibromyxoma
8970/3
8970/3
8975/1
9395/3
9425/3
Pilomyxoid astrocytoma
9431/1
Angiocentric glioma
9432/1
Pituicytoma
9471/3
9474/3
Anaplastic medulloblastoma
9506/1
Extraventricular neurocytoma
9509/1
9509/1
9591/3
9591/3
9591/3
9596/3
9597/3
9680/3
9680/3
9680/3
9680/3
9680/3
Action
continues ...
237
ICDO.indb 237
11/18/13 1:55 PM
... continued
Status
ICD-O-3
Morphology Code
Term
Code restored
9688/3
New synonym
New synonym
9698/3
9698/3
New synonym of
Mucosal associated
lymphoid tissue
lymphoma
9699/3
9702/3
9709/3
9709/3
Code restored
9712/3
9714/3
9716/3
9716/3
New synonym
9719/3
9724/3
9725/3
9726/3
9727/3
9727/3
New synonym
9734/3
9735/3
Plasmablastic lymphoma
9737/3
9738/3
9740/1
9740/1
9740/1
9740/1
9740/1
Cutaneous mastocytosis
Urticaria pigmentosa
Diffuse cutaneous mastocytosis
Solitary mastocytoma of skin
Extracutaneous mastocytoma
Action
Was 9688/3 in ICD-O-2
Extraosseous plasmacytoma
Was 9684/3
continues ...
238
ICDO.indb 238
11/18/13 1:55 PM
Appendix 7: New codes, preferred terms, related terms, and synonyms in this ICD-O, third edition, first revision
... continued
Status
ICD-O-3
Morphology Code
Term
9741/1
9741/3
9741/3
9741/3
Notes added
Notes added
Note added
9751/1
9751/1
9751/1
Behavior code
change
9751/3
Notes added
9752/1
Notes added
Notes added
9752/1
9752/1
Notes added
9753/1
Notes added
9753/1
Note added
9753/1
Notes added
9754/3
Notes added
Notes added
Notes added
Note added
9754/3
9754/3
9754/3
9754/3
9757/3
9759/3
Wording correction
9766/1
Lymphomatoid granulomatosis
9806/3
9808/3
9809/3
ICD-O Header
revision
981-983
Action
Formerly lymphoid
granulomatosis
continues ...
239
ICDO.indb 239
11/18/13 1:55 PM
... continued
Status
ICD-O-3
Morphology Code
Term
9811/3
9812/3
9814/3
9815/3
9816/3
9817/3
9818/3
Behavior code
change
New related term
9831/3
9831/3
9837/3
T lymphoblastic leukemia/lymphoma
9861/3
9861/3
9865/3
9869/3
9891/3
9895/3
Move to synonym
9895/3
New synonym
9896/3
New synonym
9897/3
9898/1
9898/3
Action
Was 9831/1
continues ...
240
ICDO.indb 240
11/18/13 1:55 PM
Appendix 7: New codes, preferred terms, related terms, and synonyms in this ICD-O, third edition, first revision
... continued
Status
ICD-O-3
Morphology Code
Term
9911/3
9920/3
9920/3
9960/3
9960/3
9960/3
9961/3
9961/3
9964/3
9964/3
9965/3
Primary myelofibrosis
Myelosclerosis with myeloid metaplasia
Chronic eosinophilic leukemia, NOS
Hypereosinophilic syndrome
Myeloid and lymphoid neoplasms with PDGFRA
rearrangement
9966/3
9967/3
9971/1
9971/1
9971/3
9975/3
9975/3
New synonym
9982/3
New synonym
9985/3
New synonym
9986/3
New synonym
9989/3
9991/3
Refractory neutropenia
9992/3
9985/3
Refractory thrombocytopenia
Refractory cytopenia of childhood
Action
241
ICDO.indb 241
11/18/13 1:55 PM
Former code
Term
Action
Code deleted
8157/1
Enteroglucagonoma, NOS
Code deleted
8157/3
Enteroglucagonoma, malignant
Code deleted
8453/1
Code deleted
8470/1
9680/3
Code deleted
9684/3
Plasmablastic lymphoma
Code deleted
9975/1
Former code
8240/1
8240/1
Term
Action
Wording change
Status
Former code
Term
Action
9680/3
Wording correction
9766/1
Lymphomatoid granulomatosis
Formerly lymphoid
granulomatosis
242
ICDO.indb 242
11/18/13 1:55 PM
ICD - O
International
Classification of
Diseases for
Oncology
Third Edition
First Revision
11/21/13 11:55 AM